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Abstract
Thyroid disease, a chronic illness, affects nearly 200 million people worldwide and is
more common among women than in men. Numerous factors make diagnosing and
treating thyroid disease in women challenging. The standard blood test for diagnosing
thyroid disease and determining treatment effectiveness is inconsistent in its accuracy.
Many women with thyroid disease are misdiagnosed or struggle with symptoms even
once receiving treatment. Although thyroid disease is highly prevalent among women and
the doctor-patient relationship is known to influence treatment outcomes, there is a gap in
the literature regarding the treatment experiences of women with thyroid disease and the
doctor-patient relationship. The purpose of this phenomenological study was to explore
female thyroid patients’ experiences of treatment and the doctor-patient relationship.
Sixteen female thyroid patients, ages 18 and older and members of an international online
support group, were individually interviewed via online chat. Data interpretation was
guided by social constructionism and feminist theory and was accomplished via
Moustakas’s analytic method. Themes related to the doctor-patient relationship were
identified, including the culture of the medical profession, diagnostic bias, and gender
differences in communication. Emergent themes included patient education level, patient
self-advocacy behaviors, and the use of natural thyroid medication. The results of this
study may contribute to positive social change by enhancing doctors’ understanding of
thyroid disease in women and the influence of the doctor-patient relationship in
determining positive treatment outcomes, thus equipping doctors with enriched
knowledge for providing their female thyroid patients with the highest quality of care.
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Chapter 1: Introduction to the Study
Introduction
Approximately 200 million people worldwide have been diagnosed with thyroid
disease, a chronic illness (Rajoria et al., 2010). According to the American Association of
Clinical Endocrinologists (AACE, 2013), approximately 30 million Americans are
affected by thyroid disease, although more than half remain undiagnosed. Across
cultures, the prevalence of thyroid disease is much higher among women than among
men (Canaris, Manowitz, Mayor, & Ridgway, 2000; Cassidy, Ahearn, & Carroll, 2002).
In fact, women have an estimated 1 in 7 chance of developing thyroid disease (Godfrey,
2007).
A number of factors make proper diagnosis and treatment of thyroid disease
challenging. For example, according to Adams (2008) and Dayan (2001), the most
commonly used blood test (thyroid stimulating hormone [TSH]) for diagnosing thyroid
disease can produce misleading results. More specifically, although use of all three main
thyroid function tests (TSH, free T3, free T4) produces the most thorough analysis of
thyroid function, the TSH test tends to be used alone (Dayan, 2001). Because of this,
clinically important diagnoses (e.g., hyperthyroidism, hypothyroidism) are sometimes
missed. In addition, as thyroid dysfunction produces symptoms similar to those of other
disorders (e.g., depression, menopause), thyroid disease is often misdiagnosed and left
untreated (Canaris et al., 2000; Godfrey, 2007; Simmons, 2010). Likewise, as the TSH
test tends to be used alone to determine treatment effectiveness, many women with
thyroid disease continue to experience symptoms even when they are receiving treatment
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(Bunevicius & Prange, 2006). In the face of such challenges, a doctor-patient relationship
based on mutual trust and collaboration helps to ensure positive treatment outcomes
(Houle, Harwood, Watkins, & Baum, 2007; Munch, 2004). In addition, effective
communication between doctors and patients is critical in both the diagnosis and
management of thyroid disease (Shimabukuro, 2008; Simmons, 2010). However, the
culture of the medical profession, diagnostic bias, and gender differences in
communication may interfere with doctor-patient discourse (Cheney & Ashcraft, 2007;
Hamberg, Risberg, & Johansson, 2004; Hoffmann & Tarzian, 2001; Kaiser, 2002;
Munch, 2004). An exploration of women’s experiences in the treatment of thyroid
disease, especially relative to these three points, may contribute to better understanding
on the part of doctors and thus more effective doctor-patient communication and
relationships.
Despite the pervasiveness of thyroid disease in women and the importance of the
doctor-patient relationship in positive treatment outcomes, there is a gap in the literature
regarding the treatment experiences of women diagnosed with thyroid disease,
particularly regarding the doctor-patient relationship. Therefore, the purpose of this
phenomenological study was to explore female thyroid patients’ experiences of treatment
and the doctor-patient relationship.
The phenomenological research approach was used, as it is designed to examine
the meaning of experiences about a particular phenomenon (e.g., thyroid disease) across
several individuals who have experienced it (Creswell, 2007). The theoretical
perspectives used to guide data interpretation included feminism and social
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constructivism. More specifically, the following issues were addressed in regard to their
relationship with women’s treatment experiences: (a) the culture of the medical
profession (see Kaiser, 2002; Thomas, 2001), (b) diagnostic bias (see Hamberg et al.,
2004; Hoffmann & Tarzian, 2001; Munch, 2004), and (c) gender differences in
communication (see Cheney & Ashcraft, 2007; Tannen, 2007).
The following paragraphs provide a review of the literature relevant to the study,
followed by the problem statement, the purpose and nature of the study, research
questions, conceptual framework, definition of terms, assumptions and limitations, and
the significance of the study.
Background of the Study
The incidence of thyroid disease is higher than previously thought (Canaris et al.,
2000), affecting an estimated 30 million Americans (AACE, 2013) and 200 million
people worldwide (Rajoria et al., 2010). Of the 30 million Americans with thyroid
disease, more than 15 million remain undiagnosed (AACE, 2013). Across cultures, the
prevalence of thyroid disease is much higher in women than men (Canaris et al., 2000;
Cassidy et al., 2002). Approximately 1 out of every 7 women develops thyroid disease,
and its prevalence increases with age (about 20% in women over age 60; Godfrey, 2007).
The two predominant conditions resulting from thyroid disease are hyperthyroidism and
hypothyroidism, with Grave’s disease and Hashimoto’s disease, respectively, as the most
common causes (Zeitlin et al., 2008). Both conditions cause a wide range of somatic and
psychiatric symptoms.
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Hyperthyroidism
Hyperthyroidism is the result of excessive thyroid hormone production (AACE,
2002) and is frequently associated with anxiety, panic, and phobias (Aslan et al., 2005).
In the United States, the most common cause of hyperthyroidism is Grave’s disease, an
autoimmune form of thyroid disease (Bunevicius & Prange, 2006). Individuals with
hyperthyroidism experience heat intolerance, hot flashes, absent menses, insomnia,
decreased libido (Godfrey, 2007), rapid heartbeat, sweating, and tremors (Aslan et al.,
2005) and may present with diffuse goiter and ophthalmological abnormalities (Ginsberg,
2003).
Hypothyroidism
Hypothyroidism results from the undersecretion of thyroid hormones from the
thyroid gland (AACE, 2002) and is frequently associated with depressive disorders
(Aslan et al., 2005). In the United States, the most common cause of hypothyroidism is
Hashimoto’s disease, an autoimmune form of thyroid disease (Erdal et al., 2008).
Individuals with hypothyroidism experience fatigue (Bono, Fancellu, Blandini, Santoro,
& Mauri, 2004), lethargy, apathy, difficulty concentrating (Aslan et al., 2005), weight
gain, dry skin, and decreased libido (Godfrey, 2007). In extreme cases, the individual
may experience slowing of thought processes, progressive cognitive impairment,
hallucinations, and delusions (Bono et al., 2004).
Diagnosis
The TSH blood test is the most commonly used test in the initial screening for
thyroid disease (Dayan, 2001) and is considered the “gold standard” for determining
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thyroid dysfunction (Adams, 2008, p. 1). However, as the use of all three main thyroid
function tests (TSH, free T3, free T4) produces the most thorough analysis of thyroid
function, the effectiveness of the TSH test alone has been debated by endocrinology
experts (Adams, 2008; Beckett, & MacKenzie, 2007). Furthermore, abnormalities in
thyroid function present with symptoms similar to those of other disorders and can be
mistaken for other conditions (Canaris et al., 2000; Godfrey, 2007; Simmons, 2010). For
example, hyperthyroidism and hypothyroidism are frequently misdiagnosed as anxiety
and depressive disorders, respectively (Aslan et al., 2005; Godfrey, 2007). Postpartum
thyroiditis, which affects more than 8% of women, is sometimes mistaken for depression
(Fassier et al., 2011). In older patients, symptoms of hyperthyroidism and
hypothyroidism often lead to inaccurate diagnoses of menopause or dementia (Godfrey,
2007; Shimabukuro, 2008). Thus, it is vital that physicians conduct a thorough
assessment of their patients, including an ongoing discussion of symptoms, to ensure
proper diagnosis and treatment.
Treatment
Hyperthyroidism. Three types of treatments are currently available for
hyperthyroidism: (a) surgical intervention, (b) antithyroid drugs, and (c) radioactive
iodine (AACE, 2002). Thyroidectomy is usually performed only when thyroid cancer is
suspected. Although antithyroid drugs have been used for over 60 years, remission rates
are variable, and relapses are frequent. Radioactive iodine (RAI) is the standard treatment
for hyperthyroidism in the United States. Regardless of the treatment chosen, individuals
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treated for hyperthyroidism become euthyroid, then hypothyroid, and require lifelong
thyroid hormone replacement therapy (AACE, 2002).
Hypothyroidism. An individual with hypothyroidism requires lifelong thyroid
hormone replacement therapy (AACE, 2002). Levothyroxine (T4; brand name Synthroid)
is the most commonly used and is recommended by the AACE. However, some experts
recommend the addition of T3 (liothyronine; name brand Cytomel) due to its
antidepressant effects (Dayan, 2001; Joffe, 2006).
As previously mentioned, proper treatment of thyroid disease is dependent upon
accurate diagnosis. Misdiagnosis of thyroid disease delays treatment and can result in
progressive psychological and physiological problems (Heinrich & Grahm, 2003;
McDermott & Ridgway, 2001) including psychosis (Gaitonde, Rowley, & Sweeney,
2012; Heinrich & Grahm, 2003) and potential heart failure (Hak et al., 2000; Roberts &
Ladenson, 2004). These risks highlight the importance of an effective doctor-patient
relationship in ensuring proper diagnosis and positive treatment outcomes.
The treatment experiences of women with thyroid disease might be best examined
from social constructionist and feminist viewpoints, as both worldviews emphasize
individuals’ experiences in social contexts (Docherty & McColl, 2003; Fernandes,
Papaikonomou, & Nieuwoudt, 2006; Hearn, 2009). From a social constructionist
viewpoint, patients’ interpretations of their illness experience are important in
understanding and treating illness. The feminist viewpoint suggests that female patients’
interpretations of their experiences are influenced by social constructs (e.g., health and
illness; masculine and feminine) related to the body and gender issues (Docherty &
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McColl, 2003). Because social constructs come from patients, physicians, and social
institutions (Hearn, 2009), women’s experiences with thyroid disease diagnosis and
management may be influenced by the culture of the medical profession, diagnostic bias,
and gender differences in communication.
Culture of the Medical Profession
In the Western medical profession, health-care practitioners are taught via the
medical model to base their diagnostic and treatment decisions on “objective evidence”
of disease (e.g., blood tests) and to disregard patients’ subjective experiences of illness
(Hoffmann & Tarzian, 2001). Additionally, as argued by Annandale and Clark (2000),
health has become “marketed as a result of lifestyle choice” (p. 58). In other words, the
patient is totally responsible for his or her condition; if a person is overweight, then he or
she must lack self-control. According to Vanderford, Stein, Sheeler, and Skochelak
(2001), the traditional medical culture has encouraged physicians to behave in a
paternalistic or authoritative manner when faced with differing treatment expectations
from their patients. Traditional doctor-patient relationships are characterized by
authoritarian and paternalistic approaches in which the physician controls the interview,
makes a diagnosis, and chooses the treatment plan without the patient’s input (Ehrenreich
& English, 2005; Vanderford et al., 2001). Research indicates that these types of doctorpatient interactions are related to lowered patient satisfaction and negative treatment
outcomes (Bradley, Sparks, & Nesdale, 2001; Chrisler & Parrett, 1995; Copeland,
Hudson Scholle, & Binko, 2003; Krupat, 1999; Stokes, Dixon-Woods, & Williams,
2006).
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Diagnostic Bias
According to Hoffman and Tarzian (2001), women’s complaints are often not
taken seriously by medical professionals because women are viewed as overly emotional
and likely to exaggerate their symptoms. Research indicates that physicians are more
likely to interpret men’s symptoms as biological and women’s symptoms as
psychosocial—that is, that women’s symptoms are a result of a mental, rather than
physical, illness (Chrisler, 2001; Hamberg et al., 2004; Hoffmann & Tarzian, 2001).
In their study on the treatment experiences of women with chronic pain, Werner
and Malterud (2003) purported that the medical profession encourages a normative,
gendered view of illness, which results in a perceived need for women to work harder in
order to be perceived as credible patients. As a result, female patients can become wary
of honestly communicating their symptoms and the psychosocial effects of those
symptoms (Peters et al., 2008).
Gender Differences in Communication
It has been argued that gender differences in medical treatment can be partially
explained by gender differences in communication. Whereas men tend to describe their
symptoms in a frank and confident manner, women often give generalized descriptions of
their symptoms (Hamberg et al., 2004). In addition, women tend to use contextual or
more subjective information (e.g., impact on personal relationships) in their symptom
reports, while men’s reports tend to be objective descriptions of physical symptoms
(Hoffmann & Tarzian, 2001). Although these generalizations do not apply to all men and
women, variations in communication patterns across genders have the potential to
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influence how physicians and patients interact (Hamberg et al., 2004; Platt, 2008;
Sandhu, Adams, Singleton, Clark-Carter, & Kidd, 2009).
With regard to conversation during medical consultations, evidence suggests that
there is a significant disparity between the communication styles preferred by patients
and those preferred by physicians. Platt (2008) reported some of this evidence, noting
that doctors commonly complain about verbose patients who tell long stories when
doctors ask questions. Additionally, Platt noted that doctors use their authority to
encourage patients to communicate in the doctors’ preferred styles. Doctor-patient
relationships are affected by communication, and gender differences in communication
styles could amplify these effects.
In summary, an effective doctor-patient relationship helps to ensure proper
diagnosis and positive treatment outcomes (Copeland et al., 2003; Houle et al., 2007;
Munch, 2004). An ineffective doctor-patient relationship, on the other hand, has the
potential to result in misdiagnosis, delayed or inappropriate medical treatment, and
termination of the doctor-patient relationship (Chrisler & Parrett, 1995; Copeland et al.,
2003; Houle et al., 2007; Stokes et al., 2006). The nature of the doctor-patient
relationship, and hence women’s treatment experiences related to thyroid disease, may be
influenced by the culture of the medical profession, diagnostic bias, and gender
differences in communication. Additional influential factors include sexism in healthcare,
the medical education system, and economics, all of which are discussed in detail in
Chapter 2.
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Problem Statement
Thyroid disease affects approximately 1 out of every 7 women, and its prevalence
increases with age (Godfrey, 2007). When properly diagnosed and treated, individuals
with thyroid disease should return to normal endocrine function and experience a
reduction in psychological and physiological symptoms (AACE, 2002; Bono et al., 2004;
Constant et al., 2006). However, due to factors that can make proper diagnosis and
treatment challenging (e.g., symptoms resemble other disorders, TSH blood test used
alone), women with thyroid disease are often misdiagnosed and receive ineffective
medical treatment (Canaris et al., 2000; Dayan, 2001; Godfrey, 2007), which can lead to
chronic and worsening health problems (Cappola & Cooper, 2015; Gaitonde et al., 2012;
Hak et al., 2000; Heinrich & Grahm, 2003; McDermott & Ridgway, 2001; Roberts &
Ladenson, 2004).
The nature of the doctor-patient relationship has the potential to determine
positive or negative treatment outcomes (Chrisler & Parrett, 1995; Copeland et al., 2003;
Stokes et al., 2006). Numerous studies have been conducted about the influence of the
doctor-patient relationship on the treatment outcomes of chronic illness (see Auerbach et
al., 2002; Copeland et al., 2003; Docherty & McColl, 2003; Hamberg et al., 2004; Houle
et al., 2007; Kralik, Koch, Price, & Howard, 2004; Kralik, Telford, Price, & Koch, 2005;
Krupat, Yeager, & Putnam, 2000; Roter, Hall, & Aoki, 2002; Street, Gordon, & Haidet,
2007; Werner & Malterud, 2005; Zandbelt, Smets, Oort, Godfried, & de Haes, 2006).
However, there exist no studies in this area related to women with thyroid disease
specifically, and even in studies that mention chronic illness generally, thyroid disease is
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rarely mentioned. Likewise, although studies have suggested that physician and patient
gender influences diagnosis and treatment decisions (Di Caccavo & Reid, 1998; Hamberg
et al., 2004; Platt, 2008; Sandhu et al., 2009), no such studies have been conducted with
female thyroid patients. Despite the pervasiveness of thyroid disease in women and the
importance of the doctor-patient relationship in positive treatment outcomes, there is a
gap in the literature regarding the treatment experiences of women diagnosed with
thyroid disease, particularly regarding the doctor-patient relationship. Exploring the
treatment experiences of women with thyroid disease and how the doctor-patient
relationship affects their treatment experiences is imperative for better determining the
needs of female thyroid patients, and therefore for more accurately diagnosing and
effectively treating this debilitating and potentially life-threatening disease.
Purpose of the Study
Exploration of the disease experience among people with thyroid disease is vital
for understanding how individuals cope with their chronic illness, thus increasing the
potential for the attainment of adequate treatment (Thomas, 2001). Understanding and
constructing meaning for chronic illness may be particularly important for women
because issues related to the body are instrumental in the formation of female selfidentity (Fernandes et al., 2006) and treatment experiences may differ by gender
(Hamberg et al., 2004; Hoffmann & Tarzian, 2001; Miaskowski, 1999). In addition, the
quality of care that patients receive is directly related to the nature of the doctor-patient
relationship (Chrisler & Parrett, 1995; Dugdale, Seigler, & Rubin, 2008; Houle et al.,
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2007). Therefore, the purpose of this phenomenological study was to explore female
thyroid patients’ experiences of treatment and the doctor-patient relationship.
Nature of the Study
This study used the phenomenological research approach because it examines the
meaning of experiences about a particular phenomenon (e.g., thyroid disease) across
several individuals who have experienced the phenomenon (Creswell, 2007). The
research questions in this study were best addressed via qualitative methodology because
the purpose of this study was to explore the treatment experiences of women with thyroid
disease. According to Marshall and Rossman (2006), human behavior cannot be fully
understood without knowledge of the framework within which people interpret their
thoughts, feelings, and actions (p. 53). Thus, the use of open-ended questions in each
interview was an appropriate method for capturing the experience of the phenomenon
(Creswell, 2007).
Using an interview guide sheet (see Appendix A) I created, data were obtained
from 16 female members (including myself) of The Thyroid Support Group, an
international online support group for individuals with thyroid disorders, via interviews
using X-IM, an encrypted online chat program (see http://www.x-im.net/). The
recommended sample size of a minimum of 10 participants for phenomenological
research corresponds to the traditional quantitative research designs based on statistical
power analyses conducted by Onwuegbuzie and Johnson (2004). See Chapter 2 for a
discussion of literature related to methodology, including an in-depth discussion of
literature related to data collection methods. The nature and methods of the study,
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including the reliability and validity of the interview guide sheet, are discussed in Chapter
3.
Research Questions
Based upon social constructivism and feminist theory, this study answered the
following research questions: “What are the treatment experiences of women with
thyroid disease?”; “How does the doctor-patient relationship affect their experiences?”;
and “Do their experiences differ based on the doctor’s gender?” These research questions
are coded as RQ1, RQ2, and RQ3, respectively, and are listed next to their corresponding
interview questions in the interview guide (see Appendix A). The research questions are
discussed in further detail in Chapter 3.
Conceptual Framework
In this study, data interpretation was guided by social constructionism and
feminist theory. Social constructionism and feminism are worldviews that are compatible
with qualitative research approaches because both emphasize individuals’ experiences in
social contexts (Docherty & McColl, 2003; Fernandes et al., 2006; Hearn, 2009).
Whereas social constructionism assigns a general significance to social and cultural
constructs in understanding the illness experience (Findlay, 1993; Docherty & McColl,
2003; Hearn, 2009; Martin & Peterson, 2009), feminist writers make specific arguments
about women’s perceptions of their bodies in light of socio-historical facts (Bohan, 2002;
Cosgrove, 2003; Fernandes et al., 2006; Shields, 2007). The conceptual framework for
the study is discussed in further detail in Chapter 2.
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Definition of Terms
The following terms are used throughout the paper and are defined below for ease
of reading.
Euthyroid: Normal serum TSH (0.4–4.0 mIU/L) regardless of free thyroxine (fT4)
concentration (Walsh et al., 2006). In this state, the individual is considered to have
normal thyroid function (AACE, 2002).
Free thyroxine (fT4): The amount of T4 hormone that is not bound to protein and
is therefore able to enter cells (normal range is 4.5–11.2 mcg/dL; AACE, 2002).
Generally, if the fT4 level is high, the individual is hyperthyroid. In contrast, if the fT4
level is low, the individual is most likely hypothyroid (Aslan et al., 2005).
Free triiodothyronine (fT3): The amount of T3 hormone that is not bound to
protein and is therefore able to enter cells (normal range is 100–200 ng/dL; AACE,
2002). Generally, if the fT3 level is high, the individual is hyperthyroid. In contrast, if
the fT3 level is low, the individual is most likely hypothyroid (Aslan et al., 2005).
Thyroid stimulating hormone (TSH): TSH, also known as thyrotropin, is secreted
from cells in the anterior pituitary and stimulates the thyroid to synthesize and release the
thyroid hormones T3 and T4 (Aslan et al., 2005). The normal range for TSH is 0.4–4.0
mIU/L (AACE, 2002).
Thyroglobulin antibodies (TgAb): Antibodies to thyroglobulin, the precursor in
the synthesis of thyroid hormones. Detection of TgAb indicates Hashimoto’s disease
(Thyrasyvoulides & Lymberi, 2004).
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Thyroperoxidase antibodies (TPOAb): Antibodies to thyroperoxidase, the enzyme
that catalyzes thyroid hormone formation. Detection of TPOAb indicates Hashimoto’s
disease (Thyrasyvoulides & Lymberi, 2004).
Thyroxine: Also known as T4. One of the two main thyroid hormones secreted by
the thyroid gland (Hall, 2010). When used as a medication, T4 is called levothyroxine
(name brand Synthroid™).
Tri-iodothyronine: Also known as T3. One of the two main thyroid hormones
secreted by the thyroid gland (Hall, 2010). When used as a medication, T3 is called
liothyronine (name brand Cytomel™).
TSH receptor antibodies (TRAb): Antibodies to the TSH receptor on the thyroid
follicular cell membrane. Detection of TRAb indicates Grave’s disease (Takamura et al.,
2003).
Assumptions
The assumptions that exist in the study have been made in reference to participant
criteria. The criteria for inclusion in the study were as follows: (a) female, (b) aged 18
years and older, (c) with a diagnosis of thyroid disease, and d) a member of The Thyroid
Support Group. As the study was conducted via the Internet and I did not meet with the
participants face to face, the participants’ ages and gender could not be verified.
Likewise, the participants’ thyroid disease diagnoses were self-reported. These
assumptions allowed for the use of a purposeful (criterion) sample appropriate to a
qualitative study rather than a representative, generalizable sample of the larger
population (Creswell, 2007).
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In addition, a number of participants considered vulnerable may have been
included, but were not targeted, in this study. Vulnerable populations include (a) pregnant
women; (b) residents of a mental health facility; (c) mentally/emotionally disabled
individuals; (d) individuals who might be less than fluent in English; (e) traumatized
individuals; and (f) economically disadvantaged individuals. Determining whether or not
an individual fits into any of the aforementioned categories would have required asking
invasive questions unrelated to the study. Furthermore, verification was impossible due to
the nature of the Internet. Participants were informed that they had the right to leave the
study at any time for any reason, without explanation.
As discussed in detail in Chapter 3, measures were taken in the study to protect
participants, including the use of consent forms, confidentiality, and secure storage of
data.
Delimitations
This study was delimited as follows: Participants were females aged 18 years and
older who had a thyroid disease diagnosis. Although thyroid disease is most common in
women ages 35 and older (Godfrey, 2007), thyroid disease can occur at any age and is
influenced by genetic and environmental (e.g., smoking) factors (Manji et al., 2006).
Excluding participants under age 35 would have likely precluded individuals who
experienced thyroid disease early in life due to genetic and environmental factors
(Godfrey, 2007; Manji et al., 2006), which would have eliminated an important subset of
experiencers. Eliminating participants over age 35 would have precluded those
individuals who experienced thyroid disease late in life due to an age-related decline in
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the thyroid hormones T3 and T4 (Begin, Langlois, Lorrain, & Cunnane, 2008; Morganti
et al., 2005). This would have eliminated another important subset of experiencers. Thus,
the wide age range is a form of maximum variation for the phenomenon that was
studied—thyroid disease in women (Creswell, 2007).
The participants were members of an online support group who chose to
participate in the study and who were able to access and install X-IM software on their
computers. Although participants could be from anywhere in the world, the sample was
delimited to individuals who were able to write in the English language.
Limitations
A limitation of the study is the potential for personal bias, as I have a thyroid
disease diagnosis and have been a member of The Thyroid Support Group since 2004. In
order to control for this limitation, reflexive journaling was used during data collection
and analysis. According to Moustakas (1994), when conducting phenomenological
research, it is important for the researcher to identify his or her opinions or bias on the
subject being studied. Therefore, I maintained a journal about personal feelings and
opinions so they could be separated from the data. Moreover, Chapter 3 of this study
contains a discussion of the role of the researcher in which my background and history as
a thyroid patient are disclosed.
While research indicates that online support groups are desirable among adults
with chronic illnesses, Internet users tend to be young, Caucasian, and have convenient
access to a computer (Fox & Jones, 2009; Kraut, Olson, Banaji, Bruckman, & Couper,
2004). As such, the results of the study may not be generalizable to older, non-Caucasian
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individuals who do not have convenient computer access. Another limitation is that the
sample was self-selected, which means that the sample may vary systematically and
therefore may not be representative of most female thyroid patients.
Significance of the Study
Thyroid disease causes a wide range of somatic and psychiatric symptoms that
can be difficult to distinguish from those of other disorders. As such, many individuals
with thyroid disease are misdiagnosed and experience progressive psychological and
physiological problems (Canaris et al., 2000; Godfrey, 2007; Heinrich & Grahm, 2003;
McDermott & Ridgway, 2001; Simmons, 2010). Within the prevalent culture of the
medical profession, these problems are particularly troublesome for female patients, who
may be met with sexism and marginalization in traditional doctor-patient relationships
(Hoffman & Tarzian 2001; Platt, 2008; Werner & Malterud, 2003).
Numerous studies on chronic illness have indicated that diagnosis, treatment
decisions, and treatment outcomes are related to physician and patient gender (Di
Caccavo & Reid, 1998; Hamberg et al., 2004; Platt, 2008; Sandhu et al., 2009) and the
nature of the doctor-patient relationship (Copeland et al., 2003; Houle et al., 2007;
Munch, 2004). Expanding upon this research to explore the treatment experiences of
women diagnosed with thyroid disease could contribute to positive social change by
enhancing our understanding of how women experience the phenomenon of treatment of
thyroid disease and the doctor-patient relationship, and ultimately help to determine the
factors related to positive treatment outcomes. Proper diagnosis and effective
management of thyroid disease can benefit female patients by preventing misdiagnosis or
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delayed diagnosis, thus minimizing the potential for progressive health problems
(Godfrey, 2007).
Considering that there are an estimated 158,288,693 women living in the United
States (U.S. Census Bureau, 2012) and that approximately 1 in every 7 women develops
thyroid disease (Godfrey, 2007), approximately 22,612,670 women in the United States
may be expected to have thyroid disease. If the findings of the study are used in crafting
follow-up studies of a quantitative nature, the results of such studies may benefit the
approximate 22,612,670 women dealing with thyroid disease, as well as secondarily
benefit the families and communities who support them. The results of such follow-up
studies may, in turn, indirectly reduce healthcare costs (Darer, Hwang, Pham, Bass, &
Anderson, 2004; Keck, Kessler, & Ross, 2008; Leifer, 2003; McKee & Peyerl, 2012;
Rothman & Wagner, 2003) along with the incidence of complaints and litigation
resulting from dissatisfied patients (Firth-Cozens, 2008a, 2008b). In light of the
widespread nature of thyroid disease, the potential for a decrease in misdiagnosis and a
reduction in complaints, litigation, and healthcare costs constitutes a substantial
contribution to positive social change.
I intend to publish a condensed version of this study in a scholarly journal so that
healthcare professionals can use the information in practice and future research.
According to Creswell (2007) and Schensul and LeCompte (1999), researchers must
shape the language of research results with their audience(s) in mind. As such, the
findings of this research will be presented in a scholarly manner, but with minimal use of
technical jargon. Some of the participants’ quotes will be used in order to personalize the
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results. Recommendations for further research will be provided, in addition to
suggestions for how patients and doctors might be able to work collaboratively and
communicate more effectively with each other.
Summary and Transition
Approximately 1 out of every 7 women develops thyroid disease, and its
prevalence increases with age, yet the most commonly used blood test for diagnosing
thyroid disease and for determining treatment effectiveness can produce misleading
results. Because of this, clinically important diagnoses are missed, and many women with
thyroid disease continue to experience symptoms even when they are receiving treatment.
In addition, even once diagnosed with thyroid disease, female patients have reported that
their physicians are not responsive to their complaints.
Despite the pervasiveness of thyroid disease in women, there is a gap in the
literature regarding the treatment experiences of women diagnosed with thyroid disease,
particularly regarding the doctor-patient relationship. Therefore, the purpose of this
phenomenological study was to explore female thyroid patients’ experiences of treatment
and the doctor-patient relationship.
Data were collected from 16 female members (including myself) of The Thyroid
Support Group via individual online chat interviews. Using ATLAS.ti software and the
analytic method recommended by Moustakas (1994), data interpretation was guided by
social constructionism and feminist theory. Themes related to the culture of the medical
profession, diagnostic bias, and gender differences in communication were identified.

21
Chapter 2 presents the literature search strategy, the conceptual framework for the
study, and a review of the literature related to the chosen methodology. A thorough
review of the literature on the doctor-patient relationship, the culture of the medical
profession, diagnostic bias, and gender differences in communication is given. Finally, a
summary of the chapter is provided.
Chapter 3 contains a description of the research design and approach of the study,
including a detailed discussion of the benefits of using a qualitative design over a
quantitative design for the population that was studied. In addition, the suitability of
phenomenology as opposed to other qualitative methods is explained. The context of the
study is provided, along with a description of the participants and the role of the
researcher. The procedures and instrumentation used for data collection are detailed, as
are the steps taken to ensure the protection of participants. Finally, data analysis,
trustworthiness, interpretation, and dissemination are discussed.
Chapter 4 presents the themes derived from the data analysis and is supplemented
with direct quotations from the participants’ responses to interview questions. Evidence
of data quality is also discussed.
Chapter 5 provides an interpretation of the findings based on the relationship
among the themes, research questions, and theories presented in Chapter 2. The chapter
concludes with a discussion about limitations of the study, recommendations for future
research, the dissemination of findings, implications for social change, and conclusions.
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Chapter 2: Literature Review
Introduction
This chapter contains a review of the literature on the treatment experiences of
women with thyroid disease. It is argued that women with thyroid disease experience the
doctor-patient relationship as fraught with difficulty owing to the culture of the medical
profession, diagnostic bias, and gender differences in communication. As the nature of
the doctor-patient relationship is related to patient satisfaction and treatment outcomes, an
understanding of the treatment experiences of women with thyroid disease may help to
enhance the potential for proper diagnosis and effective treatment in female thyroid
patients’ interactions with medical professionals.
The following section provides a description of the literature search strategy used,
followed by an overview of thyroid disease. The conceptual framework for the study is
described, and a review of the literature related to the chosen methodology is given. A
thorough review of the literature on the doctor-patient relationship, the culture of the
medical profession, diagnostic bias, and gender differences in communication is given.
Finally, a summary of the chapter is provided.
Literature Search Strategy
The effort to develop this literature review began in March 2009 with searches in
the EBSCOhost and ProQuest databases. Subsequent narrowing of the search included
the use of the following databases: Academic Search Premier, Alt HealthWatch,
CINAHL Plus with Full Text, ProQuest Dissertations & Theses Full Text, ERIC, Health
Source: Nursing/Academic Edition, MEDLINE with Full Text, ProQuest Nursing &
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Allied Health Source, ProQuest Central, ProQuest Health and Medical Complete,
ProQuest Psychology Journals, Psychology and Behavioral Sciences Collection,
PsycARTICLES, PsycBOOKS, PsycINFO, SocINDEX with Full Text, and Sociological
Collection.
The initial search included the use of the terms women and thyroid disease and
was expanded to include the terms diagnosis, treatment, gender, and doctor-patient
relationship. Upon collection of relevant articles, the following search terms were added
in June 2009: diagnostic bias, culture and medical profession, doctor education, gender
differences and communication, attitudes, perceptions, power, empathy, patient
autonomy, patient competence, and patient credibility. Between September 2009 and
October 2010, a review of the reference lists in each article resulted in the collection of
additional journal articles and books. Between November 2010 and February 2012, the
aforementioned databases were searched for articles related to conducting research on the
Internet. The following search terms were used: online research, Internet research,
online interviews, synchronous, asynchronous, chat, and ethical considerations. In
September 2012, an additional search of the aforementioned databases was conducted to
gather articles regarding economic issues associated with chronic illness. The following
search terms were used: chronic illness and economic issues, misdiagnosis and delayed
diagnosis, and healthcare costs. In December 2012 and January 2013, the
aforementioned databases were searched in order to gather literature about the steps that
various research, educational, and medical institutions have taken to enhance awareness
of gender issues in medicine. The following search terms were used: women and medical
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profession, women and inclusion and research, doctor-patient relationship and gender,
and doctor-patient relationship and women.
After conducting the study and writing Chapter 4, I searched the aforementioned
databases one more time in order to ensure that Chapter 5 would be written with
consideration of the most recent literature available. From March 2015 through June
2015, the following search terms were used, and the resulting literature was incorporated
into Chapters 1, 2, and 5: women and thyroid disease, diagnosis and treatment, natural
thyroid medication, doctor-patient relationship, gender, shared decision making, patient
self-advocacy behaviors, switching doctors, self-medicating, health information-seeking,
and patient education level. Thus, searching of the literature took place from March 2009
through January 2013 and then again from March 2015 through June 2015.
Overview of Thyroid Disease
Thyroid disease affects an estimated 30 million Americans (AACE, 2013) and
200 million people worldwide (Rajoria et al., 2010). It is estimated that of the 30 million
Americans with thyroid disease, more than half are undiagnosed (AACE, 2013). Thyroid
disease is more prevalent in women than men, regardless of culture, and occurs in
approximately 1 out of every 7 women (Canaris et al., 2000; Cassidy et al., 2002;
Godfrey, 2007). Women’s risk for developing thyroid disease increases with age (about
20% in women over age 60; Godfrey, 2007). Hyperthyroidism and hypothyroidism are
the two predominant conditions that result from thyroid disease, with Grave’s disease and
Hashimoto’s disease, respectively, as the most common causes (Zeitlin et al., 2008). Both
conditions cause a wide range of somatic and psychiatric symptoms.
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Hyperthyroidism
Hyperthyroidism results from the overproduction of thyroid hormone by the
thyroid gland (AACE, 2002), and tends to be accompanied by symptoms of anxiety and
panic disorders (Aslan et al., 2005). Other symptoms associated with hyperthyroidism
include heat intolerance, hot flashes, absent menses, insomnia, decreased libido (Godfrey,
2007), rapid heartbeat, sweating, and tremors (Aslan et al., 2005), diffuse goiter, and
ophthalmological abnormalities (Ginsberg, 2003). Grave’s disease, an autoimmune form
of thyroid disease, is the most common cause of hyperthyroidism in the United States
(Bunevicius & Prange, 2006; Goolsby & Blackwell, 2004).
Hypothyroidism
Hypothyroidism is caused by the undersecretion of thyroid hormones by the
thyroid gland (AACE, 2002), and often presents with symptoms of major depression and
bipolar depression (Aslan et al., 2005). Other symptoms that tend to occur with
hypothyroidism include fatigue (Bono et al., 2004), lethargy, apathy, difficulty
concentrating and slowing of thought processes (Aslan et al., 2005; Bono et al., 2004),
weight gain, dry skin, and decreased libido (Godfrey, 2007). In extreme cases, the
individual may experience slowing of thought processes, progressive cognitive
impairment, hallucinations, and delusions (Bono et al., 2004). Hashimoto’s disease, an
autoimmune form of thyroid disease, is the most common cause of hypothyroidism in the
United States (Erdal et al., 2008; Goolsby & Blackwell, 2004).
It is important to note that the most common causes of thyroid disease are
autoimmune in nature, as autoimmune diseases tend to co-occur. In fact, approximately
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25% of women who have an autoimmune disorder will develop thyroid disease (Godfrey,
2007). A definitive diagnosis of thyroid disease requires a physical examination and
thorough history of the patient (Goolsby & Blackwell, 2004).
Diagnosis
Making a definitive diagnosis of thyroid disease has shown to be challenging due
to a number of factors. Namely, the “gold standard” thyroid-stimulating hormone (TSH)
blood test for diagnosing thyroid disease tends to be used alone (Adams, 2008, p. 1),
despite evidence that the use of all three main thyroid function tests (TSH, free T3, free
T4) produces the most thorough analysis of thyroid function (Beckett & MacKenzie,
2007; Dayan, 2001; Rivera, Sampson, & Sola, 2015). As an example of how TSH testing
alone can produce misleading results, TSH values can be within the normal range while
free T3 and/or free T4 values indicate thyroid dysfunction (Dayan, 2001). Thus, when the
TSH blood test is used alone for initial screening of thyroid disease, clinically important
diagnoses (e.g., hyperthyroidism and hypothyroidism) may be missed. In addition,
although approximately 13 million Americans with thyroid disease remain undiagnosed
(Goolsby & Blackwell, 2004), the U.S. Preventive Services Task Force indicated a lack
of evidence for recommending for or against routine screening for thyroid disease in
adults, thus leaving the use of this potentially beneficial diagnostic measure to the
discretion of individual practitioners (Helfand, 2004). Even further, thyroid disease is
often mistaken for other conditions due to the similarity in its symptoms to other
disorders such as major depression, bipolar depression (Aslan et al., 2005; Pearce, 2015),
postpartum depression, psychosis (Fassier et al., 2011), anxiety and panic disorders,
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phobias (Aslan et al., 2005), menopause, and dementia (Godfrey, 2007; Shimabukuro,
2008). Thus, a thorough assessment, including a physical examination and complete
history of the patient, is vital for ensuring proper diagnosis and treatment of an individual
with thyroid disease (Goolsby & Blackwell, 2004).
Treatment
Hyperthyroidism. Radioactive iodine (RAI), antithyroid drugs, and
thyroidectomy are the three types of treatments available for hyperthyroidism in the
United States (AACE, 2002). An ablative dose of RAI is considered the treatment of
choice for hyperthyroidism. In cases of patients who are pregnant or nursing, antithyroid
drugs are considered safer than RAI. However, remission rates are variable and relapses
are frequent when antithyroid drugs are used alone (Goolsby & Blackwell, 2004).
Thyroidectomy tends to be performed only when cancer of the thyroid is suspected.
Regardless of the treatment chosen, individuals treated for hyperthyroidism become
euthyroid and then hypothyroid, and they require lifelong thyroid hormone replacement
therapy (AACE, 2002; Goolsby & Blackwell, 2004).
Hypothyroidism. Lifelong thyroid hormone replacement therapy is the only
treatment option available in the United States for individuals with hypothyroidism
(AACE, 2002; Goolsby & Blackwell, 2004). The most commonly used medication is
levothyroxine (T4; brand name Synthroid), which is recommended by the AACE. Some
experts recommend the addition of T3 (liothyronine; name brand Cytomel) for its
antidepressant effects (Dayan, 2001; Joffe, 2006). The dosage of these medications is
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determined by the results of the patients’ blood work (the TSH blood test, and sometimes
the free T3 and free T4 levels; AACE, 2002; Adams, 2008).
Effective treatment of thyroid disease depends upon an accurate diagnosis of
hyperthyroidism or hypothyroidism (Cappola & Cooper, 2015; Goolsby & Blackwell,
2004; Heinrich & Grahm, 2003; McDermott & Ridgway, 2001). Regular monitoring of
the thyroid patient’s symptoms and interpreting blood work are necessary for determining
treatment effectiveness. However, as previously mentioned, the TSH blood test, used
alone, does not provide the most thorough analysis of thyroid function (Adams, 2008;
Beckett & MacKenzie; Dayan, 2001; Rivera et al., 2015). Thus, in cases in which
physicians do not use all three main thyroid function tests, thyroid patients often
experience chronic or worsening symptoms (Bunevicius & Prange, 2006; Heinrich &
Grahm, 2003; McDermott & Ridgway, 2001).
Diagnostic and treatment challenges related to thyroid disease underscore the
importance of an effective doctor-patient relationship (Copeland et al., 2003; Houle et al.,
2007; Munch, 2004). Female thyroid patients’ experiences of treatment and the doctorpatient relationship might be best understood through the lens of social constructivism
and feminism, as both worldviews emphasize individuals’ experiences in social contexts
(Hearn, 2009; Docherty & McColl, 2003).
Conceptual Framework
In this study, data interpretation was guided by social constructionism and
feminist theory. Themes related to the culture of the medical profession, diagnostic bias,
and gender differences in communication—all of which are discussed later in this
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chapter—were identified. Emergent themes were also identified. This study expands the
research on women's health and adaptation to chronic illness by examining female
thyroid patients’ experiences of treatment and the doctor-patient relationship, which have
not been studied from a social constructionist/feminist perspective.
Social Constructionism
Lupton (2003) and Martin and Peterson (2009) described the trajectory in medical
thought by which social constructionism arose as a response to the biomedical model (p.
579). The biomedical model in health care arose in the 18th century. This model located
disease in specific parts of the body and reduced medical concerns to mechanistic
processes. In the 1950s, as a response to the biomedical model, Talcott Parsons
developed the functionalist perspective, in which the role of a sick individual is seen as a
social response to the deviant place in society occupied by persons with poor health
(Martin & Peterson, 2009). In the functionalist perspective, patients desire to be accepted
by society and therefore seek verification from doctors that they are not malingering
(Lupton, 2003). Although Parson’s work is acclaimed for identifying the role of society
in understanding illness, the functionalist perspective has been criticized for
characterizing patients as passive and grateful, while doctors were portrayed as
universally competent and altruistic. In addition, according to Lupton (2003), the
functionalist viewpoint did not take into consideration the potential for conflict within the
doctor-patient relationship. The social constructionist model emerged in the 1980s in
response to these criticisms.
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Within the social constructionist model, knowledge and “truth” are not
understood as universal, but rather as dependent upon the individual’s subjective
interpretation of reality (Lupton, 2003; Patton, 2002). In this perspective, all medical
issues, including health, chronic illnesses, and medical care, are socially constructed facts
that are subject to varying degrees of consensus and interpretation due to cultural factors
and social norms (Docherty & McColl, 2003; Fernandes et al., 2006; Hearn, 2009;
Lupton, 2003). In other words, in the management of illness, both the patient and the
doctor are influenced by their individual beliefs and experiences and the society in which
they live. Thus, the social constructionist perspective is appropriate to the qualitative
study of health and disease, which takes as its data the personal experiences, perceptions,
observations, and narratives of individuals (Creswell, 2007; Hearn, 2009).
The logical positivist perspective, commonly used in quantitative research,
involves an assumption that there are stable, social facts with a single reality, separated
from the feelings and beliefs of individuals (Creswell, 2007). In other words, regardless
of how an individual perceives an event, only one interpretation of that event is
considered to be appropriate or based on “truth” (Patton, 2002). For example, if an
individual is diagnosed with a chronic illness and the medical profession contends that
such a diagnosis should have a minimal emotional impact on the individual, for him or
her to react in any other manner (e.g., fearful, depressed) would be considered abnormal.
In contrast, social constructionism, commonly used in qualitative research, is based on
the belief that multiple realities are socially constructed through individual
(constructivism) and collective (constructionism) perceptions of the same situation
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(Patton, 2002). For example, on the individual (constructivist) level, one person might
view a chronic illness diagnosis as manageable, while another person might view that
same diagnosis as emotionally devastating. These individual perceptions are influenced
by the collective (constructionist) framework (e.g., cultural values and norms) in which
one lives. Within the social constructionist perspective, both of these interpretations
would be considered valid.
Docherty and McColl (2003) noted that a social constructionist approach takes
patients’ interpretations of their illness experience into account. These interpretations are
relevant because they influence the patients’ feelings, reactions, and behaviors. Fernandes
et al. (2006) noted that those adopting a social constructionist perspective view the body
in light of the ways in which society assigns meaning to it (e.g., “healthy” and
“unhealthy,” “normal” and “abnormal,” and “masculine” and “feminine”). Thus, the
female body and bodily illnesses take on certain meanings in a social context, and these
meanings influence patients’ interpretations of the illness experience (Fernandes et al.,
2006). Using a qualitative approach, Fernandes et al. interviewed women living with
breast cancer, eating disorders, and infertility and found that these women’s illnesses
manifested emotionally and socially as loss, anger, emptiness, loneliness, and isolation.
Findlay (1993) also argued that social construction is an important source of
knowledge in the fields of science and medicine. However, according to Findlay, the
technical nature of scientific and medical knowledge often results in perspectives that
neglect the social contexts and construction of this knowledge. More specifically,
diagnostic and treatment decisions tend to be based on “objective evidence” of disease
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(e.g., blood tests), and patients’ subjective experiences of illness are largely ignored
(Hoffmann & Tarzian, 2001). Furthermore, competing perspectives among
pharmaceutical, medical, and insurance companies influence diagnostic and treatment
decisions (Hearn, 2009). In order to underscore the social and political aspects of medical
knowledge and practice, Findlay (1993) argued that biomedicine defines disease as a
deviation from a particular standard viewed as biological normalcy. This standard,
though often unquestioned, is socially and culturally determined. The implications of this
can be seen, for example, in the way in which physicians treated female fertility issues in
the 1950s, which often assumed a specific, socially constructed set of values (Findlay,
1993). Findlay cited descriptions of the hormonal systems of males and females from this
period, noting that libido was emphasized in males and reproduction was emphasized in
females, and argued that acknowledgment of hormones in females was restricted to those
directly related to reproduction.
Feminists contend that women continue to be viewed by the medical profession as
being at the mercy of their reproductive hormones (Fernandes et al., 2006; Munch, 2004;
Wright & Owen, 2001). This perception could have a significant impact on women with
thyroid disease because of the psychological symptoms resulting from the hormone
imbalances involved in thyroid dysfunction (Shimabukuro, 2008). According to the
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision
(American Psychiatric Association, 2000), several of the most common cognitive, mood,
anxiety, and psychotic disorders might be best explained by thyroid dysfunction. Yet,
there are pervasive beliefs among physicians that women over-report pain and that vague
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symptoms are the results of mental, rather than physical, illness (Chrisler, 2001;
Hoffmann & Tarzian, 2001). Viewed from a social constructionist perspective, these
examples show how socio-cultural constructs, perspectives, and attitudes can influence
the field of medicine.
Feminism
Despite efforts to incorporate gender-sensitive practices into the field of medicine,
historically-based knowledge and beliefs about women persist (Chrisler, 2001; Hoffmann
& Tarzian, 2001; Sherwin, 1999). Thus, the relevance of feminism to the current
treatment of women in the medical field might be best understood from a historical
review of oppressive practices. In the 19th and early 20th centuries, women’s bodies were
viewed as unstable and their minds were viewed as fragile (Fernandes et al., 2006). These
beliefs resulted from the subordinate position that society assigned to women, who were
assumed to be more at the mercy of biological forces than were men (Fernandes et al.,
2006). Based upon theories of reproductive physiology, women were expected to
maintain specific behaviors and social roles (Bohan, 2002; Cosgrove, 2003; Shields,
2007). For example, women were thought to be naturally passive and nurturing and were
advised to remain in the home as wives and mothers, as it was believed that too much
social interaction would cause physical and emotional distress (Bohan, 2002). In addition,
psychologists asserted that obtaining a higher education would damage a woman’s ability
to reproduce (Bohan, 2002; Schultz & Schultz, 2004).
In psychology as well as in biomedicine, women were historically viewed as
fundamentally different from and inferior to men. In psychological practice, the presence
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of “feminine” emotion (e.g., fear, anxiety) was deemed problematic for women and
abnormal in men (Shields, 2007). Although assertions regarding women’s physical and
intellectual inferiority to men appeared to be supported by scientific evidence (e.g., men’s
brains are larger than women’s), the attributes assigned to each sex were based on biased
research practices (Cosgrove, 2003). More specifically, as women were thought to be
emotionally fragile and of “mediocre” intelligence compared to men, they were excluded
from scientific study (Bohan, 2002, p. 76; Sherwin, 1999). Public debates about mindbody issues (e.g., the influence of cognitive awareness of physical pain on emotion and
behavior) among non-academic writers and readers perpetuated popular notions of
women’s nature and gender differences (e.g., that women were naturally passive, as
opposed to men who were thought to have an innate drive to achieve and dominate;
Shields, 2007).
Feminism arose as a response to and rejection of such beliefs (Shildrick, 1997).
By the 1970s, feminists claimed that the relationship between selves and bodies, along
with perceptions of them, is socially constructed. Feminism attempts to redefine this
relationship such that the body is more than simply a reproductive object (Bohan, 2002;
Cosgrove, 2003; Fernandes et al., 2006). Bohan (2002) described three distinct phases in
the development of feminist psychology. The first phase was characterized by adopting
therapeutic techniques that fit into feminist philosophy with the intention of empowering
women. The second phase involved integrating feminist philosophy into psychological
theories. The final and continuing phase consists of trying to develop a unique and
comprehensive theory that explains the common experiences of women.
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With regard to the medical field, feminist theory presents a response and
challenge to the functionalist model, which asserts that physicians must adopt a position
of authority in order to assure patients’ recovery, and that patients must accept these roles
and trust physicians (Lupton, 2003; Munch, 2004). Feminists argue that patients are the
experts of their own medical conditions (Chrisler, 2001; Hoffmann & Tarzian, 2001) and
contend that medical knowledge is largely socially constructed—that is, health, chronic
illnesses, and medical care are influenced by cultural factors and social norms (Fernandes
et al., 2006; Lupton, 2003). Thus, a feminist approach to medicine encourages patients
and physicians to question concepts of “normal” and “healthy” and for physicians to
consider patients’ subjective interpretations of their own illness (Hoffmann & Tarzian,
2001; Wright & Owen, 2001).
According to Verdonk, Benschop, de Haes, and Lagro-Janssen (2008), in the
1990s, studies on women’s health began to include women’s interpretations of their
illness experiences. Such studies continue to be conducted and have expanded to include
the influence of gender relations. Nevertheless, medical knowledge is historically based
on research in which women were significantly underrepresented (Findlay, 1993;
Sherwin, 1999) and the inclusion of female participants in current medical research
continues to fall short of male participants. In their paper written on behalf of the
Endocrine Society, Alexander-Bridges and Doan (2007) reported that no mandate
currently exists to include women and other minorities in industry-sponsored drug trials.
Furthermore, despite the Food and Drug Administration’s (FDA) 1993 Guideline for the
Study and Evaluation of Sex Differences in Clinical Evaluation of Drugs, women
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continue to be unrepresented in clinical trials for the testing of drugs before marketing
(Mastroianni, Faden, & Federman, 1999). According to a study by Yang et al. (2009), in
clinical trials for 67 new drugs approved by the FDA between 2000 and 2002, women
were significantly underrepresented in early phase trials and certain areas including
cardiovascular, renal, and gastroenterology, and psychiatry products.
Sherwin (1999) argued that the process by which research is conducted may
maintain and promote medical practices that oppress women. These research and medical
practices could have a significant impact on women with thyroid disease, particularly
with those that are autoimmune in nature (i.e., Hashimoto’s and Grave’s disease), as
autoimmune diseases are the third-most common diseases in the United States, preceded
by heart disease and cancer (Committee on Women’s Health Research, 2010). According
to the Committee on Women’s Health Research (2010), although progress has been made
over the past couple decades in knowledge about the pathophysiology of autoimmune
diseases in women, research has not yet led to effective treatments beyond managing the
symptoms.
Adopting a feminist approach to qualitative research involves accepting the
narratives about the history of psychology, philosophy, and medicine that feminism
proposes. Female patients’ illness experiences can be interpreted in light of this narrative.
Alongside social constructionism, a feminist approach suggests that female patients’
interpretations of their experiences are influenced by social constructs related to the
female body, gender issues, and the experience of being a woman (Hearn, 2009).
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The Doctor-Patient Relationship
According to Dr. Francis Peabody (1927), proper diagnosis and treatment are
dependent upon the quality of the relationship between doctor and patient. Despite this
widely-acknowledged importance, traditional doctor-patient relationships have been
characterized by authoritarian, paternalistic, doctor-centered approaches, and physicians
have historically behaved in ways that marginalize women (Ehrenreich & English, 2005;
Vanderford et al., 2001). In contrast, research has shown that doctor-patient relationships
that are collaborative, respecting of patient autonomy, and non-sexist have a positive
impact on treatment outcomes (Chrisler & Parrett, 1995; Dugdale et al., 2008; Fox &
Chesla, 2008; Houle et al., 2007; Peck & Connor, 2011). I am not implying that
physicians who work in a traditional relational-style deliberately intend to marginalize or
oppress women. Rather, as oppressive practices are systemically ingrained in society by
historically-based knowledge and beliefs, “conscious and persistent effort [is required] to
resist complicity in [the] patterns” of such practices (Sherwin, 1999, p. 11). The
characteristics of traditional doctor-patient relationships are discussed in the following
paragraphs.
Traditional Doctor-Patient Relationships
Authoritarianism and paternalism. Authoritarian doctor-patient interactions are
characterized by a hierarchical relationship wherein the doctor is in a position of
authority over the patient. A paternalistic doctor-patient relationship combines this
authority with a concern for the patient’s well-being (Kittay, 2007). According to Berger
(2002) and Paterson (2000), authoritarian and paternalistic attitudes in medicine stem
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from the moral authority afforded to doctors upon taking the Hippocratic Oath. In other
words, doctors are expected to improve their patients’ lives and avoid causing harm, and
hence, the doctor acts as a father-like guide for the patient (Berger, 2002). However,
doctor-patient relationships based on authoritarianism and paternalism discourage respect
for patients’ autonomy (Kittay, 2007).
Historically, doctors have possessed specialized knowledge and medical expertise
inaccessible to the public. Although this is still the case, today’s public has greater access
to medical information (Hearn, 2009). Nevertheless, the hierarchy between patients and
physicians persists. According to Hearn (2006), physicians feel that their traditional,
paternalistic roles are threatened by well-informed patients. McGuire, McCullough,
Weller, and Whitney (2005) conducted a qualitative, cross-sectional survey of physicians.
The results indicated that, although most physicians have a positive view of patient
involvement in medical decision making, physicians view their role as that of an expert
whose duty is to educate patients and make recommendations for treatment. In this type
of relationship, the physician has decisional priority (i.e., suggests the plan of action) and
the patient has decisional authority (i.e., accepts or rejects the plan). McGuire et al.
described this one-dimensional model of shared decision making as “ethically
inadequate” because it does not account for the variability among patients regarding
desire for information and involvement (p. 466).
Based on their study of patient autonomy level and preferred doctor
communication style, Kaplan, Schneiderhan, Harrown, and Omens (2002) suggested that
physicians should base their approach to information sharing and decision making on
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their patients’ individual levels of autonomy. Kaplan et al.’s research indicated that for
female participants, the higher their level of autonomy, the stronger their preference was
for doctors who had an informative versus a paternalistic communication style. Whereas
a paternalistic communication style is directive, an informative communication style is
participative and encourages patients to make informed treatment decisions. Like female
participants, male participants preferred doctors with an informative communication
style; however, the male participants’ preferences were not influenced by their autonomy
levels.
Similar research by Bradley et al. (2001) revealed that regardless of patient
gender, patients were more satisfied with physicians who used a consultative
(informative) communication style as opposed to an authoritative (paternalistic)
communication style. When physicians used a consultative communication style, levels
of satisfaction were highest among young participants (less than 30 years of age)
regardless of physician gender, and among older participants (between 30 and 49 years of
age) when the doctor was male. When an authoritative communication style was used,
levels of satisfaction were lowest among middle-aged participants (50 years of age and
older), particularly when the physicians were female. Bradley et al. proposed that these
results might reflect conventional gender-role expectations among the middle-aged
participants.
Research indicates that authoritarian and paternalistic doctor-patient relationships
can have negative consequences for both physicians and patients. Stokes et al. (2006)
conducted a study of cases in which general practitioners (GPs) in the UK terminated
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relationships with patients. Based on accounts of the situations given by both the GPs and
the patients, the researchers concluded that the GPs were strategically exercising
symbolic power in terminating the relationship (Stokes et al., 2006, p. 613). In the cases
considered, this was often due to a conflict between GPs’ recommendations and the
patients’ requests or demands. In such cases, the GPs chose to cease treating the patients
rather than adopt a more collaborative approach to healthcare.
According to Risberg, Hamberg, and Johansson (2006), medical knowledge based
on biomedical approaches are privileged within the medical field at the top of a hierarchy
of research types. This could suggest a tendency among physicians to undervalue
patients’ knowledge or to undervalue doctor-patient relationships that do not conform to
the dominant hierarchies. In fact, patients tend to be viewed by health care professionals
as “difficult” when they do not adopt the role expected by the physician (MacDonald,
2003). Risberg et al. (2006) linked this phenomenon to gender bias in the medical field
and a resistance to gender awareness. In addition to reinforcing authoritarianism, this
state of affairs can result in gender-biased doctor-patient relationships. In their study
about the influence of “status characteristics” on doctor-patient interaction, Peck and
Connor (2011) interviewed 179 patients regarding their experiences with their physicians.
Status characteristics are based on cultural beliefs in which a higher status and level of
competence is associated with one group (e.g., men) over another (e.g., women). Results
of the study indicated that doctor-patient interactions were more paternalistic and less
patient-centered when the doctor was male and the patient was female versus interactions
in which the doctor was female and the patient was male or female. Since status beliefs
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often form and exist at a subconscious level (Rashotte & Webster, 2005), male doctors
may be unaware that they are interacting in a more paternalistic fashion with their female
patients than their male patients.
Mutter (1999) discussed the paternalistic influence of the dominant “military
metaphor” in modern medicine. This view holds that medicine is a war against disease
and death. This type of thinking, according to Mutter, encourages physicians to ignore
patients’ mental concerns and focus on the physical, emphasizing control over physical
forces acting within the patient. This can result in the presumption that the doctor knows
more about the patients’ experiences of their bodies than the patients themselves.
In a study of 20 women who had had elective hysterectomies, Lorentzen (2008)
discovered that, among negative experiences with doctors, those that were most impactful
for the participants were those in which physicians attempted to make false claims about
the women’s bodies. The participants found most disturbing those claims that they
described as “inaccurate, potentially harmful, demeaning, and as discounting the
women’s experiential knowledge of their own bodies” (p. 60). Similarly, female patients
in a study by Copeland et al. (2003) complained that doctors did not treat them with
respect, did not answer questions without getting impatient, and were judgmental,
insensitive, patronizing, and condescending. They explained that they wanted doctors to
be sensitive to the whole person, and to express an interest in their feelings, mind, body,
and spirit.
Marginalization of women. The marginalization of women by physicians can be
viewed as a byproduct of the predominant cultural view, discussed above, of women as
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physically unstable and mentally fragile (Fernandes et al., 2006). According to Werner
and Malterud (2003), at the end of the 19th century, unexplained conditions in women
were often seen as attempts to gain power or attention. Consequently, women risked
going without treatment if physicians deemed them either overly feminine or overly
aggressive and opinionated.
According to Chrisler (2001), the traditional patient role is similar to traditional
female gender roles. Both roles encourage passivity, cooperation, dependence, and
acceptance. This marginalizes women by making it difficult for them to be assertive or
challenge doctors, lest they be labeled bad patients (Chrisler, 2001). Chrisler argued that
this could result in misdiagnosis for women in the early stages of autoimmune disorders
because their symptoms are often vague.
Marginalization of women can be seen on both individual and societal levels. At
the individual level, marginalization of women is also evident in relationships between
women and psychologists. According to Wright and Owen (2001), diagnoses of mental
illness tend to devalue the female role as perceived by a socially constructed standard.
Thus, women who deviate from the normal female role are often seen as mentally ill, and
women who conform to the role could also be diagnosed with mental illness because the
role is itself marginalized.
At the societal level, medical research and physician reports have also shown a
trend of marginalization. According to Findlay (1993), the biological functions of the
female reproductive system have historically been viewed in terms of their teleology,
rather than strictly descriptively. For example, researchers in the 1950s claimed that
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changes in the uterine wall during pregnancy were designed to increase space inside the
uterus. Findlay argued that the use of this type of language and this conceptual approach
to female reproductive processes revealed a mechanistic, objectifying view of women.
Modern Doctor-Patient Relationships
Collaboration. According to Sacks (1987), a neurologist and essayist, “Whereas
modern medicine may provide invaluable insights into chemical and biological courses of
disease, only patients hold the clues to what their diseases are really like” (p. 40). Sacks’
statement indicates the importance of collaboration between doctors and their patients;
doctors cannot gain insight into patients’ experiences unless they actively attempt to
understand patients’ points of view.
With the rise of patient-centered care in the last 10 years, there has been a shift in
the communication style of many medical practitioners—a more collaborative approach
in which patients’ preferences are considered in treatment decisions (Breen et al., 2009;
Levinson, Lesser, & Epstein, 2010). In a study by Butalid, Verhaak, Boeije, and Bensing
(2012), analogue patients viewed videos of doctor-patient interactions from 1982-1984
and 2000-2001. Analogue patients confirmed a shift from doctor-centered interactions in
the earlier videos to patient-centered interactions in the more recent videos, characterized
by collaborative, solution-focused communication as opposed to directive, problemfocused communication.
Effective doctor-patient collaboration requires that doctors be willing and able to
communicate with patients as individuals. Houle et al. (2007) described the following
interpersonal skills as being vital to an effective doctor-patient relationship: (a)
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understanding, which involves a sincere desire to learn about patients’ experiences and
results in patients’ trust and belief that their doctors know them as individuals; (b)
empathy, which is the skill through which doctors express consistent, professional
concern for their patients’ feelings; and (c) relational versatility, or the ability of the
doctor to match his or her interpersonal approach to the varying communication needs of
their patients. According to Houle et al., the skill of relational versatility is dependent
upon an attitude of respect for and acceptance of others.
Collaboration in doctor-patient relationships also requires trust. Trust, as defined
by the female participants in a study by Copeland et al. (2003), is “based on feeling
confident and comfortable with the care provided…when the doctor appears sympathetic,
cares, and takes time to talk” (p. 41). According to Dugdale et al. (2008), patients trust
doctors who provide informed consent, are willing to disclose medical errors, and who
keep abreast of the current medical literature. Participants in the Copeland et al. (2003)
study expressed feeling reluctant to talk to doctors with whom they do not feel
comfortable, and were eager for doctors to know that trust affects their willingness to
listen and comply with their doctor’s advice. Likewise, the female participants in the
Houle et al. (2007) study stated that they are more likely to take a doctor’s advice if they
believe they can trust the doctor. The participants also indicated that, in order to gain
their trust, doctors must show an interest in them, listen attentively, conduct a prompt
follow-up, and be available to answer their questions.
Empirical support exists for the importance of collaboration in doctor-patient
relationships as opposed to a hierarchical relationship wherein the doctor is in a position
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of authority over the patient. Doctors’ attitudes have been shown to have a direct effect
on the quality of care patients receive, as well as patients’ ability to make informed
decisions about their health (Chrisler & Parrett, 1995). Doctor-centered attitudes are
associated with lower patient satisfaction and, according to Krupat (1999), may decrease
trust in the doctor-patient relationship.
Recent research suggests that there may be a difference in the level of
collaboration encouraged by male and female physicians. In a study conducted by Hall,
Roter, Blanch, and Frankel (2009), female medical students more accurately interpreted
their patients’ non-verbal communication (e.g., facial expressions) than did male medical
students. Doctor-patient interactions in which doctors demonstrated sensitivity to their
patients’ non-verbal cues resulted in decreased distress, longer visits, and higher
engagement among analogue patients.
A study conducted by Bloor, Freemantle, and Maynard (2008) found that male
medical professionals completed, on average, 160 more medical cases each year than
their female counterparts. According to Firth-Cozens (2008b), this disparity may reflect
the type of care given by female doctors, in contrast to the care given by male doctors.
For example, female physicians may spend more time with each patient, encouraging the
patient to speak more and be more active in the decision making process. The increased
depth of care and collaboration would result in females completing fewer cases over the
same period. Female doctors have indeed been shown to use a more patient-centered
approach with their patients than male physicians, as evidenced by longer consultations
and a more emotional, psychosocial focus in their discussions (Beach, 2000; Firth
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Cozens, 2008b; Hall & Roter, 2002; Hall et al., 2009; Roter & Hall, 2004; Shin et al.,
2015).
The more patient-centered approach adopted by most female practitioners may
have a significant positive impact for the professionals as well as for the patients.
According to a report by the National Clinical Assessment Service (NCAS, 2006), male
doctors are involved in more legal and disciplinary action than female doctors. In 2004,
42% of general practitioners were women, but only 13% of doctors referred to the NCAS
for discipline were female. According to Firth-Cozens (2008b), this statistic is a direct
result of the more sensitive approach taken by female physicians. Better doctor-patient
relationships result from female physicians’ greater emotional and communication skills,
resulting in a decreased likelihood that the doctors will be involved in disputes or
complaints.
Patient autonomy. In contrast to the traditional authoritarian and paternalistic
relationship between doctors and patients, a more egalitarian approach to healthcare has
been shown to benefit treatment outcomes. Doctors who respect patient autonomy allow
patients to participate in decisions about their own health and take patients’ concerns,
opinions, and preferences into consideration. Empirical evidence indicates that physicians
are moving toward this ideal.
Physicians in a study by McGuire et al. (2005) expressed consistently positive
attitudes towards patient participation in medical decision making. They identified patient
autonomy as essential to the doctor-patient relationship and indicated that they were
motivated by the fundamental principle of beneficence, as well as their own personal
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interest in avoiding legal liability. Similar results were found in Rogers’ (2002) study of
physicians’ attitudes toward patient autonomy in treatment for back pain. The majority of
physicians interviewed were in favor of patient autonomy regarding the use of
complementary therapies (e.g., massage), but desired to maintain control of treatment
decisions involving analgesic narcotics due to their potential for addiction.
In the case of autoimmune disorders such as those that cause hyper- and
hypothyroidism, respect for patient autonomy is particularly important (Chrisler &
Parrett, 1995). Because patients can provide important insight into the experience of their
own conditions, patients should be seen as experts on their conditions and respected as
such. Considering that the majority of physicians wish to respect patient autonomy while
avoiding legal liability (McGuire et al., 2005; Rogers, 2002), a “deliberative model”
might be appropriate in decision making. As described by Chin (2002), in the deliberative
model, the physician is both a teacher and a friend who assists the patient in evaluating
the safety and effectiveness of potential treatment modalities. Chin (2002) posited that
such a model is particularly relevant in the “Internet age,” in which patients are “flooded
with information”—not all of which is reputable (p. 154).
The increased availability of medical information to the public makes patient
autonomy a growing concern. Tu and Cohen (2008) reported that, according to an HCS
survey, in 2007, 56% of American adults sought information about a health concern,
compared to only 38% in 2001. Of those individuals who looked for information about a
health concern from sources other than a doctor, over half later spoke with a doctor about
that same health concern. This indicates that patients exercise their own autonomy and
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hope to use the information they discover in conjunction with professional consultation.
Additionally, those with chronic health concerns are more likely to seek health
information from sources other than doctors. According to Fox (2007), among Internet
users with disability or chronic illness such as thyroid disease, 86% have searched online
for information. Among those without chronic illness, only 79% have searched for
medical information online. Individuals with chronic health concerns also reported that
their medical decisions are more frequently affected by information found online.
Fox and Jones (2009) reported on a 2008 Pew Research Center study related to
patient autonomy in seeking health information from various sources. The study found
that 61% of adults use the Internet to search for health information, and over half of
online health queries are made on behalf of someone other than the Internet user.
Therefore, in order to establish effective doctor-patient relationships, physicians need to
take patient autonomy and outside sources into consideration. In addition to consulting
professionals, a majority of adults consult friends or family members, books, and other
reference material for medical assistance. Significant percentages of those interviewed
claimed that information found online affected health-related decisions they made for
themselves or someone in their care (Fox & Jones, 2009). These results underscore the
importance of online information for individuals with chronic illness, suggesting that
doctors treating such patients should be particularly aware of and sensitive to patient
autonomy and knowledge.
Non-sexist. As noted above, traditional doctor-patient relationships have tended
to marginalize women by virtue of social perceptions of the female role. In addition to
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being placed in a position of inferiority due to doctors’ medical expertise, female patients
in the care of male physicians may conform to traditional, submissive feminine roles
(Chrisler, 2001). This undermines female patients’ autonomy and makes doctor-patient
collaboration unlikely. Thus, it is important for women to feel that their feminine status
does not affect the quality of the care they receive.
Despite theoretical and empirical evidence that a more collaborative, less doctorcentered model of healthcare promotes positive healthcare outcomes (Houle et al., 2007;
Munch, 2004), the traditional forms of doctor-patient relationships persist. Factors that
contribute to the persistence of the traditional model include sexism in healthcare, the
medical education system, economics, the culture of the medical profession, and
women’s communication patterns.
Sexism in Health Care
Abundant research and theoretical literature indicates that sexism exists in the
medical profession and results in a number of problems, including under-treatment and
misdiagnosis of women’s medical issues. According to Secker (1999), male-dominated
philosophical, theological, literary, and scientific traditions have characterized women (as
opposed to men) as emotional, irrational, pathological, unintelligent, incompetent,
dishonest, passive, and childlike (p. 301). Applying these traditions in the medical
profession has resulted in a diagnostic bias whereby women’s health complaints tend to
be viewed as psychosomatic in origin (Hamberg et al., 2004; Hoffmann & Tarzian, 2001;
Richman, Jason, Taylor, & Jahn, 2000).
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Hoffman and Tarzian (2001) purported that women’s complaints are often not
taken seriously by medical professionals because women are viewed as overly emotional
and likely to exaggerate their pain. According to Cheney and Ashcraft (2007), in the
medical profession, there is “a tendency to privilege the rational over the emotional” (p.
153). Furthermore, some illnesses (e.g., depression) are perceived to primarily affect
women or are associated with femininity, further indicating a pervasive sexism within the
medical profession (Hoffman, & Tarazian, 2001).
Empirical research supports these theoretical arguments, indicating that
physicians tend to interpret men’s symptoms as biological and women’s as
psychosomatic (Hamberg et al., 2004; Hoffmann & Tarzian, 2001). When women report
pain, they are less likely than are men to be taken seriously and less likely to receive
adequate treatment (Miaskowski, 1999). Additionally, research has shown that, for
patients with diffuse symptoms, doctors give advice regarding lifestyle more often to
women than they do to men, and that they prescribe sedatives more often to women than
to men (Hamberg et al., 2004). The same study indicated that male physicians prescribe
sedatives to women more often than female physicians do, indicating that traditional
gender roles continue to play a part in doctor-patient relationships.
Munch (2004) performed a meta-analysis of the literature on physicians’
diagnosing of women’s medical complaints. The analysis revealed that physicians tend to
misdiagnose women’s complaints as psychosomatic or non-serious due to gender bias.
This is particularly true in cases when the physiological cause of the condition is
unknown. Munch’s analysis also revealed that doctors are less aggressive in treating
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coronary disease in women than in men, and that hospitalized women receive fewer
therapeutic and diagnostic procedures than men. In a study of patients with chest pain,
Elderkin-Thompson and Waitzkin (1999) found that men were more likely than women
to be admitted to the hospital. Women who were hospitalized were just as likely as men
to receive a stress test. However, women who were not hospitalized were less likely to
have received a stress test at follow-up. This could indicate that the nature of sexism in
healthcare requires women to prove that their complaints are as valid as those of their
male counterparts.
The necessity for women to prove the validity of their complaints is particularly
striking in light of evidence reported by Addis and Mahalik (2003) indicating that,
compared to women, men are less likely to seek care for nearly all mental and physical
health problems. The authors noted that traditional masculine gender socialization plays a
role in discouraging men from seeking treatment. According to the social constructionist
perspective, men are traditionally constructed as better able to cope physically and
emotionally with health problems than women.
In the past decade, significant progress has been made in the understanding of sex
differences in health and illness (Verdonk, 2009). In 2004, the American Heart
Association published evidence-based guidelines for the prevention of heart disease in
women. These guidelines were updated in 2007 (Mosca et al., 2007). Also in 2007, the
World Health Assembly passed resolution WHA60.25, which introduced the practice of
integrating gender analysis into the work of the World Health Organization (WHO,
2013). Nevertheless, gender bias in the diagnosis and treatment of illness remains
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ingrained in the medical field as a result of the biomedical focus in medical training
(Celik, Lagro-Janssen, van der Weijden, & Widdershoven, 2009). Celik et al. argued that
the incorporation of gender sensitive issues into clinical practice guidelines is insufficient
for changing medical practice, as adherence to such guidelines is not mandatory. The
authors suggested that in order to successfully address the problem of gender bias in
medicine, gender sensitive issues should become a fundamental part of medical
education.
Medical Education
The biomedical focus in medical training contributes to the perpetuation of
traditional doctor-patient relationships (Celik et al., 2009). In the Western medical
profession, health-care practitioners are taught that diagnostic and treatment decisions
should be based on objective evidence of disease, such as blood tests (Hoffmann &
Tarzian, 2001). This system encourages practitioners to disregard patients’ subjective
illness experiences, making them unlikely to treat patients as equals in a collaborative
relationship (Hoffmann & Tarzian, 2001; McGuire et al., 2005). Patients’ preferences,
concerns, and emotions are likewise not taken into account (Haidet et al., 2002). Dyche
(2007) asserted that although interpersonal communication skills are recognized as
important by some educators, they have received much less attention than task oriented,
verbal aspects of communication.
During the first two years of medical school, courses in communication typically
utilize actors who are trained to act like patients. However, during the third and fourth
years of medical school when students have contact with real patients, the focus of
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training shifts from communication skills to diagnostic skills and patient management
(Levinson, Lesser, & Epstein, 2010). According to Levinson et al. (2010), this nonsystematic teaching of communication skills results in practicing physicians who must
learn communication on their own. Various medical societies have recognized that
effective doctor-patient collaboration requires relational versatility, or the ability of
doctors to match their interpersonal approach to the communication needs of their
patients (Houle et al., 2007; Levinson et al., 2010), and have therefore developed
programs to teach patient-centered communication skills to practicing physicians.
Research into how people categorize other people into groups (social
categorization theory) has indicated that practicing physicians and medical students tend
to categorize patients as an “out group,” or similar to one another, but different from
medical professionals (with whom doctors consider themselves as an “in group”).
However, in a study by Clucas (2011), doctors who received communication skills
training viewed patients at an “intergroup” level, or dissimilar to one another and medical
professionals. In other words, doctors who received communication skills training viewed
their patients in a more personal manner. Personalization of care, in turn, leads to
collaboration, greater patient satisfaction and adherence to treatment, and fewer
malpractice lawsuits (Clucas, 2011; Firth-Cozens, 2008b).
Garden (2008) and Halpern (2007) have stressed the importance of empathy and
humility in medical training related to doctor-patient relationships. According to Halpern
(2007), in medicine, empathy traditionally refers to a “purely cognitive understanding of
patients' emotions—a special professional detached concern” (p. 696). However,
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emotionally engaged physicians communicate more effectively, suggesting a need for
increased training in empathy and emotion.
Haidet et al. (2002) reported that students in later years of medical school exhibit
more doctor-centered and paternalistic attitudes than students in earlier years of training.
This suggests that the structure of medical education encourages the development of
these attitudes even when they did not previously exist. According to Haidet et al. and
Clucas (2011), the structure of medical education undermines attempts to encourage
patient-centered healthcare and to increase patient satisfaction, as medical students
become more disease-focused as they advance through their education. Garden (2008)
hypothesized that factors contributing to this issue include long work hours and sleep
deprivation among medical students, as well as stress and burnout in medical
professionals. Garden also identified the following aspects of medical education that may
contribute to an objectification of the patient: cadaver dissection, an emphasis on basic
science, and a reliance on medical technology at the expense of listening to the patient’s
story (p. 122).
The medical education system is also related to gender bias among medical
professionals. The educational culture, in which only objective, measurable data are taken
into account in diagnosis and treatment decisions, results in a general unwillingness
among medical professionals to discuss gender issues (Risberg, Hamberg, & Johansson,
2006). According to Risberg et al., the valuation of the biomedical framework above
other perspectives leads to a negative attitude toward gender perspectives, and thereby to
gender bias.
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Sherwin (1992) asserted that physician training is based on stereotypical views of
women as people who are “excessively anxious, devious, and unintelligent; they are
taught not to take all women’s complaints seriously” (p. 224). In an analysis of medical
training material, including textbooks and examination questions, Reichenbach and
Brown (2004) discovered gender stereotypes and patriarchal views. A subsequent study
by Dijkstra, Verdonk, and Lagro-Janssen (2008) revealed scarce or absent genderspecific information in medical textbooks on internal medicine, cardiology,
pharmacology, and psychiatry. Similarly, in a review of 257 case descriptions written for
medical training, only 7% mentioned sex differences (Hamberg & Larsson, 2009).
In their discussion of gender awareness in medicine, Verdonk, Benschop, de
Haes, and Lagro-Janssen (2009) suggested a need for a structural embedding of gender
into medical education. Similarly, Risberg, Johansson, and Hamberg (2009)
recommended that role-playing activities and case discussions involving gender
perspectives be incorporated into the training of medical students.
According to Blanch, Hall, Roter, and Frankel (2008), female medical students
are more likely to display anxiety and to lack confidence in their skills than male medical
students. This is true despite evidence that female medical students perform as well as
males in academic competence and better in patient-centered clinical communication. In
a study of first-year medical students, Moffat, McConnachie, Ross, and Morrison (2004)
reported similar findings. In the study, female students reported experiencing more stress
regarding their personal competence, learning the curriculum, and assessment.
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Additionally, Cleland, Foster, and Moffat (2005) found that female students were more
apprehensive about communication than males.
Greater anxiety during medical education may contribute to issues with later
professional confidence. According to Gude et al. (2005), male medical students more
strongly identify with the role of doctor than females on completing medical school. The
researchers analyzed the factors contributing to this outcome, revealing that only females
took confidence in their own knowledge into account when assessing the extent to which
they identified with the role of doctor.
Blanch et al. (2008) discussed the reasons that female medical students experience
more anxiety and less confidence during their medical educations. The authors suggested
that males and females experience medical school differently. Evidence indicates that
females are more frequently subjected to gender discrimination and sexual harassment,
which could increase their anxiety over time. Additionally, female socialization may
include a greater degree of acceptability with regard to expression of feelings,
vulnerability, and humility. The latter explanation suggests that females could be as
confident as males in their knowledge and abilities, but less readily express this
confidence due to a higher value placed on modesty.
Economics
As the biomedical focus in medical training perpetuates traditional doctor-patient
relationships (Celik et al., 2009), the structure of the healthcare system introduces
economic issues that can act as barriers to collaborative doctor-patient relationships.
Physicians who have the ability and interest to communicate effectively with patients
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may not have time or resources to engage in such communication or to develop patientcentered practices. According to Balsa and McGuire (2001), physicians have less time to
spend with patients due to financial and administrative concerns. This can result in a
decrease in the quality of healthcare and the perpetuation of traditional, hierarchical
relationships between physicians and their patients.
According to Hearn (2006), the economics of modern medicine make it
particularly difficult to accommodate informed and active patients. The demands of
economic efficiency conflict with a respect for patient autonomy. Informing patients and
cooperatively working on a treatment plan is time-consuming, and the informed patient
tends to be demanding. Although physicians report supporting patient participation and
cooperation, they often behave according to the traditional paternalistic model due to a
heavy work load, staff shortages, and practical concerns such as reducing healthcare costs
and avoiding malpractice lawsuits (Hearn, 2009; Sherwin, 2000).
Evidence suggests that, on average, female medical consultants complete fewer
cases per year than their male counterparts. Firth-Cozens (2008b) has argued that this
may be related to the tendency for female doctors to be more patient-centered, spending
longer in consultation with each patient than men do. Seeing fewer patients could
translate to lower income, increasing the extent to which females experience economic
limitations. Additionally, if consultants work in groups, a greater proportion of income
could be allocated to the most senior team member, who is more likely to be a male.
Firth-Cozens (2008a, 2008b) noted, however, that the increased incidence of discipline
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and litigation among male doctors could offset these differences with regard to financial
concerns.
Although women often excel compared to men in areas related to developing
strong doctor-patient relationships (Firth-Cozens, 2008b), this advantage does not
necessarily translate to increased value. Nicoletti (2006) reported research indicating that,
although patients claim to value strong doctor-patient relationships, they are often
unwilling to pay more or drive further to visit doctors with whom they could develop
such relationships. Nicoletti noted, however, that the existing research studying doctorpatient relationships from an economic perspective is insufficient.
The Culture of the Medical Profession
Beyond medical education and practical economic concerns, the prevailing
culture of the medical profession continues to encourage the attitudes that characterize
ineffective communication between physicians and their patients. Research by
Vanderford et al. (2001) indicated that the traditional medical culture has encouraged
physicians to respond to patients in a paternalistic and authoritative fashion in the face of
conflict with patients. In narratives collected by Vanderford et al., medical professionals
explained that when patients had differing views of treatment, they attempted to persuade
patients to accept their advice. Patients who refused the medical professionals’ advice
were described as “difficult” and “insistent.” These trends can also be seen in the
marginalization of women and de-emphasis on chronic illness within the medical world.
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Marginalization of Women
As previously noted, the traditional doctor-patient relationship involves a
marginalization of women, which is partly a result of the historical view of women as
overly emotional. In addition, it has been argued that the medical profession encourages a
normative, gendered view of illness, which results in a perceived need for women to
work harder in order to be perceived as credible patients (Werner & Malterud, 2003).
The gendered view of illness is exemplified by Kempner’s (2003) discussion of
the common perception of migraine as a women’s illness, which is due in part to the
higher incidence of migraine among females. The author reviewed evidence suggesting
that gendering migraine has a significant impact on health and doctor-patient
relationships. Diagnosis rates and the perception of the legitimacy of migraine complaints
among female and male patients are affected. Munch (2004) noted that many such
gender biases in diagnoses were uncovered by second-wave feminist research between
1970 and 1995.
The cultural marginalization of women in healthcare extends not only to female
patients, but to female doctors and nurses, as well. Due to women’s history of oppression
and the nature of medical training, it is not uncommon for women entering medical
professions to maintain patriarchal attitudes (Carter, 1994). This phenomenon is
particularly evident in nurse-physician relationships. According to Carter, there are
“unspoken rules of communication” between nurses, who are primarily female, and
physicians (p. 368). These rules require nurses to refrain from disagreeing with
physicians and place a low value on nurses’ suggestions. However, it is not clear that
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gender bias accounts for all interactions between nurses and physicians. In a surveybased study of 125 nurses, Rothstein and Hannum (2007) found that nurses had similar
perceptions of female and male physicians with whom they interacted, suggesting that
professional differences play a role in addition to gender differences.
Kilminster, Downes, Gough, Murdoch-Eaton, and Roberts (2007) pointed out that
gender bias in research may contribute to the uncertainty regarding women’s place in the
medical field and the effect of changes in gender composition within the field. In an
extensive review of literature related to women in medicine, the authors found little
strong evidence of gender differences in practical areas of healthcare. Instead, gender
expectations in education and clinical practice were found to have a larger effect. The
researchers concluded that there has been very little research specifically focusing on
male doctors. Research practices are already gendered, treating women as the subject to
be examined.
Some suggest, in contrast to Kilminster et al. (2007), that gender-aware research
practices are positive. For example, Munch (2004) conducted a review of literature
related to second-wave feminist approaches to diagnoses from 1970 to 1995. The review
revealed that feminist perspectives were instrumental in uncovering a number of areas
where gender bias problematically affects women’s healthcare. Gender awareness in
research, therefore, may be important in uncovering areas in which the culture of the
medical profession marginalizes women.
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Treatment of Chronic Illness
Another cultural factor contributing to problematic doctor-patient relationships
relates specifically to patients with chronic illnesses. According to Chrisler (2001), the
culture of the medical profession is not supportive of chronic illness, as evidenced by the
belief among physicians that, for example, women over-report pain, and that vague
symptoms are unworthy of serious consideration. Instead of crediting patients’ reports
about their conditions, medical professionals tend to focus on acute conditions and
verifiable complaints.
Martin and Peterson (2009) defined chronic illness as “a state or passage of care
for long-term pain and suffering that may not be cured” (p. 579). These authors discussed
the social context of chronic illness from a constructionist perspective. Perhaps more than
other medical complaints, chronic illnesses require a highly personal process of meaning
construction. According to the authors, proper management of illness involves active
interpretation, not “simple biomedical labeling” (p. 580). Although doctors may provide
interpretations of chronic illness, biomedical interpretations cannot help patients
understand and experience the illness and long-term treatment. Additionally, the culture
of the medical profession may encourage patients to withhold details of their experiences
of chronic illness from physicians in order to avoid being judged as complaining.
Even when medical professionals do take patients’ experiences into account, there
is evidence suggesting that they interpret experiences according to rigid models. Telford,
Kralik, and Koch (2006) conducted a review of literature related to the view of patients
with chronic illness as understood through the terms acceptance and denial. The
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researchers found that medical professionals tend to place patient experiences within this
framework, even when the experiences do not fit the framework. According to the
authors, this tendency may affect patients’ understanding of their own experiences and
cause them to internalize predefined labels in their self-understanding. This suggests that
preconceptions and biases related to chronic illness may have a significant effect on
learning to cope with chronic illness.
The medical profession’s inability to address chronic illness in a meaningful way
and to place little importance on chronic pain may interact with the marginalization of
women, placing female patients with chronic illness and disability at risk of receiving
inadequate treatment (Thomas, 2001). Fernandes et al. (2006) suggested that
understanding and constructing meaning for chronic illness may be particularly important
for women because issues related to the body are instrumental in the formation of female
self-identity. This underscores the impact that gender has in every area of the medical
profession and its culture.
Gender Differences in Communication
With regard to conversation during medical consultations, evidence suggests that
there is a significant disparity between the communication styles preferred by patients
and those preferred by physicians. Platt (2008) reported some of this evidence, noting
that doctors commonly complain about verbose patients who tell long stories when
doctors ask questions. Additionally, Platt noted that doctors use their authority to
encourage patients to communicate in the doctors’ preferred styles, resulting in patient
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dissatisfaction. Doctor-patient relationships are affected by communication, and gender
differences in communication styles could amplify these effects.
Women’s communication patterns may be ill-suited to the logical structure of the
diagnostic tree used by physicians. Research indicates that men and women communicate
differently. These differences in communication may present a persistent obstacle to
effective communication between doctors and female patients. For example, Tannen’s
(2007) study revealed that women use conversation to generate intimacy, whereas men
use conversation to create or maintain their status in a group. These differences may
influence how physicians and patients interact within a professional setting. For example,
a meta-analytical review conducted by Roter et al. (2002) revealed that female doctors, as
opposed to male doctors, are more patient-centered, have longer consultations, show
more partnership behaviors, engage in more positive and emotionally focused talk, ask
more psychosocial questions and counsel more psychosocially, and encourage their
patients to speak more. A second review conducted by Roter and Hall (2004) reinforced
this notion.
Hamberg et al. (2004) argued that gender differences in medical treatment can be
partially explained by gender differences in communication. For example, whereas men
tend to describe their symptoms in a frank and confident manner, women often give
generalized descriptions of their symptoms. In addition, according to research by
Hoffmann and Tarzian (2001), women use contextual information (e.g., impact on
personal relationships) in their symptom reports, while men’s reports focus on objective
descriptions of physical symptoms. According to Hoffmann and Tarzian, these
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differences may be due to differences in socialization experiences. Similarly, Stewart et
al. (2003) noted that appropriate communication guidelines for men and women are
learned during the cultural socialization process. Women’s style of communication,
therefore, may not be compatible with the traditional medical interview model utilized by
most physicians (Hoffmann & Tarzian, 2001).
These issues may be ameliorated, however, when female patients are treated by
female physicians. In a study by Copeland et al. (2003), female health providers were
perceived as listening more and as being easier to talk to about a wider range of topics.
Female patient participants expressed the belief that it is harder to explain health
concerns to a man than to a woman, and that it is unlikely that men would understand
their concerns. Participants indicated that women providers were preferred primarily
because they were perceived as listening more and as being easier to talk to about a wider
range of topics.
Research examining gender-related communication differences in medical
students has revealed that female medical students perform better on measures of
interpersonal skills and communication performance than males (Bienstock, Martin,
Tzou, & Fox, 2002; Laidlaw et al., 2006; Wiskin, Allan, & Skelton, 2004; Yudkowsky,
Downing, & Ommert, 2006). These findings are consistent with findings related to
female practitioners, suggesting that women have stronger communication skills
throughout their medical careers.
Although gender differences in communication have positive implications for
female physicians, female patients may be at a disadvantage. According to Ivy and
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Backlund (2008), women have been shown to be more tentative and less confident in
their communication than men. The authors suggested that this could make females seem
uncertain and incompetent in their speech. For female patients, this could increase the
likelihood that their medical complaints will not be taken seriously.
As an example of the tentative communication style, Ivy and Backlund (2008)
discussed tag questions such as in the sentence, “This is a really beautiful day, don’t you
think?” According to the authors, such questions are primarily intended to elicit
agreement from the listener. Lakoff (1975) described tag questions as a form of “apology
for making an assertion at all” (p. 54) and argued that they represent a lack of
assertiveness more indicative of the female communication style. In addition to tag
questions, Ivy and Backlund (2008) described a number of other communication devices
stereotypically associated with women. This indicates that the female communication
style, in addition to systemic gender bias, may contribute to the tendency for medical
professionals to devalue women’s complaints, particularly when those complaints are
vague or difficult to describe or diagnose.
Diffuse Complaints and Difficult-to-Diagnose Conditions
As noted above, the traditional gender-biased culture of the medical field results
in a tendency for doctors to assume that women’s reports of pain are exaggerated or
psychosomatic (Hamberg et al., 2004; Hoffmann & Tarzian, 2001). This often results in
misdiagnosis or lack of appropriate treatment (e.g., Elderkin-Thompson & Waitzkin,
1999). Consequently, women with diffuse and persistent complaints due to a chronic or
difficult to diagnose illness may experience difficulties in their relationship with their
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doctors and with their treatment experience. This is supported by extensive research on
chronic illnesses such as lupus, fibromyalgia, and chronic fatigue–all of which share
similarities with thyroid disease (Darer et al., 2004; Kralik et al., 2005; Martin &
Peterson, 2009; Richman & Jason, 2001; Telford et al., 2006).
According to Werner and Malterud (2003), doctors report having difficulty in
managing consultations involving uncertainty and unexplained conditions. As a result,
patients, particularly female patients, report feeling ignored, belittled, and rejected in
such consultations. Similarly, Hartman, Borghuis, Lucassen, Laar, and Speckens (2009)
found that physicians find it difficult to communicate medically unexplained symptoms
to patients, so they use metaphors and nonspecific language, which can have a negative
effect on doctor-patient relationships. Martin and Peterson (2009) stated, “the role of the
doctor is to take undifferentiated or unorganized illness and to arrive at an organized
illness (more latterly a diagnosis)” (p. 581). However, evidence indicates that doctors
often have difficulty accomplishing this task.
Lupus. Chrisler and Parrett (1995) have noted that Systemic Lupus
Erythematosus has been found in the last 40 years to be fairly common, that women are 5
to 10 times more likely than men to be diagnosed with the disease, and that women of
color are disproportionately affected. Because the disease can arise at any time and can
affect any of a number of internal systems, it is often difficult to diagnose. Lupus
resembles many other diseases, and has as a result been called “the great impostor”
(Chrisler & Parrett, 1995). Diagnoses are often uncertain, and there is no definitive test to
determine the presence of lupus. Unsuccessful treatment is also common, and lupus
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patients have been found to experience a number of psychosocial consequences,
including elevated levels of depression, lowered self-esteem, changes in sexual function,
and lowered body-image. These issues can be particularly troublesome for women, who
have complained that doctors focus on their ability to be reproductively active (Chrisler
& Parrett, 1995). Psychosocial factors such as support from others and physician help
with coping strategies may help patients deal with the disease.
In a study of women living with lupus, the factors most frequently cited as
contributing to the struggle with the disease were uncertainty, an altered sense of identity,
and managing the financial burden (Mendelson, 2006). This suggests that, in addition to
biomedical issues, effective care for individuals with lupus could include mental and
emotional support.
Fibromyalgia. Female patients with fibromyalgia have consistently reported
being questioned by doctors as to the legitimacy of their symptoms. Patients report that
physicians judge their symptoms to be psychosomatic. As a result, patients employ
strategies to make doctors take them seriously (Werner & Malterud, 2003). This can have
negative effects on doctor-patient relationships, particularly when patients become wary
of honestly discussing their symptoms and the psychosocial effects of those symptoms
(Peters et al., 2008).
In an analysis of the experiences of 10 women with chronic pain, Werner and
Malterud (2005) sought to examine issues related to patient empowerment and how
doctors can help patients deal with their difficult to diagnose symptoms. Ultimately,
many of the women in the study were diagnosed with fibromyalgia. The researchers
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discussed the feelings of helplessness doctors experience when faced with patients who
have conditions about which little is understood. Additionally, the authors noted that the
way in which women are encountered and their symptoms addressed can have an effect
on their level of empowerment in coping with their medical issues. Even in cases where
diagnoses are uncertain, physicians who take women’s complaints seriously can help the
patients overcome feelings of vulnerability that exacerbate their difficulties.
Chronic fatigue syndrome. Chronic fatigue syndrome (CFS) is an autoimmune
disorder that affects women in much greater proportion than it does men (Richman &
Jason, 2001). The primary symptoms of CFS include impairment in short-term memory
or concentration, unrefreshing sleep, sore throat, new headaches, and muscle pain,
making the condition particularly difficult to diagnose as a result of the diffuse and
uncertain nature of these symptoms. As is the case with lupus and fibromyalgia, there are
no standard diagnostic criteria and the treatments developed to date have limited success.
According to Richman and Jason (2001), CFS involves a number of psychological
consequences for patients. These include placing an exaggerated importance on rest and
mistakenly assuming that they are more impaired than they are. The authors noted that,
from the perspective of the medical profession, CFS is often viewed as a psychogenic
illness wherein patients adopt the role of a sick individual in order to avoid accepted
social roles and responsibilities. As a result, according to Johnson (1996), the medical
profession has tended to trivialize CFS. In one case, male physicians to whom female
patients with CFS had been referred claimed that the referring internist had been
performing “million dollar workups on neurotic women” (p. 3). As with lupus and
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fibromyalgia, CFS patients are at risk of feeling “humiliated and ashamed instead of
empowered and understood” by physicians (Allan, 1995, p. 17).
Richman and Jason (2001) addressed CFS from a feminist social constructionist
perspective. The authors drew attention to the role of gender dynamics in explaining the
differences between physicians’ and patients’ perceptions of the disease. Literature
related to CFS from the perspective of the medical profession has focused on describing
the disease as primarily psychosomatic and stress-related, whereas patients have
emphasized the physical nature of the condition. The researchers concluded that an
increased focus among practitioners on the biomedical side of CFS could result in
identifying biological indicators, which could lead to a less dismissive attitude toward
patients with CFS.
Review of Literature Related to Methodology
Quantitative Research
Although it can be difficult to quantify issues like gender bias and doctor-patient
relationships as they pertain to chronic illness, a good deal of quantitative research
literature exists on these topics. Existing quantitative studies can generally be placed into
one of three common categories.
The majority of quantitative studies are descriptive or correlational in nature,
employing self-report surveys to measure specific variables and examining whether
relationships exist between them (e.g., Auerbach et al., 2002; Krupat et al., 2000). One
such study was conducted by Krupat et al. (2000). The researchers used the PatientPractitioner Orientation Scale (PPOS), which is designed to measure patient role
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orientations by assessing patients’ attitudes regarding doctor-patient relationships and
doctors’ interaction styles. The results indicated that patient-centered approaches resulted
in higher patient satisfaction with the doctor-patient relationship. The researchers argued
that, because this was the expected result, the PPOS was shown to be a useful tool for
predicting patient satisfaction. In general, results from such studies are strongly
conclusive and provide the clearest direction for future research. The Krupat et al. (2000)
study, however, has a significant weakness in that the participants responded to
researcher-developed scenarios related to doctor-patient relationships, and these scenarios
may have been structured or worded such that respondents were influenced to prefer the
patient-centered scenarios. This indicates that, although survey-based quantitative studies
can yield strong data, careful analysis of research design is necessary.
Another common method uses survey instruments in conjunction with coding of
recorded observations, such as physician visits (e.g., Street et al., 2007; Zandbelt et al.,
2006). For example, Zandbelt et al. (2006) videotaped 323 patients visiting 30 physicians
at an internal medicine clinic in the Netherlands in order to determine factors influencing
patient-centered behavior. The doctors’ behaviors during the visits were coded according
to a predesigned instrument and analyzed alongside data from surveys completed by both
the patients and the doctors. The researchers noted that, although they found significant
correlations, physicians may have behaved differently in consultations knowing that they
were being recorded. This is an issue that affects studies with similar designs; findings
from such studies can be difficult to interpret due to the quasi-experimental nature of
recording research environments.
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Finally, some quantitative studies reviewed employed descriptive designs wherein
narrative or open-ended data were coded by researchers and the resulting data subjected
to various statistical analyses. For example, Hamberg et al. (2004) conducted a study to
determine whether difference existed in the way male physicians treat irritable bowel
syndrome (IBS) as compared to female physicians. The researchers coded open-ended
treatment plans created for a hypothetical case of IBS. Coded variables included those
related to lifestyle advice, colon X-rays, proposed diagnoses, and others. The results
showed that there existed significant gender differences in the treatment plans. Although
this research design has the potential to reveal novel and unexpected aspects of the
research topic, quantitatively coding and analyzing open-ended narrative data can be
complicated and controversial (Hamberg et al., 2004), calling the validity and usefulness
of results into question.
One of the primary strengths of quantitative research is its ability to accommodate
large sample sizes. The quantitative studies reviewed for this chapter had sample sizes
ranging from 30 to 387 participants. By contrast, qualitative studies reviewed had sample
sizes as small as four participants. Most quantitative methods do not require researchers
to spend much time with each participant, and participants can self-administer surveys
simultaneously, allowing researchers to gather and analyze a large amount of data. This
also allows study samples to be more diverse, contributing to the generalizability of data.
For example, the study conducted by Hamberg et al. (2004) incorporated a nationwide
sample of Swedish physicians, all of whom had to take the national exam of which the
study measure was a part.
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A further benefit of quantitative research is that quantitative meta-analyses of
smaller studies can be conducted to discover general trends. One such meta-analysis was
conducted by Roter et al. (2002). The researchers synthesized a number of small studies
related to gender effects in medical communication. By gathering data from smaller
studies, the researchers were able to discover a broad tendency for female physicians to
spend more time in communication with patients. This method allows researchers to draw
more generalizable conclusions from existing data.
Although quantitative studies like those reviewed above can be useful in
determining general trends and providing information about the effectiveness of general
practices understood broadly, quantitative research methods do not yield rich narrative
data (Creswell, 2007). Qualitative research methods, on the other hand, produce the rich
narrative data necessary for discovering information related to complex interactions
between individuals and complex associations between illness and psychosocial factors.
As mentioned previously, from a social constructionist perspective, concepts of health
and illness are socially constructed and subject to varying degrees of consensus and
interpretation based on cultural factors and social norms (Hearn, 2009; Lupton, 2003). In
addition, patients’ interpretations of their illness influence their feelings, reactions, and
behaviors (Docherty & McColl, 2003; Fernandes et al., 2006). Thus, a qualitative
research approach is most appropriate for exploring the treatment experiences of women
with thyroid disease. Such an understanding could prove helpful in better determining the
needs of female thyroid patients and therefore lead to prompt, accurate diagnosis and
effective treatment.

73
Qualitative Research
Among research studies adopting a social constructionist perspective, qualitative
methods are much more common (Creswell, 2007). One reason for the prevalence of
qualitative methods in research related to chronic illness and therapeutic experience is the
ability of qualitative studies to yield descriptive, narrative data that includes nuances and
complexities of individual situations. Docherty and McColl (2003) conducted a study
examining the use of narrative as a way to understand chronic illness. The study used a
phenomenological methodology, eliciting descriptions of experiences from the
participants and interpreting them under a social constructionist framework. The
researchers identified issues that commonly arose in patients’ narrative accounts of their
illness: emotional reactions to diagnoses, impact of stress, views of death, and the
meaning of the illness. Such themes often do not arise in quantitative research, but can be
instrumental to understanding the disease experience among people with chronic illnesses
such as thyroid disease.
A number of qualitative studies related to female patients’ experiences with
chronic illness have been conducted (e.g., Copeland et al., 2003; Kralik et al., 2004;
Kralik et al., 2005; Werner & Malterud, 2003). Qualitative methods have also been used
frequently to study doctor-patient relationships and women’s healthcare experiences (e.g.,
Houle et al., 2007; Werner & Malterud, 2005).
Of the qualitative methods used in literature reviewed for this chapter,
phenomenology is the most common by a wide margin. Because phenomenology is used
to study individuals’ personal experiences, this is a logical choice for research related to

74
doctor-patient relationships, a topic that is closely connected with how those involved
experience their interactions. Furthermore, much research related to chronic illness
adopts the specific goal of understanding how patients experience illness in order to
improve treatment. Thus, the lack of non-phenomenological qualitative methodologies
(i.e., narrative, case study, ethnography, and grounded theory) in the existing literature
does not necessarily indicate that the literature is methodologically impoverished.
Within the phenomenological research reviewed, several specific approaches
were used. The most common type of design employed structured, semi-structured, or
open-ended interviews (Docherty & McColl, 2003; Kralik et al., 2004; Werner &
Malterud, 2003, 2005). Interviews allow participants to share their views about the
research topic directly with researchers and allow researchers to be flexible in the specific
aspects of the topic that they address, probing each participant in order to reveal complex
information. One example is a study conducted by Docherty and McColl (2003). The
researchers interviewed four persons with chronic illness. Two participants were male,
three were Caucasian, and they ranged in age from 29 to 74. The purpose of the study
was to explore patients’ experiences of chronic illness. From the interviews, the
researchers identified four themes relevant to understanding the experience of people
with chronic illness. Although these themes contribute to a robust understanding of the
research topic, the small participant pool and qualitative nature of the findings make
studies like this difficult to apply to future research and practice.
In addition to interviews, focus groups are common among studies examining
doctor-patient relationships and chronic illness (Copeland et al., 2003; Houle et al., 2007;
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Kralik et al., 2004; Kralik et al., 2005). These guided discussions allow multiple
participants to describe their experiences at once in dialogue with one another. Although
focus groups are typically conducted in person at a scheduled time, researchers have also
used e-mail discussion groups. Kralik et al. (2005) conducted a study related to women’s
experience of chronic fatigue in order to fill a gap in qualitative understanding of the
topic. Thirty women whose ages ranged from 21 to 65 participated in an e-mail
discussion group with the researchers. The researchers noted that the primary strength of
this design was that it allowed participants to be more reflective and go into more detail
in their responses than face-to-face focus groups would have allowed. Additionally,
participants were free to contribute at their leisure and were not constrained by a specific
meeting time. Although participants’ responses were revealing, the researchers did not
present a list of themes that arose during the discussion. In general, however, focus
groups can be useful because participants may collectively emphasize particularly
important aspects of the topic of discussion.
In one study conducted by Kralik et al. (2004), data were collected through
interviews, focus groups, and solicited autobiographies. The sample consisted of nine
people with arthritis who volunteered for the study in response to a newspaper
advertisement. The researchers asked the participants to create autobiographies in which
they described their experiences as persons with chronic illness. These open-ended texts
allowed participants the freedom to express their experiences in any way they chose and
in detail. The autobiographies became the basis for phone interviews and a discussion
group. This study clearly underscores the strengths of qualitative research; using three
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types of data allowed the researchers to identify themes and meanings on multiple levels,
and participants validated the researchers’ interpretations during the discussion group.
However, because participants self-selected, they could have been already eager to share
negative healthcare experiences, whereas more satisfied patients might not have been
interested in participating. Because qualitative research is not widely held to be
generalizable to broader populations, participant selection becomes extremely important
in generating useful findings.
Despite the number of qualitative studies related to doctor-patient relationships
and chronic illness, there exist no studies in this area related to women with thyroid
disease specifically, and even in studies that mention chronic illness generally, thyroid
disease is rarely mentioned. In addition, these qualitative studies often have small sample
sizes. One study sampled only four participants (Docherty & McColl, 2003), and the
other studies ranged in sample size from nine to 50. Small samples make it difficult to
generalize results, particularly since the narrative nature of data relates intimately to
participants’ individual experiences.
Due to the limited complexity of quantitative data and to the gap in qualitative
research related to women and thyroid disease, a qualitative approach was appropriate for
this study.
Data Collection Methods
Several methods of data collection were considered in the design of this study. In
addition to traditional face-to-face interviews, the options included interviews by
telephone or Webcam and voice-over-internet-protocol (VOIP), synchronous online
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interviews, and asynchronous online interviews. When synchronous methods are used,
researcher and participant(s) interact in real time (Ayling & Mewse, 2009). Telephone
interviews and conferences, chat using Webcam, and Internet text-based chat are
synchronous methods, as are traditional face-to-face interviews. Most asynchronous
online research employs e-mail, in which the researcher sends a group of questions to the
respondent, who replies when it is convenient to do so and sends the answers back to the
researcher, follows up in a subsequent e-mail, and continues to do so until all questions
have been answered. Asynchronous group discussions can use a similar approach by
making use of mailing lists, bulletin boards, and Internet forums (Ayling & Mewse,
2009).
There are a number of advantages and disadvantages to using any format for data
collection. Compared to online interviews, face-to-face interviews provide the researcher
with the opportunity to build a personal rapport with the participants, encouraging them
to talk freely about their experiences. Face-to-face interviews also enable the researcher
to validate the truthfulness of responses by observing body language and tone of voice
(Arksey & Knight, 1999; Bianco & Carr-Chellman, 2002). A disadvantage of in-person
face-to-face interviews is that limitations on the researcher’s ability to travel to the
interview site may result in a skewed or insufficient sample; this limitation does not apply
in the case of telephone and VOIP interviews. In contrast to asynchronous interview
methods, moreover, synchronous interviews of all types allow the researcher to seek
immediate clarification of points or additional information from participants if necessary
(Arksey & Knight, 1999). Online qualitative methods can be particularly advantageous in
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accessing hard-to-reach groups such as the elderly, disabled, housebound, or
geographically distant (Bianco & Carr-Chellman, 2002), as well as individuals and
groups who might not be forthcoming in other settings (Ayling & Mewse, 2009). Another
advantage to online methods is reduced travel and transcription costs, although
researchers should not choose an approach to data collection based on cost alone, but
should “allow our research question to drive the choice” of methods (Bianco & CarrChellman, 2002, p. 253).
Disadvantages of online interview methods, both synchronous and asynchronous,
include the possibility that relationships between researcher and participants may be
tenuous at best and that, except for Webcam chat, the opportunity to observe facial and
body language of the participants will be lost (Bianco & Carr-Chellman, 2002). Lack of
ability to observe the participant may become an issue particularly when discussing
sensitive topics (Davis, Bolding, Hart, Sherr, & Elford, 2004); however, researchers who
are at home in the online environment may be able to discern participants’ feelings from
other cues, such as terse responses in an otherwise forthcoming interviewee (Ayling &
Mewse, 2009). Another concern is for participants’ confidentiality, which may be
endangered if encrypted software is not employed (Ayling & Mewse, 2009; Crompvoets,
2010). However, this limitation can be controlled in the case of synchronous chat if
participants are advised to use fictitious screen names and anonymous e-mail accounts to
protect their identities (Ayling & Mewse, 2009). In the case of asynchronous forums or
bulletin boards, it is very difficult to find a platform that is controlled by the researcher;
as Crompvoets (2010) noted, “Finding the right tool was far from problematic [sic] as
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many that are freely offered, Google groups, for example, remain public property and
others, while potentially more secure, require an e-mail address from the participant to
register” (p. 206). The potential loss of confidentiality arising from the need for an e-mail
address can be controlled in the case of online forums and chat programs by having
participants use a fictitious name and e-mail address. Further, the anonymity of Internet
research, which may reduce the problem of socially desirable responding, may also
encourage individuals to participate more than once, especially if incentives are offered
(Bowen, Williams, & Baird, 2008). However, the problem of repeat responding is most
likely in online survey research that has a monetary incentive, as individuals can easily
fill out an online survey more than once; in one study that specifically examined the
problem, repeat responding did not occur in the non-incentivized arm of the study
(Bowen et al., 2008). In contrast to face-to-face interviews, online chat interviews can be
very time-consuming to conduct (Hinchcliffe & Gavin, 2009), although this disadvantage
may be compensated by the time saved by not having to transcribe the interview.
One of the chief goals of qualitative research is to collect rich data from which
emergent themes can be derived (Creswell, 2008). Thus, it has been speculated that one
of the potential limitations of using online chat, which involves typing questions and
answers, could be that abbreviated responses might be forthcoming that do not lend
themselves to in-depth analysis (Bianco & Carr-Chellman, 2002). Actual findings
contradict this concern. Ayling and Mewes (2009) reported that despite the relative
slowness of typing,
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Several participants were able to provide large amounts of text with minimal
prompting by the researcher; one notable interview continued for 3 hours,
producing 359 lines of transcribed text. Although this volume is considerably less
than for spoken interviews, transcripts had a particularly “condensed” feel about
them, and often one line of text contained two or more emergent themes….(p.
570)
On the other hand, participants who become uncomfortable or otherwise
disengaged can more easily end the interview (Barratt, 2011), which may necessitate a
larger potential sample to account for attrition. A concern with using an online forum, in
which the participation of more than one individual is the norm, is that too much data, or
data of the wrong sort, may be gathered (Crompvoets, 2010). This can be the case
because of the disinhibition that can occur in the online environment (Bowen et al.,
2008), and may lead to extraneous data.
Another concern that must be addressed in using Internet data collection methods
is that of sampling bias as a result of convenience sampling (Bianco & Carr-Chellman,
2002; Crompvoets, 2010). However, convenience sampling is a limitation in any study in
which random sampling of a large population is not possible, and in qualitative studies,
which do not seek to achieve generalizable results, it is perhaps less of an issue than in
statistical studies (Creswell, 2008). In qualitative research, the problem of a skewed
sample can be addressed, in part, by noting and discussing themes that are discrepant
from the main pattern of findings. Such an approach can enable the expression of
dissenting voices and divergent experiences (Ely, Vince, Downing, & Anzul, 1997).
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With the exception of archival designs, confidentiality and participants’ rights are
a major concern in all human subjects research, regardless of data collection method.
Online forums, as noted by Crompvoets (2010), pose a significant problem if the
researcher cannot establish ownership of the data. On the other hand, online chat software
such as X-IM software (see http://www.x-im.net/) makes possible encrypted, one-on-one
typed communication, and was used by Ayling and Mewes (2009) in their study of risky
sexual practices among gay men. Further, as noted by these authors, participants can be
advised to use anonymous e-mail accounts in order to log in to the software, thereby
enabling participants to remain anonymous.
To summarize, in judging which data collection method to use for the study, my
primary concerns were for the privacy and convenience of participants and for the ability
to collect rich and reliable data. Given that members of The Thyroid Support Group
(including myself) are accustomed to communicating in an online environment, as well
as the immediacy of online chat as an interviewing tool (Ayling & Mewes, 2009; Gaiser
& Schreiner, 2009), this method had great appeal. In addition, the ability of chat software
to transcribe the interview as well as the absence of hesitations and inaudible statements
characteristic of audiotaped interviews (Gaiser & Schreiner, 2009), led me to favor this
approach over other interview methods. Further, the potentially greater security of chat
software (Ayling & Mewes, 2009) made it superior to online forums and bulletin boards
(Crompvoets, 2010). The final concern, convenience, related to participants’ ability to
access a program and administrative rights for installing it on their computer (Gaiser &
Schreiner, 2009) did not seem insurmountable. For these reasons, I chose to use X-IM
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software to conduct individual, online, synchronous interviews with the participants in
my study.
Summary
This chapter was a review of the existing empirical and theoretical literature
related to the research topic. A description of the literature search strategy and an
overview of thyroid disease were followed by descriptions of the conceptual frameworks
for the study. This was followed by a thorough review of the literature on the doctorpatient relationship, the culture of the medical profession, gender differences in
communication, and diagnostic bias.
Thyroid disorders are often characterized by vague, diffuse symptoms that can be
difficult to diagnose. This presents a problem for patients seeking treatment within the
prevalent culture of the medical profession. These problems are particularly troublesome
for female patients, who are often met with sexism and marginalization in traditional
doctor-patient relationships. Although there is empirical evidence suggesting that a more
collaborative, nonsexist approach to individual healthcare is beneficial for both patients
and doctors, the traditional system persists for a number of historical, cultural, and
economic reasons.
This study expands upon the research on women’s health and adaptation to
chronic illness by looking at female thyroid patients’ experience of treatment and doctorpatient relationship, which has not been studied from a social constructionist/feminist
perspective. The social constructionist/feminist approach was chosen for the study
because it can take patients’ subjective illness experiences into account, and because it
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assumes that patients are experts on the phenomenological aspects of their conditions.
This contrasts with the traditional culture of biomedical education, practice, and research,
which overvalues verifiable, objective symptoms and conditions and undervalues
patients’ subjective reports (Hoffmann & Tarzian, 2001).
Regarding patient competence, Secker (1999) argued that, given the premium
placed on reasonableness, rationality, and understanding, and given the nature of
stereotypical views of women as emotional, irrational, and unintelligent, it is highly
likely that such views influence perceptions of women’s competence to make healthrelated decisions (p. 302).
The issue of patient competence is particularly important in cases related to
autoimmune disorders such as those that commonly cause hypo- and hyperthyroidism.
Such conditions can often be difficult to diagnose, and if physicians dismiss women’s
complaints due to sexism or traditional views of patient competence, misdiagnoses or
delayed diagnosis could result (Chrisler & Parrett, 1995). Indeed, women experiencing
vague and unexplained conditions have repeatedly reported feeling ignored and
disrespected by medical professionals. In order to contribute to the understanding of these
phenomena, their causes, and their potential solutions, the study will investigate the
doctor-patient relationships experienced by female thyroid patients. The following
chapter outlines the methodological approach and research design including a description
of the participants, instrumentation, and procedure.
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Chapter 3: Research Method
Introduction
As can be seen from the previous review of literature, no studies exist in the
chronic illness literature that are related to women with thyroid disease specifically; and
even in studies that discuss chronic illness generally, thyroid disease is rarely mentioned,
despite its pervasiveness in women. Thus, a gap in the literature exists regarding the
treatment experiences of women diagnosed with thyroid disease, and particularly their
experiences of the doctor-patient relationship. To address this gap, in this qualitative,
phenomenological study I examined female thyroid patients’ experiences of treatment
and the doctor-patient relationship and sought to answer the following research questions:
“What are the treatment experiences of women with thyroid disease?”; “How does the
doctor-patient relationship affect their experiences?”; and “Do their experiences differ
based on the doctor’s gender?”
The present chapter of this study contains an in-depth explanation of the research
approach, rationale, and design; participants; context of the study; role of the researcher;
research questions; data collection and instrumentation; data analysis; ethical protection
of participants; qualitative trustworthiness; and dissemination of findings. The chapter is
organized accordingly and concludes with a summary.
Research Approach, Rationale, and Design
Research Approach
Whereas quantitative research involves deductive reasoning, qualitative research
is inductive in that the researcher builds abstractions and concepts based upon the data
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collected (Creswell, 2007). The research questions in this study were best addressed via
qualitative methodology because the purpose of the study was to explore female thyroid
patients’ experiences of treatment and the doctor-patient relationship. According to
Marshall and Rossman (2006), human behavior cannot be fully understood without
knowledge of the framework within which people interpret their thoughts, feelings, and
actions (p. 53). Thus, the use of open-ended questions via individual online interviews
was an appropriate method for capturing the experience of the phenomenon (e.g., thyroid
disease; Creswell, 2007).
Creswell (2007) identified narrative, phenomenology, case study, grounded
theory, and ethnography as the five most commonly used qualitative research approaches.
The narrative approach provides a description of an event or events in a chronological
manner and is best used when the researcher wishes to focus on the experience of a single
individual or small group (Creswell, 2007). The narrative approach was ruled out in favor
of phenomenology because of my interest in exploring the experiences of unrelated
individuals involved in a common phenomenon or experience. Because phenomenology
involves several individuals rather than one individual or a small group and focuses on
the experiences of the participant and the meaning of those experiences (Creswell, 2007),
it was deemed more appropriate than the narrative approach. Grounded theory was also
considered, but because of its sociological focus on generating theory that is based on the
interactions of groups of people (Creswell, 2007), it was deemed inappropriate for this
study, in which I was not seeking to generate a theory and did not focus on group
interactions.
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As in grounded theory, ethnography involves examining individuals who share
the same process, action, or interaction (Creswell, 2007). In ethnographic research, these
shared patterns are examined within one cultural group. Neither grounded theory nor
ethnography were appropriate for the study, as unrelated individuals were examined
across cultures in order to learn about their individual experiences; not learned and shared
patterns of values, behaviors, beliefs, and language (Creswell, 2007, p. 68). Finally, case
study (one or more cases in a particular setting or context) was not broad enough for this
research because of its focus on in-depth examination of multiple data sources regarding
a single individual or site (Creswell, 2007). The participants in this study did not share a
common boundary in time or physical space and therefore cannot be considered a “case”
(Creswell, 2007). Because of the foregoing rationale, phenomenology was the chosen
method for the study.
Rationale
The phenomenological research approach was used because it involves examining
the meaning of experiences about a particular phenomenon (e.g., thyroid disease) across
several individuals who have experienced it (Creswell, 2007). The phenomenological
method originated in the philosophy of Husserl (1931). Phenomenological research is not
simply description and is not focused solely on themes or concepts (Van Manen, 1997). It
also can be inspirational, bringing the researcher to moments of insight. I chose to use the
Stevick/Colaizzi/Keen approach as modified by Moustakas (1994), a form of
phenomenological research that explicitly uses the experience of the researcher as a part
of the research and in which participants are regarded as coresearchers. The

87
Stevick/Colaizzi/Keen approach is further described in the section entitled “Data
Analysis.”
According to Creswell (2007), in qualitative research, the researcher is the
instrument; therefore, regardless of the method chosen, I would be a part of the research.
In Moustakas’s (1994) view of phenomenology, research is guided by four major
processes: epoche, phenomenological reduction, imaginative variation, and synthesis.
Epoche is a Greek word meaning “to refrain from judgment” and was first introduced in
the qualitative research literature by Husserl (1931) to describe the suspension of
“everyday understandings, judgments, and knowings” regarding the phenomenon being
studied (Moustakas, 1994, p. 33). By achieving a state of epoche prior to, during, and
following participant interviews, the researcher eliminates any of his or her
preconceptions regarding the phenomenon, thus allowing the phenomenon to be
examined in its purest form (Creswell, 2007; Moustakas, 1994).
Phenomenological reduction involves creating a textural description of what one
observes, both external and internal, regarding the phenomenon and its relationship to the
self (Moustakas, 1994). The lived experiences of the researcher and the participants are
vividly portrayed as individual depictions written by the researcher. Phenomenological
reduction is “called ‘phenomenological’ because it transforms the world into mere
phenomena. It is called ‘reduction’ because it leads us back (Lat. reducere) to the source
of the meaning and existence of the experienced world” (Schmitt, 1967, p. 61). In order
to fully comprehend the essence of the phenomenon, the researcher sets aside any
assumptions regarding the participants’ experiences (i.e., bracketing) and creates a list of
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all significant statements gathered during the interviews (i.e., horizonalizing; Creswell,
2007). All statements are initially given equal value and are organized into themes;
irrelevant or overlapping statements are later deleted (Moustakas, 1994).
Following phenomenological reduction, the researcher writes a structural
description of the phenomenon to represent how the phenomenon was experienced by the
entire group of participants (Creswell, 2007). This process, referred to as imaginative
variation, involves identifying underlying structural themes that account for the
phenomenon. By “approaching the phenomenon from divergent perspectives, different
positions, roles, or functions,” the researcher seeks to understand the “precipitating
factors that account for what is being experienced” (Moustakas, 1994, p. 97). Synthesis is
the final step, in which the researcher combines the textural and structural descriptions
into a composite depiction of the essence of the phenomenon (Moustakas, 1994).
According to Polkinghorne (1989), the synthesis should provide the reader with an
understanding of “what it is like for someone to experience [the phenomenon]” (p. 46).
In addition to Moustakas’s (1994) view of phenomenology, my understanding of
phenomenology has been enriched by Van Manen (1997), who developed five principles
that contribute to good phenomenological research: lived thoroughness, evocativeness,
intensity, tone, and epiphany. Lived thoroughness means that the phenomenon of interest
is concretely situated in the real world such that those reading the research document
recognize it as being rooted in true experience (Van Manen, 1997). Evocativeness refers
to language that enables the reader to understand the phenomenon through the senses, so
that it is part of their own experience. This is valuable because it gives the reader the
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feeling of being close to the research participants and helps bring them to life (Van
Manen, 1997). Intensity refers to an emphasis on key terms or expressions within the
research document. Intensity makes it possible for the reader to trace how the research
participant creates meaning out of the phenomenon. Intensification is the use of
repetition, but it also involves the use of evocative language to communicate fully (Van
Manen, 1997). Tone is the way a statement sounds, such as serious, funny, and so on
(Van Manen, 1997).
Van Manen’s approach (1997) is consistent with the university’s mission to effect
positive social change, as it emphasizes understanding lived experience in order to
change practice, whether in health care or teaching. Research and reflection focus on the
improvement of professional practice, so that change is built on reflectivity and is a
product of reflective engagement with the world. Thus, the nature of the researcherparticipant relationship gives rise to an improved doctor-patient relationship, in which the
doctor reflectively deals with patients, rather than treating them automatically or
prejudicially.
Research Design
Using online chat, I individually interviewed 16 female thyroid patients
(including myself) who were members of The Thyroid Support Group, an international
online support group for individuals with thyroid disorders. The recommended sample
size of a minimum of 10 participants for phenomenological research corresponds to the
traditional quantitative research designs based on statistical power analyses conducted by
Onwuegbuzie and Johnson (2004).
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Participants
The sample included 16 females aged 18 years and older, with a diagnosis of
thyroid disease, who were members of The Thyroid Support Group. The recommended
sample size of a minimum of 10 participants for phenomenological research corresponds
to the traditional quantitative research designs based on statistical power analyses
conducted by Onwuegbuzie and Johnson (2004). By aiming for at least 10 participants, I
was able to interview until data saturation occurred. Data are considered saturated when
interviewees introduce no new information or perspectives on the topic being examined
(Moustakas, 1994).
Selection of Participants
Criterion sampling was used in this study, as all participants were required to
meet specific criteria to be eligible for participation. According to Creswell (2007),
criterion sampling works well with phenomenological studies and helps with quality
assurance. The criteria for inclusion were as follows: (a) female, (b) age 18 years and
older, (c) with a self-proclaimed diagnosis of thyroid disease, and (d) a member of The
Thyroid Support Group. Since the prevalence of thyroid disease is much higher in women
than men (Canaris et al., 2000; Cassidy et al., 2002) and the purpose of this study was to
explore women’s treatment experiences, male group members were excluded from the
study. Due to the vulnerable nature of children, individuals who were under 18 years of
age were also excluded. Non-members of The Thyroid Support Group (e.g., spouse of
member) were excluded as well.
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Vulnerable participants. A number of participants considered vulnerable by the
university’s IRB may have been included, but were not targeted, in this study. The
following are descriptions of vulnerable populations and explanations for their potential
inclusion in this study: (a) Elderly individuals: Because the prevalence of thyroid disease
in women increases with age (about 20% in women over age 60; Godfrey, 2007),
eliminating participants over age 60 would have precluded those individuals who
experienced thyroid disease late in life due to an age-related decline in thyroid hormones.
(b) Pregnant women: Because thyroid disease is common in pregnant and postpartum
women, the experiences of these women are important for a detailed understanding of the
treatment experiences of women with thyroid disease; (c) Residents of a mental health
facility: Determining whether or not an individual is a resident of a mental health facility
would have required asking invasive questions unrelated to the study. In addition,
verification was impossible due to the nature of the Internet; (d) Mentally/emotionally
disabled individuals: Affective disorders commonly co-occur with thyroid disease. The
experience of an affective disorder in conjunction with thyroid disease is vital to
understanding the overall treatment experiences of women with thyroid disease; (e)
Individuals who might be less than fluent in English: The online support group from
which participants were obtained is international. Obtaining information from women
who have thyroid disease from various parts of the world may help to provide a universal
understanding of women with thyroid disease. However, because I do not speak any
languages other than English, the interviews were conducted in English. Therefore,
individuals who are not fluent in English were not included in the study; (f) Traumatized
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individuals: Determining whether or not an individual is traumatized would have required
asking invasive questions unrelated to the study; and (g) Economically disadvantaged
individuals: Some of the individuals in the online support group are low income and/or
have poor health insurance coverage. As such, some group members obtain much of their
treatment advice, medications, or both via the Internet. These individuals may help to
provide a more thorough understanding of women's treatment experiences.
Recruitment of Participants
Although I utilized the services of a colleague in data analysis and interpretation
(as discussed in the section “Qualitative Trustworthiness”), I was the only person to
recruit and interact with the group owner, group members, and study participants.
Permission was sought and obtained from the group owner-moderator of The Thyroid
Support Group via a letter of cooperation (see Appendix B), after which members of The
Thyroid Support Group were invited via an on-list e-mail to participate in the study (see
Appendix C). If more than 16 equally qualified individuals had offered to volunteer, I
would have selected the participants in the order in which their off-list e-mails were
received. However, more than 16 participants did not offer to volunteer for participation.
All participants were informed that they had the right to leave the study at any time for
any reason, without explanation.
Context of the Study
Data were obtained via individual interviews with members of The Thyroid
Support Group, an international online support group for individuals with thyroid
disorders (see http://health.groups.yahoo.com/group/The_Thyroid_Support_Group/),
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using the encrypted online chat software X-IM (see http://www.x-im.net/ for program
specifications). Per the requirements of the university’s IRB regarding conducting
research in an organization, a letter of cooperation (see Appendix B) was obtained from
the group owner-moderator to solicit group members for participation. Although
permission to solicit group members to participate in research was not required from the
group owner-moderator, I believed that requesting permission was perceived by the
owner-moderator as a gesture of respect and good will.
Role of the Researcher
I was the sole researcher involved with the recruiting, selecting, and interviewing
of participants, with entering transcripts into the ATLAS.ti software and saving the data,
and with the dissemination of the findings of the study. To help ensure data
trustworthiness and quality, I utilized the services of a colleague (on a voluntary basis) to
assist me with data analysis and interpretation. My colleague’s qualifications included a
PhD in English Literature, a Master’s degree in Counseling Psychology, and two decades
of teaching. She is also a technical editor and published author.
As the sole interviewer, I gathered data as a participant-observer, that is, as
someone who already held a position in the community before acting as an observer
(Creswell, 2007). As mentioned previously, the method of this study was
phenomenological because the research was inspired by my personal interest in and
experience with the phenomenon. Thus, my consciousness was the primary data analysis
tool (Creswell, 2007; Moustakas, 1994; Willig & Rogers, 2008). Because of my role as
designer of the study and collector and interpreter of data, it behooved me to discuss my
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role as the researcher in the study and to state any latent biases that might have affected
the study’s process and results.
The researcher’s self-examination process, termed reflexivity, involves
“confronting, and often challenging your own assumptions, and recognizing the extent to
which your thoughts, actions and decisions shape how you research and what you see”
(Mason, 2002, p. 5). Reflexivity allowed me, as a researcher, to discern and clarify how
my position shaped the research process and its interpretations (Willig & Rogers, 2008).
Willig and Rogers (2008) distinguished between personal and epistemological reflexivity.
Personal reflexivity has to do with the researcher’s own principles, beliefs, and social
roles that have an impact on the research. Epistemological reflexivity refers to the way
decisions and assumptions about the nature of knowledge have shaped the research, and
foregrounds the framing of the research question and how that places limits on what can
be learned about the phenomenon of interest (Willig & Rogers, 2008).
This section includes a personal reflexive account in which I considered my social
identity, principles and beliefs, technical ability, and research background as these related
to the research. I looked at three major features of Willig and Rogers’ (2008) definition of
personal reflexivity: (a) my identity as a person, (b) how I was related to the research
topic, and (c) my identity as a researcher.
My identity as a person. I am a Caucasian female and an American citizen, and
have lived in the United States all my life.
My relationship to the research project. As a student in psychology, I have
learned much about mental illness, its diagnosis, and manifestations. While employed by
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the Social Security Administration (SSA), I worked directly with individuals applying for
disability benefits—some due to mental illness, others due to physical disability, and in
some cases, both. Many of my clients expressed frustration with their experiences, not
only with maintaining employment, but also with the impact of the illness on their
relationships with coworkers, friends, and family members. More specifically, my clients
shared that others perceived them as “lazy” for not maintaining a job. I personally
experienced judgment by others for similar difficulties brought about by consistent,
debilitating fatigue, inability to concentrate, anxiety, and depressed mood. In 2004, I was
diagnosed with Hashimoto’s disease, an autoimmune form of thyroid disease.
I initially felt empowered by my diagnosis and understood my symptoms to be a
result of the disease. However, in the first three years of my experience as a thyroid
patient, I felt disempowered as endocrinologists consistently told me that my fatigue,
mood changes, and weight gain were not due to thyroid disease. Rather, I was informed
that I simply needed to diet, exercise, obtain treatment for premenstrual syndrome, and
“just relax.” I sought support and information from The Thyroid Support Group and
learned that there were many other women diagnosed with thyroid disease who were also
dissatisfied with their treatment experiences. My shared experiences with these other
women and the lack of information in the literature about thyroid patients’ experience of
treatment and doctor-patient relationship inspired me to conduct this research.
My identity as a researcher. I graduated in 2003 with a Master’s Degree in
Education, with a focus on Community Counseling. After receiving my degree, I was
employed initially as an editor and research consultant with a private writing, research,
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and editing firm and then became employed by the SSA. I currently work as an adjunct
instructor of psychology at a proprietary higher education institution.
My influence on the research. As a woman with thyroid disease, I realize that
this research is both inspired and limited by my views, life experiences, technical skill,
and academic experience. That I have a disorder the same as or similar to those of the
research participants and am a member of The Thyroid Support Group may have
increased the willingness of potential participants to share their perceptions and
experiences with me. However, that shared background may have also limited my ability
to identify the influence of my assumptions on my interpretations and may lead to overidentification with the research topic or participants. The fact that I am American, female,
and White and that participants were female may also have influenced the way we
interacted and the way I interpreted their statements, as would the fact that some
participants were non-White and could have been from countries other than the United
States. I discuss the steps taken to limit researcher bias and ensure data trustworthiness
and quality in the section entitled “Qualitative Trustworthiness.”
Research Questions
As noted previously, the research questions used to guide this study were:
RQ1. What are the treatment experiences of women with thyroid disease?
RQ 2. How does the doctor-patient relationship affect their experiences?
RQ 3. Do their experiences differ based on the doctor’s gender?
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Data Collection and Instrumentation
Data Collection
As discussed in Chapter 2 under “Data Collection Methods,” data were gathered
via individual interviews via online chat using X-IM encrypted software to establish and
record communication with participants. According to Creswell (2007), the use of openended questions is most appropriate for phenomenological research, as they gather
information on the everyday lived experiences of individuals, from which the researcher
can identify themes. Therefore, as the sole interviewer, I collected data via open-ended
questions in online chat with the participants regarding their experiences with thyroid
disease, including their physical and emotional experiences, perceptions of physicians’
attitudes, satisfaction with treatment (e.g., medications), and lifestyle changes due to
thyroid disease. For example, participants were asked to answer, “Please tell me, what
has been your experience in seeking treatment for thyroid disease?” and “How do you
feel about the treatments you are receiving for thyroid disease?” (see Table 1 and
Appendix A). Demographic data collected at the beginning of the interview included age,
ethnicity, education level, thyroid disease diagnosis, number of years since diagnoses,
treatment (e.g., medications), and gender of physician(s).
In order to triangulate data gathered from the interviews, participants were asked
to provide copies of their electronic journals or diaries, if available and only if the
participants wished to provide them. Data triangulation and additional steps taken to
ensure data trustworthiness and quality are further discussed in the section entitled
“Qualitative Trustworthiness.” At the end of each interview, I asked the participant if she
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would like to review her individual interview transcript for accuracy, as well as if she
would like me to contact her via off-list email to share the findings of the research.
Instrumentation
An interview guide I created (see Appendix A) was used to gather data. An
external panel of three experts in qualitative methods was consulted regarding the
accuracy of the interview guide. In order to enhance the reliability and validity of the
interview guide, feedback from the expert panel regarding the wording and order of the
interview questions was incorporated into the final version of the guide. The research
questions are coded as RQ1, RQ2, and RQ3 respectively, and are listed next to their
corresponding interview questions in the interview guide (see Appendix A). The research
question matrix shown in Table 1 depicts the relationship between the nine interview
questions and the research questions.

99
Table 1
Interview Questions as They Relate to the Research Questions
Interview Question

Research Question

1. Please tell me, what has been your experience in
seeking treatment for thyroid disease?
- Possible probe: How did you come to be
diagnosed?
- Possible probe: How long have you been being
treated?

1. What are the treatment experiences of women
with thyroid disease?

2. How would you describe your current
relationship with the doctor who treats you for
thyroid disease?

1. What are the treatment experiences of women
with thyroid disease?
2. How does the doctor-patient relationship affect
their experiences?

3. How do you feel about the treatments you are
receiving for thyroid disease?

1. What are the treatment experiences of women
with thyroid disease?
2. How does the doctor-patient relationship affect
their experiences?

4. How clearly do you believe your doctor explains
things to you?
- Possible probe: What do you believe your doctor
could do to make his or her communication clearer?

2. How does the doctor-patient relationship affect
their experiences?

5. Do you think it matters whether your doctor is a
man or a woman? Why or why not?

3. Do their experiences differ based on the doctor’s
gender?

6. How does being a woman, as opposed to being a
man, influence your relationship with your doctor?

1. What are the treatment experiences of women
with thyroid disease?
2. How does the doctor-patient relationship affect
their experiences?
3. Do their experiences differ based on the doctor’s
gender?

7. How comfortable do you feel in talking with
your doctor about symptoms or medical issues you
have experienced that you believe might be related
to thyroid disease?

1. What are the treatment experiences of women
with thyroid disease?
2. How does the doctor-patient relationship affect
their experiences?

8. What do you believe might help you to feel more
comfortable in sharing your experience of these
symptoms with your doctor?

2. How does the doctor-patient relationship affect
their experiences?
3. Do their experiences differ based on the doctor’s
gender?

9. Is there anything else you would like to add?
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Data Management
Interview data collected via X-IM software consisted of automatically transcribed,
typed transcripts with each participant. After each interview, I personally copied and
pasted each transcript verbatim onto a password-protected thumb drive. The drive is
stored in a locked cabinet in my office.
Data Analysis
To help ensure data trustworthiness and quality, I utilized the services of a
colleague (on a voluntary basis) to assist me with data interpretation. Before any data
analysis and interpretation began, my colleague and I signed a confidentiality agreement
(see Appendix E). I uploaded the confidentiality agreement to ShareFile.com for her to
sign. Sharefile.com offers a paid service through which files can be shared securely via
encryption and password-protection. My colleague returned the Confidentiality
Agreement to me via the same website.
After I personally organized the interviews, I followed the Stevick/Colaizzi/Keen
method as modified by Moustakas (1994) for each source. This method involved the
following steps:
1. Begin by describing the researcher’s own personal experience with the
phenomenon in order to disclose and attempt to set aside biases.
2. Examine the interview transcripts or other data, looking for significant
statements about how the participants experience the phenomenon, in order to
develop a comprehensive list of non-overlapping statements.
3. Group these statements into categories or themes.
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4. Write a description of what (“textural description”) the participants
experienced with the phenomenon, including verbatim examples.
5. Write a description of how (“structural description”) the experience occurred.
6. Combine the textural and structural descriptions into a composite depiction of
the essence of the experience.
I personally entered the interview transcripts into the ATLAS.ti software, which
allowed me to code, annotate, and compare segments of information (Creswell, 2007).
Both a priori coding and emergent coding was used. The latter allows “opening up the
codes to reflect the views of the participants in a traditional qualitative way” (Creswell,
2007, p. 152). I identified significant statements and themes based on the theoretical
perspectives of feminism and social constructivism (a priori coding). More specifically,
statements and themes related to the issues of (a) communication (gender differences; see
Cheney & Ashcraft, 2007; Tannen, 2007), (b) culture (medical profession and education;
see Kaiser, 2002; Thomas, 2001), and (c) diagnostic bias (see Hamberg et al., 2004;
Hoffmann & Tarzian, 2001; Munch, 2004).
Once I identified patterns and themes in participants’ experiences using the
ATLAS.ti software, I interpreted the findings based on feminist theory and social
constructionism, as well as existing literature. While it is known that the prevalence of
thyroid disease is much higher in women than men across cultures (Canaris et al., 2000;
Cassidy et al., 2002), and that many women continue to experience symptoms even when
they are receiving treatment (Dayan, 2001), the treatment experiences of women
diagnosed with thyroid disease remain unexplored. Based upon my communications with
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members of The Thyroid Support Group and current feminist literature, I had anticipated
that themes will emerge in the following areas: (a) gender differences in communication
(see Cheney & Ashcraft, 2007; Tannen, 2007), (b) culture of the medical profession (see
Kaiser, 2002; Thomas, 2001), and (c) gender in diagnostic bias (see Hamberg et al.,
2004; Hoffmann & Tarzian, 2001; Munch, 2004). In addition, as the support group was
international, it was possible that various patterns could emerge based on the participants’
culture, ethnicity, or both. In order to help validate the findings, I asked the participants
to review the findings for accuracy and thoroughness.
I uploaded the interview transcripts along with my interpretations to
ShareFile.com for my colleague to download. My colleague saved the participants’
interview transcripts and my interpretations onto a password-protected thumb drive. My
colleague reviewed my interpretations of the data and provided me with feedback. After
sending me her feedback via ShareFile.com, my colleague destroyed all data related to
my study. I used my colleague’s feedback as a “reality check” to guard against my
subjectivity as an individual with thyroid disease.
Ethical Protection of Participants
Permission to conduct the study was sought and obtained from the university’s
IRB (approval #12-19-13-0055511). Permission was also sought and obtained from the
group owner-moderator of The Thyroid Support Group via a letter of cooperation (see
Appendix B), after which members of The Thyroid Support Group were invited via an
on-list e-mail to participate in the study (see Appendix C). Through the invitation, per the
guidance of Ayling and Mewes (2009), I instructed interested members to create a free
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email account using a fictitious name and to respond to my invitation via off-list,
individual email with their new email account and fictitious name.
I responded to the first 15 volunteers (not including myself) via off-list, individual
emails and sent them a Consent Form (see Appendix D) explaining that they were chosen
for the study because they are women with a thyroid disease diagnosis. Please note that I
used implied, rather than informed, consent to safeguard participant anonymity. I
instructed each volunteer to review the consent form and to respond to my email off-list
using her new email account and fictitious name to set up a date and time for her
individual interview if she was still interested in participating. The consent form
informed prospective participants about the procedures and time commitments of the
study, potential risks and benefits, limits to confidentiality, their right to withdraw from
the study at any time without penalty, and contact information for myself and my advisor.
The consent form also explained that by emailing me to establish a date and time for an
individual interview, their consent to participate in the study was implied. Upon receiving
implied consent via off-list, individual emails from volunteers, I individually emailed
each participant to establish a date and time for her individual online interview.
Each participant was asked to not respond to my e-mails from her workplace, as
employers may have legal access to her e-mail (Keller & Lee, 2003). I instructed
participants to use their new e-mail account using a fictitious name in order to log in to
the X-IM software for the interview. For additional security, I encouraged participants to
engage in the interview in a private, non-public area (Kraut et al., 2004). As noted under
“Data Management,” I copied and pasted each interview transcript onto a password-
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protected thumb drive, which I will store in a locked cabinet in my office for a period of
five years, after which the drive(s) will be destroyed. As my colleague had access to the
data, she was asked to sign a confidentiality agreement (see Appendix E) before any data
analysis or interpretation began. My colleague saved the participants’ interview
transcripts, electronic journals/diaries, and my interpretations onto a password-protected
thumb drive and destroyed all data related to my study after sending me her feedback via
ShareFile.com.
Qualitative Trustworthiness
Data trustworthiness and quality was verified through use of the following
techniques: prolonged engagement, triangulation, member checking, and reflexive
journaling.
Prolonged Engagement
Prolonged engagement involves an understanding of the culture one plans to
investigate, as well as building trust with one’s participants (Creswell, 2007; Schensul &
LeCompte, 1999). Because I have been a member of The Thyroid Support Group since
2004, trust had been established with the group owner-moderator and potential
participants. In addition, as a member, I have a comprehensive understanding of the
context and phenomena under study.
Triangulation
Triangulation includes the use of different sources, theories, and investigators in
an attempt to substantiate evidence (Creswell, 2007, 2008; Schensul & LeCompte, 1999).
I collected data from an interview guide and had planned to collect personal electronic
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journals or diaries. However, no electronic journals or diaries were available.
Triangulation was achieved by using more than one theoretical position (feminism and
social constructionism) to interpret the data (theoretical triangulation; Denzin, 1970). I
also used the services (on a voluntary basis) of a colleague for data interpretation
(consensual validation; Eisner, 1991).
Member Checking
Member checking involves seeking and including participants’ feedback in
assessing the credibility of the study’s findings (Creswell, 2007; Schensul & LeCompte,
1999). At the end of each interview, participants reviewed their individual interview
transcript for accuracy. I also asked the participants to review the findings of the research
for accuracy and thoroughness.
Reflexive Journaling
Reflexive journaling involves acknowledging and keeping a record of one’s
personal thoughts and feelings while conducting research in an attempt to eliminate
researcher bias (Creswell, 2007; Moustakas, 1994). I maintained a record of personal
thoughts and feelings that occurred throughout the research process.
Dissemination of Findings
I will be the sole researcher involved in the dissemination of the findings.
Findings of this study will be disseminated in several ways. First, results will be shared
with participants who indicated an interest in reading the study. Second, I plan to publish
a condensed form of the study in a scholarly journal so that healthcare professionals can
utilize the information in practice and future research. Third, I will condense the study to
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the scope of a conference paper with the intention of presenting the study and its results
at appropriate conferences.
Summary
This qualitative, phenomenological study explored the lived experiences of a
sample of 16 women diagnosed with thyroid disease in order to answer questions
regarding their treatment experiences and the effect of gender on their relationships with
their doctors. Using the phenomenological approach of Stevick/Colaizzi/Keen as
modified by Moustakas (1994) and enriched by Van Manen (1997), I identified common
themes as well as discordant information among the participants. Two approaches to
understanding participants’ experiences, social constructionism and feminism, were used
in data interpretation. Results of this study may, consistent with Van Manen’s five
principles and the university’s mission to effect positive social change, result in
improvements in medical practice with female patients with thyroid disease.
Chapter 4 presents the findings of this phenomenological study. In Chapter 5, the
findings are interpreted and discussed along with implications for social change and
recommendations for further research.
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Chapter 4: Results
Introduction
The purpose of this study was to explore treatment experiences and doctor-patient
relationships among female thyroid patients. A phenomenological approach was used in
order to examine the meaning of the experience of thyroid disease treatment as described
by women who had experienced treatment for thyroid disease. Based upon the theories of
social constructivism and feminism, the following research questions were answered:
“What are the treatment experiences of women with thyroid disease?”; “How does the
doctor-patient relationship affect their experiences?”; and “Do their experiences differ
based on the doctor’s gender?” This chapter presents the results. I discuss the setting,
participant demographics, data collection and management, data analysis, evidence of
trustworthiness, and the major themes and subthemes that emerged during data analysis.
Setting
Data were collected via individual online chat interviews with members of The
Thyroid Support Group. Before each interview, participants were informed that they had
the right to leave the study at any time for any reason, without explanation. Participants
were provided with free, international crisis hotline telephone numbers in case they felt
upset as a result of their interviews (see Appendix D, Consent Form). To my knowledge,
none of the participants became upset due to their interviews. It is not known if any of the
participants used the crisis hotline telephone numbers provided. No unexpected events
occurred that might have influenced my interpretation of the data.
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Participant Demographics
In order to participate in the study, all volunteers were required to meet the
following criteria: (a) female, (b) aged 18 years and older, (c) with a self-proclaimed
thyroid disease diagnosis, and (d) member of The Thyroid Support Group. Demographic
information for all 16 participants is listed in Tables 2 and 3. Please note that the
participants’ names are pseudonyms. More specifically, the participants’ names are the
fictitious names created by the participants in order to log in to the X-IM software for
their individual interviews.
The sample of 16 participants had an average age of 55 years. The median age
was 54 years, with the youngest participant at 32 years old and the oldest participant at 82
years old. The sample was mostly Caucasian (14 out of 16 participants), with one
participant identifying as Hispanic and another participant identifying as Czech Polish.
The majority of the participants (15 out of 16) reported having education beyond high
school. More specifically, three participants reported having “some college,” two had
associate’s degrees, seven had bachelor’s degrees, and three had master’s degrees. Eight
of the participants reported having male doctors, six reported having female doctors, and
two reported having both male and female doctors. The majority of the participants’
doctors were Caucasian (13 out of 18 total doctors), two were Middle Eastern, one was
Asian, one was East Indian, and one was Nigerian (see Table 2).
All 16 participants reported having a diagnosis of hypothyroidism. Eight
participants specified Hashimoto’s disease diagnoses, and one participant specified
having a diagnosis of Grave’s disease. Half of the participants (eight out of 16) reported
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taking natural thyroid medication alone as treatment for thyroid disease. More
specifically, five reported taking Armour thyroid, two reported taking Nature-throid, and
one reported taking compounded porcine thyroid. Three participants reported taking a
combination of natural thyroid and synthetic thyroid medications. More specifically, one
participant reported taking Armour thyroid and Tirosint, one participant reported taking
desiccated porcine thyroid and levothyroxine, and one participant reported taking NP
thyroid and Cytomel. Five of the 16 participants reported taking synthetic thyroid
medication only. More specifically, three participants reported taking levothyroxine, one
reported taking a combination of Synthroid and Cytomel, and one reported taking
Tirosint and Cytomel. Additional diagnoses reported by the participants included
hypertension (four out of 16), osteopenia (three out of 16), diabetes (two out of 16), high
cholesterol (two out of 16), and breast cancer (two out of 16). All reported additional
diagnoses are listed in Table 3.
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Table 2
Participant Demographics
Participant

Age

Ethnicity

Highest education
level completed

Doctor(s)’
gender

Doctor(s)’
ethnicity

1: Alicia

46

Caucasian

Bachelor’s degree

Male

Caucasian

2: Anne

52

Caucasian

Bachelor’s degree

Female

Caucasian

3: April

34

Caucasian

Bachelor’s degree

Male

Caucasian

4: Autumn

48

Caucasian

Associate’s degree

Male

Middle Eastern

5: Carla

56

Caucasian

High School

Female

Nigerian

6: Diane

41

Hispanic

Business Associate’s
degree

Male

East Indian

7: Emily

52

Caucasian

Master’s degree

Female

Caucasian

8: Jenna

48

Caucasian

Some college

Male

Caucasian

9: Jessica

58

CzechPolish

Bachelor’s degree

Male
Female

Caucasian
Middle Eastern

10: Karen

64

Caucasian

Some college

Female

Caucasian

11: Kari

78

Caucasian

Bachelor’s degree

Female

Caucasian

12: Kim

82

Caucasian

Bachelor’s degree

Female

Caucasian

13: Leanne

37

Caucasian

Master’s degree

Male

Caucasian

14:Michelle

61

Caucasian

Bachelor’s degree

Male

Caucasian

15: Sarah

66

Caucasian

Some college

Female
Male

Asian
Caucasian

16: Shawna

59

Caucasian

Master’s degree

Male

Caucasian
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Table 3
Participant Demographics: Diagnoses and Treatments
Participant

Thyroid disease diagnoses

Treatment

Other medical diagnoses

1: Alicia

Hypothyroidism

Levothyroxine

Breast cancer

2: Anne

Hypothyroidism

Compounded porcine- thyroid

None

3: April

Hypothyroidism

Armour thyroid

Cancer

4: Autumn

Hypothyroidism

Armour thyroid

None

5: Carla

Hypothyroidism

Desiccated porcine- thyroid
Levothyroxine

Diabetes
High cholesterol
Mobility-impaired

6: Diane

Hashimoto’s disease
Hypothyroidism

Armour thyroid
Tirosont

None

7: Emily

Hashimoto’s disease
Hypothyroidism

Cytomel
Synthroid

Breast cancer
Gastroesophageal refluxdisease
Irritable bowel syndrome

8: Jenna

Hypothyroidism

Levothyroxine

Rosacea
Seizure disorder

9: Jessica

Hashimoto’s disease
Hypothyroidism

Naturethroid

Allergies

10: Karen

Grave’s disease
Hypothyroidism

Armour thyroid

Arthritis
Polymyalgia

11: Kari

Hypothyroidism

Armour thyroid

Diabetes

12: Kim

Hashimoto’s disease
Hypothyroidism

Cytomel
NP thyroid

Chronic obstructivepulmonary disease
Hypertension
Osteoarthritis
Osteopenia

13: Leanne

Hashimoto’s disease
Hypothyroidism

Armour thyroid

Fibromyalgia
Osteopenia

14:Michelle

Hashimoto’s disease
Hypothyroidism

Cytomel
Tirosint

High cholesterol
Hypertension

15: Sarah

Hashimoto’s disease
Hypothyroidism

Naturethroid

Hypertension

16: Shawna

Hashimoto’s disease
Hypothyroidism

Levothyroxine

Hypertension
Osteopenia
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Participant Profiles
Using the Stevick/Colaizzi/Keen approach as modified by Moustakas (1994; see
Chapter 3), I constructed a textural-structural description for each participant (see
Appendix G). Because Moustakas’s method is a form of phenomenological research that
explicitly uses the experience of the researcher as a part of the research, my own texturalstructural description is included as well. In order for the reader to fully understand the
essence of the participants’ experiences with thyroid disease treatment and the doctorpatient relationship (Polkinghorne, 1989), I provided narratives in the participants’ own
words where necessary.
Data Collection and Management
For the study, I conducted 15 interviews (see Appendix A) via individual
interviews via online chat using X-IM encrypted software over a period of approximately
three weeks (between January 12, 2014 and February 5, 2014). Each interview lasted
between half an hour to one hour each, depending upon how much each participant chose
to share. After each interview, participants were asked to review their interview transcript
for accuracy and thoroughness. I copied and pasted each automatically-transcribed
interview onto a password-protected thumb drive. The thumb drive is stored in a locked
cabinet in my office.
In an attempt to triangulate data gathered from the interviews, I asked participants
to provide copies of their electronic journals or diaries. However, no electronic journals
or diaries were available because none of the participants had electronic journals or
diaries to share.
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According to Moustakas’s (1994) method, the researcher is to provide a
description of his or her own experience of the phenomenon being explored (p. 122). As
such, I responded to the interview questions, which resulted in a total of 16 interviews.
My own demographic information is also included in Tables 2 and 3.
Data Analysis
After completing each interview, I followed the Stevick/Colaizzi/Keen method as
modified by Moustakas (1994). I wrote a textural-structural description for each
participant’s experience, including my own, based on her responses to the interview
questions (see Appendix G). A member check validated the details of the texturalstructural descriptions. Each participant reviewed her individual textural-structural
description for accuracy and thoroughness.
After all interviews were completed and textural-structural descriptions were
written, I entered the interview transcripts into the ATLAS.ti software and used a priori
coding to help identify comments and themes relevant to the theoretical perspectives of
feminism and social constructivism. The following themes were identified: (a) doctorpatient relationship, (b) patient self-advocacy, (c) doctor-patient communication, (d) and
culture of the medical profession (see Appendix H).
I conducted a second review of the interview transcripts in ATLAS.ti and used
emergent coding in order to identify and group similar ideas by conceptual theme. For
example, statements related to traditional doctor-patient relationships and collaborative
doctor-patient relationships became subthemes under the theme Doctor-Patient
Relationship. Appendix H presents the full list of themes and subthemes.
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While reviewing the interview transcripts along with their corresponding texturalstructural descriptions, I recognized some additional noteworthy findings that were
relevant for some participants, but did not represent the experience of the group as a
whole. In considering desire of all participants for their doctors to be open to their unique
experiences [e.g., “Listen to someone that is ‘living it’ and throw away the Synthroid
book” (Carla) and “[My doctor] does not understand that there is not one size fits all”
(Anne)], I have chosen to refer to these data as “additional findings” rather than refer to
this as “discrepant data.”
Statements that were irrelevant to the discussion and did not represent the
participants’ experiences with thyroid disease treatment and the doctor-patient
relationship were excluded from analysis. For example, “I now work on a volunteer basis
with families all over the world to help them to advocate for the best possible treatment
for their terminally ill children” (Alicia); and “I see patients all the time myself as a
speech-language pathologist and some of them have been not treated/diagnosed
correctly” (Shawna).
Evidence of Trustworthiness
Data trustworthiness was verified during the process of data collection and
analysis through the use of the following techniques: prolonged engagement, reflexive
journaling, member checking, and triangulation (see Chapter 3). Prolonged engagement
was achieved, as I had established trust with the group owner-moderator and participants.
During data collection and analysis, I utilized reflexive journaling. More specifically,
when personal thoughts and feelings surfaced as I read the participants’ interviews and

115
wrote their textural-structural descriptions, I made note of my thoughts and feelings in a
journal and then set the journal aside to return to the participants’ experiences. I address
these thoughts and feelings in the discussion of the results in Chapter 5.
At the end of each interview, participants reviewed their individual interview
transcript for accuracy. In addition, participants were asked to review their individual
textural-structural descriptions for accuracy and thoroughness. I had planned to collect
personal electronic journals or diaries in addition to the data gathered from the interview
guide. However, no electronic journals or diaries were available. Nevertheless,
triangulation was achieved by interpreting the data from two theoretical positions
(feminism and social constructionism). I also used the services (on a voluntary basis) of a
colleague for data interpretation. I discuss my colleague’s feedback and its impact on data
interpretation in Chapter 5.
Results
In this study, I explored female thyroid patients’ experiences of treatment and the
doctor-patient relationship. The interview questions created for the study reflected upon
the following research questions: “What are the treatment experiences of women with
thyroid disease?”; “How does the doctor-patient relationship affect their experiences?”;
“Do their experiences differ based on the doctor’s gender?”
Numerous factors influenced each participant’s experience with thyroid disease
treatment. While the majority of participants expressed some type of dissatisfaction with
their treatment experiences, some participants conveyed only positive comments about
their experiences. Many of the participants who were dissatisfied with their treatment
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experiences switched doctors and were ultimately satisfied with their treatment. Some
participants remained dissatisfied despite having seen more than one doctor. The
participants’ stories provide a comprehensive review of treatment experiences
surrounding the doctor-patient relationship, doctor-patient communication, and the
culture of the medical profession. Appendix G presents detailed descriptions of each
participant’s story. In order to provide a thorough examination of the participants’
experiences, the following review of themes and subthemes includes quotes from each
participant, as applicable. All participant quotes were collected during the interviews.
Theme 1: Doctor-Patient Relationship
Each interview began with asking participants to describe their experience with
seeking treatment for thyroid disease. The participants’ responses revealed two types of
doctor-patient relationships: traditional and collaborative.
Subtheme 1: Traditional relationships. Eleven of the 16 total participants
(Anne, April, Carla, Diane, Jenna, Jessica, Karen, Kim, Leanne, Sarah, and Shawna)
experienced traditional doctor-patient relationships. Among these participants, 8 felt
unheard by their doctors, 10 felt invalidated by their doctors, 8 felt dismissed by their
doctors, 4 experienced a lack of empathy from their doctors, and 3 felt disrespected by
their doctors.
Feeling unheard. Eight of the 11 participants who experienced a traditional
doctor-patient relationship (April, Carla, Diane, Jenna, Jessica, Leanne, Sarah, and
Shawna) indicated that they felt unheard by their doctors.
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“The [doctor] flat out told me to ‘trust her, she had control of the situation’ [but]
she worked by my levels NOT by my feelings and how I was living life…[and she had] a
negative and controlling attitude…[I wish she would] LISTEN.” (April)
“I felt that my dose [of thyroid medicine] was wrong, I was getting worse and
worse each year. Every time I talked to a doc about it I was demeaned and/or ignored.”
(Carla)
“As I aged, I experienced illnesses that showed me I had a compromised immune
system and something wasn't right, but no doctor would further investigate.” (Diane)
“He doesn’t listen…When I tried to explain to him my hair was falling out and I
was tired ALL the time he just blew it off as not being related…[I wish he would]
LISTEN instead of being pushy.” (Jenna)
“I am tiered [sic] of doctors thinking that we are just anxious…and will not
believe us. They want to put us on antidepressants instead of helping us. This causes
more anxiety and is very sad.” (Jessica)
“[My] doctor poo-pawed anything I would bring up…questioning whether it
was…a symptom of the hypothyroidism instead of some new disease she wanted to
prescribe more medication for.” (Sarah)
“I start to explain [my] history…but he interrupts me at the point I say the
Naturopath put me on levo and launches into a tirade about how I don’t have a thyroid
problem and should never have been put on meds and they will cause palpitations…hair
loss and high BP etc…ignoring I have been on them 9 months with none of those
problems…” (Shawna)
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Feeling invalidated. Ten of the 11 participants who experienced a traditional
doctor-patient relationship (Anne, April, Carla, Diane, Jenna, Jessica, Kim, Leanne,
Sarah, and Shawna) indicated that they felt invalidated by their doctors.
“I do tend to get emotional which I think makes doctors (and anyone) give less
credence to my depiction of my symptoms.” (Anne)
“I went [to my appointments] with knowledge and she told me to get off
google...[and] when I asked her to test my reverse T3, she refused saying it was no more
important than the type of blood I had.” (April)
“I felt that my dose [of thyroid medicine] was wrong, I was getting worse and
worse each year. Every time I talked to a doc about it I was demeaned and/or ignored.”
(Carla)
“As I aged, I experienced illnesses that showed me I had a compromised immune
system and something wasn't right, but no doctor would further investigate.” (Diane)
“When I tried to explain to him my hair was falling out and I was tired ALL the
time he just blew it off as not being related.” (Jenna)
“I am tiered [sic] of doctors thinking that we are just anxious…and will not
believe us. They want to put us on antidepressants instead of helping us. This causes
more anxiety and is very sad.” (Jessica)
“[I complained] about a lump in my throat and a choking sensation. That doctor
found nothing wrong. I think he felt it was my imagination.” (Kim)
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“[My] doctor poo-pawed anything I would bring up…questioning whether it
was…a symptom of the hypothyroidism instead of some new disease she wanted to
prescribe more medication for.” (Sarah)
“I start to explain [my] history…but he interrupts me at the point I say the
Naturopath put me on levo and launches into a tirade about how I don’t have a thyroid
problem and should never have been put on meds and they will cause palpitations…hair
loss and high BP etc…ignoring I have been on them 9 months with none of those
problems…” (Shawna)
Feeling dismissed. Eight of the 11 participants who experienced traditional a
doctor-patient relationship (Anne, April, Carla, Diane, Jenna, Leanne, Sarah, and
Shawna) indicated that they felt dismissed by their doctors.
“Last February, at my last appointment with him, he said I seemed to be doing
fine [and] gave me a year’s prescription for the compounded thyroid and wished me well.
I didn’t occur to me that he had fired me until I was telling someone else about this
appointment. Out of curiosity, I requested my records. In his notes from our last
appointment, he said it appeared I was treating myself. This surprised me quite a bit
because he had always seemed to appreciate that I was a somewhat informed patient.”
(Anne)
“I went [to my appointments] with knowledge and she told me to get off
google...[and] when I asked her to test my reverse T3, she refused saying it was no more
important than the type of blood I had.” (April)
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“I went in for a BMI and my level was 21. I had no weight to lose...yet I'd lost 40
pounds...Headed in to see a doc... he told me that I was ‘too fat to be sick’ went on to tell
me to leave, there were others that really needed him.” (Carla)
“As I aged, I experienced illnesses that showed me I had a compromised immune
system and something wasn't right, but no doctor would further investigate.” (Diane)
“When I tried to explain to him my hair was falling out and I was tired ALL the
time he just blew it off as not being related.” (Jenna)
“[My] doctor poo-pawed anything I would bring up…questioning whether it
was…a symptom of the hypothyroidism instead of some new disease she wanted to
prescribe more medication for.” (Sarah)
“I had taken my labs to the primary doc’s office when I went in for a tick bite, and
asked him to get back with me about what he thought and whether I could switch from
the compounded to something [that would] be covered by insurance, but he never got
back to me. I work at a hospital and lots of people think he has gotten less caring over the
years.” (Shawna)
Experienced a lack of empathy. Four of the 12 participants who experienced a
traditional doctor-patient relationship (Emily, Jessica, Leanne, and Shawna) indicated
that they experienced a lack of empathy from their doctors.
“Sometimes I think men doctors don’t take some female symptoms seriously, but
then I’ve had women doctors that also didn’t seem to be sympathetic to a formally [sic]
skinny patient who quickly put on 20 pounds.” (Emily)
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“[I wish doctors would] just let me know they care and take more time to figure
stuff out and explain things.” (Jessica)
“I had taken my labs to the primary doc’s office when I went in for a tick bite, and
asked him to get back with me about what he thought and whether I could switch from
the compounded to something [that would] be covered by insurance, but he never got
back to me. I work at a hospital and lots of people think he has gotten less caring over the
years.” (Shawna)
Feeling disrespected. Three of the 12 participants who experienced a traditional
doctor-patient relationship (Carla, Leanne, and Shawna) indicated that they felt
disrespected by their doctors.
“I felt that my dose [of thyroid medicine] was wrong, I was getting worse and
worse each year. Every time I talked to a doc about it I was demeaned and/or
ignored…[the doctor] said that I was a 'smart ass' and to stay on the same dose…then
hung up on me.” (Carla)
“I start to explain [my] history…but he interrupts me at the point I say the
Naturopath put me on levo and launches into a tirade about how I don’t have a thyroid
problem and should never have been put on meds and they will cause palpitations…hair
loss and high BP etc…ignoring I have been on them 9 months with none of those
problems…” (Shawna)
Subtheme 2: Collaborative relationships. Thirteen of the 16 total participants
(Alicia, April, Autumn, Carla, Diane, Emily, Jenna, Karen, Kari, Kim, Leanne, Michelle,
and Shawna) experienced collaborative doctor-patient relationships. Among these
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participants, 10 felt heard by their doctors, eight felt validated by their doctors, four felt
unrushed by their doctors, and 12 participated in shared decision making with their
doctors.
Feeling heard. Ten of the 13 participants who experienced a collaborative doctorpatient relationship (Alicia, April, Autumn, Diane, Emily, Karen, Kari, Kim, Leanne, and
Michelle) indicated that they felt heard by their doctors.
“I have chosen to stay with the physician because I believe he will listen to me. I
research, bring my research to him and we discuss what to do with it.” (Alicia)
“[My doctor] wants to know what I know…[he] confirms I am not stupid and if
need be, he will correct or add more info to what I already know.” (April)
“I was very comfortable [sharing my symptoms] with [my previous doctor, but]
have no clue about the new one.” (Autumn)
“[My doctor] does take into consideration what I'm saying to him, and gives me
feedback. I appreciate that.” (Diane)
“I had written all my issues out before seeing the endocrinologist and she still
went through the whole list of possible symptoms to see which I was experiencing and to
what extent. She was very thorough.” (Emily)
“We discuss things clearly and she listens well and makes adjustments based on
my response.” (Karen)
“My Dr. is easy to talk to…she takes her time and the main thing [is that] she
does listen.” (Kari)
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“I figured out the dose equivalent to my 75 mcg of T4 and my 25 mcg of T3, and
the new doctor agreed my calculations were correct and prescribed 2 grains of Armour
and an additional 5 or 10 mcg of Cytomel.” (Kim)
“He has made clear that he is a good listener and has my best interest at heart.”
(Michelle)
Feeling validated. Eight of the 13 participants who experienced a collaborative
doctor-patient relationship (Alicia, April, Diane, Emily, Karen, Kim, Leanne, and
Michelle) indicated that they felt validated by their doctors.
“I think my doctor understands that I am not the person I used to be—that I know
how to do the research and that I know what is reasonable.” (Alicia)
“[My doctor] wants to know what I know…[he] confirms I am not stupid and if
need be, he will correct or add more info to what I already know.” (April)
“[My doctor] does take into consideration what I'm saying to him, and gives me
feedback. I appreciate that.” (Diane)
“I had written all my issues out before seeing the endocrinologist and she still
went through the whole list of possible symptoms to see which I was experiencing and to
what extent. She was very thorough.” (Emily)
“We discuss things clearly and she listens well and makes adjustments based on
my response.” (Karen)
“I figured out the dose equivalent to my 75 mcg of T4 and my 25 mcg of T3, and
the new doctor agreed my calculations were correct and prescribed 2 grains of Armour
and an additional 5 or 10 mcg of Cytomel.” (Kim)
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“He has learned that my body reacts differently than others termed “normal” and
is very interested in working with me to “optimize” my thyroid hormone needs.”
(Michelle)
Feeling unrushed. Four of the 13 participants who experienced a collaborative
doctor-patient relationship (Emily, Kari, Leanne, Shawna) indicated that they felt
unrushed by their doctors.
“I had written all my issues out before seeing the endocrinologist and she still
went through the whole list of possible symptoms to see which I was experiencing and to
what extent. She was very thorough.” (Emily)
“My Dr. is easy to talk to…she takes her time and the main thing [is that] she
does listen.” (Kari)
“I like the new D.O. …he seems to be on the right track and he spends a lot of
time with you.” (Shawna)
Shared decision making. Twelve of the 13 participants who experienced a
collaborative doctor-patient relationship (Alicia, April, Carla, Diane, Emily, Jenna,
Karen, Kari, Kim, Leanne, Michelle, and Shawna) indicated that they participated in
shared decision making with their doctors.
“I feel that we are carefully working toward finding the best way to treat
me….We have a good working relationship. While he tends to be satisfied if my numbers
are within the normal range, he does listen when I tell him how I am feeling and that we
need to continue working on treatment (adjusting medication dosages and testing) until I
am thriving.” (Alicia)
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“[My doctor] wants to know what I know…[he] confirms I am not stupid and if
need be, he will correct or add more info to what I already know.” (April)
“I don't have a lot of trust in her anymore…but I will admit that she is now talking
with me more…and we are working on compromises.” (Carla)
“[My doctor] does take into consideration what I'm saying to him, and gives me
feedback. I appreciate that…We're working on seeing if I have any issues with my
adrenal glands.” (Diane)
“I appreciate that my endo is open to trying natural hormone if necessary as my
PCP seems to think Synthroid is the only option.” (Emily)
“[My doctor] has been decent about letting me raise my dosage…he DOES test
free t3 and free t4 because I asked him to.” (Jenna)
“We discuss things clearly and she listens well and makes adjustments based on
my response.” (Karen)
“[I] educate [my doctor] from what I learned reading Mary Shomon’s newsletters
and book.” (Kari)
“I figured out the dose equivalent to my 75 mcg of T4 and my 25 mcg of T3, and
the new doctor agreed my calculations were correct and prescribed 2 grains of Armour
and an additional 5 or 10 mcg of Cytomel.” (Kim)
“He has learned that my body reacts differently than others termed “normal” and
is very interested in working with me to “optimize” my thyroid hormone needs.”
(Michelle)
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“[My doctor] orders the thyroid tests but forgets the antibodies. I call her up and
she says ‘just put Thyro Pero on that order and also whatever you want’ [so] I add
Ferritin and B12 based on my internet research.” (Shawna)
Theme 2: Patient Self-Advocacy
In describing their experiences with thyroid disease treatment, 15 of the 16 total
participants (Alicia, Anne, April, Carla, Diane, Emily, Jenna, Jessica, Karen, Kari, Kim,
Leanne, Michelle, and Shawna) described participation in some form of self-advocacy,
including health information-seeking and switching doctors. Two of these participants
(Karen and Kim) made statements that indicated a personal belief that “doctor knows
best.”
Subtheme 1: Health information-seeking. Twelve of the 15 participants who
participated in some form of self-advocacy (Alicia, Anne, April, Carla, Diane, Emily,
Jenna, Karen, Kari, Kim, Leanne, and Shawna) conducted health information-seeking.
“I think my doctor understands that I am not the person I used to be—that I know
how to do the research and that I know what is reasonable.” (Alicia)
“By this time I had joined the on-line support group and done some research online I did finally find a doctor who agreed to include free t3 and t4 in the blood tests and
she prescribed Armour.” (Anne)
“I went [to my appointments] with knowledge and she told me to get off google.”
(April)
“I'd been online learning…had heard of whole gland desiccated…found a place to
buy it…borrowed the money and waited for it to come.” (Carla)
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“I have searched for over 30 years as to what was the cause of my rapid weight
gain, and constant fatigue.” (Diane)
“The endocrinologist seems well versed in my diagnosis, but I only know that
because of extensive research I’ve done on my own.” (Emily)
“I think there’s a lot that is overlooked…he REALLY pushes for me to do RAI
which based on MY research, I don’t feel is needed.” (Jenna)
“I learned a bank of knowledge that helped me whittle thru all the mediocre docs
and find the right one. It took over a year but it was worth it.” (Karen)
“[I] educate [my doctor] from what I learned reading Mary Shomon’s newsletters
and book.” (Kari)
“I know enough about thyroid function and my thyroid problem and what works
best for me that I am in a position to explain to the doctor what I need, not the other way
around!” (Kim)
“I feel that if I hadn’t been aggressive in all my research I would have just been
kept being told that my [levels were] ‘normal’ when they were clearly not.” (Shawna)
Subtheme 2: Switching doctors. Nine of the 15 participants who participated in
some form of self-advocacy (Anne, April, Diane, Jessica, Karen, Kim, Leanne, Michelle,
and Shawna) switched doctors.
“I began looking for a Dr. who would do more than t4 replacement… This was an
awful time. I went to at least 4 doctors seeking help. This was especially difficult because
with each new appointment, I would get my hopes up that this doctor was the ONE who
would help me. The letdown after each appointment was devastating.” (Anne)
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“I hesitated leaving [my doctor] when I got pregnant, [but] she promised she
would get me through my pregnancy and she did…As soon as we moved (baby was 2
weeks old) I felt more secure [in switching doctors].” (April)
“I saw several doctors and were [sic] prescribed anti dizziness medication,
depression pills, etc. All doctors said my blood work came back fine, including
thyroid. However, I was still bedridden and in danger of losing my job.” (Diane)
“[My experience has been] very frustrating. Been through three endo's in five
months. The last one is really trying to work with me, but the other two got frustrated and
abusive with me because I was not tolerating the thyroid meds well.” (Jessica)
“When I was younger I did not argue with my doctor because I always thought
they knew best. But after years of mistreatment I finally took the bull by the horns…I
went through 5 Endos before I found one who knew what she was doing.” (Karen)
“I think I may be a little more comfortable with a man. I’m more likely to argue
with a female doctor if I think her approach is wrong. If I feel a male doctor’s approach
to thyroid care is wrong for me, I simply don’t go back to him and begin looking for
another doctor.” (Kim)
“I felt better not taking anything compared to taking Synthroid. It took me another
2 years before I found an Internal Medicine Dr. who would prescribe me something other
than Synthroid.” (Michelle)
“I am asking around at the hospital where I work and hear that the newer doctor
that started in 2013 is one who will get to the bottom of things and spend a lot of time.”
(Shawna)
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Subtheme 3: Belief that “doctor knows best.” Two of the 15 participants who
participated in some form of self-advocacy (Karen and Kim) made statements that
indicated a personal belief that “doctor knows best.”
“When I was younger I did not argue with my doctor because I always thought
they knew best.” (Karen)
“I’m more likely to argue with a female doctor if I think her approach is wrong.
If I feel a male doctor’s approach to thyroid care is wrong for me, I simply don’t go back
to him and begin looking for another doctor.” (Kim)
Theme 3: Doctor-Patient Communication
Participants’ responses to interview questions regarding communication indicated
that their experiences with thyroid disease treatment were impacted by their ability to
communicate with their doctors. Doctor-patient communication appeared to be
influenced by the participant’s desire to be informed, the participant’s level of trust in her
doctor, and by being female.
Subtheme 1: Desire to be informed. Six of the 16 total participants (Anne,
April, Emily, Kim, Leanne, and Michelle) expressed a desire for their doctors to inform
them about the results of lab work and treatment options.
“I have some work to do to figure out how I can either get her to make me
understand where she is coming from…or if I can get her to understand that I am
backsliding again…” (Anne)
“I will tell them what I know, what I want to know and [learn] what their opinion
is and their thoughts.” (April)
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“She doesn’t come forward with all she’s thinking unless I push the
conversation.” (Emily)
“I need to get the testing done to see where my frees are on the new product.”
(Kim)
“She was a teaching Dr. and taught me how to read the numbers on all the
appropriate tests---not just TSH, but also FT3 & FT4.” (Michelle)
Subtheme 2: Role of trust. In responding to interview questions regarding
communication, nine out of the 16 total participants (Anne, April, Carla, Jenna, Kim,
Leanne, Michelle, Sarah, and Shawna) indicated that their ability to communicate with
their doctors was influenced by their level of trust in their doctors. Four of these nine
participants explicitly expressed distrusting their doctors, six refused treatment, three
engaged in secret-keeping, and six engaged in self-treatment.
Lack of trust. Four out of the nine participants (Carla, Leanne, Sarah, and
Shawna) who indicated that their ability to communicate with their doctors was
influenced by their level of trust in their doctors explicitly expressed distrusting their
doctors.
“[I am] guarded…I don't have a lot of trust in her anymore.” (Carla)
“My distrust is at such a high level after being misdiagnosed for over half of my
life that it will be hard to share [with a doctor] in the future.” (Sarah)
“I am keeping a folder of my labs now. I have learned to get copies of them and
not believe what the doctor’s office tells me.” (Shawna)
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Treatment refusal. Six out of the nine participants (Anne, April, Jenna, Leanne,
Michelle, and Sarah) who indicated that their ability to communicate with their doctors
was influenced by their level of trust in their doctors explained that they had refused
treatment.
“…this doctor knew of nothing else to do but go back to Synthroid and did not
understand when I was upset at that suggestion.” (Anne)
“I will not always go with their recommendations (I have refused RAI 3 times
now, twice with the first dr, once with the second…” (April)
“I've rejected several drugs offered to me since the Diabetes diagnosis…and no
longer open a bottle till I know what it will do.” (Carla)
“I made it CLEAR I was not doing RAI.” (Jenna)
“I finally had to go off of Synthroid (on my own) after a year because I felt so bad
on it. I felt better not taking anything compared to taking Synthroid.” (Michelle)
“[I] gradually tapered off most unnecessary prescriptions over a two-year period
[and] then left the Doctor I'd had for over 23 years…” (Sarah)
Secret-keeping. Three out of the nine participants (Kim, Leanne, and Sarah) who
indicated that their ability to communicate with their doctors was influenced by their
level of trust in their doctors explained that they had kept secrets from their doctors.
“My other doctor, whom I’d kept as my primary for everything but thyroid, kept
ordering TSH and I simply refused the test when I got to the lab. I just told him I was
seeing another doctor for my thyroid treatment…We sometimes have to resort to
trickery!” (Kim)
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“After knowing I would die if I continued this way, I started taking charge of my
own health…added supplements, and gradually tapered off most unnecessary
prescriptions over a two-year period [and] then left the Doctor I'd had for over 23
years…” (Sarah)
Self-treatment. Six out of the nine participants (Carla, Jenna, Leanne, Michelle,
Sarah, and Shawna) who indicated that their ability to communicate with their doctors
was influenced by their level of trust in their doctors explained that they had engaged in
self-treatment.
“I started self-treating in July of 2002 and pretty much consider myself to still be
self-treating [and] the current doc/insurance just run my labs.” (Carla)
“A friend who has thyroid issues got me on a multivitamin and 10k units of
vitamin D3. Our local herbalist gave me a supplement which offered thyroid and adrenal
support.” (Jenna)
“I finally had to go off of Synthroid (on my own) after a year because I felt so bad
on it. I felt better not taking anything compared to taking Synthroid.” (Michelle)
“[I] added supplements, and gradually tapered off most unnecessary prescriptions
over a two-year period [and] then left the Doctor I'd had for over 23 years and started
self-treating with Thyroid replacement ordered online, treating adrenals, plus additional
vitamins and supplements gradually added.” (Sarah)
“I thought since the doctors kept saying my thyroid was okay, maybe I just
needed something natural as a boost, not really having a lot of information. I also was
clicking on ads on the internet and read some doctor that insisted we are all iodine

133
deficient and promoting his pills. I ordered them and took them [for] 1 month…”
(Shawna)
Subtheme 3: Role of gender. The majority of participants’ responses to
questions regarding the potential influence of gender on treatment experiences revealed
that the doctors’ gender had little influence on doctor-patient communication. However,
participant responses indicated that being female influenced doctor-patient
communication, particularly regarding the participants’ perceptions of being taken
seriously and when the participants expressed emotion.
No preference for specific doctor gender. Thirteen of the 16 total participants
(Alicia, Anne, April, Autumn, Diane, Emily, Jessica, Karen, Kim, Leanne, Michelle,
Sarah, and Shawna) indicated no preference for a male or female doctor.
“I’m not sure. I wonder if a woman might be more understanding, but I feel that
my [male] physician is very understanding.” (Alicia)
“No…It seems that both men and women doctors are TSH driven.” (Anne)
“I had a female [doctor] who hated me…I now have a man who allows me to
control my health. HUGE difference.” (April)
“I don't think [the doctor’s gender] matters much…most of them are just in and
out doing as little as they possibly have to do.” (Autumn)
“If they have a thorough understanding of the female body, then there shouldn't
be difference [between male and female doctors].” (Diane)
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“I would probably feel comfortable with either [male or female] if they seem
sympathetic to my concerns and serious about continually working on a plan to get my
body back to normal.” (Emily)
“I think a woman doctor can relate better to her female patient having the same
functioning system and emotional background caused by hormones; [however], my first
endo was a woman…and she was brutal.” (Jessica)
“It's not the sex of the doctor but the compassion and caring of the doctor that
makes one good.” (Karen)
“It doesn’t matter to me [if my doctor is male or female]. My previous thyroid
doctor who died was a man, and he was an internal medicine doc whose special interest
was in hormone treatment (of all kinds, not just thyroid). He was excellent for thyroid
care. I’ve had female doctors who would only prescribe Synthroid.” (Kim)
“No----have been treated by both [male and female doctors]. Dr./Patient
relationship is most important.” (Michelle)
“I've been pleased with both genders, it really depends on the individual.” (Sarah)
“No. I just care about their competence.” (Shawna)
Preference for female doctor. Three of the 16 total participants indicated a
preference for female doctors.
“Every woman doctor I have had, all of 3, [have] been far more empathetic and
able to listen.” (Carla)
“I think a woman might be a little more compassionate and understanding.”
(Jenna)
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“I like woman Dr.'s better. Men are too arrogant about their education.” (Kari)
Being taken seriously. Nine out of the 16 total participants (Alicia, Anne, April,
Carla, Diane, Emily, Jenna, Leanne, and Sarah) indicated that being taken seriously
influenced their ability to communicate with their doctors.
“Knowing that he takes me seriously helps me to feel comfortable sharing my
symptoms with my doctor.” (Alicia)
“…my opinion is that doctors, both men and women, take men more seriously. I
do tend to get emotional which I think makes doctors give less credence to my depiction
of my symptoms.” (Anne)
“[I would feel more comfortable sharing my symptoms] if my dr took my
research serious and didn’t just humor me.” (April)
“She is certain that the only test needed for thyroid is TSH and it's an inside joke
that I will allow her to run TSH as long as she also runs Free T4 and Free T3 for me.”
(Carla)
“It makes me feel confident that he takes me a little more seriously than most of
the other doctors who poo-pooed me.” (Diane)
“Sometimes I think men doctors don’t take some female symptoms seriously, but
then I’ve had women doctors that also didn’t seem to be sympathetic to a formally [sic]
skinny patient who quickly put on 20 pounds.” (Emily)
“[I would feel more comfortable sharing my symptoms] if he would LISTEN and
take me seriously and not think it’s all in my head.” (Jenna)
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“[My] previous Doctor poo-pawed anything I would bring up and questioning
whether it was thyroid related.” (Sarah)
Presence of emotion. Three out of the 16 total participants (Alicia, Anne, and
Leanne) indicated that showing emotion influenced communication with their doctors.
“It was not until I broke down in tears with my radiation oncologist that he
suggested metabolic testing…[and to] follow this up with my primary care physician.”
(Alicia)
“I do tend to get emotional which I think makes doctors give less credence to my
depiction of my symptoms.” (Anne)
Theme 4: Culture of the Medical Profession
Participant responses to interview questions indicated that their experiences with
thyroid disease treatment were influenced by the culture of the medical profession. More
specifically, participants’ treatment experiences were influenced by diagnostic bias, their
doctors’ medical knowledge, and economics.
Subtheme 1: Diagnostic bias. Eight of the 16 total participants (Alicia, Anne,
Carla, Diane, Jenna, Jessica, Kim, and Leanne) whose treatment experiences were
influenced by the culture of the medical profession encountered diagnostic bias. More
specifically, seven participants’ doctors considered their symptoms to be psychosomatic
and three participants were told by their doctors that their symptoms were due to their
lifestyle.
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Symptoms considered psychosomatic. Seven of the 15 participants (Alicia, Anne,
Diane, Jenna, Jessica, Kim, and Leanne) who experienced diagnostic bias had doctors
who considered their symptoms to be psychosomatic.
“I knew something was wrong following my treatment for breast cancer and
recovery. I kept mentioning that something was not right to my oncologist and radiation
oncologist. I think they attributed my symptoms to recovery from treatment and grief due
to the death of my 8 year old son to cancer. It was not until I broke down in tears with my
radiation oncologist that he suggested metabolic testing.” (Alicia)
“…my opinion is that doctors, both men and women, take men more seriously. I
do tend to get emotional which I think makes doctors give less credence to my depiction
of my symptoms.” (Anne)
“[I had an] inability to swallow pills that started about 10 years ago (doctors
thought it was in my head)…[and when] I could no longer drive and could barely walk, I
saw several doctors and were [sic] prescribed anti dizziness medication, depression pills,
etc.” (Diane)
“[I would feel more comfortable sharing my symptoms] if he would LISTEN and
take me seriously and not think it’s all in my head.” (Jenna)
“I am tiered [sic] of doctors thinking that we are just anxious…and will not
believe us. They want to put us on antidepressants instead of helping us. This causes
more anxiety and is very sad.” (Jessica)
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“I had been taken to a doctor because of complaining about a lump in my throat
and a choking sensation. That doctor found nothing wrong. I think he felt it was my
imagination.” (Kim)
Symptoms attributed to lifestyle. Three of the 15 participants (Carla, Jenna, and
Leanne) who experienced diagnostic bias had doctors who attributed their symptoms to
their lifestyle.
“[the doctor] told me that I was ‘too fat to be sick’…[and] with each job change I
got new insurance and new docs and they were all the same. Weight gain is from being a
lazy slob [because] I laid around eating bon bons all day long. Didn't matter that I was a
body builder before all this, didn't matter that I used to have physical jobs before all this...
I was just a lazy, fat, stupid... slob.” (Carla)
“I had complained to the doc about not being able to lose weight but he said it
was my diet, not enough exercise etc… how i wish i had only known that it was
something wrong with me physically instead of ‘I'm fat’, ‘I'm out of shape’…” (Jenna)
Subtheme 2: Medical knowledge. The treatment experiences of 15 of the 16
total participants (Anne, April, Autumn, Carla, Diane, Emily, Jenna, Jessica, Karen, Kari,
Kim, Leanne, Michelle, Sarah, and Shawna) who were affected by the culture of the
medical profession appeared to be specifically influenced by their doctors’ medical
knowledge. More specifically, 9 participants’ treatment experiences were affected by the
use of the TSH blood test alone to determine thyroid function, and 10 participants’
treatment experiences were affected by the use of synthetic medication as the only
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treatment option for thyroid disease. In addition, according to 15 participants, continuing
education for doctors about thyroid disease is needed.
TSH testing is standard. Nine out of the 15 total participants (Anne, Carla, Diane,
Jenna, Karen, Kim, Michelle, Sarah, and Shawna) whose treatment experiences were
influenced by their doctors’ medical knowledge appeared to be specifically affected by
the use of the TSH blood test alone as the standard for determining thyroid function.
“It seems that both men and women doctors are TSH driven…Even the doctors I
have seen that are okay with [natural medication] still put much more weight on TSH
than symptoms or the frees. It is enough to make one feel hopeless at times.” (Anne)
“[My doctor] is certain that the only test needed for thyroid is TSH and it’s an
inside joke that I will allow her to run TSH as long as she also runs Free T4 and Free T3
for me.” (Carla)
“I have searched for over 30 years as to what was the cause of my rapid weight
gain, and constant fatigue. Each time, my thyroid would be tested and I was told
everything was fine. Meanwhile, I struggled daily for energy, and experienced numerous
illnesses over the years that puzzled me.” (Diane)
“My doctor’s] MAIN concern is my TSH getting below .5, [though] he DOES test
free t3 and free t4 because I asked him to.” (Jenna)
“I do honestly believe that only being treated with Synthroid and only a TSH test
being run each year it actually caused me to go through early menopause at the age of
34.” (Karen)
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“When I was tested at the end of that year, my TSH (the only thyroid test that
doctor used) was .01, and he wanted me to discontinue Synthroid because I had ‘gone
hyper’. I reminded him I’d been taking thyroid replacement since I was 16 or 17 and I
was quite certain I needed it. So he compromised and let me drop the Synthroid to 50
mcg.” (Kim)
“I was ‘finally’ diagnosed after many years of begging [doctors] to be diagnosed
(numbers were ‘normal’), [then] it took me another 2 years before I found an Internal
Medicine Dr. who would…test not only TSH, but also FT3 & FT4.” (Michelle)
“[My doctor] totally ignored my symptoms, any thyroid numbers but TSH, and
this resulted in [many] diagnoses…and [I was] heavily medicated for each of them, on as
many as twelve different prescriptions in any given day.” (Sarah)
“I don’t like that he is not open to natural thyroid and isn’t testing my T3 and
antibodies.” (Shawna)
Synthetic medication is standard. Ten out of the 15 total participants (Anne,
Carla, Emily, Jessica, Karen, Kim, Leanne, Michelle, Sarah, and Shawna) whose
treatment experiences were influenced by their doctors’ medical knowledge appeared to
be specifically affected by the use of synthetic medication as the only treatment option
for thyroid disease.
“[When] the armour shortage hit [my] doctor knew of nothing else to do but go
back to synthroid and did not understand when I was upset at that suggestion…The
thought of having to settle for synthroid again honestly scared me.” (Anne)
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“I was started on Synthroid…it made me sick…they tried levothyroxine, it made
me sick…then tried levothroid, it made me sick…Nauseous, headache...” (Carla)
“I appreciate that my endo is open to trying natural hormone if necessary as my
PCP seems to think Synthroid is the only option.” (Emily)
“[My doctors] got frustrated and abusive with me because I was not tolerating the
[synthetic] thyroid meds well…[synthetic thyroid] meds gave me severe reactions,
altered my mental state, and made me feel worse.” (Jessica)
“I was treated with Synthroid for 38 years [and] getting worse and worse every
year…It took 38 years for someone to realize I am a very poor converter and my system
was not converting the synthetic thyroid down as it should be.” (Karen)
“[I had] no problems until I changed to Synthroid. When I found it didn’t work as
well and I wanted to change back to Armour I could not find a doctor who would permit
the change. They all said Armour was outmoded and Synthroid was better.” (Kim)
“When I kept saying the Synthroid was making me feel bad, I was told “that’s all
we can prescribe”!!” (Michelle)
“Started treatment in 2006 and then left on Synthroid for five years, same low
dose. After knowing I would die if I continued this way, I started taking charge of my
own health…” (Sarah)
“I don’t like that he is not open to natural thyroid and isn’t testing my T3 and
antibodies.” (Shawna)
Continuing education is needed. According to all 15 of the participants (Anne,
April, Autumn, Carla, Diane, Emily, Jenna, Jessica, Karen, Kari, Kim, Leanne, Michelle,
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Sarah, and Shawna) whose treatment experiences were influenced by their doctors’
medical knowledge, continuing education for doctors about thyroid disease is needed.
“[My treatment] is being managed by someone who does not understand that
there is not ‘one size fits all’.” (Anne)
“…when I asked her to test my reverse T3, she refused saying it was no more
important than the type of blood I had.” (April)
“[Doctors] could actually find out how to really treat thyroid [disease…] but even
when I thought this place did […] still nope!” (Autumn)
“Listen to someone that is ‘living it’ and throw away the Synthroid book…maybe
it will click in [my doctor’s] brain that the stuff that was shoved down her throat does not
apply to all folks with thyroid disorders.” (Carla)
“It is scary how little doctors actually know about [thyroid] disease, let alone
Hashimoto’s [disease]…it seems that I am more knowledgeable about some areas of
Hashimoto's than he is.” (Diane)
“[My PCP is] not aware that many of my symptoms could be caused by low
thyroid and she tries to treat them individually – quickly stockpiling my medicine
cabinet.” (Emily)
“I think [my doctor] could be a little more up to date but again, going through a
free clinic I am limited.” (Jenna)
“Doctors are not explaining things clearly. I have heard more I dont [sic] knows
these past few months that it is unbelieveable [sic].” (Jessica)
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“It helped that my regular doc took extra courses to learn more about thyroid
dieses after I explained to her the problems I had with each rejected endo she sent me to.
I was not her only patient with thyroid problems so she was eager to learn more.” (Karen)
“[It has been] difficult to find a Dr. who knows anything about Thyroid
problems…I am explaining more to her then [sic] she to me [about thyroid disease].”
(Kari)
“Sometimes I have to teach [doctors] what some of the recognized symptoms [of
thyroid disease] are!” (Kim)
“When I was finally diagnosed in 2005 after many years of begging [doctors] to
be diagnosed (numbers were “normal”), I found a female PCP to diagnose me. She was a
teaching Dr. and taught me how to read the numbers on all the appropriate tests---not just
TSH, but also FT3 & FT4.” (Michelle)
“I would love to see in the future that Doctors would pay more attention to the
FT3's and FT4's than the stupid TSH levels. I have a Doctor I see for bioidentical
hormones and she is the very first one who has said we'll skip the TSH. I see hope with
her and may at some point trust her to treat my thyroid.” (Sarah)
“[The doctor] says the Hashi’s antibodies ‘just mean that someday your thyroid
might completely stop working. We don’t treat you unless you get a goiter. We don’t
treat people as they age unless their TSH is 10 or even 20.’” (Shawna)
Subtheme 3: Economics. The treatment experiences of 11 out of the 16 total
participants (Anne, April, Autumn, Carla, Jenna, Karen, Kari, Kim, Leanne, Michelle,
and Shawna) who were affected by the culture of the medical profession appeared to be
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specifically influenced by economics. More specifically, three participants reported
feeling rushed by their doctors, eight participants had difficulty with accessing a doctor,
and six participants had difficulty with accessing thyroid medication.
Feeling rushed. Three out of the 11 total participants (Autumn, Jessica, and
Leanne) whose treatment experiences were influenced by economics reported feeling
rushed by their doctors.
“Most [doctors] are just in and out doing as little as they possibly have to do…It
would help if they weren’t so rushed.” (Autumn)
“[I wish doctors would] take more time to figure stuff out and explain things.”
(Jessica)
Access to doctor. Eight out of the 11 total participants (Autumn, Carla, Jenna,
Kim, Leanne, Michelle, Sarah, and Shawna) whose treatment experiences were
influenced by economics had difficulty with accessing a doctor.
“I was very comfortable with Angela [the doctor who quit]…have no clue about
the new one.” (Autumn)
“I got bad sick…and no insurance…couldn't go see a doc…[then, finally] for the
first time in 15 years I had access to a doc again [when I] became eligible for a few
things, including medical care…” (Carla)
“I think [my doctor] could be a little more up to date but again, going through a
free clinic I am limited.” (Jenna)
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“[My relationship with my doctor is] not ideal, but the best I can have
here…There is not Endo around for at least 150 miles and I can't make these long trips.”
(Kari)
“This doctor was the first one ever to test my frees and also the first and only to
test me for Hashi’s antibodies. He has recently passed away, so I’ve had to find a new
doctor again.” (Kim)
“When I was finally diagnosed in 2005 after many years of begging [doctors] to
be diagnosed (numbers were “normal”), I found a female PCP to diagnose me. She was a
teaching Dr. and taught me how to read the numbers on all the appropriate tests---not just
TSH, but also FT3 & FT4. Followup PCP Drs continued to test TSH only & when I kept
saying the Synthroid was making me feel bad, I was told “that’s all we can prescribe”!!”
(Michelle)
“[My Naturopath] cancelled my August recheck because she was too busy as a
school nurse. Said to wait until Nov since I was doing fine.” (Shawna)
Access to medication. Six out of the 11 total participants (Anne, April, Carla,
Karen, Kim, and Shawna) whose treatment experiences were influenced by economics
had difficulty with accessing thyroid medication.
“I was happy until the Armour shortage hit. When that happened, this doctor
knew of nothing else to do but go back to synthroid and did not understand when I was
upset at that suggestion.” (Anne)
“I used Synthroid 150 and Cytomel for almost 3 years but it was costing $60+ a
month. I recently switched to Armour and it is less than $8 a month.” (April)
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“[My doctor] allowed me to stay on the replacements that I've been taking when
we found that my state assistance insurance only covers synthetic T4 and I have a very
poor body response to that.” (Carla)
“I was happy but now that the FDA no longer approves Armour as a medication I
will have to start all over again trying to find a natural product my system can work
with. I have a very sensitive system so it is hard to find a good treatment.” (Karen)
“[I had] no problems until I changed to Synthroid. When I found it didn’t work as
well and I wanted to change back to Armour I could not find a doctor who would permit
the change. They all said Armour was outmoded and Synthroid was better.” (Kim)
“I had taken my labs to the primary doc’s office when I went in for a tick bite, and
asked him to get back with me about what he thought and whether I could switch from
the compounded to something [that would] be covered by insurance, but he never got
back to me.” (Shawna)
Additional Findings
As previously mentioned, I recognized some additional findings that were
meaningful to some participants. Although these findings do not represent the treatment
experiences of the participants as a whole, these data are nevertheless poignant examples
of the phenomenon from individuals who have lived the phenomenon. Additional
findings include the belief that the public is misinformed about thyroid disease (Diane),
the experience of grief (Carla), the experience of empathy from one’s doctor (Michelle),
and the experience of respect from one’s doctor (Michelle).
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Public is misinformed. Diane reported a belief that the public is misinformed
about thyroid disease.
“[I] think the public is grossly misinformed. Their impression is that you just take
a little pill and all is well. This is far from the truth, as it can be very complicated.”
Experience of grief. In sharing her thyroid disease treatment experience, one of
Carla’s comments was indicative of grief.
“I got to watch my iodine uptake...I had such a perfect gland...It was just twice
normal size. I have two half siblings with the same genetic defect I have. Both got proper
care in a timely manner. Both are doing fine. Healthy weight, good jobs, real lives.”
Experience of empathy. Michelle indicated that she experienced empathy from
her doctor.
“[My doctor] is very caring and listens to my needs…he has made clear that he is
a good listener and has my best interest at heart.”
Experience of respect. Michelle indicated that she experienced respect from her
doctor.
“I think [my doctor] is so respectful of his patients that it does not matter if [it is
a] male or female patient.”
Composite Description
According to Moustakas (1994), integrating participants’ textural-structural
descriptions into one composite description provides the reader with a deeper
understanding of the phenomenon being studied. Based on the themes identified from the
individual participant interviews, the following composite description provides answers
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to the research questions: “What are the treatment experiences of women with thyroid
disease?”; “How does the doctor-patient relationship affect their experiences?”; “Do their
experiences differ based on the doctor’s gender?” and represents the experience of the
group as a whole with thyroid disease treatment and the doctor-patient relationship.
Women who develop thyroid disease experience a number of disturbing physical
and emotional symptoms, sometimes years before obtaining a diagnosis. When reported
to their doctors, symptoms are often considered to be “normal” aspects of aging,
particularly when test results indicate no thyroid dysfunction. Nevertheless, many of the
women in this study continued to report a feeling that “something is wrong” (Alicia).
Whether they chose to believe that “doctor knows best” (Karen) or to pursue further
information or a second opinion, these women sought support from others with similar
experiences. Due to its convenience and wealth of information, the Internet is a popular
medium for individuals seeking information or interaction with other people. Online
support groups enable their members to interact anonymously, thus providing members
with a safe and supportive environment in which to share their experiences, information,
and resources. The women in this study found The Thyroid Support Group to be a
reliable source for support and information about thyroid disease symptoms, treatment
approaches, testing for thyroid disease, how to interpret such tests, and the names of
recommended doctors.
For the women in this study, dissatisfaction with one’s doctor seemed to result
from feeling unheard and invalidated by one’s doctor, more so than misdiagnosis in
general. When these women shared their concerns with their doctors, they trusted that
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they would be listened to and taken seriously. When these women brought information to
their doctors, they expected their doctors to review the information and to include their
thoughts and concerns in the diagnostic and treatment planning processes. The women in
this study felt disrespected when their doctors rushed or interrupted them. Feelings of
distrust in doctors developed when these women felt dismissed or as if their doctors did
not care about them––when their doctors seemed to view them and their experiences by
“the numbers” (Michelle) rather than as people. For some of the women in this study,
their dissatisfaction with their doctors lead to feelings of hopelessness.
Feeling heard and validated by one’s doctor, on the other hand, engenders trust.
When the thoughts and concerns of the women in this study were considered––when they
were taken seriously––they felt hopeful that they would someday feel well instead of
constantly feeling tired, “foggy,” anxious, and depressed. According to the women in this
study, not rushing or interrupting one’s patient demonstrates respect for the patient,
which in turn, leads to respect for one’s doctor. In addition, including women with
thyroid disease in the diagnostic and treatment planning processes encourages authentic
communication and patient satisfaction.
Many of the women in this study who did not feel heard or taken seriously by
their doctors advocated for themselves––conducted research, sought new doctors,
refused treatment, self-treated, and kept secrets if they believed it is necessary—including
individuals who believed (at least at one point) that “doctor knows best.” The majority of
the women interviewed expressed no preference for their doctors to be female or male.
They simply wished to be heard and taken seriously. Some of these women in this study
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feared not being taken seriously because they tend to show emotion as they describe their
symptoms and share their experiences. They feared being viewed as weak and
unintelligent by their doctors.
The general culture of the medical profession seemed to devalue the experiences
of the women in this study––labeling their symptoms as psychosomatic, as solely related
to diet and exercise, or due to “women’s problems” for which there are clear treatment
guidelines. When these women questioned their diagnosis or did not feel better after
following their doctor’s orders, they were labeled as difficult––and sometimes even
“fired” by their doctors (Anne). Based on what they learned in medical school, both male
and female doctors tend to value the TSH blood test above all other tests available for
thyroid disease––despite the fact that a “full thyroid panel” offers the most thorough
analysis of thyroid function. The women in this study who were aware of this
discrepancy and brought it to the attention of their doctors because they were still not
feeling well were often dismissed.
Similarly, although synthetic thyroid medication is standard in treating
hypothyroidism, it does not work for everyone. Some of the women in this study actually
felt worse on synthetic thyroid medication than on no medication at all. The women who
learned about natural thyroid treatments and who brought information about this option to
the attention of their doctors were often told that such treatments are outdated or
ineffective. Even the women who had taken natural thyroid medication in the past and
felt better were told that natural thyroid medication was not a treatment option. But these
women knew otherwise––they had learned from their own experiences or from others
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like them that doctors who prescribe natural thyroid medication do exist. Through sharing
with other women with thyroid disease, they had learned that it is possible that they might
feel better taking natural thyroid medication.
For some of the women in this study, financial difficulties, limited health
insurance benefits, and geographic location sometimes interfered with finding a good
doctor or the medication needed for thyroid disease. In addition, many of the women in
this study had the impression that they were more knowledgeable about thyroid disease
than their doctors. For the women whose doctors were receptive to a collaborative
relationship, treatment planning ensued with shared information, respect for experience,
patience, and the understanding that medication would be adjusted until the patients felt
well. Some of the women with doctors who functioned in a more paternalistic manner
were told to “get off Google” (April). Regardless of their relationship style, it seems that
doctors (and their patients, in turn) might benefit from continuing education on thyroid
disease––particularly considering its prevalence. Likewise, it seems prudent that research
be conducted on the use of natural thyroid medication because of the many women in this
study did not feel better while taking synthetic thyroid medication.
Doctors who diagnose and treat women with thyroid disease are in a position to
empower their patients (“I have chosen to stay with the physician because I believe he
will listen to me. I research, bring my research to him and we discuss what to do with it
[and we will] continue working on treatment until I am thriving”; Alicia) or to respond in
a manner that elicits feelings of hopelessness and devastation: “It is enough to make one
feel hopeless at times…I would get my hopes up that this doctor was the ONE who
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would help me. The letdown after each appointment was devastating” (Anne). Based on
the experiences of the women in this study, it seems that women with thyroid disease
grieve their health and long to feel well again. They desperately wish for their
experiences to be known and understood” “Listen to someone that is ‘living it’ and throw
away the Synthroid book” (Carla).
Summary
In Chapter 4, I described the findings from this phenomenological study of female
thyroid patients’ experiences of treatment and the doctor-patient relationship. Upon
analyzing the participants’ interview transcripts, four themes emerged: (a) doctor-patient
relationship, (b) patient self-advocacy, (c) doctor-patient communication, (d) and culture
of the medical profession (see Appendix H). Within the main themes, 11 subthemes
emerged. Appendix H presents the full list of themes and subthemes. An interpretation of
findings follows in Chapter 5.
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Chapter 5: Summary and Recommendations
Introduction
The purpose of this chapter is to summarize and discuss the findings presented in
Chapter 4 about the treatment experiences of a sample of women with thyroid disease. A
review of the research literature in Chapter 2 revealed a significant gap specifically
concerning the treatment experiences of women with thyroid disease diagnoses and the
doctor-patient relationship. An understanding of how women with thyroid disease
experience treatment and the doctor-patient relationship can enhance doctors’ knowledge
of women’s health and chronic illness and can help to determine factors related to
positive treatment outcomes. Between January 12, 2014 and February 5, 2014, I
individually interviewed via online chat 16 female thyroid patients who were members of
The Thyroid Support Group. This phenomenological study resulted in a rich description
of the participants’ experiences with thyroid disease treatment and the doctor-patient
relationship.
Criterion sampling was used to recruit 16 participants who were female, who
were aged 18 years and older, who had self-proclaimed thyroid disease diagnoses, and
who were members of The Thyroid Support Group. Data were collected using an
interview guide that I created, which was validated by an external panel of three experts
in qualitative methods (see Appendix A). The data analysis revealed four themes and 11
subthemes. The four themes consisted of experiences surrounding (a) the doctor-patient
relationship, (b) patient self-advocacy, (c) doctor-patient communication, (d) and the
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culture of the medical profession. Appendix H presents the full list of themes and
subthemes that emerged from the data analysis.
Exploration of the manner in which people assign meaning to their thoughts,
feelings, and actions is required for understanding human behavior (Marshall &
Rossman, 2006, p. 53). Thus, the participants’ experiences with thyroid disease treatment
and the doctor-patient relationship were formed into textural-structural descriptions (see
Appendix G) within the conceptual frameworks introduced in Chapters 1 and 2:
phenomenology, social constructionism, and feminism. Both social constructionism and
feminism emphasize individuals’ experiences in social contexts (Docherty & McColl,
2003; Fernandes et al., 2006; Hearn, 2009), and together, they suggest that social
constructs associated with gender issues and the female body have an effect on female
patients’ interpretations of their experiences (Hearn, 2009). In the sample interviewed,
participants shared their thoughts and experiences regarding the influence of gender,
autonomy, knowledge, and communication on their perceptions of thyroid disease
treatment and doctor-patient relationships.
The remainder of the chapter presents an interpretation of findings by major
themes and subthemes, a discussion of the limitations of the study, recommendations for
future research, implications for social change, and conclusions.
Interpretation of Findings
The textural-structural descriptions of a sample of 16 women with thyroid disease
provide information with which one might begin to understand the treatment experiences
of women with thyroid disease and their relationships with their doctors. Numerous
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factors influenced each participant’s experience with thyroid disease treatment. The
following four themes were identified: (a) doctor-patient relationship, (b) patient selfadvocacy, (c) doctor-patient communication, (d) and culture of the medical profession.
Within these four main themes, 11 subthemes emerged (see Table 4 and Appendix H). In
the following sections, the themes and subthemes are discussed in detail through the
lenses of social constructionism and feminism.
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Table 4
Themes and Subthemes
Themes

Subthemes

Sub-subthemes

Doctor-patient relationship

Traditional relationships

Feeling unheard
Feeling invalidated
Feeling dismissed
Experienced a lack of empathy
Feeling disrespected
Feeling heard

Collaborative relationships

Feeling validated
Feeling unrushed
Shared decision making

Health information seeking

None

Switching doctors

None

Belief that “doctor knows
best”

None

Desire to be informed

None

Role of trust

Lack of trust in doctor
Treatment refusal
Secret keeping
Self-treatment

Role of gender

No preference for specific doctor gender
Preference for female doctor
Being taken seriously
Presence of emotion

Diagnostic bias

Symptoms considered psychosomatic
Symptoms attributed to lifestyle

Medical knowledge

TSH testing is standard
Synthetic medication is standard
Continuing education may be needed

Patient self-advocacy

Doctor-patient communication

Culture of the medical profession

Economics

Feeling rushed
Access to doctor
Access to medication

Note. Additional findings included the following: public is misinformed, experience of
grief, experience of empathy, and experience of respect.
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Theme 1: Doctor-Patient Relationship
Research indicates that the nature of the doctor-patient relationship has the
potential to determine positive or negative treatment outcomes (Copeland et al., 2003;
Houle et al., 2007; Munch, 2004; Stokes et al., 2006). Participant interviews revealed
experiences with two types of doctor-patient relationships: traditional and collaborative.
The two subthemes within Theme 1: Doctor-Patient Relationship are Subtheme 1:
Traditional Relationships (feeling unheard, feeling invalidated, feeling dismissed,
experienced a lack of empathy, and feeling disrespected) and Subtheme 2: Collaborative
Relationships (feeling heard, feeling validated, feeling unrushed, and shared decision
making).
Subtheme 1: Traditional relationships. As discussed in Chapter 2, traditional
doctor-patient relationships are hierarchical in nature, with the doctor in a position of
authority over the patient (Berger, 2002). In traditional doctor-patient relationships, the
doctor controls the discussion, makes a diagnosis, and chooses the treatment plan without
the patient’s input (Bradley et al., 2001; Ehrenreich & English, 2005; McGuire et al.,
2005; Vanderford et al., 2001). The majority of the participants interviewed in this study
(11 out of 16) reported experiencing this type of relationship with their doctors. Within
Subtheme 1: Traditional Doctor-Patient Relationships are the following subthemes:
feeling unheard, feeling invalidated, feeling dismissed, experienced a lack of empathy,
and feeling disrespected.
Feeling unheard. With their doctors controlling the discussions, eight of the 11
participants who experienced a traditional doctor-patient relationship felt unheard.
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According to Hedberg and Lynoe (2013), doctors who listen to their patients without
interrupting are demonstrating that they are interested in what their patients have to say
and are committed to understanding the patient’s perspective. When attempting to
describe her medical history, Shawna’s doctor interrupted her and “launch[ed] into a
tirade about how I don’t have a thyroid problem and should never have been put on
meds.” Similarly, Jenna expressed a desire for her doctor to “LISTEN instead of being
pushy,” explaining that when she shared that her hair was falling out and she was “tired
ALL the time,” the doctor “just blew it off as not being related [to thyroid disease].”
Because there is a positive correlation between physician listening and patients’
perceptions that their physician cares for their well-being (Jagosh, Boudreau, Steinert,
MacDonald, & Ingram, 2011), feeling unheard by one’s doctor has the potential to lead
patients to feeling that their doctors are disinterested and do not care about them as
patients.
In addition to feeling unheard, April felt invalidated, explaining that her doctor
maintained a “negative and controlling attitude” and that when she tried to describe how
she was feeling, her doctor told her “to ‘trust her, she had control of the situation’.”
April’s experience is reminiscent of Mutter’s (1999) “military metaphor” in healthcare,
which purports that medicine is a war against disease and death. In following this
rationale, doctors tend to focus on and attempt to take control of the patient’s physical
processes while ignoring mental and emotional concerns. According to Mutter, this type
of thinking can give patients the impression that the doctors believe they know more
about their patients’ experiences than the patients themselves. In contrast, doctors can
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facilitate their patients’ ability to manage the emotions associated with their illnesses by
listening attentively, showing an interest in what their patients are saying, and validating
their patients’ feelings (Street, Makoul, Aurora, & Epstein, 2009).
Feeling invalidated. All eight of the participants who felt unheard by their
doctors also felt invalidated by their doctors. Two additional participants (Kim and Anne)
felt invalidated, for a total of 10 participants to report feeling invalidated by their doctors.
Kim felt invalidated because her doctor believed that the choking sensation she felt was
“in [her] imagination.” She did not report feeling unheard, however, because her doctor
offered to investigate her symptoms. Although Anne did not mention feeling heard or
unheard, she reported feeling invalidated in that her doctor did not give “credence to [her]
depiction of [her] symptoms” because she becomes “emotional” when she discusses her
symptoms. If Anne’s doctor had validated her perspective and demonstrated empathy, her
experience of negative emotions (i.e., hopelessness and frustration) may have been
reduced (Street et al., 2009, p. 297).
According to Malterud and Ulriksen (2010), all experiences are valid—even those
that seem to be distorted by emotion—because they are subjective (p. 208). Thus,
attempting to understand a patient’s illness experience from her perspective is vital to
validating the patient. Diane reported feeling invalidated by her doctors because “no
doctor would further investigate” her symptoms when she informed them that “something
wasn’t right.” Similarly, when Carla repeatedly expressed to her doctor that she believed
her dose of thyroid medicine was incorrect because she did not feel well, she was
“demeaned and/or ignored.” Jessica expressed frustration that doctors would “not believe
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[her]” and insisted in prescribing antidepressants instead of further investigating her
symptoms. A study by Epstein et al. (2007b) revealed that unnecessary prescribing of
medications is reduced when doctors use “inquiry, openness, empathy, and validation,
rather than cutoffs and assertion of [their own] agenda.” (p. 26).
Feeling dismissed. All eight of the participants who felt invalidated by their
doctors also felt dismissed by their doctors. Carla’s doctor told her that she “…was ‘too
fat to be sick’ and “went on to tell [her] to leave, there were others that really needed
him.” Carla’s experience is reminiscent of the female participants in Copeland et al.’s
(2003) study who indicated that their doctors and were insensitive, patronizing,
condescending, impatient, and disrespectful. The most frequently expressed desire by
participants in Copeland and colleagues’ study was for their doctors to allow them to
express their concerns without interrupting (p. 40). The type of interruption that Carla
experienced would be referred to by Florian and Al-Roubaie (2008) as “non-supportive”
and “power driven” as opposed to “supportive,” or “clarifying,” and “relationship driven”
(pp. 648-651). Non-supportive, power driven interruptions by the doctor are a “violation
of a speaker’s rights,” are intimidating for patients (Florian & Al-Roubaie, 2008, p. 651),
and have the potential to reduce a patient’s trust in their doctor (Skirbekk, Middelthon,
Hjortdahl, & Finset, 2011).
While Carla was actively dismissed by her doctor, other participants were
passively dismissed by their doctors. For example, Anne—an individual who becomes
emotional when she discusses her symptoms—was “fired” by her doctor without any
warning:
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Last February, at my last appointment with him, he said I seemed to be doing fine
[and] gave me a year’s prescription for the compounded thyroid and wished me
well. I didn’t occur to me that he had fired me until I was telling someone else
about this appointment. Out of curiosity, I requested my records. In his notes from
our last appointment, he said it appeared I was treating myself. This surprised me
quite a bit because he had always seemed to appreciate that I was a somewhat
informed patient.
Based on the results of their study, Stokes et al. (2006) argued that general
practitioners who terminated their relationships with their patients were exercising
symbolic power—and that the doctors’ decisions appeared to be based upon their refusal
to adopt a collaborative approach to healthcare. According to Stokes et al., being “fired”
by one’s doctor is experienced by patients as an “overtly violent” symbolic act (p. 613).
Particularly considering that patients tend to be reluctant to share psychosocial aspects of
their illness due to fear of dismissal by their doctors (Shattock, Williamson, Caldwell,
Anderson, & Peters, 2013), if patients choose to disclose their suffering, doctors have an
ethical obligation to relieve their suffering by responding with empathy and compassion
(Gelhaus, 2012a, 2012b), not dismissal.
In Shawna’s experience, her doctor simply never responded to her inquiry:
[I] asked him to get back with me about what he thought and whether I could
switch from the compounded to something [that would] be covered by insurance,
but he never got back to me.

162
The actual cause of Shawna’s doctor not following up with her is unknown.
Nevertheless, because Shawna already felt unheard and invalidated by her doctor, the
added feeling of dismissal prompted her to seek a new doctor (discussed in section
“Theme 2: Patient Self-Advocacy”).
Experienced a lack of empathy. Four of the 11 participants who experienced a
traditional doctor-patient relationship specifically expressed experiencing a lack of
empathy from their doctors. Empathy, as demonstrated by a physician, is an
understanding of the patient’s “feelings, sensations (e.g., pain)…hopes and fears about
the disease and of the role and options of the physician and the therapy” (Gelhaus, 2012a,
pp. 105-106). Research has indicated that empathy is a vital component to an effective
doctor-patient relationship and positive health outcomes (Houle et al., 2007; Neumann et
al., 2009; Pollak et al., 2011; Rakel et al., 2011). According to Gelhaus (2012a), one of
the most important aspects of physician empathy is “…taking seriously the patient as a
complete, distinct, unique human being, not only as a carrier of diseases and symptoms to
treat” (p. 112). For a patient to not experience empathy in the clinical encounter has the
potential to cause the patient to feel misunderstood and unaccepted (Neumann et al.,
2009).
Shawna explained that one of her doctors had become “less caring over the years”
and that in her search to find a doctor, she has come to no longer trust doctors (discussed
in section “Theme 3: Doctor-Patient Communication”). In addition to wanting to feel
heard and validated by her doctors, Jessica expressed a desire for her doctors to “just let
[her] know they care.” Similarly, in conjunction with not being taken seriously by her
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doctors (discussed in section “Theme 3: Doctor-Patient Communication”), Emily
described a lack of empathy from her doctors regarding her thyroid disease-related
weight gain: “Sometimes I think men doctors don’t take some female symptoms
seriously, but then I’ve had women doctors that also didn’t seem to be sympathetic to a
formally [sic] skinny patient who quickly put on 20 pounds.”
Kim and Karen did not describe experiencing a lack of empathy from their
doctors. However, they acknowledged the importance of empathy in the doctor-patient
relationship. For Kim, a “doctor’s accepting attitude and understanding, empathetic
approach helps” her to feel comfortable with sharing her symptoms. When asked whether
the gender of her doctor is important to her, Karen responded, “It’s not the sex of the
doctor but the compassion and caring of the doctor that makes one good” (discussed in
section “Theme 3: Doctor-Patient Communication”). Michelle is the only participant to
express having experienced empathy from her doctor: “He is very caring and listens to
my needs…he has made clear that he is a good listener and has my best interest at heart.”
Michelle’s experience of empathy from her doctor is discussed in the “Additional
Findings” section.
Even though the majority of participants did not specifically state that they did not
receive empathy from their doctors, considering Gelhaus’ (2012a) assertion that
physician empathy involves “…taking seriously the patient as a complete, distinct,
unique human being…” (p. 112), many of the participants’ experiences are indicative of
doctors who seem to struggle with demonstrating empathy. For example, Carla’s doctor
told her that she was ‘too fat to be sick’ and asked her to leave his office; Anne’s doctor
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“fired” her without any discussion or warning; and Jenna’s doctor “blew her off” when
she complained that she was losing her hair and felt “tired ALL the time.”
Annas (2012) purported that in medicine, patients are “treated as enemies, as
machines whose bodily plumbing becomes coextensive with medical machinery” and
contends that only “vigorous enforcement of patient rights” will ensure that patients be
viewed by doctors as autonomous individuals deserving of empathy and warmth (pp. 3031). Considering that the medical profession has a tendency to dehumanize patients and,
historically, patients have been expected to be passive and submissive with their doctors
(Annas, 2012; Lupton, 2003), it is possible that the participants in this study who
experienced a lack of empathy did not specifically describe their experiences as such
because they were unaware of their right to empathy. Because empathy has the potential
to reduce patients’ anxiety (Finset, 2012; Fogarty, Curbow, Wingard, McDonnell, &
Somerfield, 1999) and even enhance patients’ immune system response (Rakel et al.,
2009; Rakel et al., 2011), additional training in empathic communication may be
warranted (Gelhaus, 2012a, 2012b; Pollak et al., 2011).
Feeling disrespected. Three of the 11 participants who experienced a traditional
doctor-patient relationship indicated that they felt disrespected by their doctors. All three
of these participants also reported feeling unheard, invalidated, and dismissed by their
doctors. According to research by Wessel et al. (2012), feeling respected is associated
with doctors who listen to their patients, answer their questions, and take seriously what
their patients are sharing. Similarly, participants in Salt et al.’s (2012) study described
effective physician communication as respectful when physicians demonstrated empathy,
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concern, and patience. However, doctors have reported struggling with consultations with
patients who have unexplained symptoms (Werner & Malterud, 2003), who tell long
stories (Platt, 2008), and who do not adopt a passive role in their treatment (MacDonald,
2003).
Shawna reported that when she attempted to describe her medical history, her
doctor interrupted her and “launch[ed] into a tirade about how [she didn’t] have a thyroid
problem and should never have been put on meds.” Carla explained that she had
repeatedly told her doctor she believed her “dose [of thyroid medicine] was wrong”
because she was feeling worse each year. During one such discussion on the telephone,
Carla’s doctor called her “a 'smart ass' and [told her] to stay on the same dose…then hung
up on [her].” Shawna’s and Carla’s experiences of disrespectful responses from their
doctors might be related to their attempts to be active participants in their treatment. In a
study by Frosch, May, Rendle, Tietbohl, and Elwyn (2012), participants who attempted
to participate in shared decision making with their doctors reported feeling unheard and
disrespected by their doctors. Frosch et al. asserted that doctors may lack the skills
needed to create an environment conducive to open communication and shared decision
making. According to Chin (2002), doctors have a responsibility to work collaboratively
with their patients in creating treatment plans that include not only the doctors’
recommendations, but also considers the patients’ ideas, concerns, and expectations.
Subtheme 2: Collaborative relationships. The majority of the participants
interviewed (13 out of 16) also experienced collaborative doctor-patient relationships. At
some point in their experiences with treatment for thyroid disease, nine of these 13
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participants who experienced a collaborative doctor-patient relationship also had doctors
who worked in a traditional paternalistic manner. In other words, only four (Alicia,
Autumn, Karen, and Kari) out of the 16 participants interviewed consistently had doctors
who did not make them feel unheard, invalidated, dismissed, not empathized with, or
disrespected.
As discussed in Chapter 2, in collaborative doctor-patient relationships, doctors
tend to listen attentively to their patients, visits tend to be longer, and patients’
preferences are considered in treatment decisions (Breen et al., 2009; Hall et al., 2009;
Houle et al., 2007; Levinson, Lesser, & Epstein, 2010; Salt et al., 2012; Wessel et al.,
2012). In contrast to traditional doctor-patient relationships, collaborative doctor-patient
relationships in which patient autonomy is respected help to encourage positive treatment
outcomes (Chrisler & Parrett, 1995; Dugdale et al., 2008; Fox & Chesla, 2008; Houle et
al., 2007; Peck & Connor, 2011). According to Chin (2002), doctors have a responsibility
to work collaboratively with their patients in creating treatment plans that include not
only the doctors’ recommendations, but also considers the patients’ ideas, concerns, and
expectations. Within Subtheme 2: Collaborative Relationships are the following
subthemes: feeling heard, feeling validated, feeling unrushed, and shared decision
making.
Feeling heard. Ten of the 13 participants who experienced a collaborative doctorpatient relationship indicated that they felt heard by their doctors. Research indicates that
when patients feel heard by their doctors, they are more likely to be satisfied with their
treatment (Levinson, 2011; Peters et al., 2008). Patients are also more likely to trust their
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doctors if they perceive that their doctors are listening attentively and answer their
questions (Houle et al., 2007; King et al., 2015). Alicia explained, “I have chosen to stay
with the physician because I believe he will listen to me.” Kari described her doctor as
“easy to talk to” and explained that even though her doctor is lacking in knowledge about
thyroid disease, “the main thing [is that] she does listen.” Similarly, Diane expressed
appreciation that her doctor “take[s] into consideration what [she’s] saying to him, and
gives [her] feedback.”
According to Houle et al. (2007) and Jagosh et al. (2011), in conjunction with
feeling heard by one’s doctor, patients who believe that their doctors have a genuine
interest in their well-being are more likely to trust their doctors. Trust, in turn, tends to
result in patients’ willingness to share with their doctors and to consider their advice
(Copeland et al., 2003; Peters et al., 2008). After years of trying to find a doctor she felt
comfortable with, Michelle found a doctor who “made clear that he is a good listener and
has [her] best interest at heart.” Because patients experience their illnesses in the context
of their own social worlds, doctors who encourage patients to share their thoughts and
concerns from their own perspectives tend to be more effective than doctors who do not
actively listen and seek patients’ personal interpretations (Epstein & Street, 2011; Lang,
Floyd, & Beine, 2000). When patients feel comfortable sharing their experiences with
their doctors, the likelihood of misdiagnosis and delayed treatment is decreased (Lang et
al., 2000).
Feeling validated. Eight of the 13 participants who experienced a collaborative
doctor-patient relationship indicated that they felt validated by their doctors. All of the
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participants who reported feeling validated by their doctors had also reported feeling
heard. For example, Diane reported appreciating that her doctor “take[s] into
consideration what [she shares with] him” when expressing her concerns and discussing
treatment options. Although April had reported feeling unheard and invalidated by her
previous doctor, she described feeling comfortable sharing her concerns with her new
doctor because he “wants to know what [she knows] and confirms that [she is] not
stupid.” Alicia explained that her doctor welcomes her thoughts: “I think my doctor
understands that I am not the person I used to be [before treatment for breast cancer]—
that I know how to do the research and that I know what is reasonable.” Similarly,
Michelle expressed that her doctor validates her by understanding that “[her] body reacts
differently than others termed ‘normal’ and is very interested in working with [her] to
‘optimize’ [her] thyroid hormone needs.”
Validating one’s patients engenders productive, therapeutic communication
because when patients feel safe in sharing their symptoms, doctors can ask relevant
questions and may recognize undiagnosed or misdiagnosed illnesses (Dean & Street,
2014; Hedberg & Lynoe, 2013). Shields et al.’s (2013) study of the relationship between
doctor-patient communication and the undertreatment of pain revealed that doctors who
explored and validated their patients’ experiences conducted more thorough pain
assessments than doctors who did not express a curiosity about their patients’ concerns.
Research indicates that thorough assessments are more likely to lead to accurate
diagnoses and appropriate treatments (Epstein et al., 2007b; Shields et al., 2013).
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Furthermore, patients who feel validated by their doctors tend to experience improved
psychosocial well-being (e.g., feelings of optimism and self-worth; Street et al., 2009).
Feeling unrushed. Four of the 13 participants who experienced a collaborative
doctor-patient relationship indicated that they felt unrushed by their doctors. After
leaving the doctor who interrupted her, Shawna found a doctor she liked, stating, “I like
the new D.O. …he seems to be on the right track and he spends a lot of time with you.”
Similarly, Kari described her doctor as “…easy to talk to…she takes her time.” Emily
was more detailed in her description of how her doctor made her feel unrushed,
explaining, “I had written all my issues out before seeing the endocrinologist and she still
went through the whole list of possible symptoms to see which I was experiencing and to
what extent. She was very thorough.”
According to Salt et al.’s (2012) study of individuals with rheumatoid arthritis,
having sufficient time to discuss their concerns with their doctors without feeling rushed
was a crucial factor in patients’ perceived quality of care. In addition to feeling
comfortable with and trusting of one’s doctor (Copeland et al., 2003; Houle et al., 2007;
Sutherns, 2004), research indicates that patients who do not feel rushed by their doctors
also feel valued and supported by their doctors (Sutherns, 2004; Swancutt, Greenfield,
Luesley, & Wilson, 2011). An additional benefit to feeling unrushed by one’s doctor is
that patients find it easier to ask questions, which reduces the potential for
misunderstanding health information and treatment recommendations (Heinrich &
Karner, 2010).
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Shared decision making. Twelve of the 13 participants who experienced a
collaborative doctor-patient relationship indicated that they participated in shared
decision making with their doctors. Alicia explained,
I feel that we are carefully working toward finding the best way to treat me….We
have a good working relationship…he does listen when I tell him how I am
feeling and [we will] continue working on treatment (adjusting medication
dosages and testing) until I am thriving.
Diane described a similar experience with her doctor, stating, “[My doctor takes] into
consideration what I'm saying to him, and gives me feedback…We’re [currently]
working on seeing if I have any issues with my adrenal glands.” Likewise, Michelle
reported that her doctor is “very interested in working with [her] to “optimize” [her]
thyroid hormone needs.” April’s experience involves her bringing research to her doctor.
She explained, “[My doctor] wants to know what I know…[and] if need be, he will
correct or add more info to what I already know.”
With the passing of the Affordable Care Act of 2010, shared decision making
between patients and doctors became a requirement in the doctor-patient relationship
(Frosch et al., 2012). However, traditional doctor-patient relationships in which the
doctor makes treatment decisions without the patient’s input continue to persist.
According to Frosch et al., doctors may lack the skills needed to create an environment
conducive to open communication and shared decision making.
Research indicates that most patients desire to be involved in the decision making
process (Barry & Edgman-Levitan, 2012; Chin, 2002; Flynn, Smith, & Vanness, 2006;

171
Quaschning, Korner, & Wirtz, 2012). According to Barry and Edgman-Levitan (2012),
shared decision making is the “most important attribute of patient-centered care” (p. 780).
Chin (2002) asserted that in order to successfully negotiate a treatment plan with one’s
patient, the doctor must be sincere in the shared decision making process. In other words,
it is essential that the doctor attempts to understand the patient’s point of view and is
open to incorporating the patient’s ideas and concerns into the treatment plan. Shared
decision making also requires mutual trust (Chin, 2002; Crooks et al., 2015). In Carla’s
experience, her doctor’s willingness to include her in the decision making process is a
significant aspect of earning Carla’s trust. Carla explained, “I don't have a lot of trust in
her anymore…but I will admit that she is now talking with me more…and we are
working on compromises.”
Studies show that involving patients in the decision making process increases
patient satisfaction and treatment acceptance (Barry & Edgman-Levitan, 2012; den
Ouden, Vos, Reidsma, & Rutten, 2015; Elwyn et al., 2012; Epstein & Street, 2011; Flynn
et al., 2006; Quaschning et al., 2012). According to Chin (2002), another benefit of
shared decision making is that it can help to ensure that patients are not left alone in a
position of evaluating the efficacy of various treatments. Epstein and Street (2011)
contend that even if a patient does not initially choose the best treatment option, a
worsened condition can be promptly addressed by the doctor due to the mutual trust
established via shared-decision making. In addition, the fact that the patient feels
understood, respected, and involved in the decision making process might alleviate any
resulting distress associated with the patient’s symptoms (Epstein & Street, 2011).
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According to McNutt (2004), involving the patient in the decision making process is vital
because “only the patient will suffer or enjoy the probabilistic outcomes associated with
choosing one option over another” (p. 2516).
Theme 2: Patient Self-Advocacy
In describing their experiences with thyroid disease treatment, 15 of the 16 total
participants described participation in some form of self-advocacy, including health
information-seeking and switching doctors. The majority of these participants (12 out of
15) experienced a traditional doctor-patient relationship at some point. Two of the 15
participants who participated in a form of self-advocacy (Karen and Kim) made
statements that indicated a belief that “doctor knows best” (discussed at end of this
section). The subthemes within Theme 2: Patient Self-Advocacy are Subtheme 1: Health
Information-Seeking, Subtheme 2: Switching Doctors, and Subtheme 3: Belief that
“Doctor Knows Best.”
Subtheme 1: Health information-seeking. Twelve of the 15 participants who
participated in some form of self-advocacy conducted health information-seeking. Two
of these participants sought health information for use in shared decision making with
their doctors. Alicia explained, “[My doctor understands that] I know how to do the
research and that I know what is reasonable.” Although Kari described having difficulty
with “find[ing] a Dr. who knows anything about Thyroid problems,” she explained that
her doctor was receptive when she shared “what [she] learned [from] reading Mary
Shomon’s newsletters and book.”
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Ten of the 12 participants who sought health-information did so because they
continued to feel unwell despite being treated for thyroid disease. Karen reported that
after 38 years of not feeling better from treatment for thyroid disease, she sought
information online and “learned a bank of knowledge that helped [her] whittle thru all the
mediocre docs and find the right one”—a doctor who “listens well and makes
adjustments based on [her] response.” In some cases, participants learned that additional
blood tests might give a clearer picture of their thyroid function. Shawna explained, “I
feel that if I hadn’t been aggressive in all my research I would have just been kept being
told that my [levels were] ‘normal’ when they were clearly not.” Anne reported that she
“had joined the on-line support group and done some research on-line [and] did finally
find a doctor who agreed to include free t3 and t4 [levels] in the blood tests.”
Other participants chose to conduct research in order to make informed decisions
regarding their treatment. Jenna explained, “[My doctor] REALLY pushes for me to do
RAI which based on MY research, I don’t feel is needed.” Emily described appreciating
that her endocrinologist is “open to trying natural hormone” and commented, “[my
endocrinologist] seems well versed in my diagnosis, but I only know that because of
extensive research I’ve done on my own.” Kim reported that she has been conducting
research over the 66 years she has been treated for thyroid disease. She stated, “I know
enough about thyroid function and my thyroid problem and what works best for me that I
am in a position to explain to the doctor what I need, not the other way around!”
Similarly, April explained, “I know my shit and will tell them what I know, what I want
to know and what their opinion is and their thoughts. I will not always go with their
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recommendations (I have refused RAI 3 times now…).” April elaborated on her
experience with conducting research to share with her doctor, “I went [to my
appointments] with knowledge and she told me to get off google.”
According to Tustin (2010), doctors tend to view patients who bring information
from the Internet to their appointments as burdensome. Historically, doctors have had
access to medical knowledge unavailable to the public. Although this continues to be
true, patients now have greater access to health information (Hearn, 2009). Contributing
factors to patients performing their own research include having insufficient time to ask
questions at doctor’s appointments (Tustin, 2010), not trusting the doctor’s advice
(Frosch et al., 2012; Tustin, 2010), and perceived lack of empathy from one’s doctor
(Tustin, 2010). Research indicates that individuals who join online health support groups
do so because they desire emotional support in dealing with the anxiety and uncertainty
related to their illness (Oh & Cho, 2015; Ye, 2014). Results of a national survey
conducted by Fox (2011) for the Pew Research Center revealed that 23% of Internet users
with a chronic health condition used the Internet to find others who share their health
concerns.
A study by Tustin (2010) indicated that even patients who were satisfied with
their treatment tended to conduct online research about their health concerns. However,
unlike patients who were dissatisfied with their care, patients who reported being
satisfied reported that they relied more on their doctors than on the Internet for health
information. Participants in a study by Frosch et al. (2012) expressed a desire to share
information with their doctor and to participate in treatment decisions. However, the
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participants reported hesitation to do so because they feared being labelled by their
doctors as “difficult.” Risberg et al. (2006) asserted that doctors have a tendency to
undervalue patients’ knowledge. According to MacDonald (2003), because health care
professionals have been traditionally thought of as “all knowing,” patients who seem to
challenge professionals’ expertise become thought of as “difficult” by professionals.
Research conducted by Amante, Hogan, Pagoto, English, and Lapane (2015)
indicated that the likelihood of using the Internet to seek health information increased
with education level—particularly among female patients. Similarly, a study by Flynn et
al. (2006) revealed that patients who are female and who have a higher educational
attainment tend to desire the most active involvement in the decision making process
with their doctors. In the current study, 11 of the 12 participants who sought health
information acquired education beyond high school (see Table 2 in Chapter 4). Seven of
the 12 participants who conducted information-seeking (Anne, April, Diane, Karen, Kim,
Leanne, Shawna) also switched doctors.
Subtheme 2: Switching doctors. Nine of the 15 participants who participated in
some form of self-advocacy switched doctors. Jessica explained that she had “been
through three endo's [sic] in five months [because the first] two got frustrated and abusive
with [her] because [she] was not tolerating the thyroid meds well.” Similarly, Michelle
reported, “It took me another 2 years before I found an Internal Medicine Dr. who would
prescribe me something other than Synthroid.” Anne commented,
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I went to at least 4 doctors seeking help. This was especially difficult because
with each new appointment, I would get my hopes up that this doctor was the
ONE who would help me. The letdown after each appointment was devastating.
Likewise, Karen reported that she “went through 5 Endos before [she] found one who
knew what she was doing.” Diane shared that she “saw several doctors [who] prescribed
anti dizziness medication, depression pills, etc.” She elaborated, “All doctors said my
blood work came back fine, including thyroid. However, I was still bedridden and in
danger of losing my job.” April explained that she “hesitated leaving [her doctor] when
[she] got pregnant,” but added that she “felt more secure” and switched doctors once the
baby was born.
Research indicates that the most common reasons given by patients for switching
doctors include dissatisfaction with and lack of trust in one’s doctor (Berry et al., 2008;
Calnan & Rowe, 2008; Liu, Yen, Lo, & Chen, 2014; Platanova, Kennedy, & Shewchuk,
2008; Kessler & Mylod, 2011; Torres, Vasquez-Parraga, & Barra, 2009). A study by Liu
et al. (2014) revealed that feeling understood and accepted by one’s doctor is a significant
predictor to trusting one’s doctor, and thus, choosing to remain committed to the doctorpatient relationship. According to research by Platanova et al. (2008), a patient’s
satisfaction with and trust in one’s doctor are stronger predictors of a patient’s
commitment to the doctor-patient relationship than are the monetary costs of switching
doctors. In other words, patients who are not satisfied with or do not trust their doctors
will switch doctors even if switching results in a greater expense.
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Unlike traditional doctor-patient relationships in which patients adopted a passive
role in their healthcare, modern patients view themselves as consumers who wish to be
informed and to work collaboratively with their doctors (Calnan & Rowe, 2008). A study
by Harris (2003) revealed that patients who have had unsatisfactory experiences with
doctors are more likely to consult formal sources of information (e.g., patient surveys and
websites), as opposed to the opinions of friends and family, in order to find a new doctor.
In turn, patients who choose their doctors based on formal information are more likely to
switch doctors if they are dissatisfied with their care. In the current study, seven of the
nine participants who switched doctors (Anne, April, Diane, Karen, Kim, Leanne,
Shawna) had conducted health information-seeking.
Subtheme 3: Belief that “doctor knows best.” According to Campbell, Gillet,
and Jones (2005), a paternalistic approach in medicine reflects a “rather arrogant
assumption that one knows best” (p. 3) and is in direct contrast with patient autonomy.
Two of the 15 participants who participated in some form of self-advocacy made
statements that indicated a personal belief that “doctor knows best.” In other words,
during their interviews, Karen (age 64) and Kim (age 82) made comments that suggest
they had accepted paternalism and adopted passive (rather than autonomous) roles in
their experiences with doctor-patient relationships. Research by Deber, Kraetschmer,
Urowitz, and Sharpe (2007) revealed that individuals over age 55 tend to favor a
paternalistic approach from their doctors. Benbassat, Pilpel, and Tidhar (1998) argued
that older patients may expect a paternalistic type of doctor-patient relationship because it
was the cultural norm in the recent past.
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During her interview, Karen (age 64) explained that she had accepted a
paternalistic approach from her doctors and adopted a passive role as a patient for 38
years. Karen stated, “When I was younger I did not argue with my doctor because I
always thought they knew best. But after years of mistreatment I finally took the bull by
the horns…I went through 5 Endos before I found one who knew what she was doing.”
Kim (age 82), the oldest participant in the current study, reported that she has been
treated for thyroid disease for 66 years. Although she adopted a more autonomous role as
a patient when her doctor switched her medication from Armour thyroid to Synthroid in
1958, Kim appears to be more tolerant of paternalistic behavior from male doctors than
from female doctors. More specifically, Kim stated, “I’m more likely to argue with a
female doctor if I think her approach is wrong. If I feel a male doctor’s approach to
thyroid care is wrong for me, I simply don’t go back to him and begin looking for another
doctor.”
Research indicates that female patients with high levels of autonomy prefer
doctors who communicate in an informative rather than paternalistic manner (Flynn et al.,
2006; Kaplan et al., 2002). Both Karen and Kim demonstrated autonomous behaviors
when they sought health information and eventually switched doctors. However, Kim’s
differing reactions to female versus male doctors’ approaches suggest an internalization
of status beliefs (culture-based beliefs in which a higher status is associated with one
group over another; Peck & Connor, 2011; Rashotte & Webster, 2005). In other words,
Kim may be more willing to tolerate a paternalistic approach from a male doctor than
from a female doctor because, on a subconscious level, she believes that male doctors are
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higher in status than female doctors. Research by Bradley et al. (2001) revealed that
levels of satisfaction among patients ages 50 and older are significantly lower when
female doctors (as opposed to male doctors) use a paternalistic communication style.
Bradley et al. (2001) argued that these results might reflect conventional gender-role
expectations among middle-aged individuals.
Numerous studies (Benbassat et al., 1998; Briel et al., 2007; Brom et al., 2014;
Deber et al., 2007; Kennelly & Bowling, 2001; McKinstry, 2000) suggest that patients
ages 55 and older prefer a largely passive role in their care, with their doctors making
treatment decisions. In addition, older patients are more likely to accept their doctor’s
advice without question (Kennelly & Bowling, 2001). However, research also indicates
that female patients with a higher educational attainment tend to desire active
involvement in the decision making process with their doctors (Flynn et al., 2006). Both
Karen and Kim attained education beyond high school. Although Kim is less likely to
argue with a male doctor than a female doctor, both Karen and Kim appeared to move
from passive to autonomous roles when they sought health information and new doctors
when they became dissatisfied with their treatment.
Theme 3: Doctor-Patient Communication
Participants’ responses to interview questions regarding communication indicated
that their experiences with thyroid disease treatment were impacted by their ability to
communicate with their doctors. Doctor-patient communication appeared to be
influenced by the participant’s desire to be informed, the participant’s level of trust in her
doctor, and by being female. The subthemes within Theme 3: Doctor-Patient
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Communication are Subtheme 1: Desire to Be Informed, Subtheme 2: Role of Trust (lack
of trust in doctor, treatment refusal, secret-keeping, and self-treatment), and Subtheme 3:
Role of Gender (no preference for specific doctor gender, preference for female doctor,
being taken seriously, and presence of emotion).
Subtheme 1: Desire to be informed. Six of the 16 total participants expressed a
desire for their doctors to inform them about the results of lab work and treatment
options. Research indicates that although the majority of patients seek information about
their diagnoses and treatment options from external sources (e.g., the Internet, books),
patients continue to refer to their doctors as their primary source for health information
(Bernhardt, 2001; Cegala et al., 2008; Cotten & Gupta, 2004; Hassling, Babic, Lonn, &
Casimir-Ahn, 2003). April’s experience reflects this finding. She stated, “I will tell them
what I know, what I want to know and [learn] what their opinion is and their thoughts.”
Although April conducted research about her diagnosis and treatment options, she did not
seek a new doctor. Similarly, Emily conducted her own research but did not seek a new
doctor despite expressing frustration that her doctor “doesn’t come forward with all she’s
thinking unless [Emily] push[es] the conversation.” Before Michelle’s doctor moved to a
teaching position, she was comfortable with relying on her doctor for health information.
Michelle explained, “She was a teaching Dr. and taught me how to read the numbers on
all the appropriate tests---not just TSH, but also FT3 & FT4.”
With the shift from paternalistic doctor-patient relationships to patient-centered
care, the value of information exchange between doctors and patients has come into focus
(Carlsen & Aakvik, 2006; Deber et al., 2007). Research conducted by Flynn et al. (2006)
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revealed that even patients who do not want to make treatment decisions desire for their
doctors to disclose all treatment options (Flynn et al., 2006). In addition, patients believe
that their doctors need to know their entire medical history in order to provide good care
(Flynn et al., 2006). According to Cegala et al. (2008), a central outcome of informed
patients is their ability to communicate effectively with their doctors by asking important
questions and reporting relevant symptoms. Regarding Anne’s desire for information
exchange with her doctor, she explained, “I have some work to do to figure out how I can
either get her to make me understand where she is coming from…or if I can get her to
understand that I am backsliding again.” Anne’s experience is similar to participants in
Cegala et al.’s study in which patients became less satisfied with their doctor’s
communication after receiving treatment for their conditions. Furthermore, almost 40%
of the participants felt less informed regarding their treatment options than about
diagnostic information.
Research suggests that individuals with chronic illness keep current with
information regarding their illness in an attempt to gain control over their health (Leach
& Schoenberg, 2008; Mirzaei et al., 2013). Of particular importance to patients with
chronic illness is information about recent treatment advances and the potential outcomes
and side effects of treatments (Mirzaei et al., 2013). Kim explained that she is in a “waitand-see mode” regarding how she feels after switching from a synthetic medication to a
natural thyroid medication. She stated, “I need to get the testing done to see where my
frees are on the new product.”
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Hassling et al. (2003) suggested that in order to reduce potential feelings of
insecurity due to insufficient information, doctors should offer to educate their patients
about their illnesses. Murtagh (2006) asserted that doctors demonstrate respect for their
patients’ autonomy by ensuring that they are fully informed. According to Carlsen and
Aakvik’s (2006) study, patients prefer doctors who readily offer them health information.
As previously mentioned, patient satisfaction and trust in one’s doctor are common in
patient-centered approaches in which doctors respect patient autonomy, listen attentively,
and answer questions (Copeland et al., 2003; Firth Cozens, 2008b; Fuertes, Anand,
Haggerty, Kestenbaum, & Rosenblum, 2015; Hall et al., 2009; Houle et al., 2007; Jagosh
et al., 2011).
Subtheme 2: Role of trust. In responding to interview questions regarding
communication, nine out of the 16 total participants indicated that their ability to
communicate with their doctors was influenced by their level of trust in their doctors.
Four of these nine participants explicitly expressed distrusting their doctors, six refused
treatment, three engaged in secret-keeping, and six engaged in self-treatment. Within
Subtheme 2: Role of Trust are the following subthemes: lack of trust in doctor, treatment
refusal, secret-keeping, and self-treatment.
Lack of trust. Four out of the nine participants who indicated that their ability to
communicate with their doctors was influenced by their level of trust in their doctors
explicitly expressed distrusting their doctors. Carla commented, “[I am] guarded…I don't
have a lot of trust in her anymore.” She explained,
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During the first visit [my doctor] seemed open minded. She ran the correct tests,
she allowed me to stay on the replacements that I've been taking…But by the
third visit she was pushing Synthroid, questioning what I have been taking.
Shawna shared that after continually being told by her doctor that her lab work was
“normal” and learning otherwise through her own research, she is “keeping a folder of
[her] labs now,” explaining, “I have learned to get copies of them and not believe what
the doctor’s office tells me.” Similarly, Sarah commented, “My distrust is at such a high
level after being misdiagnosed for over half of my life that it will be hard to share [with a
doctor] in the future.”
Kraetschmer, Sharpe, Urowitz, and Deber (2004) described trust as “a complex
concept, which includes both technical (expertise) and interpersonal (e.g. communication,
respect) elements” (p. 318). Research indicates that trust in one’s doctor is necessary for
patients to feel comfortable in sharing their symptoms and illness experiences (Copeland
et al., 2003; Houle et al., 2007; Lee & Lin, 2010; Peters et al., 2008). Participants in
Skirbekk et al.’s (2011) and Houle et al.’s (2007) studies revealed that doctors must show
an interest in their patients, listen attentively, and be available to answer their questions in
order to gain their patients’ trust. Participants in Skirbekk et al.’s study further added that
doctors must demonstrate sensitivity to their emotions. In the current study, all
participants who expressed distrusting their doctors had also reported feeling unheard,
invalidated, and dismissed by their doctors.
Trust in one’s doctor has been shown to be a predictor of patient adherence to
medical advice (Houle et al., 2007; Lee & Lin, 2010; Peters et al., 2008). A study by
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Kraetschmer et al. (2004) indicated that even patients who have high levels of autonomy
are more willing to follow their doctors’ advice if they trust their doctors. Kraetschmer et
al.’s study further revealed that patients with low levels of autonomy who tend to prefer a
more passive role in their care begin to adopt a more active role as their trust in their
doctors declines.
Treatment refusal. Six out of the nine participants who indicated that their ability
to communicate with their doctors was influenced by their level of trust in their doctors
explained that they had refused treatment. Jenna shared that her doctor “doesn’t listen”
and “blows [her] off a lot” when she attempts to discuss her research. She explained, “He
REALLY pushes for me to do RAI which based on MY research, I don’t feel is
needed…I made it CLEAR I was not doing RAI.” Likewise, April shared, she would feel
more comfortable with her doctors if they “took [her] research serious and didn’t just
humor [her].” She added, “I will not always go with their recommendations (I have
refused RAI 3 times now, twice with the first dr, once with the second).”
Carla described her experience with treatment refusal,
I've rejected several drugs offered to me since the Diabetes diagnosis…and no
longer open a bottle till I know what it will do. The combo of drugs she put me on
to control high blood pressure are KNOWN TRIGGERS for Type 2 [and] I'm still
kicking myself for not doing the research before opening the bottles.
According to Anne, her doctor does not take her seriously and “did not understand
when [she] was upset” at the doctor’s suggestion of taking Synthroid when there was a
shortage in Armour thyroid. Similarly, Michelle explained that doctors would not listen
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when she told them she did not feel well on Synthroid. She stated, “I finally had to go off
of Synthroid (on my own) after a year because I felt so bad on it. I felt better not taking
anything compared to taking Synthroid.” Like Michelle, Sarah also refused medication
and “gradually tapered off most unnecessary prescriptions over a two-year period.” Sarah
then “left the Doctor [she] had for over 23 years” because her doctor “poo-pawed” her
when she would try to discuss not feeling well.
Numerous studies have revealed that doctors’ ability to communicate with their
patients enhances their patients’ level of comfort and trust in the doctors’ treatment
recommendations (Copeland et al., 2003; Epstein & Street, 2011; Goff, Mazor, Meterko,
Dodd, & Sabin, 2007; Moore et al., 2004; Skirbekk et al., 2011; Vina, Masi, Green, &
Utset, 2012). According to research by Goff et al., (2007), poor communication reduces
patients’ confidence in their doctors’ treatment recommendations. Participants in Goff et
al.’s study explained that before considering their doctors’ treatment recommendations,
they must first trust their doctors; and, that in order to trust their doctors, they must feel
understood by their doctors. Participants in Epstein and Street’s (2001) study also
reported that feeling understood by one’s doctor is a prerequisite to trust. Likewise,
patients interviewed by Skirbekk et al. (2011) explained that trusting one’s doctor and
considering their doctors’ advice was dependent upon feeling heard and being taken
seriously.
Additional reasons given by patients for not trusting and refusing their doctors’
treatment advice is feeling as if they have not received good care from their doctors in the
past (Sharf, Stelljes, & Gordon, 2005), and receiving inadequate information from one’s
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doctor regarding the potential side effects of treatment (Fukaya, 2000). Research by
Piette, Heisler, Krein, and Kerr (2005) indicated that the level of trust in one’s doctor is a
stronger predictor of medication compliance among patients with high out-of-pocket
costs than the expense of the medication. According to Lee and Lin (2010), trust in the
doctor-patient relationship increases the likelihood of full patient disclosure. Patient
disclosure is particularly important in cases in which doctors and patients do not agree on
the treatment approach because, with full patient disclosure, doctors might be better
equipped to appropriately modify the patient’s treatment plan (Lee & Lin, 2010).
Secret-keeping. Three out of the nine participants who indicated that their ability
to communicate with their doctors was influenced by their level of trust in their doctors
explained that they had kept secrets from their doctors. The finding of “secret-keeping” in
the current study prompted a perusal of the literature for studies related to the issue of
patients withholding information from their doctors. A thorough search of the literature,
using the search terms secret-keeping, withholding information, lying, and disclosure, in
relation to trust resulted in numerous studies related to patients seeking pain medication
(e.g., Buchman & Ho, 2014; Maakaron, Manchanda, Hoang, & Steinmetz, 2014; Palmieri
& Stern, 2009; Sokol, 2014; Stogner, Sanders, & Miller, 2015; Worley & Thomas, 2014)
and doctors utilizing “therapeutic privilege” to withhold information from their patients
for the “good of the patient” (e.g., Collis & Sleeman, 2013; Everett et al., 2011;
Hodkinson, 2013; Kanaan, 2009; Richard, Lajeunesse, & Lussier, 2010; Matthes &
Caples, 2013; Self, 2014; Shahidi, 2010). However, a gap in the literature was discovered
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regarding the practice of secret-keeping by patients in an attempt to regain control over
their own health.
According to Fainzang (2005), the purpose of secret-keeping on the part of the
patient is “not the exercise of power but the expression of resistance to the power of [the
doctor]” (p. 18). For example, in the current study, Sarah shared that her doctor did not
listen to her or take her seriously when she complained that she did not feel well on
Synthroid. Sarah explained,
After knowing I would die if I continued this way, I started taking charge of my
own health…added supplements, and gradually tapered off most unnecessary
prescriptions over a two-year period [and] then left the Doctor I'd had for over 23
years…
Sarah did not inform her doctor that she was self-treating and seeking a new doctor
during this two-year period because her doctor continually “poo-pawed anything [she]
would bring up,” and added that her “distrust [in her doctor was] at such a high level after
being misdiagnosed for over half of [her] life…”
Fainzang (2005) argued that while lying is “justified, even legitimized in doctors
[it is] condemned in patients” (p. 6). Through the lenses of feminism and social
constructionism, medical knowledge regarding women’s bodies is understood as being
influenced by cultural factors and social norms (Docherty & McColl, 2003; Fernandes et
al., 2006; Lupton, 2003). Concepts of women’s health, illness, and methods for managing
illness are created and managed by pharmaceutical companies and physicians who
maintain positions of authority over patients (Findlay, 1993; Hearn, 2009; Lupton, 2003;
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Munch, 2004). However, feminists argue that patients are the experts of their own
medical conditions (Chrisler, 2001; Fernandes et al., 2006; Hoffmann & Tarzian, 2001;
Wright & Owen, 2001). As such, when an individual experiences a phenomenon that she
considers to be abnormal for her body and takes action based on her own interpretation of
the phenomenon, she is reclaiming power and control over her body (Fainzang, 2005,
2015).
Kim is 82 years old and has been receiving treatment for thyroid disease for 66
years. When the doctor who had been treating her for thyroid disease passed away, she
had to seek a new doctor—one who would be willing to continue her prescription for
Armour thyroid, as well as order a full thyroid panel (not the TSH blood test alone) for
her blood work. Kim explained, “My other doctor, whom I’d kept as my primary for
everything but thyroid, kept ordering TSH and I simply refused the test when I got to the
lab. I just told him I was seeing another doctor for my thyroid treatment…We sometimes
have to resort to trickery!” Rather than telling her primary care doctor that she was not
satisfied with a TSH-only blood test, Kim chose to tell her doctor that she had already
found another doctor to treat her for thyroid disease even though she was still seeking a
doctor. As discussed previously in section “Belief that ‘Doctor Knows Best,’” Kim seems
to be willing to tolerate a paternalistic approach from a male doctor, and this could be due
to her age. As such, Kim likely considers her primary care doctor to be an authority
figure—an “authority in the face of which one does not dare to openly show resistance or
refusal” (Fainzang, 2005, p. 12). According to Fainzang (2005), patients who do not wish
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to demonstrate “open opposition” to their doctors will sometimes lie in order to “avoid
conflict, criticism, or blame” (p. 10).
Nevertheless, while it is considered unacceptable for patients to withhold
information from their doctors, for a doctor to withhold information “comes within the
framework of permissible lying” (Fainzang, 2005, p. 17). According to Fainzang (2005),
“Numerous doctors claim the privilege of knowledge concerning the patient’s body and
tend not to disclose information that might enable the patient to make his own choices
concerning his being” (p. 17). In addition, patients’ knowledge tends to be undervalued
by doctors (Risberg, 2006); and decisions regarding diagnosis and treatment are based on
“objective evidence” of disease (e.g., blood tests) while patients’ subjective experiences
of illness are largely ignored (Hoffmann & Tarzian, 2001).
Research indicates that patients are more likely to trust doctors who listen to them
and show a genuine interest in their well-being (Houle et al., 2007; Jagosh et al., 2011).
In turn, trust in one’s doctor increases the likelihood that patients will disclose
information to their doctors (Copeland et al., 2003; Peters et al., 2008). Considering that
the majority of patients wish to actively participate in their healthcare (Barry & EdgmanLevitan, 2012; Chin, 2002; Flynn et al., 2006; Quaschning et al., 2012) and effective
doctor-patient collaboration requires mutual trust (Chin, 2002; Lee & Lin, 2010), it is
vital that doctors attempt to understand their patients’ points of view and remain open to
their ideas, preferences, and concerns (Barry & Edgman-Levitan, 2012; Chin, 2002;
Epstein & Street, 2011; McNutt, 2004; Salt et al., 2012; Wessel et al., 2012).
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Self-treatment. Six out of the nine participants who indicated that their ability to
communicate with their doctors was influenced by their level of trust in their doctors
explained that they had engaged in self-treatment. As with the issue of secret-keeping, the
majority of the literature on self-treatment places patients in a subservient position to the
doctor and largely focuses on “self-medication” with unauthorized drugs and alcohol
(e.g., Larance et al., 2011; Mehuys et al., 2012; Neafsey et al., 2011; Robinson, Sareen,
Cox, & Bolton, 2011; Schuman-Olivier et al., 2010). Self-medication is defined by
Verma, Mohan, and Pandey (2010) as “the use of medication by a patient on his own
initiative or on the advice of a pharmacist or a lay person instead of consulting a medical
practitioner” (p. 60). Fainzang (2013) argued that patient self-medication is a form of
self-advocacy that involves a thoughtful process of “self-examination, self-diagnosis, and
self-prescription” (p. 495) that patients initiate when their doctor “does not agree with
[the patient’s] interpretation of a phenomenon” (p. 499). Because female patients in
particular often need to prove the validity of their complaints (Hoffman & Tarzian, 2001;
Munch, 2004) and patients who challenge their doctors tend to be thought of as
“difficult” (Frosch et al., 2012; MacDonald, 2003), female patients who self-medicate
might be considered as self-advocating by taking control of their health (Fainzang, 2005,
2013, 2015). In the current study, the term “self-treatment” was chosen instead of “selfmedication” due to its negative connotation in the majority of the literature.
In the current study, six participants chose to either stop or start taking a
medication or supplement without consulting their doctors. For example, Jenna shared
that she was struggling with symptoms from thyroid cancer, which remained undiagnosed
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for approximately four months because her blood work continued to show as “normal.”
After growths were discovered on Jenna’s thyroid, her thyroid was surgically removed.
During the fourth month period before her diagnosis, Jenna spoke with a friend “who has
thyroid issues [and] got [her] on a multivitamin and 10k units of vitamin D3.” Jenna
added, “Our local herbalist gave me a supplement which offered thyroid and adrenal
support.”
Carla reported that her doctor bases her recommendations solely on the results of
blood work, ignores her symptoms, pushes her to take Synthroid even though she felt sick
taking it, and does not take Carla seriously. As a result, Carla explained, “I started selftreating in July of 2002 and pretty much consider myself to still be self-treating [and] the
current doc/insurance just run my labs.” Similarly, Michelle stated, “I finally had to go
off of Synthroid (on my own) after a year because I felt so bad on it. I felt better not
taking anything compared to taking Synthroid.” Likewise, Sarah explained,
[I] added supplements, and gradually tapered off most unnecessary prescriptions
over a two-year period [and] then left the Doctor I'd had for over 23 years and
started self-treating with Thyroid replacement ordered online, treating adrenals,
plus additional vitamins and supplements gradually added.
According to Verma et al. (2010), self-treatment practices among patients are
increasing internationally. Research conducted by Holtgräfe and Zentes (2012) revealed a
correlation between patient self-treatment and distrust in the opinion of health
professionals. In a study of individuals with gastrointestinal disorders, patients with a
graduate-level education were more likely to self-treat than those with a secondary
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education or below (Kua, Ng, Lhode, Kowalski, & Gwee, 2012). Educational attainment
is positively correlated with “health literacy,” or “the degree to which individuals have
the capacity to obtain, process, and understand basic health information to make
appropriate health decisions (Lubetkin et al., 2015; White, Osborn, Gebretsadik,
Kripalani, & Rothman, 2013, p. 1756). In White et al.’s (2013) study about patients’ nonadherence to medication, higher health literacy was associated with lower trust in one’s
doctor and a greater likelihood of being non-adherent to medication. White and
colleagues argued that patients who are highly health literate are less likely to trust their
doctors’ recommendations without verifying the information and exploring additional
options.
Regardless of patients’ reasons for self-treatment, there are potential risks to
stopping or starting medications and supplements without consulting a doctor. According
to Ruiz (2010), potential risks include incorrect self-diagnosis, adverse reactions, and
dangerous drug interactions. In Shawna’s experience, her choice to self-treat with iodine
supplements may have caused a significant spike in her level of thyroid antibodies—
which worsens the symptoms of Hashimoto’s disease. Shawna explained,
I thought since the doctors kept saying my thyroid was okay, maybe I just needed
something natural as a boost, not really having a lot of information. I also was
clicking on ads on the internet and read some doctor that insisted we are all iodine
deficient and promoting his pills. I ordered them and took them [for] 1 month.
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Having felt unheard, invalidated, dismissed, and disrespected by her doctor, Shawna
came to “distrust [her doctor] at such a high level…that it will be hard to share [with a
doctor] in the future.”
Including patients in the decision making process helps to ensure that they are not
left alone in a position of evaluating the efficacy of various treatments (Chin, 2002).
Considering that most patients want to be involved in the decision making process (Barry
& Edgman-Levitan, 2012; Chin, 2002; Flynn et al., 2006; Quaschning et al., 2012) and
shared decision making requires mutual trust (Chin, 2002; Crooks et al., 2015; Epstein &
Street, 2011), it is important for doctors to establish trust with their patients. As
previously discussed, patients trust doctors who listen to them without interrupting
(Hedberg & Lynoe, 2013; Skirbekk et al., 2011) and who take their time (Copeland et al.,
2003; Houle et al., 2007), who answer their questions and show a genuine interest in their
well-being (Houle et al., 2007; Jagosh et al., 2011; Liu et al., 2014; Skirbekk et al., 2011),
who validate them (Epstein et al., 2007b; Malterud & Ulriksen, 2010; Street et al., 2009),
and are sensitive to their emotions (Skirbekk et al., 2011).
Subtheme 3: Role of gender. The majority of participants’ responses to
questions regarding the potential influence of gender on treatment experiences revealed
that the doctors’ gender had little influence on doctor-patient communication. However,
participant responses indicated that being female influenced doctor-patient
communication, particularly regarding the participants’ perceptions of being taken
seriously and when the participants expressed emotion. Within Subtheme 3: Role of
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Gender are the following subthemes: no preference for specific doctor gender, preference
for female doctor, being taken seriously, and presence of emotion.
No preference for specific doctor gender. When asked if it mattered whether
their doctors were male or female, the majority of participants (13 out of 16) indicated no
preference for their doctor to be a specific gender. Sarah stated, “I've been pleased with
both genders, it really depends on the individual.” According to Karen, “It’s not the sex
of the doctor but the compassion and caring of the doctor that makes one good.”
Similarly, Emily explained that she would feel comfortable with either a male or female
doctor as long as “they seem sympathetic to [her] concerns and [are] serious about
continually working on a plan to get [her] body back to normal.” Emily also related the
issue of doctor gender to being taken seriously as a female patient (discussed in section
“Being Taken Seriously”). Michelle shared that she has been treated by both male and
female doctors and she believes that the “Dr./Patient relationship is most important.”
Likewise, Shawna reported that she simply “care[s] about their competence.” Diane
added, “If they have a thorough understanding of the female body, then there shouldn't be
difference [between male and female doctors].”
Autumn’s and Ann’s responses to the interview question regarding gender
preference demonstrated a general dissatisfaction with both male and female doctors.
Autumn responded, “I don't think [the doctor’s gender] matters much…most of them are
just in and out doing as little as they possibly have to do.” Anne replied, “No…It seems
that both men and women doctors are TSH driven.” Anne also related the issue of doctor
gender to being taken seriously as a female patient (discussed in section “Being Taken
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Seriously”). Both of Anne’s and Autumn’s comments are discussed further in section
“Subtheme 4: Culture of the Medical Profession,” specifically as they relate to the issues
the TSH blood test and economics.
Although Alicia’s and Jessica’s responses suggested an initial preference for a
female doctor, they ultimately expressed no preference for their doctor to be a specific
gender. When asked if it mattered whether their doctors were male or female, Alicia
responded, “I’m not sure. I wonder if a woman might be more understanding, but I feel
that my [male] physician is very understanding.” Jessica replied, “I think a woman doctor
can relate better to her female patient having the same functioning system and emotional
background caused by hormones; [however], my first endo was a woman…and she was
brutal.”
The literature regarding patients’ gender preferences for doctors is divided.
Although a number of studies indicate that patients prefer doctors of the same gender
(e.g., Bonds, Foley, Dugan, Hall, & Extrom, 2004; Fang et al., 2004; Garcia, Paterniti,
Romano, & Kravitz, 2003; Godager, 2012), many studies suggest that patients do not
have a gender preference for their doctors (Bender, 2007; Delgado et al., 2011; Makam,
Saroja, & Edwards, 2010; Tempest, Vowler, & Simpson, 2005). Rather, the competence
and communication skills of doctors appear to be more important to patients than the
doctors’ gender (Bertakis & Azari, 2012; Bourke, 2002; Mavis, Vasilenko, Schnuth,
Marshall, & Jeffs, 2005; Tempest et al., 2005; Yuen-man Siu, 2015). This finding is
consistent with the results of the current study, with 13 out of 16 participants referring to
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the importance of their doctors’ competence and communication skills in lieu of their
doctors’ gender.
The ability for doctors to communicate effectively with their patients is crucial to
meeting their patients’ needs and expectations (Godager, 2012). Numerous studies have
revealed that patients prefer doctors who listen attentively, answer their questions, and
include them in decision making—practices that are characteristic of patient-centered
approaches (Carlsen & Aakvik, 2006; Copeland et al., 2003; Firth Cozens, 2008b; Hall et
al., 2009; Houle et al., 2007; Jagosh et al., 2011). Research indicates that female doctors
tend to use patient-centered approaches more often than male doctors, as evidenced by
longer consultations and a greater psychosocial focus in their discussions (Beach, 2000;
Bertakis, 2009; Bertakis & Azari, 2012; Firth Cozens, 2008b; Hall & Roter, 2002; Hall et
al., 2009; Roter & Hall, 2004; Sandhu et al., 2009; Shin et al., 2015).
Considering the aforementioned findings regarding patient-centered approaches, it
was expected that the participants in the current study would express a preference for
female doctors. The fact that the participants in the current study reported no preference
for a specific doctor gender might be due to the fact that only four out of the 16
participants interviewed (Alicia, Autumn, Kari, and Karen) consistently had doctors who
did not make them feel unheard, invalidated, dismissed, not empathized with, or
disrespected (discussed previously in “Subtheme 2: Participant Self-Advocacy”). In other
words, during the time of their interviews, the majority of the participants might have still
been seeking doctors who use a patient-centered approach. If this is the case, the gender
of the doctors ultimately chosen by participants remains unknown because at the time of
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the interviews, participants were not asked whether or not they were seeking or
considering seeking new doctors. Future studies might consider asking participants how
many doctors they have had, the gender of those doctors, their reasons for seeking new
doctors, and whether or not participants have decided to keep their current doctor.
Preference for female doctor. When asked if it mattered whether their doctors
were male or female, three of the 16 total participants indicated a preference for female
doctors. Kari, who has a female doctor, explained, “I like woman Dr.'s better. Men are
too arrogant about their education.” As previously discussed, patient-centered approaches
in which doctors listen to and involve their patients are frequently used by female doctors
(Bertakis & Azari, 2012; Firth Cozens, 2008b; Hall et al., 2009; Sandhu et al., 2009).
Because Kari reported feeling heard and being involved in the decision making process, it
is likely that Kari’s doctor utilized a patient-centered approach. Regarding Kari’s
comment about male doctors being “too arrogant in their education,” because Kari is 78
years old, it is likely that she experienced paternalistic doctor-patient relationships in the
past. Carla’s doctor is also female. According to Carla, “Every woman doctor [she’s] had,
all of 3, [have] been far more empathetic and able to listen.” Although she considers
herself to be “guarded” with her current doctor, Carla expressed a particular distrust in
male doctors because “it was a male doctor’s prejudice and ignorance that basically cost
[Carla her] life.”
Jenna, whose doctor is male, stated, “I think a woman might be a little more
compassionate and understanding.” Although Jenna would prefer to have a female
doctor, she is “limited in options [because she goes] through a free clinic” (discussed
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further in section “Theme 4: Culture of the Medical Profession”), and is therefore, unable
to seek a new doctor. Jenna had reported feeling unheard, invalidated, and dismissed, as
well as shared that she sought health information, refused treatment, and self-treated.
Whether or not these experiences are related to her doctor’s gender cannot be determined.
Jenna’s assumption that female doctors might be more “compassionate and
understanding” could be due to her negative experience with her male doctor or based on
a conventional view of women as nurturers (Bertakis & Azari, 2012; Hall, Roter, BlanchHartigan, Schmid Mast, & Pitegoff, 2015; Shields, 2007). According to Bertakis and
Azari (2012), traditional gender role expectations among both patients and doctors may
be unconsciously reinforced by gender differences in communication.
Being taken seriously. Nine out of the 16 total participants indicated that being
taken seriously influenced their ability to communicate with their doctors. Of these nine
participants, Alicia and Diane were the only individuals who felt like their doctors took
them seriously. Alicia explained, “Knowing that he takes me seriously helps me to feel
comfortable sharing my symptoms with my doctor.” Similarly, Diane stated, “It makes
me feel confident that he takes me a little more seriously than most of the other doctors
who poo-pooed me.” When asked what might help her to feel more comfortable in
sharing her symptoms with her doctor, Jenna responded, “If he would LISTEN and take
me seriously and not think it’s all in my head.” Likewise, April replied, “If my dr took
my research serious and didn’t just humor me.”
Emily and Anne related their experiences with not being taken seriously to
gender. More specifically, Emily and Anne indicated believing that both male and female
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doctors are less likely to take women’s complaints as seriously as men’s complaints.
Emily explained, “Sometimes I think men doctors don’t take some female symptoms
seriously, but then I’ve had women doctors that also didn’t seem to be sympathetic to a
formally [sic] skinny patient who quickly put on 20 pounds.” Anne stated, “…my opinion
is that doctors, both men and women, take men more seriously. I do tend to get emotional
which I think makes doctors give less credence to my depiction of my symptoms.” The
presence of emotion in the clinical encounter is discussed in the section, “Presence of
Emotion.”
Werner and Malterud (2003) and Hoffmann and Tarzian (2001) contend that the
medical profession encourages a normative, gendered view of illness that disregards
patients’ subjective illness experiences. As a result, women often need to work harder in
order to be perceived as credible patients. According to Soderberg, Olsson, and Skar
(2012), it is a “violation of a person’s dignity” to not be taken seriously (p. 145). In a
study of 1.5 million individuals regarding their trust and confidence in their doctors,
being taken seriously by one’s doctor was found to be the strongest predictor of patient
trust and confidence (Croker et al., 2013).
Gensichen et al.’s (2012) study of women being treated for depression revealed
that patients felt well-cared for and trusted their doctors because their symptoms were
taken seriously. Likewise, in Stenberg, Fjellman-Wiklund, and Ahlgren’s (2012) study of
individuals being treated for neck and back pain, patients expressed that being taken
seriously by their doctors was essential for feeling comfortable in communicating with
their doctors. Participants who did not feel like they were taken seriously reported feeling
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rejected and ashamed; and this experience was more common among female participants
than male participants. Stenberg and colleagues argued that the pain levels of the female
participants in their study may have been underestimated, and that this might be due to a
stereotypical view of women as overly emotional and complaining. Female participants
in Soderberg et al.’s (2012) study reported believing that they were not taken seriously by
their doctors because they were female. The authors likened the participants’ experiences
of not being taken seriously to being disqualified as people (p. 148). The participants
indicated that, as a result of not being taken seriously, they felt like that had no influence
in their communication with their doctors.
According to Hedberg and Lynoe (2013), doctors who are considered to be
competent by their patients listen to their patients, take them seriously, answer their
questions, and invite them to participate in their care. In addition to being perceived as
competent, doctors are perceived as trustworthy by their patients when they demonstrate
sensitivity to their patients’ emotions (Skirbekk et al., 2011). By creating an environment
in which patients feel safe in communicating about their illness experiences, doctors are
better able to ask relevant questions and recognize potentially misdiagnosed or
undiagnosed illnesses (Dean & Street, 2014; Hedberg & Lynoe, 2013).
Presence of emotion. Three out of the 16 total participants indicated that showing
emotion influenced communication with their doctors. More specifically, in Alicia’s
experience, the presence of emotion prompted effective communication with her doctor.
However, the presence of emotion appeared to be problematic for Anne’s and Leanne’s
attempts to communicate effectively with their doctors. Anne explained, “I do tend to get
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emotional which I think makes doctors give less credence to my depiction of my
symptoms.” According to Hoffman and Tarzian (2001) and Connolly (2001), because
women tend to be perceived as overly emotional and likely to exaggerate their symptoms,
women’s complaints are often dismissed by medical professionals. Research indicates
that men’s symptoms are more likely to be interpreted as biological by doctors, while
women’s symptoms are construed to be psychosomatic—that is, that women’s symptoms
are a result of a mental, rather than physical, illness (Chrisler, 2001; Hamberg et al.,
2004; Hoffmann & Tarzian, 2001). The issue of women’s symptoms being considered
psychosomatic is discussed further in section “Theme 4: Culture of the Medical
Profession.”
Whereas Anne related her emotional communication to her doctor not perceiving
her as credible, Alicia explained that her emotional communication roused her doctor’s
attention. Alicia explained, “It was not until I broke down in tears with my radiation
oncologist that he suggested metabolic testing…[and to] follow this up with my primary
care physician.” In Johansson, Hamberg, Lindgren, and Westman’s (1996) study of
female patients experiencing pain, participants reported employing various strategies in
an attempt to convince their doctors they were “deserving” of medical attention (p. 500).
When doctors were not responsive to the women’s descriptions of bodily symptoms, the
women then referred to authorities outside of themselves (e.g., “I saw on television…”).
If this was unproductive, the women eventually “plead” (i.e., cried) with their doctors,
usually with success (p. 500). Similar results were found in Werner and Malterud’s
(2003) study of women who sought to obtain their doctors’ validation of their chronic
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pain through using assertiveness and “surrendering” (i.e., no longer challenging the
doctor; p. 1413). According to Werner, Isaksen, and Malterud (2004), female patients
need to utilize such strategies in order to fit in with normative, biomedical expectations of
illness and be perceived as credible patients.
Although Anne’s and Alicia’s experiences with demonstrating emotion seem to
be on opposite ends of the spectrum (i.e., with Anne’s emotion being problematic for
communication with her doctor; and Alicia’s emotion encouraging communication with
her doctor), their experiences shared the commonality of needing to convince their
doctors that their symptoms were deserving of attention. Research indicates that whether
patients’ emotional cues are subtle or obvious, doctors often fail to acknowledge and
validate their patients’ concerns using empathic communication (Epstein et al., 2007a;
Finset, 2012; Hakanson, Sahlberg-Blom, & Ternestedt, 2010; Kennifer et al., 2009). In
some cases, patients’ emotions are dismissed by their doctors (Hakanson et al., 2010;
Kennifer et al., 2009), and in other cases, doctors respond to their patients’ emotions with
biomedical questioning (Epstein et al., 2007a; Finset, 2012).
In Hakanson et al.’s (2010) study of individuals with irritable bowel syndrome,
participants reported feeling dismissed when their doctors told them to “calm down” or
“stop being hysterical” (p. 1120). Even if it was not their doctors’ intention, the patients
felt patronized by their doctors and as if they were being accused of exaggerating their
symptoms. Finset (2012) argued that doctors sometimes offer reassurance prematurely in
response to their patients’ distress (e.g., “don’t worry). According to Epstein et al.
(2007a), simple reassurance may cause patients to feel dismissed unless the reassurance
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is accompanied by medical explanations based on a genuine understanding of the
patients’ concerns. As such, incorporating empathy-related communication techniques
into medical training programs may help doctors to be better equipped to handle
emotions in the clinical encounter (Finset, 2012) and to respond constructively.
Theme 4: Culture of the Medical Profession
Participant responses to interview questions indicated that their experiences with
thyroid disease treatment were influenced by the culture of the medical profession. More
specifically, participants’ treatment experiences were influenced by diagnostic bias, their
doctors’ medical knowledge, and economics. The subthemes within Theme 4: Culture of
the Medical Profession are Subtheme 1: Diagnostic Bias (symptoms considered
psychosomatic and symptoms attributed to lifestyle), Subtheme 2: Medical Knowledge
(TSH testing is standard, synthetic medication is standard, and continuing education may
be needed), and Subtheme 3: Economics (feeling rushed, access to doctor, and access to
medication).
Subtheme 1: Diagnostic bias. Eight of the 16 total participants whose treatment
experiences were influenced by the culture of the medical profession encountered
diagnostic bias, which resulted in diagnostic error. More specifically, eight participants’
doctors did not recognize that the participants’ symptoms were due to thyroid disease.
Seven of the participants’ doctors considered their symptoms to be psychosomatic and
three participants were told by their doctors that their symptoms were due to their
lifestyle. Within Subtheme 1: Diagnostic Bias are the following subthemes: symptoms
considered psychosomatic and symptoms attributed to lifestyle.
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Alegría and colleagues (2008) defined diagnostic bias as unconscious, systematic
errors in the collection or processing of information that may influence the clinician’s
judgment of patients’ illness (p. S26). Gender bias is one of many types of bias (e.g.,
ethnic, cultural, etc.) and is regarded as an unintended, systematic neglect of either
women or men (Hamberg, 2008, p. 237). In the medical field, gender bias occurs as a
result of stereotyped preconceptions about a person’s health, behavior, experiences, and
needs based on their gender (Hamberg, 2008). Based upon the experiences of the eight
participants who received inaccurate diagnoses, it appears that their doctors’ errors might
be explained by gender bias.
Research indicates that the paternalistic nature of the medical profession
encourages gender bias. As a result, women’s medical problems are often misdiagnosed
and undertreated (Connolly, 2001; Chrisler, 2001; Hamberg et al., 2004; Hoffmann &
Tarzian, 2001; Richman et al., 2000; Soderberg et al., 2012; Stenberg et al., 2012;
Werner & Malterud, 2003; Werner et al., 2004). Secker (1999) asserted that depictions of
women as emotional, irrational, and unintelligent are systemically ingrained in the
medical profession because philosophical, theological, literary, and scientific traditions
have been male-dominated. As such, women’s health complaints that are not
substantiated by objective evidence (e.g., blood tests) tend to be viewed as
psychosomatic, rather than physiological, in origin (Hamberg et al., 2004; Hoffmann &
Tarzian, 2001; Richman et al., 2000; Werner et al., 2004).
Symptoms considered psychosomatic. Seven of the 15 participants who
experienced diagnostic bias had doctors who considered their symptoms to be
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psychosomatic. Kim explained, “I had been taken to a doctor because of complaining
about a lump in my throat and a choking sensation. That doctor found nothing wrong. I
think he felt it was my imagination.” Similarly, Diane reported,
[I had an] inability to swallow pills that started about 10 years ago (doctors
thought it was in my head)…[and when] I could no longer drive and could barely
walk, I saw several doctors and were [sic] prescribed anti dizziness medication,
depression pills, etc.
Jenna indicated that she would feel more comfortable sharing her symptoms with her
doctor “...if he would LISTEN and take [her] seriously and not think it’s all in [her]
head.” Likewise, Anne explained, “I do tend to get emotional which I think makes
doctors give less credence to my depiction of my symptoms.” Jessica shared, “I am tiered
[sic] of doctors thinking that we are just anxious…and will not believe us. They want to
put us on antidepressants instead of helping us. This causes more anxiety and is very
sad.”
Numerous studies indicate that doctors tend to interpret men’s symptoms as
physiological and women’s symptoms as psychosomatic (Bernardes & Lima, 2011;
Chrisler, 2001; Elderkin-Thompson & Waitzkin, 1999; Hamberg et al., 2004; Hoffmann
& Tarzian, 2001; Lillrank, 2003; Munch, 2004; Newton, Southall, Raphael, Ashford, &
LeMarchand, 2010; Mullersdorf & Soderback, 2000; Stenberg et al., 2012; Werner &
Malterud, 2004). According to Werner et al. (2004), female patients with chronic pain are
often judged by their doctors to be experiencing imaginary illnesses and are given
psychiatric diagnoses—and even stereotyped as “crazy, lazy, illness-fixed, or weak” (p.
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1043). In Mullersdorf and Soderback’s (2000) study of individuals with back pain, men
received physiological interventions (e.g., joint manipulation) more often than women,
who were mostly treated with psychotropic medication. Werner and Malterud’s (2003)
study of women with chronic pain revealed that patients felt the need to “work hard” in
order to make their symptoms real and visible to their doctors. More specifically, in order
to be perceived as credible, patients were cautious to not appear to be too healthy or too
sick, too strong or too weak, too assertive or too passive in their interactions with their
doctors. In other words, they struggled “to be perceived as somatically ill, whilst
simultaneously avoiding appearing mentally unbalanced” (p. 1414).
Research also indicates that women are less likely than men to receive diagnostic
testing even when presenting with the same symptoms (Hamberg, 2008; Napoli, Choo, &
McGregor, 2014). Newton, Southall, Raphael, Ashford, & LeMarchand, 2010;
Mullersdorf & Soderback, 2000; Stenberg et al., 2012; Stålnacke and colleagues’ (2014)
study of individuals with chronic pain revealed that male patients were significantly more
likely than female patients to be referred for physiotherapy and radiological examination
even though the female patients reported a greater number of pain sites than male
patients. Similarly, a study of patients with acute coronary syndrome revealed that fewer
female patients received cardiac catheterizations than male patients, even after adjusting
for the patients’ presenting complaint, history, diagnosis, and cardiac risk (Chang et al.,
2007).
Furthermore, there is a discrepancy in how doctors respond to male and female
patients with diffuse symptoms (e.g., as with chronic fatigue syndrome; Werner &
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Malterud, 2003). For example, research indicates that when the physiological cause of a
patient’s symptoms is unknown, doctors tend to prescribe sedatives and offer advice
regarding lifestyle more often to female patients than to male patients (Hamberg et al.,
2004; Munch, 2004; Vaccaro & Huffman, 2012).
Symptoms attributed to lifestyle. Three of the 15 participants who experienced
diagnostic bias had doctors who attributed their symptoms to their lifestyle. In each case,
doctors’ lifestyle advice was related to weight loss. Before being diagnosed with thyroid
disease, Jenna’s doctor insisted that her weight gain was due to her diet and not enough
exercise. She commented, “how I wish I had only known that it was something wrong
with me physically instead of ‘I'm fat’, ‘I'm out of shape’…” Carla reported that her
doctors made her feel like her “weight gain [was] from being a lazy slob [because she]
laid around eating bon bons all day long.” She further explained, “Didn't matter that I was
a body builder before all this, didn't matter that I used to have physical jobs before all
this... I was just a lazy, fat, stupid... slob.”
According to Stone (2014), both patients and doctors experience frustration when
patients’ symptoms are not explained by objective evidence (e.g., blood tests). While
patients feel invalidated and at fault due to lack of “proof” of their illness, doctors
experience feelings of helplessness and guilt because they are expected to cure their
patients. In Western medicine, symptoms that are not validated by objective evidence are
considered to be of the mind, and therefore, related to choice and responsibility (Stone,
2014). Annandale and Clark (2000) contend that health is “marketed as a result of
lifestyle choice” (p. 58). In other words, patients are thought to be responsible for their
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conditions (e.g., people who are obese must lack self-control). As explained by Solomon,
Nahas, Segal, and Young (2010), “In medicine we are most comfortable with blaming the
pathology (and, when that fails, with blaming the patient)” (p. 516).
Research indicates that doctors offer lifestyle advice more often to women than
men (Hamberg et al., 2004; Munch, 2004; Vaccaro & Huffman, 2012). With regard to
weight loss as medical advice, a study by Dutton, Perri, Stine, Goble, and Van Vessem
(2010) revealed that doctors recommended significantly stricter weight loss goals for
obese female patients than obese male patients. Malterud and Ulrikesen (2010) suggested
that in cases in which obesity is a concern, doctors should consider endocrine disorders as
a potential cause of patients’ weight gain.
Regardless of whether or not laboratory tests support the cause of obesity to be
physiological, doctors should use sensitivity when offering lifestyle advice. Because body
image is a fundamental aspect of a person’s identity and Western culture views obesity as
a symptom of lack of self-control (Malterud & Ulriksen, 2010), it is important that
doctors share information in a manner that does cause the patient to feel blamed. In
addition, offering emotional support to patients engenders trust, which is vital for
establishing and maintaining an effective doctor-patient relationship (Houle et al., 2007;
Skirbekk et al., 2011; Stone, 2014).
With regard to diagnostic bias and medical advice, it is important to consider the
doctors’ specialties. As noted by Ogdie et al. (2012), doctors are more prone to errors in
diagnosis when presented with problems outside of their specialty. The current study did
not investigate the specialties of participants’ doctors. It is recommended that the
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influence of doctors’ specialties on choice of diagnostic tests, diagnosis, and medical
advice be investigated in future research.
Subtheme 2: Medical knowledge. The treatment experiences of 15 out of the 16
participants who were influenced by the culture of the medical profession appeared to be
specifically affected by their doctors’ medical knowledge. More specifically, nine
participants’ treatment experiences were affected by the use of the TSH blood test alone
as the standard to determine thyroid function, and 10 participants’ treatment experiences
were affected by the use of synthetic medication as the only treatment option for thyroid
disease. In addition, according to 15 participants, continuing education for doctors about
thyroid disease is needed. Within Subtheme 2: Medical Knowledge are the following
subthemes: TSH testing is standard, synthetic medication is standard, and continuing
education may be needed.
TSH testing is standard. Nine out of the 15 total participants whose treatment
experiences were influenced by their doctors’ medical knowledge appeared to be
specifically affected by the use of the TSH blood test alone as the standard for
determining thyroid function. Three of these participants (Diane, Michelle, and Sarah)
specifically experienced difficulty with obtaining a diagnosis of thyroid dysfunction due
to a “normal” TSH blood test. Diane explained,
I have searched for over 30 years as to what was the cause of my rapid weight
gain, and constant fatigue. Each time, my thyroid would be tested and I was told
everything was fine. Meanwhile, I struggled daily for energy, and experienced
numerous illnesses over the years that puzzled me.
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Sarah reported, “[My doctor] totally ignored my symptoms, any thyroid numbers but
TSH, and this resulted in [many] diagnoses…and [I was] heavily medicated for each of
them, on as many as twelve different prescriptions in any given day.” Michelle shared,
I was ‘finally’ diagnosed after many years of begging [doctors] to be diagnosed
(numbers were ‘normal’), [then] it took me another 2 years before I found an
Internal Medicine Dr. who would…test not only TSH, but also FT3 & FT4.
The majority of participants who were affected by the use of the TSH blood test
alone specifically reported being undertreated for thyroid dysfunction do to a “normal”
TSH blood test. Anne commented,
It seems that both men and women doctors are TSH driven…Even the doctors I
have seen that are okay with [natural medication] still put much more weight on
TSH than symptoms or the frees. It is enough to make one feel hopeless at times.
Similarly, Kim, who is 82 years old and has been treated for thyroid disease for
66 years, reported,
When I was tested at the end of that year, my TSH (the only thyroid test that
doctor used) was .01, and he wanted me to discontinue Synthroid because I had
‘gone hyper’. I reminded him I’d been taking thyroid replacement since I was 16
or 17 and I was quite certain I needed it. So he compromised and let me drop the
Synthroid to 50 mcg.
Three of the participants (Carla, Jenna, and Shawna) who believed they were
undertreated for thyroid dysfunction based on the results of the TSH blood test alone
(instead of also including the free T3, free T4, and antibodies blood tests) specifically
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discussed the addition of the following blood tests to the TSH blood test: free T3, free T4,
and antibodies. Carla stated, “[My doctor] is certain that the only test needed for thyroid
is TSH and it’s an inside joke that I will allow her to run TSH as long as she also runs
Free T4 and Free T3 for me.” Similarly, Jenna explained, “[My doctor’s] MAIN concern
is my TSH getting below .5, [though] he DOES test free t3 and free t4 because I asked
him to.” Shawna shared, “I don’t like that he is not open to natural thyroid and isn’t
testing my T3 and antibodies.”
The TSH blood test is considered the “gold standard” for determining thyroid
function (Adams, 2008, p. 1). However, its efficacy is debatable due to inconsistent data
from various studies (Adams, 2008; Beckett & MacKenzie, 2007; Wheatland, 2010).
Experts on thyroid function differ in opinion regarding the accuracy of the current range
limits for the TSH blood test, as well as whether or not age-specific ranges should be
created (Adams, 2008). Referring to the TSH blood test as a “waste of resources,”
Wheatland (2010) argued that it should not be used for determining thyroid function due
to its poor diagnostic accuracy (p. 458). Furthermore, despite evidence that including the
free T3 and free T4 blood tests with the TSH blood test produces the most accurate
thyroid function analysis, the TSH blood test is most often used exclusively (Beckett &
MacKenzie, 2007; Dayan, 2001). When the TSH blood test is used alone, clinically
important diagnoses may be missed (Dayan, 2001), and thyroid patients may be
undertreated (Baisier, Hertoghe, & Eeckhaut, 2000).
In addition to ordering the TSH, free T3, and free T4 blood tests, doctors should
investigate the potential presence of thyroid autoantibodies (i.e., TgAb, TPOAb, and
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TRAb) in order to determine if thyroid dysfunction is autoimmune in nature (i.e., caused
by Hashimoto’s disease or Grave’s disease; Bunevicius & Prange, 2006; Dayan, 2001).
Furthermore, in cases in which a patient is already receiving treatment and is determined
to be euthyroid (i.e., “normal” levels of thyroid hormone are detected in the blood), levels
of antibodies can fluctuate and cause psychiatric symptoms (e.g., depression and anxiety;
Bunevicius & Prange, 2006). Thus, in conjunction with the patient’s reported symptoms,
a review of all thyroid function tests provides the most thorough analysis for properly
diagnosing and treating thyroid dysfunction (Adams, 2008; Aslan et al., 2005;
Bunevicius & Prange, 2006; Canaris et al., 2000; Dayan, 2001; Fassier et al., 2011;
Godfrey, 2007; Rivera et al., 2015; Shimabukuro, 2008; Simmons, 2010).
In some cases, despite thyroid tests being “normal,” patients continue to report
symptoms of hypothyroidism. As such, doctors may decide to treat their patients with
thyroid hormone medication or increase their patients’ dose of medication. Wheatland
(2010) argued that a trial of thyroid hormone medication is the “best method for
achieving diagnostic certainty” and ultimately alleviating thyroid patients’ symptoms (p.
458). According to Adams (2008), thyroid experts contend that deciding to treat patients
based on symptoms should be left to the discretion of the doctor (p. 15).
Synthetic medication is standard. Ten out of the 15 total participants whose
treatment experiences were influenced by their doctors’ medical knowledge appeared to
be specifically affected by the use of synthetic medication as the only treatment option
for thyroid disease. More specifically, 10 participants reported having difficulty in
convincing their doctors that synthetic thyroid medication caused them to not feel well. In
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addition, the participants’ doctors would not consider prescribing them natural thyroid
medication instead of synthetic thyroid medication. Jessica explained, “[My doctors] got
frustrated and abusive with me because I was not tolerating the [synthetic] thyroid meds
well…[synthetic thyroid] meds gave me severe reactions, altered my mental state, and
made me feel worse.” Likewise, Carla reported, “I was started on Synthroid…it made me
sick…they tried levothyroxine, it made me sick…then tried levothroid, it made me
sick…Nauseous, headache...” Michelle shared, “When I kept saying the Synthroid was
making me feel bad, I was told “that’s all we can prescribe”!!”
According to Anne,
[When] the Armour shortage hit [my] doctor knew of nothing else to do but go
back to Synthroid and did not understand when I was upset at that
suggestion…The thought of having to settle for Synthroid again honestly scared
me.
Karen shared that she struggled for energy for 38 years and that it took doctors that long
to realize that her body was “not converting the synthetic thyroid down as it should be.”
Emily commented, “I appreciate that my endo is open to trying natural hormone if
necessary as my PCP seems to think Synthroid is the only option.”
Kim explained,
[I had] no problems until I changed to Synthroid. When I found it didn’t work as
well and I wanted to change back to Armour I could not find a doctor who would
permit the change. They all said Armour was outmoded and Synthroid was better.
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Kim’s experience with natural and synthetic thyroid medication warrants extra discussion
because she is 82 years old and has been treated for thyroid disease for 66 years. Kim
shared that when she was 16 years old, her doctor diagnosed her as hypothyroid based on
her symptoms alone and prescribed her Armour thyroid, the standard treatment at the
time. According to Kim, “The only test available back then was the basal
metabolism…but there was no way I could get to the testing facility without an hour’s
bus and streetcar rides…So he began treatment without my having been tested.” When
Synthroid was created in 1958 without undergoing any clinical trials (Tybout &
Hennessy, 2013), Kim’s doctor began prescribing her Synthroid, the new standard,
instead of Armour thyroid. As mentioned previously, Kim “had no problems until [she]
changed to Synthroid.”
Because today’s public has greater access to medical information via the Internet
(Hearn, 2009; Tustin, 2010), doctors who oppose the use of natural thyroid medication
might argue that patients who don’t feel well on Synthroid are experiencing the “nocebo
effect.” In other words, reading about the potential negative symptoms one might
experience from a medication can actually cause a person to experience those symptoms
(Wells, 2012). In addition, there is a vast amount of information online about the positive
experiences of thyroid patients taking natural thyroid medication—written by the patients
themselves (e.g., http://www.stopthethyroidmadness.com;
http://thyroid.about.com/bio/Mary-Shomon-350.htm; http://dearthyroid.org;
http://www.butterflynationproject.org). Although the nocebo effect is one potential cause
for the participants in the current study to not feel well on Synthroid, it is extremely
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unlikely for Kim because she experienced negative effects from Synthroid when she
switched from Armour thyroid in 1958—before the advent of the Internet.
According to Gaby (2004), a medical doctor who prescribes Armour thyroid and
Bongiorno (2015), a naturopathic doctor who prescribes Armour thyroid, a significant
number of thyroid patients who continue to experience symptoms of hypothyroidism
while on Synthroid experience relief of those symptoms on Armour thyroid. Gaby (2004)
purported that the negative reaction of the conventional medical community to the use of
natural thyroid medication “represents, at least in part, a biased attitude” (p. 168). He
continued, “Whatever the reason, it appears that conventional medicine has not made a
serious attempt to evaluate the evidence regarding the empirical use of [natural] thyroid
hormone” (p. 168). In a study by Goff et al. (2012), patients who did not trust their
doctors’ recommendations for medication reported concern that their doctors’
recommendations were influenced by pharmaceutical companies rather than centered on
the patients’ needs.
In the Western medical education system, doctors are taught to make diagnostic
and treatment decisions in accord with “objective evidence” of disease in lieu of patients’
subjective illness experiences (Hoffmann & Tarzian, 2001; Werner & Malterud, 2003).
Because the majority of medical textbooks and review articles recommend synthetic
medication as the only appropriate treatment for hypothyroidism (Gaby, 2004), it is
understandable that doctors are hesitant to prescribe anything else. However, considering
the many narratives of patients who report feeling well on natural thyroid medication
(e.g., http://www.stopthethyroidmadness.com; http://thyroid.about.com/bio/Mary-
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Shomon-350.htm; http://dearthyroid.org; http://www.butterflynationproject.org), it seems
that research on natural thyroid medication is warranted (Gaby, 2004). On a personal
note, one of my previous doctors was an Endocrinologist who was also a teaching doctor.
I liked him; he was pleasant, easy to talk to, and empathic. However, he refused to
prescribe natural thyroid medication (I did not feel well on synthetic thyroid medication).
At one point, I asked him, “I know you prefer to prescribe synthetic thyroid medication;
however, would you consider prescribing me natural thyroid medication?” He responded,
“It’s not a matter of preference…it’s what we’re taught.”
Because medical professionals have a tendency to undervalue patients’
knowledge (Risberg et al., 2006) and doctors have been traditionally thought of as “all
knowing,” patients who seem to challenge their doctors’ expertise become thought of as
“difficult” (MacDonald, 2003). Female patients, particularly those with a higher
educational attainment, tend to conduct research about their illnesses (Ye, 2014) and
desire the most active involvement in the decision making process with their doctors
(Flynn et al., 2006). Of the 16 participants in the current study, 15 participants attained an
education beyond high school, 12 conducted research about thyroid disease, and 12
desired to actively participate in the decision making process. However, when female
patients are perceived to be “complaining too much,” they risk having their complaints
interpreted as exaggerated or imaginary (Frantsve & Kerns, 2007; Richardson, 2005;
Werner et al., 2003).
According to Carla, her doctor’s “prejudice and ignorance…cost [Carla her] life.”
She continued, “I have two half siblings with the same genetic defect I have. Both got
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proper care in a timely manner. Both are doing fine. Healthy weight, good jobs, real
lives.” Carla’s experience highlights the importance of doctors’ mindfulness regarding
the potential for diagnostic bias. Left undiagnosed or undertreated, thyroid disease can
result in progressive psychological and physiological problems (Bunevicius & Prange,
2006; Gaitonde et al., 2012; Heinrich & Grahm, 2003; McDermott & Ridgway, 2001;
Roberts & Ladenson, 2004). Thus, it is imperative that doctors who treat thyroid disease
consider thyroid patients’ knowledge and subjective illness experiences in conjunction
with what they learned in medical school.
Continuing education is needed. According to all 15 of the participants whose
treatment experiences were influenced by their doctor’s medical knowledge, continuing
education for doctors about thyroid disease is needed. In some cases, participants
believed they knew more about thyroid disease than their doctors. Kari explained, “[It has
been] difficult to find a Dr. who knows anything about Thyroid problems…I am
explaining more to her then [sic] she to me [about thyroid disease].” Kim stated,
“Sometimes I have to teach [doctors] what some of the recognized symptoms [of thyroid
disease] are!” Likewise, Diane commented, “It is scary how little doctors actually know
about [thyroid] disease, let alone Hashimoto’s [disease]…it seems that I am more
knowledgeable about some areas of Hashimoto's than he is.” Sarah shared,
I would love to see in the future that Doctors would pay more attention to the
FT3's and FT4's than the stupid TSH levels. I have a Doctor I see for bioidentical
hormones and she is the very first one who has said we'll skip the TSH. I see hope
with her and may at some point trust her to treat my thyroid.
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Other participants expressed frustration that their doctors would not believe their
symptoms were a result of following conventional treatment guidelines (e.g., TSH blood
test, synthetic medication). For example, Carla commented that she wished her doctor
would “listen to someone that is ‘living it’ and throw away the Synthroid book,”
continuing, “Maybe it will click in [my doctor’s] brain that the stuff that was shoved
down her throat does not apply to all folks with thyroid disorders.” Similarly, Anne
reported, “[My treatment] is being managed by someone who does not understand that
there is not ‘one size fits all’.”
Karen and Michelle had positive experiences with their doctors’ knowledge of
thyroid disease. Karen explained, “It helped that my regular doc took extra courses to
learn more about thyroid dieses after I explained to her the problems I had with each
rejected endo she sent me to. I was not her only patient with thyroid problems so she was
eager to learn more.” Similarly, Michelle shared,
When I was finally diagnosed in 2005 after many years of begging [doctors] to be
diagnosed (numbers were “normal”), I found a female PCP to diagnose me. She
was a teaching Dr. and taught me how to read the numbers on all the appropriate
tests---not just TSH, but also FT3 & FT4.
As mentioned previously, the majority of patients refer to their doctors as their primary
source for health information—including patients who seek information about diagnostic
and treatment options from external sources (e.g., the Internet, books; Bernhardt, 2001;
Cegala et al., 2008; Cotten & Gupta, 2004; Fox, 2011; Hassling et al., 2003). In fact,
Fox’s (2011) study of patients with chronic illness who sought information and peers
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online revealed that participants did not use the Internet to self-diagnose and selfmedicate. Rather, participants indicated that they considered the information they
gathered as a supplement they wished to share with their doctors. Thus, it is vital that
doctors remain current with the literature regarding the illnesses they treat. In addition,
responding to information-seeking patients in a manner such as Karen’s and Michelle’s
doctors (i.e., taking extra courses, including the patient) would help to validate patients’
concerns and establish trust while demonstrating patient-centered behavior.
With the rise of patient-centered care in the last 10 years, various medical
societies have acknowledged that the traditional biomedical focus in medical training
perpetuates traditional styles of doctor-patient relationships in which the belief that the
“doctor knows best” endures (Campbell et al., 2005; Celik et al., 2009) and patients’
preferences, concerns, and emotions are largely disregarded (Haidet et al., 2002;
Hoffmann & Tarzian, 2001; McGuire et al., 2005). In addition, scholars and members of
the medical community have recognized that medical knowledge is historically based on
research in which women were significantly underrepresented (Miller & Bahn, 2013;
Findlay, 1993; Sherwin, 1999) and that gender bias persists in modern medical textbooks
(Dijkstra et al., 2008; Hamberg & Larsson, 2009; Hochleitnera, Nachtschattb, &
Sillervan, 2013; Leerdam, Rietveld, Teunissen, & Lagro-Janssen, 2014). As such,
policies that require the inclusion of women in medical research have been created and
women’s health programs have been implemented (Miller & Bahn, 2013; Pinn, 2013).
Furthermore, in response to patient demands for doctors who are able to match their
relational approaches to the communication needs of their patients, medical societies
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have developed training programs to teach patient-centered communication skills to
medical students and practicing doctors (Houle et al., 2007; Levinson et al., 2010; Ross &
Haidet, 2011).
According to Pinn (2013), although sex and gender differences in healthcare are
almost universally recognized by the medical community, further research and education
regarding women’s specific healthcare needs is crucial. In the current study, Anne
commented, “I am not a doctor so there is a lot I do not understand. But it seems to me
that the vast majority of endocrinologists have on blinders.” The significance of Anne’s
comment is two-fold: (a) she demonstrated respect for her doctors’ knowledge by
acknowledging her own shortcomings, and (b) she alluded to her desire for doctors to
take her seriously. With regard to knowledge of how to diagnose and treat thyroid
disease, as stated previously, it is important to consider the doctors’ specialties. However,
if doctors choose to treat their patients for medical conditions in which they do not
specialize, it is essential that they continually seek the latest information regarding those
conditions. Considering the debatable efficacy of the TSH blood test (Adams, 2008;
Beckett & MacKenzie, 2007; Wheatland, 2010) and the vast number of patients reporting
not feeling well on synthetic thyroid medication (see
http://www.stopthethyroidmadness.com; http://thyroid.about.com/bio/Mary-Shomon350.htm; http://dearthyroid.org; http://www.butterflynationproject.org), it seems that
additional research and education is needed on how to meet the unique needs of female
thyroid patients.
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Subtheme 3: Economics. The treatment experiences of 11 out of the 16 total
participants who were affected by the culture of the medical profession appeared to be
specifically influenced by economics. More specifically, three participants reported
feeling rushed by their doctors, eight participants had difficulty with accessing a doctor,
and six participants had difficulty with accessing thyroid medication. Within Subtheme 3:
Economics are the following subthemes: feeling rushed, access to doctor, and access to
medication.
Feeling rushed. Three out of the 11 participants whose treatment experiences
were influenced by economics reported feeling rushed by their doctors. Autumn
explained that in her experience, “Most [doctors] are just in and out doing as little as they
possibly have to do,” and continued, “It would help if they weren’t so rushed.” Jessica
expressed a desire for her doctors to “take more time to figure stuff out and explain
things.”
Research indicates that having sufficient time to discuss health concerns with
one’s doctor is a crucial factor in patients’ perceived quality of communication and
overall satisfaction (Heinrich & Karner, 2010; Salt et al., 2012; Sutherns, 2004; Swancutt
et al., 2011). However, the organization of the healthcare system produces economic
concerns that can act as obstacles to collaborative doctor-patient relationships. Due to
financial and administrative concerns, doctors who are capable of communicating with
their patients in a collaborative manner may be impeded by time constraints and limited
resources for developing patient-centered practices (Balsa & McGuire, 2001; Dunn,
2003; Greenfield et al., 2014). As a result, the quality of the healthcare suffers and
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traditional, hierarchical doctor-patient relationships persist (Levinson, 2011; Peters et al.,
2008; Swancutt et al., 2011).
According to Hearn (2006), doctors struggle to accommodate informed and active
patients due to economic efficiency demands. Even doctors who support patient
participation often behave in a paternalistic manner due to a heavy work load, staff
shortages, and practical concerns such as reducing healthcare costs and avoiding
malpractice lawsuits (Hearn, 2009; Sherwin, 2000). However, Greenfield et al. (2014)
argued that, when viewed from both a micro- (patient) and macro- (public health)
perspective, longer, patient-centered visits might actually be cost-effective. More
specifically, from the micro-perspective, the healthcare system may ultimately reduce
costs by allowing doctors to properly address their patients’ concerns and to
collaboratively choose the most appropriate course of treatment; from the macroperspective, because chronic illnesses are the primary cause of mortality worldwide and
patient-centered approaches are fundamental to high-quality care, utilizing a patientcentered approaches may reduce the need for patients with chronic illness to see multiple
providers.
Research indicates that patient satisfaction and trust in one’s doctor are stronger
predictors of patients’ commitment to the doctor-patient relationship than are the
monetary costs of switching doctors (Platanova et al., 2008). In other words, patients who
are not satisfied with or do not trust their doctors will seek new doctors even if switching
results in a greater expense. Nevertheless, not all patients have equal access to the types
of doctors they prefer.

223
Access to doctor. Eight out of the 11 participants whose treatment experiences
were influenced by economics had difficulty with accessing a doctor. Kari had hoped to
see an endocrinologist for her treatment. An endocrinologist is a doctor that specializes in
disorders of the endocrine system, which includes the thyroid (AACE, 2015). However,
there were no endocrinologists in Kari’s area. She explained, “[My relationship with my
doctor is] not ideal, but the best I can have here…There is not Endo around for at least
150 miles and I can't make these long trips.” In 2007, the national supply of
endocrinologists was at least 15% lower than demand (Anderson, 2007). According to
Vigersky et al. (2014), the number of endocrinologists in the United States is insufficient
for satisfying current and future demand.
Shawna expressed frustration because her naturopath “cancelled [her] August
recheck because [her naturopath] was too busy as a school nurse.” Shawna stated, “[She]
to wait until Nov since I was doing fine, [so] on my own, I did more reading and added
[another supplement].” As discussed previously, Shawna felt dismissed and switched
doctors.
Some participants expressed difficulty with accessing a doctor due to financial
constraints. In Diane’s search for a doctor, the initial cost for seeing the doctor who
listened to her and took her seriously was $400. While Diane was able to afford this fee,
an out-of-pocket payment of $400 is too expensive for many patients. For example, Jenna
shared, “I think [my doctor] could be a little more up to date but again, going through a
free clinic I am limited.” Similarly, Carla stated, “I got bad sick…and no
insurance…couldn't go see a doc…[then, finally] for the first time in 15 years I had
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access to a doc again [when I] became eligible for a few things, including medical
care…” Jenna’s and Carla’s experiences highlight the disparities in healthcare due to
socioeconomic status (Comber, Brunsdon, & Radburn, 2011; Piper, Glover, Elder, Baek,
& Wilkinson, 2010; Shi, Lebrun, & Tsai, 2010). According to Comber et al. (2011),
access to healthcare involves not only having health insurance, but also locating a doctor
and obtaining transportation to the facility. In addition to affecting patients’ access to
doctor, financial constraints can also prevent patients from accessing their medication.
Access to medication. Six out of the 11 participants whose treatment experiences
were influenced by economics had difficulty with accessing thyroid medication. Carla
explained that struggled with accessing natural thyroid medication, stating, “[My doctor]
allowed me to stay on the replacements that I've been taking when we found that my state
assistance insurance only covers synthetic T4 and I have a very poor body response to
that.” More specifically, because Carla’s insurance would not cover the type of thyroid
medication she needed, Carla ordered non-prescription thyroid supplements online. April
reported switching from synthetic thyroid medication to natural thyroid medication in
order to save money. She explained, “I used Synthroid 150 and Cytomel for almost 3
years but it was costing $60+ a month. I recently switched to Armour and it is less than
$8 a month.”
Other participants struggled with accessing natural thyroid medication due to
recalls by the Food and Drug Administration (FDA). Karen explained,
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I was happy but now that the FDA no longer approves Armour as a medication I
will have to start all over again trying to find a natural product my system can
work with. I have a very sensitive system so it is hard to find a good treatment.
Likewise, Anne shared, “I was happy until the Armour shortage hit. When that happened,
this doctor knew of nothing else to do but go back to Synthroid and did not understand
when I was upset at that suggestion.”
Since its invention in 1958, synthetic thyroid medication (name brand Synthroid)
has been the standard treatment for hypothyroidism (Tybout & Hennessy, 2013).
However, as previously mentioned, numerous thyroid patients don’t feel well on
synthetic thyroid medication and report feeling better taking natural thyroid medication
(Armour thyroid is the most popular brand). Although some doctors prescribe natural
thyroid medication, the general consensus of the conventional medical field is that
Armour thyroid is outdated and Synthroid is better (Dommisse, 2009; Gaby, 2004).
Furthermore, Armour thyroid is periodically removed from the market by the FDA due to
issues related to “quality” (Dommisse, 2009), leaving patients who take Armour thyroid
without thyroid medication.
According to Gaby (2004), the negative reaction of the conventional medical
community to natural thyroid medication “represents, at least in part, a biased attitude”
(p. 168). Dommisse (2009) contends that the medical community’s preference for
synthetic thyroid medication is based upon biased research in which pharmaceutical
companies are involved. Research indicates that diagnostic and treatment decisions are
influenced by competing perspectives among pharmaceutical, medical, and insurance
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companies (Hearn, 2009) and that patients fear their doctors’ recommendations for
medication are influenced by pharmaceutical companies (Goff et al., 2012). Thus,
considering that numerous patients report feeling well on natural thyroid medication, it
seems that research on natural thyroid medication is warranted.
Additional Findings
As previously mentioned, I recognized some additional findings that were
meaningful to some participants. Although these findings do not represent the treatment
experiences of the participants as a whole, these data are nevertheless poignant examples
of the phenomenon from individuals who have lived the phenomenon. Additional
findings include a belief that the public is misinformed about thyroid disease (Diane), the
experience of grief (Carla), the experience of empathy from one’s doctor (Michelle), and
the experience of respect from one’s doctor (Michelle).
Public is misinformed. Diane reported a belief that the public is misinformed
about thyroid disease. She commented, “[I] think the public is grossly misinformed. Their
impression is that you just take a little pill and all is well. This is far from the truth, as it
can be very complicated.” Diane’s comments mirror the experiences of patients with
chronic pain and medically unexplained symptoms. More specifically, individuals with
chronic pain and medically unexplained symptoms often report feeling discredited by not
only their doctors, but their family and friends as well (Nettleton, 2006; Slade, Molloy, &
Keating, 2009; Stenberg et al., 2012). Diane shared that she searched for over 30 years
for the cause of her rapid weight gain and chronic fatigue. At one point, her symptoms
were so severe that she was “bedridden and in danger of losing [her] job.” Lacking a
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diagnosis for many years, Diane would have had no recourse if she lost her employment.
Diane struggled and worked hard for her thyroid-related symptoms to be perceived as
legitimate and worthy of attention.
Experience of grief. In sharing her thyroid disease treatment experience, one of
Carla’s comments was indicative of grief. Carla stated,
I got to watch my iodine uptake...I had such a perfect gland...It was just twice
normal size. I have two half siblings with the same genetic defect I have. Both got
proper care in a timely manner. Both are doing fine. Healthy weight, good jobs,
real lives.
Research indicates that individuals with chronic illness (e.g., thyroid disease, diabetes,
arthritis) experience grief over time as a result of loss of health or functioning (Dysvik,
Natvig, & Furnes, 2013; Schulman-Green, Jaser, & Martin, 2012). According to Dysvik
et al. (2013), grief also occurs in response to needing to leave jobs and social networks,
resulting in feelings of loneliness and despair. In sharing her experience, Carla reported
that she used to be a body builder and had a successful career. However, Carla is now
mobility impaired as a result of not receiving treatment in time for her “thyroid storm” 20
years ago. She also lost her career and health insurance. Before receiving radioactive
iodine treatment for her thyroid storm, the doctor gave her an informed consent form and
told her, “Sign it or die.” I signed it,” Carla said.
Experience of empathy. Michelle indicated that she experienced empathy from
her doctor. She stated, “[My doctor] is very caring and listens to my needs…he has made
clear that he is a good listener and has my best interest at heart.” Michelle further
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expressed appreciation that her doctor listens to her, takes her seriously, and works with
her collaboratively.
Research indicates that empathy is a vital component to an effective doctorpatient relationship and positive health outcomes (Houle et al., 2007; Neumann et al.,
2009; Pollak et al., 2011; Rakel et al., 2011). According to Gelhaus (2012a), empathy
involves “…taking seriously the patient as a complete, distinct, unique human being…”
(p. 112). Although only four of the 16 total participants interviewed in this study
specifically expressed experiencing a lack of empathy from their doctors, Michelle is the
only participant to specifically indicate that she experienced empathy from her doctor.
Furthermore, considering that nine of the 16 total participants believed their doctors did
not take them seriously, it could be argued that at least nine participants had doctors who
struggled with demonstrating empathy. Because empathy has the potential to reduce
patients’ anxiety (Finset, 2012; Fogarty et al., 1999) and even enhance patients’ immune
system response (Rakel et al., 2009; Rakel et al., 2011), additional training in empathic
communication may be warranted (Gelhaus, 2012a, 2012b; Pollak et al., 2011).
Experience of respect. Michelle indicated that she experienced respect from her
doctor—the same doctor who provided her with empathy. When asked whether or not the
gender of her doctor is important, Michelle responded, “I think he is so respectful of his
patients that it does not matter if [it is a] male or female patient.”
Only three of the 16 total participants interviewed in this study specifically
expressed experiencing disrespect. However, Michelle is the only participant to
specifically indicate feeling respected by her doctor. Feeling respected by one’s doctor is
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associated with feeling heard and taken seriously (King et al., 2015; Wessel et al., 2012),
as well as being met with empathy, concern, and patience (Salt et al., 2012)—all of which
are components of patient-centered approaches. As previously discussed, patient-centered
approaches engender trust in one’s doctor (Copeland et al., 2003; Firth Cozens, 2008b;
Hall et al., 2009; Houle et al., 2007; Jagosh et al., 2011). Trust, in turn, tends to result in
patients’ willingness to share with their doctors and to consider their advice (Copeland et
al., 2003; Peters et al., 2008). Thus, demonstrating respect to one’s patients is a vital
component to establishing and maintaining effective doctor-patient relationships.
Limitations of the Study
Although the contributions of the participants add to the literature on the
experience of thyroid disease and the doctor-patient relationship, findings should be
considered with caution due to limitations of the study. Because this study was conducted
via the Internet and I did not meet with the participants face-to-face, the participants’ age
and gender could not be verified. Likewise, the participants’ thyroid disease diagnoses
were self-reported. The sample was self-selected from members of The Thyroid Support
Group, which means that the sample may vary systematically and therefore may not be
representative of most female thyroid patients. Because participants chose to participate
in the study, they might have been enthusiastic about sharing their negative healthcare
experiences, while patients who were satisfied with their treatment experiences had no
interest in participating. In addition, the sample was mostly Caucasian, which reflects the
findings of studies that indicate most Internet users tend to be Caucasian and have
convenient access to a computer (e.g., Fox & Jones, 2009; Kraut et al., 2004). As such,
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the results of this study may not be generalizable to non-Caucasian individuals who do
not have convenient computer access. The mean age of the participants was 55 years; and
the majority of participants reported having an education beyond high school. Therefore,
the results of this study may not reflect the experiences of younger thyroid patients who
do not have a higher education. The majority of participants’ doctors were Caucasian and
male. As such, the results of this study may not be generalizable to thyroid patients with
non-Caucasian, female doctors. Furthermore, because this study focused on the
experiences of female patients with thyroid disease, the findings may not reflect the
experiences of male thyroid patients.
Another limitation of this study is the potential for personal bias, as I have a
thyroid disease diagnosis and have been a member of The Thyroid Support Group since
2004. In order to control for this limitation, I utilized reflexive journaling during data
collection and analysis. More specifically, I maintained a journal about my personal
feelings and opinions so they could be separated from the data. As I read and re-read
participants’ experiences, I recalled having similar experiences and felt the emotions of
sadness and anger. Through journaling about my feelings regarding the participants’
experiences, I realized that in some instances, I was transferring my own emotions to
their statements. In other words, I ultimately made certain that the emotions of the
participants discussed in this study were the emotions of the participants and not my own.
A final limitation of this study is that none of the participants had electronic
journals to share. I had planned to collect personal electronic journals in addition to the
data gathered from the interview guide in order to triangulate the data. Nevertheless,
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triangulation was achieved because more than one theoretical position (feminism and
social constructionism) was utilized to interpret the data. In addition, I used the services
(on a voluntary basis) of a colleague for data interpretation.
Data Triangulation
In addition to using two theoretical positions (feminism and social
constructionism) to interpret the data, utilizing the services of a colleague for data
interpretation (on a voluntary basis) helped to triangulate the data in order to ensure data
trustworthiness and quality. During the process of data analysis, my colleague reviewed
my work regarding the identification of themes and subthemes. After I recognized the
theme of “Doctor-Patient Relationship” with the subthemes, “Traditional” and
“Collaborative,” I created a section called “Dissatisfaction with Treatment” beneath the
“Traditional” subtheme. My colleague suggested that I was underemphasizing
satisfaction with treatment. I agreed with her analysis and carefully reviewed
participants’ comments regarding instances in which they felt heard, validated, and taken
seriously by their doctors. In conjunction with reflexive journaling, receiving my
colleague’s feedback regarding this issue helped me to realize that I was focusing on the
participants’ negative experiences and not giving credence to their positive experiences.
Another issue recognized by colleague was the practice of self-advocacy
behaviors among participants, specifically as the behaviors related to doctor-patient
communication. I had identified the processes of health information-seeking, seeking new
doctors, treatment refusal, and self-treatment as related to the participants’ autonomy and
in response to doctors who did not listen to, validate, or take the participants seriously.
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Considering my colleague’s feedback, it became evident that being dissatisfied with
one’s treatment was not necessarily a prerequisite to participating in self-advocacy
behaviors. In other words, even participants who felt heard, validated, and taken seriously
by their doctors sought health information, refused treatment, and self-treated.
Recommendations for Future Research
A thorough review of the participants’ interviews and resulting themes revealed a
number of issues in need of further research. These issues include: (a) the education
levels of female patients who seek health information, (b) patients’ self-advocacy
behaviors (i.e., seeking new doctors, self-treatment, and secret-keeping, (c) the role of
gender in the doctor-patient relationship, (d) the efficacy of the TSH blood test for
diagnosing thyroid dysfunction, (e) doctors’ specialties in relation to diagnostic bias, (f)
the use of natural thyroid medication, and (g) grief as it relates to thyroid disease.
Education Level of Female Patients
The research reviewed for this study indicated that female patients—particularly
those with a higher educational attainment—tend to conduct research about their illnesses
(Ye, 2014), desire the most active involvement in the decision making process with their
doctors (Flynn et al., 2006), and are more likely to self-treat (Kua et al., 2012). The
results of the current study reinforced these findings: of the 16 participants interviewed,
15 participants attained an education beyond high school (see Table 2 in Chapter 4), 12
conducted research about thyroid disease, 12 desired to actively participate in the
decision making process, and seven self-treated. As discussed previously, the majority of
patients refer to their doctors as their primary source for health information—even
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patients who seek information from external sources (Cegala et al., 2008; Cotten &
Gupta, 2004; Fox, 2011). Thus, it is recommended that future research examine the
relationship between the education level of female patients and the doctor-patient
relationship.
Patient Self-Advocacy Behaviors
In the current study, the process of switching doctors was considered a form of
self-advocacy. Although the processes of “secret-keeping” and “self-treatment” were
previously discussed in relation to trust and doctor-patient communication, I believe they
are also self-advocacy behaviors. I will explain in the following sections.
Switching doctors. In my initial search of the literature for information about the
process of switching doctors, I came across the term “doctor shopping.” The term doctor
shopping has a negative connotation and generally refers to patients who are seeking
prescription pain killers (e.g., Peirce, Smith, Abate, & Halverson, 2012; Worley, 2012;
Worley & Thomas, 2012). While research in the area of preventing abuse of pain killers
is valuable, I had difficulty with finding information relevant to patients who switched
doctors due to dissatisfaction with their current doctor. A search of the literature using the
words “switching doctors” revealed a few studies (e.g., Liu et al., 2014; Platanova et al.,
2008; Kessler & Mylod, 2011; Ravichandran, 2015; Torres, Vasquez-Parraga, & Barra,
2009). However, these studies focused on “patient loyalty” and “patient commitment” to
the doctor-patient relationship—terms that place the sole responsibility for the doctorpatient relationship onto the patient.
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In reading studies about patient-centered care, I stumbled upon the term
“disengaging” to describe patients’ decisions to switch doctors due to dissatisfaction with
their care. However, I only found two such studies (McGowan, Escott, Luker, Creed, &
Chew-Graham, 2010; Stone, 2014). Thus, further research is needed on research
regarding patients who “disengage” from their current doctor due to dissatisfaction.
Secret keeping. The finding of “secret-keeping” in the current study prompted a
search of the literature for studies related to patients withholding information from their
doctors. Numerous studies were found in relation to patients seeking pain medication
(e.g., Buchman & Ho, 2014; Maakaron et al., 2014; Sokol, 2014; Stogner et al., 2015)
and doctors utilizing “therapeutic privilege” to withhold information from their patients
for the “good of the patient” (e.g., Collis & Sleeman, 2013; Hodkinson, 2013; Matthes &
Caples, 2013; Self, 2014). However, a gap was discovered regarding the practice of
secret-keeping by patients as a form of self-advocacy in an attempt to regain control over
their own health. As discussed previously, the purpose of secret-keeping by participants
in the current study was “not the exercise of power but the expression of resistance to the
power of [the doctor]” in which patients attempted to reclaim power and control over
their own bodies (Fainzang, 2005; p. 18). Because patients are the experts of their own
medical conditions (Chrisler, 2001; Fernandes et al., 2006; Hoffmann & Tarzian, 2001),
yet patients fear conflict and criticism from their doctors (Fainzang, 2005, 2015), further
research is needed about patients keeping secrets from their doctors as a form of selfadvocacy.
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Self-treatment. As with the issues of seeking new doctors and secret-keeping, the
majority of the literature on self-treatment places patients in a subservient position to the
doctor. Searching the literature with the term “self-treatment” resulted in numerous
studies related to “self-medication” with unauthorized drugs and alcohol (e.g., Larance et
al., 2011; Mehuys et al., 2012; Neafsey et al., 2011; Robinson et al., 2011). However,
participants in the current study initiated self-treatment after a thoughtful process of “selfexamination [and] self-diagnosis” (Fainzang, 2013, p. 495) in response to doctors who
dismissed their complaints that they did not feel well on the medication their doctors
prescribed. Because female patients in particular often need to prove the validity of their
complaints (Hoffman & Tarzian, 2001; Munch, 2004) and patients who challenge their
doctors tend to be thought of as “difficult” (Frosch et al., 2012; MacDonald, 2003),
female patients who choose to self-treat might be considered as self-advocating
(Fainzang, 2005, 2013, 2015) rather than behaving as “non-compliant” patients. Further
research needs to be conducted on the process of self-treating as a form of self-advocacy.
Role of Gender
In the beginning of the study, I anticipated that participants would describe
greater satisfaction with female doctors than male doctors due to women’s shared history
of social subordination to men (see Bohan, 2002; Cosgrove, 2003; Shields, 2007;
Sherwin, 1999). However, the majority of participants’ responses to questions regarding
the potential influence of gender on treatment experiences revealed that the doctors’
gender had little impact on their experiences. The literature regarding patients’ gender
preferences for doctors is divided. Although a number of studies indicate that patients
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prefer doctors of the same gender (e.g., Bonds et al., 2004; Fang et al., 2004; Godager,
2012), many studies suggest that patients do not have a gender preference for their
doctors (e.g., Bender, 2007; Delgado et al., 2011; Makam et al., 2010; Tempest et al.,
2005). Studies that focused on doctors’ perceived competence and communication skills
indicated that patients who perceived their doctors to be competent and easy to talk to
had no specific gender preferences for their doctors (Bertakis & Azari, 2012; Bourke,
2002; Mavis et al., 2005; Tempest et al., 2005). These finding are consistent with the
results of the current study, with 13 out of 16 participants referring to the importance of
their doctors’ competence and communication skills in lieu of their doctors’ gender.
Further research is recommended on the doctor gender preferences of patients being
treated for thyroid disease.
Efficacy of the TSH Blood Test
The efficacy of the TSH blood test for determining thyroid function is under
debate due to inconsistent data from various studies (Adams, 2008; Beckett &
MacKenzie, 2007; Wheatland, 2010). Experts on thyroid function differ in opinion
regarding the accuracy of the current range limits and question whether or not agespecific ranges should be created (Adams, 2008). Furthermore, despite evidence that
including the free T3 and free T4 blood tests with the TSH blood test produces the most
accurate analysis of thyroid function, an unaccompanied TSH blood test tends to be
utilized (Beckett & MacKenzie, 2007; Dayan, 2001). As a result, clinically important
diagnoses may be missed (Dayan, 2001), and thyroid patients may be undertreated
(Baisier et al., 2000). As such, there is a need for further research on the efficacy of the
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TSH blood test when used alone and in conjunction with the free T3, free T4, and thyroid
antibodies blood tests.
Doctor Specialty and Diagnostic Bias
Half of the participants in the current study reported experiencing diagnostic bias.
According to numerous studies (e.g., Bernardes & Lima, 2011; Soderberg et al., 2012;
Stenberg et al., 2012), women’s medical problems are often misdiagnosed and
undertreated. Furthermore, doctors tend to give lifestyle advice more often to women
than they do to men (Hamberg et al., 2004; Munch, 2004; Vaccaro & Huffman, 2012);
and women are less likely than men to receive diagnostic testing even when presenting
with the same symptoms (Hamberg, 2008; Napoli et al., 2014). However, it is important
to note that doctors are more prone to diagnostic bias and error when presented with
problems outside of their specialty (Ogdie et al., 2012); and the current study did not
investigate the specialties of the participants’ doctors. As such, it is recommended that
future research investigate the influence of doctors’ specialties on their choice of
diagnostic tests, diagnosis, and medical advice regarding thyroid disease.
Natural Thyroid Medication
As confirmed by the experiences of 10 out of 16 total participants in the current
study, synthetic thyroid medication is not an effective treatment for all individuals with
thyroid disease. A review of the literature on thyroid medication revealed a dearth of
studies related to the efficacy natural thyroid medication. Gaby (2004) argued that the
negative reaction of the conventional medical community to the use of natural thyroid
medication “represents, at least in part, a biased attitude” (p. 168). Further, Dommisse
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(2009) asserted that the medical community’s preference for synthetic thyroid medication
is based upon biased research in which pharmaceutical companies are involved.
Since its creation in 1958, synthetic thyroid medication (name brand Synthroid)
has been the standard treatment for hypothyroidism (Tybout & Hennessy, 2013).
According to Reynold and Olsen (1969), although natural thyroid was the standard
treatment at the time Synthroid was created, the pharmaceutical industry needed to “learn
how to obtain the effect of desiccated thyroid” via synthetic medication because the
demand for natural thyroid medication was too high for the available supply of fresh
glands (p. 1). Furthermore, because Synthroid preceded the current stringent drug
approval process, Synthroid was accepted by the FDA without any clinical trials (Tybout
& Hennessy, 2013). Due to the threat of generic medications, when Boots Pharmaceutical
purchased Synthroid from Flint Laboratories in 1986, Boots commissioned a pharmacist
to conduct a study with the hopes of proving that Synthroid was superior. However, the
results indicated that the generic medications were bioequivalent (Tybout & Hennessy,
2013). According to Tybout and Hennessy, Boots suppressed the results of the study for
seven years, at which time a lawsuit was filed on behalf of patients who had overpaid for
Synthroid based on the false proclamation that it was superior to other synthetic thyroid
medications.
I personally believe that the experiences of thyroid patients who do not feel well
on synthetic thyroid medication, but are denied an opportunity to try natural thyroid
medication, are comparable to the experiences of patients with medically unexplained
symptoms. More specifically, as with patients who have medically unexplained
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symptoms, thyroid patients who require natural thyroid medication to function are often
dismissed and do not feel heard, understood, or taken seriously (Peters et al., 2008;
Shattock et al., 2013; Stone, 2014; Werner et al., 2003); Like patients with medically
unexplained symptoms, these thyroid patients must work hard to be perceived as credible
patients with legitimate symptoms (Johansson et al., 1996; Werner & Malterud, 2003;
Werner et al., 2004). According to Stenberg et al. (2012), patients who believe their
doctors do not take them seriously feel rejected and ashamed. Considering the many
narratives of patients who report not feeling well on synthetic thyroid medication, it is
strongly recommended that further research be conducted on the efficacy of natural
thyroid medication.
Grief and Thyroid Disease
Carla’s experience of grief prompted a search of the literature about the
relationship between grief and thyroid disease. Although many studies were discovered
about the grieving process in relation to other chronic illnesses (e.g., Dysvik et al., 2013;
Novak, Costantini, Schneider, & Beanlands, 2013; Schulman-Green et al., 2012), no such
studies were found specifically about thyroid disease. Research indicates that individuals
with chronic illness experience grief over time as a result of loss of health or functioning
(Dysvik et al., 2013; Schulman-Green et al., 2012); and thyroid disease is a chronic
illness that affects an estimated 30 million Americans (AACE, 2013) and 200 million
people worldwide (Rajoria et al., 2010). As such, further research is recommended
regarding the experience of grief in individuals with thyroid disease.
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Dissemination of Findings
The findings of this study will be disseminated in several ways. First, the results
will be shared via individual emails with participants who indicated an interest in reading
the study. Second, I plan to publish a condensed form of this study in a scholarly journal
so that healthcare professionals can utilize the information in practice and future research.
Third, I will condense this study to the scope of a conference paper with the intention of
presenting the study and its results at appropriate conferences. Finally, I will build upon
the findings of this study by conducting further research in the areas of the relationship
between thyroid patients’ education levels and doctor-patient communication, thyroid
patient self-advocacy behaviors, and the experience of grief as it relates to thyroid
disease.
Implications for Social Change
The results of the current study contribute to positive social change by expanding
upon the existing research on women’s health and chronic illness to include thyroid
disease, thus enabling medical professionals to better determine and meet the unique
needs of female patients with thyroid disease. Based on the results of this study, the
processes of diagnosing and treating thyroid disease appear to be influenced by a number
of factors, including the nature of the doctor-patient relationship, doctor-patient
communication, the structure of the healthcare system and medical education, diagnostic
and gender bias, and economics. Additional factors that seem to be intricately related to
these processes include patients’ education levels and self-advocacy behaviors. It is
recommended that additional research be conducted in these areas in order to further

241
enhance our understanding of thyroid disease and the doctor-patient relationship and
ultimately ensure positive health outcomes.
The results of the current study indicate a need for doctors who treat thyroid
patients to learn how to recognize the communication needs of their patients and match
their relational approach to those needs (Briel et al., 2007; Houle et al., 2007; Levinson et
al., 2010). Flynn et al. (2006) suggested that doctors gather information regarding
patients’ preferences for involvement on intake forms to assist doctors in tailoring their
approach to meet their patients’ needs. However, even doctors who wish to work
collaboratively with their patients may not have the time or resources to employ patientcentered practices (Celik et al., 2009). In order for doctors to provide patient-centered
care, policy makers must develop payment models that encourage efforts toward patient
involvement, and with regard to care, a focus on quality rather than quantity (Bernabeo &
Holombow, 2013; Epstein & Street, 2011; Kerr & Hayward, 2013).
With regard to knowledge of how to diagnose and treat thyroid disease, as stated
previously, it is important to consider the doctors’ specialties. However, if doctors choose
to treat their patients for medical conditions in which they do not specialize, it is essential
that they continually seek the latest information regarding those conditions. Considering
the aforementioned issues with the TSH blood test (see Adams, 2008; Beckett &
MacKenzie, 2007; Bunevicius & Prange, 2006; Dayan, 2001; Wheatland, 2010) and the
reaction of numerous individuals to synthetic thyroid medication (see
http://www.stopthethyroidmadness.com; http://thyroid.about.com/bio/Mary-Shomon350.htm; http://dearthyroid.org; http://www.butterflynationproject.org), in conjunction
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with the reported experiences of the participants in the current study, it seems that
additional research and education is needed on the use of the TSH blood test for
determining thyroid function and the use of natural medication for treating thyroid
disease.
Conclusions
Although 30 million Americans are affected by thyroid disease, more than half
remain undiagnosed (AACE, 2013). Even after beginning treatment for thyroid disease,
many women report not feeling well despite taking synthetic thyroid medication (the
standard treatment for hypothyroidism) and their TSH blood test results showing as
“normal.” Because thyroid dysfunction produces symptoms similar to other disorders
(e.g., depression, menopause), thyroid disease is often misdiagnosed and left untreated
(Canaris et al., 2000; Godfrey, 2007; Pearce, 2015; Simmons, 2010). In addition, the
undertreatment of thyroid disease results in numerous distressing physical and emotional
symptoms and declining functioning (Cappola & Cooper, 2015; Gaitonde et al., 2012;
Heinrich & Grahm, 2003; Roberts & Ladenson, 2004). Despite being considered the
“gold standard” for determining thyroid function, the efficacy of the TSH blood test is
debatable due to inconsistent data from various studies (Adams, 2008; Beckett &
MacKenzie, 2007; Wheatland, 2010); and the TSH blood test tends to be used alone to
determine treatment effectiveness even though the full panel (TSH, free T3, free T4, and
antibodies tests) provides the most thorough analysis of thyroid function (Beckett &
MacKenzie, 2007; Bunevicius & Prange, 2006; Dayan, 2001). Furthermore, as supported
by the results of the current study, numerous thyroid patients report not feeling well
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taking synthetic thyroid medication and describe feeling better with natural thyroid
medication. However, the majority of doctors hesitate to prescribe natural thyroid
medication because they learn in medical school that synthetic thyroid medication is the
only appropriate treatment for hypothyroidism (Dommisse, 2009; Gaby, 2004).
In the face of such challenges, a doctor-patient relationship based on mutual trust
and collaboration helps to ensure positive treatment outcomes (Crooks et al., 2015; Houle
et al., 2007; Shimabukuro, 2008; Simmons, 2010). Research indicates that patients trust
doctors with whom they feel heard, validated, and taken seriously—all of which are
positively correlated with the likelihood of considering doctors’ recommendations (Houle
et al., 2007; Jagosh et al., 2011; Quaschning et al., 2012). Likewise, including patients in
the decision making process and responding to patient concerns with empathy encourages
authentic communication and patient satisfaction (Barry & Edgman-Levitan, 2012;
Gelhaus, 2012a, 2012b; Platanova et al., 2008). Patients who do not feel heard, validated,
or taken seriously by their doctors are likely to participate in self-advocacy behaviors
(e.g., conduct research, seek a new doctor, refuse treatment, self-treat, and keep secrets;
Fainzang, 2005, 2013, 2015; Fox, 2011; Ye, 2014)—particularly female patients with a
higher education (Flynn et al., 2006; Kua et al., 2012; Ye, 2014).
Research indicates that patients wish to work with their doctors—even patients
who seek health information, refuse treatment, and self-treat (Barry & Edgman-Levitan,
2012; McNutt, 2010; Quaschning et al., 2012). However, traditionally, doctors have been
taught to adopt a position of authority over their patients in order to ensure their patients’
recovery; and patients have been expected to accept a passive role and trust their doctors
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(Lupton, 2003; Munch, 2004). According to MacDonald (2003), because society has
changed and patients want to be active participants in their care, doctors must be willing
to surrender some authority (p. 306). As previously stated, I am not implying that doctors
who work in a traditional relational-style deliberately intend to oppress their patients.
Rather, because oppressive practices are systemically ingrained in society by historicallybased knowledge and beliefs, “conscious and persistent effort [is required] to resist
complicity in [the] patterns” of such practices (Sherwin, 1999, p. 11).
Historically oppressive practices in medicine continue to be challenged by
patient-centered care initiatives in which doctor-patient collaboration is encouraged
(Barry & Edgman-Levitan, 2012; Deber et al., 2007; Miller & Bahn, 2013; Pinn, 2013;
Ross & Haidet, 2011). As such, it is important for practicing doctors to work
collaboratively with patients who prefer a collaborative relational style (Chin, 2002;
Flynn et al., 2006; Houle et al., 2007; Levinson et al., 2010). Furthermore, discussion of
gender sensitive issues, sex differences in healthcare needs, and gender bias continues to
be integrated into modern medical curriculum (Miller & Bahn, 2013; Pinn, 2013). As
discussed previously, gender bias in medicine occurs as a result of stereotyped
preconceptions about a person’s health, behavior, experiences, and needs based on their
gender (Hamberg, 2008). From a feminist viewpoint, historically-based beliefs in
psychology and biomedicine that women are fragile, unintelligent, and inferior to men
continue to have a negative impact on both men and women (Chrisler, 2001; Hamberg,
2008; Hoffmann & Tarzian, 2001; Sherwin, 1999). Traditionally, in psychological
practice, the presence of “feminine” emotion (e.g., fear, anxiety) is considered
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problematic for women and abnormal in men (Shields, 2007). In addition, “female
disorders” in psychology and biomedicine—or disorders that are typically assigned to
women based on stereotypes—are often unrecognized and misdiagnosed in men
(Boysena, Ebersolea, Casnera, & Coston, 2014; Field et al., 2014). For example, men are
undertreated for osteoporosis and eating disorders as compared to women because these
disorders are traditionally thought of as “feminine” (Field et al., 2014; Shingleton,
Thompson-Brenner, Thompson, Pratt, & Franko, 2015; Walldorf et al., 2013). Likewise,
women are undertreated for back and chest pain as compared to men because these
symptoms tend to be thought of as “masculine” (Chang et al., 2007; Hoffmann &
Tarzian, 2001; Werner & Malterud, 2003). Thus, it is essential that doctors recognize the
potential for gender bias and to remain current with the literature regarding the illnesses
they treat (Napoli et al., 2014; Newton et al., 2010; Stenberg et al., 2012).
In conjunction with feminism, a social constructionist perspective of illness
asserts that objective views of the human body are socially constructed (Fernandes et al.,
2006). In other words, society and its establishments (e.g., medicine) assign meaning to
the human body (e.g., “healthy” and “unhealthy,” “normal” and “abnormal,” “masculine”
and “feminine”) and disregard individuals’ subjective illness experiences. From a
feminist/social constructionist viewpoint, patients’ interpretations of their own illness
experiences are valid and patients are considered experts of their own medical conditions
(Chrisler, 2001; Docherty & McColl, 2003; Hoffmann & Tarzian, 2001; Lupton, 2003).
Adopting a feminist/social constructionist approach to medicine encourages patients and
doctors to question concepts of “normal” and “healthy” and for doctors to consider
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patients’ subjective interpretations of their own illness—techniques that are characteristic
of patient-centered care (Barry & Edgman-Levitan, 2012; Hoffmann & Tarzian, 2001;
Levinson et al., 2010; Miller & Bahn, 2013; Pinn, 2013; Wright & Owen, 2001).
The reported experiences of the women in the current study provide information
with which one might begin to understand the treatment experiences of women with
thyroid disease and their relationships with their doctors. Overall, the most commonly
expressed needs shared by participants were to feel heard and be taken seriously by their
doctors—both of which are common in collaborative doctor-patient relationships and
patient-centered practices. Doctors who diagnose and treat women with thyroid disease
are in a position to empower their patients. Based on the results of the current study,
women who have thyroid disease desperately wish to feel well again and for their
experiences to be known and understood. Further research on the treatment experiences
of women with thyroid disease and the doctor-patient relationship is imperative for better
understanding the unique needs of female thyroid patients in order to more accurately
diagnose and effectively treat this debilitating and potentially life-threatening disease.

247
References
Adams, S. L. (2008). Studies, data and dialogue needed to determine TSH range: The
gold standard for thyroid dysfunction screening remains debatable. Endocrine
Today, 6(10), 1-14. Retrieved from http://www.endocrinetoday.com/default.aspx
Addis, M. E., & Mahalik, J. R. (2003). Men, masculinity, and the contexts of helpseeking. American Psychologist, 58, 5-14. doi:10.1037/0003-066X.58.1.5
Alegría, M., Nakash, O., Lapatin, S., Oddo, V., Gao, S., Lin, J., & Normand, S.-L.
(2008). How missing information in diagnosis can lead to disparities in the
clinical encounter. Journal of Public Health Management and Practice, 14, S26–
S35. doi:10.1097/01.PHH.0000338384.82436.0d
Alexander-Bridges, M., & Doan, L. L. (2007). Commentary: “Increasing minority
participation in clinical research”: A white paper from the Endocrine Society.
Journal of Clinical Endocrinology & Metabolism, 92(12), 4557–4559.
doi:10.1210/jc.2007-2172
Allan, T. (1995). Searching for quality of life in the face of physical pain. The CFIDS
Chronicle, 8(3), 17-19. Retrieved from http://www.cfids.org/default.asp
Amante, D. J., Hogan, T. P., Pagoto, S. L., English, T. M., & Lapane, K. L. (2015).
Access to care and use of the internet to search for health information: Results
from the US National Health Interview Survey. Journal of Medical Internet
Research, 17(4), e106-e127. Retrieved from
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430679/

248
American Association of Clinical Endocrinologists. (2002). Medical guidelines for
clinical practice for the evaluation and treatment of hyperthyroidism and
hypothyroidism. Endocrine Practice, 8(6), 457-469. Retrieved from
http://www.mythyroid.com/documents/AACE%20Thyroid%20Guideslines%202002.pdf
American Association of Clinical Endocrinologists. (2013). Are you one of the
unsuspecting 15 million Americans? Retrieved from http://media.aace.com/pressrelease/are-you-one-unsuspecting-15-million-americans-0
American Association of Clinical Endocrinologists. (2015). What is an endocrinologist?
Retrieved from http://www.empoweryourhealth.org/frequently_asked_questions
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental
disorders (4th ed., text rev.). Washington, DC: Author.
Anderson, J. (2007). Endocrinologist shortage worsens. Clinical Endocrinology News,
2(2), 15. doi:10.1016/S1558-0164(07)70049-4
Annandale, E., & Clark, J. (2000). Gender, postmodernism and health. In M. Calnan, J.
Gabe, & S. J. Williams (Eds.), Health, medicine and society: Key theories, future
agendas (pp. 51-64). Florence, KY: Routledge.
Annas, G. J. (2012). The rights of patients: The basic ACLU guide to patient rights. New
York, NY: Springer Science & Business Media.
Arksey, H., & Knight, P. (1999). Interviewing for social scientists: An introductory
resource with examples. London, England: Sage.

249
Aslan, S., Ersoy, R., Kuruoglu, A. C., Karakoc, A., & Cakir, N. (2005). Psychiatric
symptoms and diagnoses in thyroid disorders: A cross-sectional study.
International Journal of Psychiatry in Clinical Practice, 9(3), 187-192.
doi:10.1080/13651500510029129
Auerbach, S. M., Clore, J. N., Kiesler, D. J., Orr, T., Pegg, P. O., Quick, B. G., &
Wagner, C. (2002). Relation of diabetic patients’ health-related control appraisals
and physician–patient interpersonal impacts to patients’ metabolic control and
satisfaction with treatment. Journal of Behavioral Medicine, 25(1), 17-31.
doi:0160-7715/02/0200-0017/0
Ayling, R., & Mewse, A. J. (2009). Evaluating internet interviews with gay men.
Qualitative Health Research, 19, 566-576. doi:10.1177/1049732309332121
Baisier, W. V., Hertoghe, J., & Eeckhaut, W. (2000). Thyroid insufficiency. Is TSH
measurement the only diagnostic tool? Journal of Nutritional & Environmental
Medicine, 10(2), 105-113. doi:10.1080/13590840050043521
Balsa, A. I., & McGuire, T. G. (2001). Statistical discrimination in health care. Journal of
Health Economics, 20, 881-907. doi:10.1016/S0167-6296(01)00101-1
Barry, M. J., & Edgman-Levitan, S. (2012). Shared decision making—The pinnacle of
patient-centered care. New England Journal of Medicine, 366, 780-781.
doi:10.1056/NEJMp1109283
Barratt, M. J. (2011). The efficacy of interviewing young drug users through online chat.
Drug and Alcohol Review, 31(4), 566-572. doi:10.1111/j.14653362.2011.00399.x

250
Beach, M. C. (2000). Interpersonal expectations in the patient-physician relationship.
Journal of General Internal Medicine, 15, 825-827. doi:10.1046/j.15251497.2000.00918.x
Beckett, G., & MacKenzie, F. (2007). Thyroid guidelines – are thyroid stimulating
hormone assays fit for purpose? Annals of Clinical Biochemistry, 44, 203-208.
doi:10.1258/000456307780480945
Begin, M. E., Langlois, M. F., Lorrain, D., & Cunnane, S. C. (2008). Thyroid function
and cognition during aging. Current Gerontology and Geriatrics Research,
474868, 1-11. doi:10.1155/2008/474868.
Bender, D. J. (2007). Patient preference for a racially or gender-concordant student
dentist. Journal of Dental Education, 1(6), 726-745. Retrieved from
https://www.researchgate.net/publication/6282906_Patient_preference_for_a_raci
ally_or_gender-concordant_student_dentist
Benhassat, J., Pilpel, D., & Tidhar, M. (1998). Patients' preferences for participation in
clinical decision making: A review of published surveys. Behavioral Medicine,
24, 81-88. doi: 10.1080/08964289809596384
Berger, M. (2002). Chronically diseased patients and their doctors. Medical Teacher,
24(6), 642-644. doi:10.1080/0142159021000063989
Bernabeo, E., & Holmboe, E. S. (2013). Patients, providers, and systems need to acquire
a specific set of competencies to achieve truly patient-centered care. Health
Affairs, 32(2), 250-258. doi:10.1377/hlthaff.2012.1120

251
Bernardes, S. F., & Lima, M. L. (2011). On the contextual nature of sex-related biases in
pain judgments: The effects of pain duration, patient’s distress and judge’s sex.
European Journal of Pain, 15, 950–957. doi:10.1016/j.ejpain.2011.03.010
Bernhardt, J. M. (2001). Tailoring messages and design in a Web-based skin cancer
prevention intervention. International Electronic Journal of Health Education, 4,
290–297. Retrieved from
https://www.researchgate.net/publication/254740474_Tailoring_Messages_and_D
esign_in_a_Web-Based_Skin_Cancer_Prevention_Intervention
Berry, L. L., Parish, J. T., Janakiraman, R., Ogburn-Russell, L., Couchman, G. R., &
Rayburn, W. L. (2008). Patients’ commitment to their primary physician and why
it matters. Annals of Family Medicine, 6, 6–13. doi:10.1370/afm.757
Bertakis, K. D. (2009). The influence of gender on the doctor–patient interaction. Patient
Education and Counseling, 76(3), 356–360. doi:10.1016/j.pec.2009.07.022
Bertakis, K. D., & Azari, R. (2012). Patient-centered care: The influence of patient and
resident physician gender and gender concordance in primary care. Journal of
Women's Health, 21(3), 326-333. doi:10.1089/jwh.2011.2903
Bianco, M. B., & Carr-Chellman, A. A. (2002). Exploring qualitative methodologies in
online learning environments. Quarterly Review of Distance Education, 3(3), 251260. Retrieved from
http://www.eric.ed.gov/ERICWebPortal/detail?accno=EJ657869

252
Bienstock, J. L., Martin, S., Tzou, W., & Fox, H. E. (2002). Medical students’ gender is a
predictor of success in the obstetrics and gynecology basic clerkship. Teaching &
Learning in Medicine, 14, 240–243. doi:10.1207/S15328015TLM1404_7
Blanch, D. C., Hall, J. A., Roter, D. L., & Frankel, R. M. (2008). Medical student gender
and issues of confidence. Patient Education and Counseling, 72, 374–381.
doi:10.1016/j.pec.2008.05.021
Bloor, K., Freemantle, N., & Maynard, A. (2008). Gender and variation in activity rates
of hospital consultants. Journal of the Royal Society of Medicine, 101, 27-33.
doi:10.1258/jrsm.2007.070424
Bohan, J. S. (2002). Sex differences and/in the self: Classic themes, feminist variations,
postmodern challenges. Psychology of Women Quarterly, 26, 74-88.
doi:10.1111/1471-6402.00045
Bonds, D. E., Foley, K. L., Dugan, E., Hall, M. A., & Extrom, P. (2004). An exploration
of patients’ trust in physicians in training. Journal of Healthcare for the Poor and
Underserved, 15, 294-306. doi:10.1353/hpu.2004.0018
Bongiorno, P. (2015). Holistic solutions for anxiety & depression in therapy: Combining
natural remedies with conventional care. New York, NY: W.W. Norton &
Company.
Bono, G., Fancellu, R., Blandini, F., Santoro, G., & Mauri, M. (2004). Cognitive and
affective status in mild hypothyroidism and interactions with l-thyroxine
treatment. Acta Neurological Scandinavica, 110, 59–66. doi:10.1111/j.16000404.2004.00262.x

253
Bourke, L. (2002). Do people prefer general practitioners of the same sex? Australian
Family Physician, 31(10), 974-986. Retrieved from
https://www.researchgate.net/publication/11058946_Do_people_prefer_general_p
ractitioners_of_the_same_sex
Bowen, A., C., Williams, D. M., & Baird, G. (2008). Identifying multiple submissions in
internet research: Preserving data integrity. AIDS and Behavior, 12, 964-973.
doi:10.1007/s10461-007-9352-2
Boysena, G., Ebersolea, A., Casnera, R., & Coston, N. (2014). Gendered mental
disorders: Masculine and feminine stereotypes about mental disorders and their
relation to stigma. Journal of Social Psychology, 154(6), 546-565.
doi:10.1080/00224545.2014.953028
Bradley, G., Sparks, B., & Nesdale, D. (2001). Doctor communication style and patient
outcomes: Gender and age as moderators. Journal of Applied Social Psychology,
31, 1749-1773. doi:10.1111/j.1559-1816.2001.tb02749.x
Breen, G. M., Wan, T. T., Zhang, N. J., Marathe, S. S., Seblega, B. K., & Paek, S. C.
(2009). Improving doctor-patient communication: Examining innovative
modalities vis-à-vis effective patient-centric care management technology.
Journal of Medical Systems, 33, 155-162. doi:10.1007/s10916-008-9175-3
Briel, M., Young, J., Tschudi, P., Hugenschmidt, C., Bucher, H. C., & Langewitzc, W.
(2007). Shared-decision making in general practice: Do patients with respiratory
tract infections actually want it? Swiss Medical Weekly, 137, 483-485. Retrieved
from http://www.smw.ch/docs/pdf200x/2007/33/smw-11891.pdf

254
Brom, L., Hopmans, W., Pasman, H. R., Timmermans, D., Widdershoven, G., &
Onwuteaka-Philipsen, B. D. (2014). Congruence between patients’ preferred and
perceived participation in medical decision making: A review of the literature.
BMC Medical Informatics and Decision Making, 14, 25-41. Retrieved from
http://www.biomedcentral.com/1472-6947/14/25
Buchman, D. Z., & Ho, A. (2014). What's trust got to do with it? Revisiting opioid
contracts. Journal of Medical Ethics, 40(10), 673-677. doi:10.1136/medethics2013-101320
Bunevicius, R., & Prange, A. J. (2006). Psychiatric manifestations of Graves’
hyperthyroidism: Pathophysiology and treatment options. CNS Drugs, 20(11),
897-909. doi:10.2165/00023210-200620110-00003
Butalid, L., Verhaak, P., Boeije, H. R., & Bensing, J. M. (2012). Patients’ views on
changes in doctor-patient communication between 1982 and 2001: A mixedmethods study. BMC Family Practice, 13(80), 1-12. Retrieved from
http://www.biomedcentral.com/1471-2296/13/80
Calnan, M., & Rowe, R. (2008). Trust matters in health care. Buckingham, UK: Open
University Press.
Campbell, A., Gillet, G., & Jones, G. (2005). Medical ethics (4th ed.). New York, NY:
Oxford University Press.
Canaris, G. J., Manowitz, N. R., Mayor, G., & Ridgway, E. C. (2000). The Colorado
thyroid disease prevalence study. Archives of Internal Medicine, 160, 526-534.
doi:10.1001/archinte.160.4.526

255
Cappola, A. R., & Cooper, D. S. (2015). Screening and treating subclinical thyroid
disease: Getting past the impasse. Annals of Internal Medicine, 162(9), 664-665.
doi:10.7326/M15-0640
Carlsen, B., & Aakvik, A. (2006). Patient involvement in clinical decision making: the
effect of GP attitude on patient satisfaction. Health Expectations, 9, 148–157.
doi:10.1111/j.1369-7625.2006.00385.x
Carter, H. (1994). Confronting patriarchal attitudes in the fight for professional
recognition. Journal of Advanced Nursing, 19, 367-372. doi:10.1111/j.13652648.1994.tb01094.x
Cassidy, F., Ahearn, E. P., & Carroll, B. J. (2002). Thyroid function in mixed and pure
manic episodes. Bipolar Disorder, 4, 393–397. doi:10.1034/j.13995618.2002.01214.x
Cegala, D. J., Bahnson, R., Clinton, S. K., David, P., Gong, M. P., Monk, J. P., Nag, S.,
& Pohar, K. S. (2008). Information seeking and satisfaction with physicianpatient communication among prostate cancer survivors. Health Communication,
23, 62–69. doi: 10.1080/10410230701806982
Celik, H., Lagro-Janssen, T., Klinge, I., van der Weijden, T., & Widdershoven, G.
(2009). Maintaining gender sensitivity in the family practice: Facilitators and
barriers. Journal of Evaluation in Clinical Practice, 15, 1220–1225.
doi:10.1111/j.1365-2753.2009.01128.x

256
Chang, A. M., Mumma, B., Sease, K. L., Robey, J. L., Shofer, F. S., & Hollander, J. E.
(2007). Gender bias in cardiovascular testing persists after adjustment for
presenting characteristics and cardiac risk. Academic Emergency Medicine, 14,
599–605. doi:10.1197/j.aem.2007.03.1355
Cheney, G., & Ashcraft, K. L. (2007). Considering ‘‘the professional’’ in communication
studies: Implications for theory and research within and beyond the boundaries of
organizational communication. Communication Theory, 17(2), 146–175.
doi:10.1111/j.1468-2885.2007.00290.x
Chin, J. J. (2002). Doctor-patient relationship: From medical paternalism to enhanced
autonomy. Singapore Medical Journal, 43(3), 152-155. Retrieved from
http://www.psy.med.br/textos/medico_paciente/modelo-relacao1.pdf
Chrisler, J. C. (2001). How can feminist therapists support women with autoimmune
disorders? Women & Therapy, 23(1), 7-22. doi:10.1300/J015v23n01_02
Chrisler, J. C., & Parrett, K. L. (1995). Women and autoimmune disorders. In A. L.
Stanton & S. J. Gallant (Eds.), The psychology of women's health: Progress and
challenges in research and application (pp. 171-195). Washington, DC: APA
Books.
Cleland, J., Foster, K., & Moffat, M. (2005). Undergraduate students’ attitudes to
communication skills learning differ depending on year of study and gender.
Medical Teacher, 27, 246–251. doi:10.1080/01421590400029541

257
Clucas, C. (2011). Relationship between communication skills training and doctors’
perceptions of patient similarity. International Journal of Medical Education, 2,
30-35. doi:10.5116/ijme.4d8e.2715
Collis, E., & Sleeman, K. E. (2013). Do patients need to know they are terminally ill?
Yes. British Medical Journal, 346(f2589), 1-2. doi:10.1136/bmj.f2589
Comber, A. J., Brunsdon, C., & Radburn, R. (2011). A spatial analysis of variations in
health access: Linking geography, socio-economic status and access perceptions.
International Journal of Health Geographics, 10(44), 1-11. Retrieved from
http://www.biomedcentral.com/content/pdf/1476-072X-10-44.pdf
Committee on Women's Health Research. (2010). Research on conditions with particular
relevance to women. In Women's health research: Progress, pitfalls, and promise
(pp. 95-171). Retrieved from
https://download.nap.edu/catalog.php?record_id=12908
Connolly, M. (2001). Female embodiment and clinical practice. In S. K. Toombs (Ed.),
Handbook of phenomenology and medicine (pp.177-196). Dordrecht,
Netherlands: Kluwer Academic Publishers.
Constant, E. L., Adam, S., Seron, X., Bruyer, R., Seghers, A., & Daumerie, C. (2006).
Hypothyroidism and major depression: A common executive dysfunction?
Journal of Clinical and Experimental Neuropsychology, 28, 790–807.
doi:10.1080/13803390591000990

258
Copeland, V. C., Hudson Scholle, S., & Binko, J. (2003). Patient satisfaction: African
American women’s views of the patient-doctor relationship. Journal of Health &
Social Policy, 17(2), 35-48. doi:10.1300/J045v17n02_02
Cosgrove, L. (2003). Feminism, postmodernism, and psychological research. Hypatia,
18(3), 85-112. doi:10.1353/hyp.2003.0056
Cotten, S. R., & Gupta, S. S. (2004). Characteristics of online and offline health
information seekers and factors that discriminate between them. Social Science
and Medicine, 59, 1795–1806. doi:10.1016/j.socscimed.2004.02.020
Creswell, J. W. (2007). Qualitative inquiry and research design: Choosing among five
approaches (2nd ed.). Thousand Oaks, CA: Sage.
Creswell, J. W. (2008). Research design: Qualitative, quantitative, and mixed-method
approaches (3rd ed.). Thousand Oaks, CA: Sage.
Croker, J. E., Swancutt, D. R., Roberts, M. J., Abel, G. A., Roland, M., & Campbell, J. L.
(2013). Factors affecting patients’ trust and confidence in GPs: Evidence from the
English national GP patient survey. BMJ Open, 3(e002762), 1-8. doi:10.1136/
bmjopen-2013-002762
Crompvoets, S. (2010). Using online qualitative research methods in medical education.
International Journal of Multiple Research Approaches, 4, 206–213.
doi:10.5172/mra.2010.4.3.206

259
Crooks, V. A., Neville, L., Snyder, J., Dharamsi, S., Benjaminy, S., Jacob, K. J., & Illes,
J. (2015). “You don’t want to lose that trust that you’ve built with this patient…”:
(Dis)trust, medical tourism, and the Canadian family physician-patient
relationship. BMC Family Practice, 16(25), 1-7. Retrieved from
http://www.biomedcentral.com/1471-2296/16/25
Darer, J. D., Hwang, W., Pham, H. H., Bass, E. B., & Anderson, G. (2004). More training
needed in chronic care: A survey of U.S. physicians. Academic Medicine, 79(6),
541-548. doi:10.1097/00001888-200406000-00009
Davis, M., Bolding, G., Hart, G., Sherr, L., & Elford, J. (2004). Reflecting on the
experience of interviewing online: Perspectives from the Internet and HIV study
in London. AIDS CARE, 16(8), 944-952. doi:10.1080/09540120412331292499
Dayan, C. M. (2001). Interpretation of thyroid function tests. Lancet, 357, 619-624.
doi:10.1016/S0140-6736(00)04060-5
Dean, M., & Street, R. L. (2014). A 3-stage model of patient-centered communication for
addressing cancer patients’ emotional distress. Patient Education and Counseling
94(2), 143–148. doi:http://dx.doi.org/10.1016/j.pec.2013.09.025
Deber, R. B., Kraetschmer, N., Urowitz, S., & Sharpe, N. (2007). Do people want to be
autonomous patients? Preferred roles in treatment decision making in several
patient populations. Health Expectations, 10(3), 248–258. doi:10.1111/j.13697625.2007.00441.x

260
Delgado, A., Lopez-Fernandez, L., de Dios Luna, J., Saletti-Cuesta, L., Gil, N., &
Jimenez, M. (2011). The role of expectations in preferences of patients for a
female or male general practitioner. Patient Education and Counseling, 82(1),
49–57. doi:10.1016/j.pec.2010.02.028
den Ouden, H., Vos, R. C., Reidsma, C., & Rutten, G. (2015). Shared decision making in
type 2 diabetes with a support decision tool that takes into account clinical factors,
the intensity of treatment and patient preferences: Design of a cluster randomised
(OPTIMAL) trial. BMC Family Practice, 16(27), 1-8. Retrieved from
http://www.biomedcentral.com/1471-2296/16/27
Denzin, N. K. (1970). The research act in sociology. Chicago, IL: Aldine.
Di Caccavo, A., & Reid, F. (1998). The influence of attitudes toward male and female
patients on treatment decisions in general practice. Sex Roles, 38(7/8), 613-629.
doi:10.1023/A:1018711410463
Dijkstra, A. F., Verdonk, P., & Lagro-Janssen, A. (2008). Gender bias in medical
textbooks: Examples from coronary heart disease, depression, alcohol abuse and
pharmacology. Medical Education, 42(10), 1021–1028. doi:10.1111/j.13652923.2008.03150.x
Docherty, D., & McColl, M. A. (2003). Illness stories: Themes emerging through
narrative. Social Work in Health Care, 37(1), 19-39. doi:10.1300/J010v37n01_02

261
Dommisse, J. (2009). Best kept secret: A successful approach to underactive thyroid
hormone function. Wise Traditions. Retrieved from
http://hypothyroidismoptimaltreatment.com/uploads/3/1/3/7/3137106/hypothyroid
ism-bestkeptsecretapproachpublished-dommisse-09626.pdf
Dugdale, L. S., Seigler, M., & Rubin, D. T. (2008). Medical professionalism and the
doctor-patient relationship. Perspectives in Biology & Medicine, 52(4), 547-553.
Retrieved from
http://muse.jhu.edu/login?uri=/journals/perspectives_in_biology_and_medicine/v
051/51.4.dugdale.pdf
Dunn, N. (2003). Practical issues around putting the patient at the centre of care. Journal
of the Royal Society of Medicine, 96(7), 325–327. Retrieved from
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC539534/
Dutton, G. R., Perri, M. G., Stine, C., Goble, M., & Van Vessem, N. (2010). Comparison
of physician weight loss goals for obese male and female patients. Preventive
Medicine, 50(4), 186-188. doi:10.1016/j.ypmed.2010.01.014.
Dyche, L. (2007). Interpersonal skill in medicine: The essential partner of verbal
communication. Journal of General Internal Medicine, 22, 1035-1039.
doi:10.1007/s11606-007-0153-0
Dysvik, E., Natvig, G. K., & Furnes, B. (2013). A narrative approach to explore grief
experiences and treatment adherence in people with chronic pain after
participation in a pain-management program: A 6-year follow-up study. Patient
Preference and Adherence, 7, 751–759. doi:10.2147/PPA.S46272

262
Ehrenreich, B., & English, D. (2005). For her own good: Two centuries of the experts’
advice to women. New York, NY: Anchor Books.
Eide, H., Frankel, R., Haaversen, A. C., Vaupel, K. A., Graugaard, P. K, & Finset, A.
(2004). Listening for feelings: Identifying and coding empathic and potential
empathic opportunities in medical dialogues. Patient Education and Counselling,
54(3), 291-297. doi:10.1016/j.pec.2003.09.006
Eisner, E. W. (1991). The enlightened eye: Qualitative inquiry and the enhancement of
educational practice. New York, NY: Macmillan.
Elasy, T. (2006). Caring for the patient: Necessary, but not sufficient. Clinical Diabetes,
24(4), 147. doi:10.2337/diaclin.24.4.147
Elderkin-Thompson, V., & Waitzkin, H. (1999). Differences in clinical communication
by gender. Journal of General Internal Medicine, 14, 112-121.
doi:10.1046/j.1525-1497.1999.00296.x
Elwyn, G., Frosch, D., Thomson, R., Joseph-Williams, N., Lloyd, A., Kinnersley, P.,
Cording, E., Tomson, D., Dodd, C., Rollnick, S., Edwards, A., & Barry, M.
(2012). Shared decision making: A model for clinical practice. Journal of General
Internal Medicine, 27(10), 1361-1370. doi:10.1007/s11606-012-2077-6
Ely, M., Vince, R., Downing, M., & Anzul, M. (1997). On writing qualitative research:
Living by words. Bristol, PA: Falmer.
Engum, A., Bjøro, T., Mykletun, A., & Dahl, A. A. (2002). An association between
depression, anxiety and thyroid function: A clinical fact or an artefact? Acta
Psychiatrica Scandinavica, 106, 27–34. doi:10.1034/j.1600-0447.2002.01250.x

263
Epstein, R. M., Hadee, T., Carroll, J., Meldrum, S. C., Lardner, J., & Shields, C. G.
(2007a). “Could this be something serious?” Reassurance, uncertainty, and
empathy in response to patients’ expressions of worry. Journal of General
Internal Medicine, 22, 1731–1739. doi:10.1007/s11606-007-0416-9
Epstein, R. M., Shields, C. G., Franks, P. F., Meldrum, S. C., Feldman, M., & Kravitz, R.
L. (2007b). Exploring and validating patient concerns: Relation to prescribing for
depression. Annals of Family Medicine, 5(1), 21-28. doi:10.1370/afm.621
Epstein, R. M., & Street, R. L. (2011). The values and value of patient-centered care.
Annals of Family Medicine, 9, 100-103. doi:10.1370/afm.1239
Erdal, M., Sahin, M., Hasimi, Uckaya, G., Kutlu, M., & Saglam, K. (2008). Trace
element levels in Hashimoto thyroiditis patients with subclinical hypothyroidism.
Biol Trace Elem Res, 123, 1-7. doi:10.1007/s12011-008-8117-8
Everett, J. P., Walters, C. A., Stottlemyer, D. L., Knight, C. A., Oppenberg, A., & Orr, R.
D. (2011). To lie or not to lie: Resident physician attitudes about the use of
deception in clinical practice. Journal of Medical Ethics, 37, 333-338.
doi:10.1136/jme.2010.040683
Fainzang, S. (2005). Lying and illness: Power and performance. Amsterdam,
Netherlands: Hel Spinuis. Retrieved from
http://classiques.uqac.ca/contemporains/Fainzang_sylvie/when_doctors_patiens_li
e/when_doctors_patiens_lie.pdf

264
Fainzang, S. (2013). The other side of medicalization: Self-medicalization and selfmedication. Culture, Medicine, and Psychiatry, 37, 488-504. doi:10.1007/s11013013-9330-2
Fainzang, S. (2015). An anthropology of lying: Information in the doctor-patient
relationship. Burlington, VT: Ashgate Publishing.
Fang, M., McCarthy, E., & Singer, D. (2004). Are patients more likely to see physicians
of the same sex? Recent national trends in primary care medicine. American
Journal of Medicine, 117(8), 575–581. doi:10.1016/j.amjmed.2004.03.043
Fassier, T., Guffon, N., Acquaviva, C., D'Amato, T., Durand, D., & Domenech, P.
(2011). Misdiagnosed postpartum psychosis revealing a late-onset urea cycle
disorder. American Journal of Psychiatry, 168, 576-580. Retrieved from
http://ajp.psychiatryonline.org/article.aspx?articleid=115946
Fernandes, P., Papaikonomou, M., & Nieuwoudt, J. M. (2006). Women suffering through
their bodies. South African Journal of Psychology, 36(4), 851–879. Retrieved
from http://www.journals.co.za/ej/ejour_sapsyc.html
Field, A. E., Sonneville, K. R., Crosby, Swanson, S. A., Eddy, K. T., Camargo, C. A.,
Horton, N. J., & Micali, N. (2014). Prospective associations of concerns about
physique and the development of obesity, binge drinking, and drug use among
adolescent boys and young adult men. JAMA Pediatrics, 168(1), 34-39.
doi:10.1001/jamapediatrics.2013.2915

265
Findlay, D. (1993). The good, the normal and the healthy: The social construction of
medical knowledge about women. Canadian Journal of Sociology, 18(2), 115135. doi:10.2307/3341254
Finset, A. (2012). “I am worried, Doctor!” Emotions in the doctor–patient relationship.
Patient Education and Counseling, 88(3), 359-363.
doi:10.1016/j.pec.2012.06.022
Firth-Cozens, J. (2008a). Doctors with difficulties: Why so few women? Postgraduate
Medical Journal, 84, 318-320. doi:10.1136/pgmj.2008.068478
Firth-Cozens, J. (2008b). Effects of gender on performance in medicine: Men may have
higher output than women, but this is possibly offset by litigation and disciplinary
action. BMJ, 336, 731-732. doi:10.1136/bmj.39526.359630.BE
Florian, M., & Al-Roubaie, A. (2008). Interruptions, status and gender in medical
interviews: The harder you brake, the longer it takes. Discourse & Society, 19(5),
645–666. doi:10.1177/0957926508092247
Flynn, K. E., Smith, M. A., & Vanness, D. (2006). A typology of preferences for
participation in healthcare decision making. Social Science & Medicine, 63(5),
1158–1169. doi:10.1016/j.socscimed.2006.03.030
Food and Drug Administration. (1993). Guideline for the study and evaluation of sex
differences in clinical evaluation of drugs. Fed Register, 58, 39406. Retrieved
from http://www.fda.gov/RegulatoryInformation/Guidances/ucm126552.htm

266
Fogarty, L. A., Curbow, B. A., Wingard, J. R., McDonnell, K., & Somerfield, M. R.
(1999). Can 40 seconds of compassion reduce patient anxiety? Journal of Clinical
Oncology, 17(1), 371-379. Retrieved from
http://www.unf.edu/uploadedFiles/aa/brooks/global_health/40%20seconds%20of
%20compassion.pdf
Fox, S. (2007). E-patients with a disability or chronic disease. Pew Internet & American
Life Project. Retrieved from http://www.pewinternet.org/Reports/2007/EpatientsWith-a-Disability-or-Chronic-Disease.aspx
Fox, S. (2011). Peer-to-peer healthcare. Pew Internet and American Life Project.
Retrieved from http://www.pewinternet.org/files/oldmedia//Files/Reports/2011/Pew_P2PHealthcare_2011.pdf
Fox, S., & Chesla, C. (2008). Living with chronic illness: A phenomenological study of
the health effects of the patient–provider relationship. Journal of the American
Academy of Nurse Practitioners, 20(3), 109-117. doi:10.1111/j.17457599.2007.00295.x
Fox, S., & Jones, S. (2009). The social life of health information. Pew Internet &
American Life Project. Retrieved from
http://www.pewinternet.org/Reports/2009/8-The-Social-Life-of-HealthInformation.aspx

267
Frantsve, L. M. E., & Kerns, R. D. (2007). Patient-provider interactions in the
management of chronic pain: Current findings within the context of shared
medical decision making. Pain Medicine, 8(1), 25–35. doi:10.1111/j.15264637.2007.00250.x
Frosch, D. L., May, S. G., Rendle, K.A.S., Tietbohl, C., & Elwyn, G. (2012).
Authoritarian physicians and patients’ fear of being labeled ‘difficult’ among key
obstacles to shared decision making. Health Affairs, 31(5), 1030-1038.
doi:10.1377/hlthaff.2011.0576
Fukaya, M. (2000). Why do patients with atopic dermatitis refuse to apply topical
corticosteroids? Dermatology, 201(3), 242-245. doi:10.1159/000018495
Fuertes, J. N., Anand, P., Haggerty, G., Kestenbaum, M., & Rosenblum, G. C. (2015).
The physician–patient working alliance and patient psychological attachment,
adherence, outcome expectations, and satisfaction in a sample of rheumatology
patients. Behavioral Medicine, 41(2), 60-68. doi:10.1080/08964289.2013.875885
Gaby, A. R. (2004). “Sub-laboratory” hypothyroidism and the empirical use of Armour®
Thyroid. Alternative Medicine Review, 9(2), 157-179. Retrieved from
http://www.altmedrev.com/publications/9/2/157.pdf
Gaiser, T. J., & Schreiner, A. E. (2009). A guide to conducting online research. Thousand
Oaks, CA: Sage. doi:10.4135/9780857029003
Gaitonde, D. Y., Rowley, K. D., & Sweeney, L. B. (2012). Hypothyroidism: An update.
American Family Physician, 86(3), 244-251. Retrieved from
http://www.safpj.co.za/index.php/safpj/article/download/3668/4339

268
Garcia, J. A., Paterniti, D. A., Romano, P. S., & Kravitz, R. L. (2003). Patient preferences
for physician characteristics in university-based primary care clinics. Ethnicity
and Disease, 13, 259-267. Retrieved from
https://www.researchgate.net/publication/10727422_Patient_preferences_for_phy
sician_characteristics_in_university-based_primary_care_clinics
Garden, R. (2008). Expanding clinical empathy: An activist perspective. Journal of
General Internal Medicine, 24(1), 122-125. Retrieved from
http://www.springer.com/medicine/internal/journal/11606
Gelhaus, P. (2012a). The desired moral attitude of the physician: (I) Empathy. Medicine,
Healthcare and Philosophy, 15, 103-113. doi:10.1007/s11019-011-9366-4
Gelhaus, P. (2012b). The desired moral attitude of the physician: (II) Compassion.
Medicine, Healthcare and Philosophy, 15, 397-410. doi: 10.1007/s11019-0119368-2
Gensichen, J., Guethlin, C., Sarmand, N., Sivakumaran, D., Jager, C., Mergenthal, K.,
Gerlach, F. M., & Petersen, J. J. (2012). Patients’ perspectives on depression case
management in general practice – A qualitative study. Patient Education and
Counseling, 86, 114–119. doi:10.1016/j.pec.2011.02.020
Ginsberg, J. (2003). Diagnosis and management of Graves’ disease. Canadian Medical
Association Journal, 168(5), 575-585. Retrieved from
http://www.cmaj.ca/content/168/5/575.full

269
Godager, G. (2012). Birds of a feather flock together: A study of doctor–patient
matching. Journal of Health Economics, 31, 296–305.
doi:10.1016/j.jhealeco.2011.11.003
Godfrey, J. R. (2007). Toward optimal health: Robert J. McConnell, M.D., discusses the
clinical opportunities for improved thyroid disease management in women.
Journal of Women’s Health, 16(4), 458-462. doi:10.1089/jwh.2007.C074
Goff, S. L., Mazor, K. M., Meterko, V., Dodd, K., & Sabin, J. (2007). Patients’ beliefs
and preferences regarding doctors’ medication recommendations. Journal of
General Internal Medicine, 23(3), 236–241. doi:10.1007/s11606-007-0470-3
Goolsby, M. J., & Blackwell, J. (2004). Evaluation and treatment of hyperthyroidism and
hypothyroidism. Clinical Practice Guidelines, 16(10), 422-425.
doi:10.1111/j.1745-7599.2004.tb00418.x
Greenfield, G., Ignatowicz, A. M., Belsi, A., Pappas, Y., Car, J., Majeed, A., & Harris,
M. (2014). Wake up, wake up! It’s me! It’s my life! Patient narratives on personcenteredness in the integrated care context: a qualitative study. BMC Health
Services Research, 14, 619-630. doi:10.1186/s12913-014-0619-9
Gude, T., Vaglum, P., Tyssen, R., Ekeberg, O., Hem, E., Rovik, J. O., Finset, K., &
Gronvold, N. T. (2005). Identification with the role of doctor at the end of
medical school: A nationwide longitudinal study. Medical Education, 39, 66–74.
doi:10.1111/j.1365-2929.2004.02034.x

270
Haidet, P., Dains, J. E., Paterniti, D. A., Hechtel, L., Chang, T., Tseng, E., & Rogers, J.
C. (2002). Medical student attitudes toward the doctor–patient relationship.
Medical Education, 36, 568–574. doi:10.1046/j.1365-2923.2002.01233.x
Hak, A. E., Pols, H. A. P., Visser, T. J., Drexhage, H. A., Hofman, A., & Witteman, J. C.
M. (2000). Subclinical hypothyroidism is an independent risk factor for
atherosclerosis and myocardial infarction in elderly women: The Rotterdam study.
Annals of Internal Medicine, 132, 42-83. Retrieved from
http://repub.eur.nl/res/pub/9259/10681281.pdf
Hakanson, C., Sahlberg-Blom, E., & Ternestedt, B. M. (2010). Being in the patient
position: Experiences of health care among people with irritable bowel syndrome.
Qualitative Health Research, 20(8), 1116-1127. doi:10.1177/1049732310369914
Hall, S. (2010). Prescribing in thyroid disease. Nurse Prescribing, 8(8), 382-387.
Retrieved from http://www.internurse.com/cgibin/go.pl/library/contents.html?uid=3724;journal_uid=15
Hall, J. A., & Roter, D. L. (2002). Do patients talk differently to male and female
physicians? A meta-analytic review. Patient Education and Counseling, 48, 217224. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12477606
Hall, J. A., & Roter, D. L., Blanch, D. C., & Frankel, R. M. (2009). Nonverbal sensitivity
in medical students: Implications for clinical interactions. Journal of General
Internal Medicine, 24(11), 1217–1222. doi:10.1007/s11606-009-1107-5

271
Hall, J. A., Roter, D. L., Blanch-Hartigan, D., Schmid Mast, M., & Pitegoff, C. A.
(2015). How patient-centered do female physicians need to be? Analogue
patients’ satisfaction with male and female physicians’ identical behaviors. Health
Communication, 30(9), 894-900. doi:10.1080/10410236.2014.900892
Halpern, J. (2007). Empathy and patient-physician conflicts. Journal of General Internal
Medicine, 22, 696-700. doi:10.1007/s11606-006-0102-3
Hamberg, K. (2008). Gender bias in medicine. Women's Health, 4(3), 237–243.
doi:10.2217/17455057.4.3.237
Hamberg, K., Risberg, G., & Johansson, E. E. (2004). Male and female physicians show
different patterns of gender bias: A paper-case study of management of irritable
bowel syndrome. Scandinavian Journal of Public Health, 32, 144–152.
doi:10.1080/14034940310015401
Hamberg, K., & Larsson, M. L. (2009). Still far to go – An investigation of gender
perspective in written cases used at a Swedish medical school. Medical Teacher,
31(4), e131-e138. doi:10.1080/01421590802516806
Harris, K. M. (2003). How do patients choose physicians? Evidence from a national
survey of enrollees in employment-related health plans. Health Services
Research, 38(2), 711-732. doi: 10.1111/1475-6773.00141
Hartman, T. C., Borghuis, M. S., Lucassen, P. L., Laar, F. A., & Speckens, A. E. (2009).
Medically unexplained symptoms, somatisation disorder and hypochondriasis:
Course and prognosis. A systematic review. Journal of Psychosomatic Research,
66, 363–377. doi:10.1016/j.jpsychores.2008.09.018

272
Hassling, L., Babic, A., Lonn, U., & Casimir-Ahn, H. (2003). A web-based patient
information system—Identification of patients’ information needs. Journal of
Medical Systems, 27(3), 247-257. doi:10.1023/A:1022523427947
Hearn, G. (2009). No Clue – What shall we do? Physicians and functional syndromes.
International Review of Modern Sociology, 35, 95-113. Retrieved from
http://www.jstor.org/stable/41421340
Hedberg, C., & Lynoe, N. (2013). What is meant by patient-centredness being valuebased? Scandinavian Journal of Primary Health Care, 31, 188–189.
doi:10.3109/02813432.2013.848543
Heinrich, C., & Karner, K. (2010). Ways to optimize understanding health related
information: The patients’ perspective. Geriatric Nursing, 32(1), 29-38. Retrieved
from http://www.gnjournal.com/article/S0197-4572%2810%2900436-2/pdf
Heinrich, T. W., & Grahm, G. (2003). Hypothyroidism presenting as psychosis:
Myxedema madness revisited. The Primary Care Companion to the Journal of
Clinical Psychiatry, 5(6), 260-266. Retrieved from
http://www.psychiatrist.com/pcc/pccpdf/v05n06/v05n0603.pdf
Helfand, M. (2004). Screening for subclinical thyroid dysfunction in nonpregnant adults:
A summary of the evidence for the U.S. Preventive Services Task Force. Annals
of Internal Medicine, 140, 128. Retrieved from
http://www.uspreventiveservicestaskforce.org/3rduspstf/thyroid/thyrsum.pdf

273
Hinchcliffe, V., & Gavin, H. (2009). Social and virtual networks: Evaluating
synchronous online interviewing using instant messenger. The Qualitative Report,
14 (2), 318-340. Retrieved from http://www.nova.edu/ssss/QR/QR142/hinchcliffe.pdf
Hochleitnera, M., Nachtschattb, U., & Sillervan, H. (2013). How do we get gender
medicine into medical education? Health Care for Women International, 34(1), 313. doi:10.1080/07399332.2012.721419
Hodkinson, K. (2013). The need to know—Therapeutic privilege: A way forward. Health
Care Analysis, 21(2), 105-129. doi:10.1007/s10728-012-0204-5
Hoffmann, D. E., & Tarzian, A. J. (2001). The girl who cried pain: A bias against women
in the treatment of pain. Journal of Law, Medicine & Ethics, 29, 13-27.
doi:10.1111/j.1748-720X.2001.tb00037.x
Holtgräfe, C., & Zentes, J. (2012). Multifaceted determinants of online non-prescription
drug information seeking and the impact on consumers’ use of purchase channels.
Health Informatics Journal, 18(2), 95–110. doi:10.1177/1460458212439487
Houle, C., Harwood, E., Watkins, A., & Baum, K. D. (2007). What women want from
their physicians: A qualitative analysis. Journal of Women’s Health, 16(4), 543550. doi:10.1089/jwh.2006.M079
Husserl, E. (1931). Ideas: General introduction to pure phenomenology (D. Carr, Trans.).
Evanston, IL: Northwestern University Press.
Ivy, D. K., & Backlund, P. (2008). Gender speak: Personal effectiveness in gender
communication (4th ed.). New York, NY: Allyn and Bacon.

274
Jagosh, J., Boudreau, J. D., Steinert, Y., MacDonald, M. E., & Ingram, L. (2011). The
importance of physician listening from the patients’ perspective: Enhancing
diagnosis, healing, and the doctor–patient relationship. Patient Education and
Counseling, 85(3), 369-374. doi:10.1016/j.pec.2011.01.028
Joffe, R. T. (2006). Is the thyroid still important in major depression? Journal of
Psychiatry & Neuroscience, 31(6), 367-368. Retrieved from
http://www.cma.ca/multimedia/staticContent/HTML/N0/l2/jpn/vol-31/issue6/pdf/pg367.pdf
Johansson, E., Hamberg, K., Lindgren, G., & Westman, G. (1996). “I've been crying my
way”—Qualitative analysis of a group of female patients' consultation
experiences. Family Practice, 13(6), 498-503. doi:10.1093/fampra/13.6.498
Johnson, H. (1996). Osler’s web: Inside the labyrinth of the chronic fatigue syndrome
epidemic. New York, NY: Crown.
Kaiser, R. (2002). Fixing identity by denying uniqueness: An analysis of professional
identity in medicine. Journal of Medical Humanities, 23(2), 95-105.
doi:10.1023/A:1014821614175
Kanaan, R. (2009). When doctors deceive. American Journal of Bioethics, 9(12), 29-30.
doi:10.1080/15265160903234102
Kaplan, K. J., Schneiderhan, M., Harrown, M., & Omens, R. (2002). Autonomy, gender,
and preference for paternalistic or informative physicians: A study of the doctorpatient relation. Ethics & Medicine, 18(1), 49-60. Retrieved from
http://www.ncbi.nlm.nih.gov/pubmed/14700020

275
Keck, P. E., Kessler, R. C., & Ross, R. (2008). Clinical and economic effects of
unrecognized or inadequately treated bipolar disorder. Journal of Psychiatric
Practice, 14(6), 31-38. doi:10.1097/01.pra.0000320124.91799.2a
Keller, H. E., & Lee, S. (2003). Ethical issues surrounding human participants research
using the internet. Ethics & Behavior, 13(3), 211–219.
doi:10.1207/S15327019EB1303_01
Kempner, J. (2003, August). Is migraine a woman’s disease?: Reflections on a gendered
illness. Paper presented at the annual meeting of the American Sociological
Association, San Francisco, CA. Retrieved from
http://convention2.allacademic.com/one/asa/asa/index.php?cmd=Download+Doc
ument&key=unpublished_manuscript&file_index=4&pop_up=true&no_click_ke
y=true&attachment_style=attachment&PHPSESSID=u2apt7fdos985accrfcrkhvdc
4
Kennifer, S.L., Alexander, S. C., Pollak, K. I., Jefreys, A. S., Olsen, M. K., & Rodriguez,
K. L. (2009). Negative emotions in cancer care: Do oncologists’ responses depend
on severity and type of emotion? Patient Education and Counseling, 76, 51–56.
doi:10.1016/j.pec.2008.10.003
Kennelly, C., & Bowling, A. (2001). Suffering in deference: A focus group study of older
cardiac patients’ preferences for treatment and perceptions of risk. Quality in
Healthcare, 10, i23-i28. Retrieved from
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1765735/pdf/v010p00i23.pdf

276
Kerr, E. A., & Hayward, R. A. (2013). Patient-centered performance management
enhancing value for patients and health care systems. Journal of the American
Medical Association, 310(2), 137-138. doi:10.1001/jama.2013.6828
Kessler, D.P., & Mylod, D. (2011). Does patient satisfaction affect patient loyalty?
International Journal of Health Care Quality Assurance, 24(4), 266-273.
doi:10.1108/09526861111125570
Kilminster, S., Downes, J., Gough, B., Murdoch-Eaton, D., & Roberts, T. (2007).
Women in medicine − is there a problem? A literature review of the changing
gender composition, structures and occupational cultures in medicine. Medical
Education, 41(1), 39–49. doi:10.1111/j.1365-2929.2006.02645.x
King, P., Cederbaum, J. A., Kurzban, S., Norton, T., Palmer, S. C., & Coyne, J. C.
(2015). Role of patient treatment beliefs and provider characteristics in
establishing patient–provider relationships. Family Practice, 32(2), 224-231.
doi:10.1093/fampra/cmu085
Kittay, E. F. (2007). Beyond autonomy and paternalism: The caring transparent self (pp.
23-70). In Y. Denier, T. Nys, & T. Vandevelde (Eds.) Autonomy and paternalism:
Reflections on the theory and practice of health care (pp. 23-70). Leuven,
Belgium: Peeters Publishers.
Kraetschmer, N., Sharpe, N., Urowitz, S., & Deber, R. B. (2004). How does trust affect
patient preferences for participation in decision making? Health Expectations, 7,
317-326. doi:10.1111/j.1369-7625.2004.00296.x

277
Kralik, D., Koch, T., Price, K., & Howard, N. (2004). Chronic illness self-management:
Taking action to create order. Journal of Clinical Nursing, 13, 259–267.
doi:10.1046/j.1365-2702.2003.00826.x
Kralik, D., Telford, K., Price, K., & Koch, T. (2005). Women’s experiences of fatigue in
chronic illness. Journal of Advanced Nursing, 52(4), 372–380.
doi:10.1111/j.1365-2648.2005.03602.x
Kraut , R., Olson, J., Banaji, M., Bruckman, A., & Couper, M. (2004). Psychological
research online: Report of Board of Scientific Affairs’ Advisory Group on the
conduct of research on the internet. American Psychologist, 59(2), 105–117.
doi:10.1037/0003-066X.59.2.105
Krupat, E. (1999). The practice orientations of doctors and patients: The effect of doctor–
patient congruence on satisfaction. Patient Education and Counselling, 39, 49-59.
Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11013547
Krupat, E., Yeager, C. M., & Putnam, S. (2000). Patient role orientations, doctor-patient
fit, and visit satisfaction. Psychology & Health, 15(5), 707-719.
doi:10.1080/08870440008405481
Kua, C., Ng, S., Lhode, R., Kowalski, S., & Gwee, K. (2012). Irritable bowel syndrome
and other gastrointestinal disorders: Evaluating self-medication in an Asian
community setting. International Journal of Clinical Pharmacology, 34, 561–568.
doi:10.1007/s11096-012-9644-0

278
Laidlaw, T. S., Kaufman, D. M., MacLeod, H., van Zanten, S., Simpson, D., & Wrixon,
W. (2006). Relationship of resident characteristics, attitudes, prior training and
clinical knowledge to communication skills performance. Medical Education, 40,
18–25. doi:10.1111/j.1365-2929.2005.02345.x
Lang, F., Floyd, M. R., & Beine, K.L. (2000). Clues to patients’ explanations and
concerns about their illnesses: A call for active listening. Archives of Family
Medicine, 9, 222-227. Retrieved from
http://triggered.edina.clockss.org/ServeContent?rft_id=info:doi/10.1001/archfami.
9.3.222
Lakoff, R. (1975). Language and woman’s place. New York, NY: Harper & Row.
Larance, B., Degenhardt, L., Lintzeris, N., Winstock, A., & Mattick, R. (2011).
Definitions related to the use of pharmaceutical opioids: Extramedical use,
diversion, non-adherence and aberrant medication-related behaviours. Drug and
Alcohol Review, 30(3), 236-245. doi:10.1111/j.1465-3362.2010.00283.x
Leach, C. R., & Schoenberg, N. E. (2008). Striving for control: Cognitive, self-care, and
faith strategies employed by vulnerable black and white older adults with multiple
chronic conditions. Journal of Cross-Cultural Gerontology, 23, 377-399.
doi:10.1007/s10823-008-9086-2
Lee, Y. Y., & Lin, J. L. (2010). How much does trust really matter? A study of the
longitudinal effects of trust and decision making preferences on diabetic patient
outcomes. Patient Education and Counseling, 85, 406-412.
doi:10.1016/j.pec.2010.12.005

279
Leifer, B. P. (2003). Early diagnosis of Alzheimer's disease: Clinical and economic
benefits. Journal of the American Geriatrics Society, 51(5S2), S281–S288.
doi:10.1046/j.1532-5415.5153.x
Levinson, W. (2011). Patient-centred communication: A sophisticated procedure. British
Medical Journal, 20, 823-825. doi:10.1136/bmjqs-2011-000323
Levinson, W., Gorawara-Bhat, R., & Lamb, J. (2000). A study of patient clues and
physician responses in primary care and surgical settings. Journal of the American
Medical Association, 284(8), 1021-1027. doi:10.1001/jama.284.8.1021
Levinson, W., Lesser, C. S., & Epstein, R. M. (2010). Developing physician
communication skills for patient-centered care. Health Affairs, 29(7), 1310-1318.
doi:10.1377/hlthaff.2009.0450
Lillrank, A. (2003). Back pain and the resolution of diagnostic uncertainty in illness
narratives. Social Science & Medicine, 57(6), 1045–1054. doi:10.1016/S02779536(02)00479-3
Liu, L., Yen, H., Lo, C., & Chen, C. (2014). Risk communication, trust and patient
commitment. Journal of Accounting, Finance & Management Strategy, 9(1), 89114. Retrieved from
http://search.proquest.com.ezp.waldenulibrary.org/docview/1628954987?accounti
d=14872
Lorentzen, J. M. (2008). ‘I know my own body’: Power and resistance in women’s
experiences of medical interactions. Body and Society, 14(3), 49-79.
doi:10.1177/1357034X08093572

280
Lubetkin, E. I., Zabor, E. C., Isaac, K., Brennessel, D., Kemeny, M., & Hay, J. L. (2015).
Health literacy, information seeking, and trust in information in Haitians.
American Journal of Health Behavior, 39(3), 441-450.
doi:http://dx.doi.org/10.5993/AJHB.39.3.16
Lupton, D. (2003). Medicine as culture: Illness, disease and the body in Western
societies. Thousand Oaks, CA: Sage.
Maakaron, J. E., Manchanda, N., Hoang, A., & Steinmetz, C. (2014). Patient fraud: A
tale of two tales. American Journal of Medicine, 127(10), e5–e6. Retrieved from
http://www.amjmed.com/article/S0002-9343%2814%2900572-5/pdf
MacDonald, M. (2003). Seeing the cage: Stigma and its potential to inform the concept of
the difficult patient. Clinical Nurse Specialist, 17(6), 305-310.
doi:10.1097/00002800-200311000-00012
Makam, A., Saroja, C., & Edwards, G. (2010). Do women seeking care from
obstetrician–gynecologists prefer to see a female or a male doctor? Archives of
Gynecology and Obstetrics, 281(3), 443-447. doi:10.1007/s00404-009-1199-5
Malterud, K., & Ulriksen, K. (2010). Obesity in general practice: A focus group study on
patient experiences. Scandinavian Journal of Primary Health Care, 28, 205–210.
doi:10.3109/02813432.2010.526773

281
Manji, N., Carr-Smith, J. D., Boelaert, K., Allahabadia, A., Armitage, M., Chatterjee, V.
K., Lazarus, J. H., Pearce, S. H., Vaidya, B., Gough, S. C., & Franklyn, J. A.
(2006). Influences of age, gender, smoking, and family history on autoimmune
thyroid disease phenotype. Journal of Clinical Endocrinology and Metabolism,
91(12), 4873-4880. doi:10.1210/jc.2006-1402
Marshall, C., & Rossman, G. (2006). Designing qualitative research. Newbury Park, CA:
Sage.
Martin, C. M., & Peterson, C. (2009). The social construction of chronicity – a key to
understanding chronic care transformations. Journal of Evaluation in Clinical
Practice, 15, 578–585. doi:10.1111/j.1365-2753.2008.01025.x
Mastroianni, A. C., Faden, R., & Federman, D. (Eds.). (1999). Women and Health
Research: Ethical and legal issues of including women in clinical studies: Vol. 2.
Workshop and commissioned papers. Retrieved from
http://www.nap.edu/catalog/2343.html
Matthes, J., & Caples, H. (2013). Ethical issues in using deception to facilitate
rehabilitation for a patient with severe traumatic brain injury. Journal of Head
Trauma Rehabilitation, 28(2), 126–130. doi:10.1097/HTR.0b013e31822cc3dd

282
Mavis, B., Vasilenko, P., Schnuth, R., Marshall, J., Jeffs, M. C. (2005). Female patients’
preferences related to interpersonal communications, clinical competence, and
gender when selecting a physician. Academic Medicine, 80(12), 1159-1165.
Retrieved from
http://journals.lww.com/academicmedicine/Fulltext/2005/12000/Female_Patients
__Preferences_Related_to.22.aspx#
McDermott, M. T., & Ridgway, E. C. (2001). Subclinical hypothyroidism is mild thyroid
failure and should be treated. The Journal of Clinical Endocrinology &
Metabolism, 86(10), 4585-4590. Retrieved from
http://jcem.endojournals.org/content/86/10/4585.full
McGowan, L., Escott, D., Luker, K., Creed, F., & Chew-Graham, C. (2010). Is chronic
pelvic pain a comfortable diagnosis for primary care practitioners: A qualitative
study. BMC Family Practice, 11(7), 1-4. Retrieved from
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835666/
McGuire, M. C., McCullough, L. B., Weller, S. C., & Whitney, S. N. (2005). Physicians’
views of patients’ participation in medical decision making. Medical Care, 43(5),
466-470. doi:10.1097/01.mlr.0000160415.08497.11
McKee, A., & Peyerl, F. (2012). TSI assay utilization: Impact on costs of graves'
hyperthyroidism diagnosis. American Journal of Managed Care, 18(1), e1-e14.
Retrieved from http://www.ajmc.com/articles/TSI-Assay-Utilization-Impact-onCosts-of-Gravesu2019-Hyperthyroidism-Diagnosis/

283
McKinstry, B. (2000). Do patients wish to be involved in decision making in the
consultation? A cross sectional survey with video vignettes. British Medical
Journal, 321, 867-871. Retrieved from
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC27496/pdf/867.pdf
McNutt, R. A. (2004). Shared medical decision making: Problems, process, progress.
Journal of the American Medical Association, 292(20), 2516-2518.
doi:10.1001/jama.292.20.2516
Mehuys, E., Paemeleire, K., Van Hees, T., Christiaens, T., Van Bortel, L. M., Van
Tongelen, I., De Bolle1, L., Remon, J. P., & Boussery, K. (2012). Self-medication
of regular headache: A community pharmacy-based survey. European Journal of
Neurology, 19(8), 1093-1099. doi:10.1111/j.1468-1331.2012.03681.x
Mendelson, C. (2006). Managing a medically and socially complex life: Women living
with lupus. Qualitative Health Research, 16(7), 982-997.
doi:10.1177/1049732306290132
Miaskowski, G. (1999). The role of sex and gender in pain perception and responses to
treatment, In R. J. Gatchel & D. G. Turk (Eds.), Psychosocial factors in pain:
Critical perspectives (pp. 401-411). New York, NY: Guildford Press.
Miller, V. M., & Bahn, R. S. (2013). Mentoring interdisciplinary research teams for the
study of sex and gender differences in health and disease. Global Advances in
Health and Medicine, 2(5), 109-112. doi:10.1187/cbe.10-03-0027

284
Mirzaei, M., Aspin, C., Essue, B., Jeon, Y., Dugdale, P., Usherwood, T., & Leeder, S.
(2013). A patient-centred approach to health service delivery: Improving health
outcomes for people with chronic illness. BMC Health Services Research,
13(251), 1-11. Retrieved from http://www.biomedcentral.com/1472-6963/13/251
Moffat, K. J., McConnachie, A., Ross, S., & Morrison, J. M. (2004). First year medical
student stress and coping in a problem-based learning medical curriculum.
Medical Education, 38, 482-491. doi:10.1046/j.1365-2929.2004.01814.x
Moore, P. J., Sickel, A. E., Malat, J., Williams, D., Jackson, J., & Adler, N. E. (2004).
Psychosocial factors in medical and psychological treatment avoidance: The role
of the doctor–patient relationship. Journal of Health Psychology, 9, 421–433.
doi:10.1177/1359105304042351
Morganti, S., Ceda, G. P., Saccani, M., Milli, B., Ugolotti, D., Prampolini, R., Maggio,
M., Valenti, G., & Ceresini, G. (2005). Thyroid disease in the elderly: Sex-related
differences in clinical expression. Journal of Endocrinological Investigation,
28(11), 101-114. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16760635
Mosca, L., Banka, C. L., Benjamin, E. J., Berra, K., Bushnell, C., & Dolor, R. J. (2007).
Evidence-based guidelines for cardiovascular disease prevention in women: 2007
update. Circulation, 115, 1481–1501.
doi:10.1161/CIRCULATIONAHA.107.181546

285
Moustakas, C. (1994). Phenomenological research methods. Thousand Oaks, CA: Sage.
Mullersdorf, M., & Soderback, I. (2000). The actual state of the effects, treatment and
incidence of disabling pain in a gender perspective – A Swedish study. Disability
and Rehabilitation, 22, 840–854. doi:10.1080/09638280050207893
Munch, S. (2004). Gender-biased diagnosing of women's medical complaints:
Contributions of feminist thought, 1970-1995. Women & Health, 10(1), 101-121.
doi:10.1300/J013v40n01_06
Murtagh, A. T. (2006). Evaluation and ethical review of a tool to explore patient
preferences for information and involvement in decision making. Journal of
Medical Ethics, 32, 311–315. doi:10.1136/jme.2005.012484
Napoli, A. M., Choo, E. K., & McGregor, A. (2014). Gender disparities in stress test
utilization in chest pain unit patients based upon the ordering physician's gender.
Critical Pathways in Cardiology, 13, 152–155.
doi:10.1097/HPC.0000000000000026
National Clinical Assessment Service. (2006). Analysis of the first four years’ referral
data. National Patient Safety Service. Retrieved from
http://www.ncas.nhs.uk/EasySiteWeb/GatewayLink.aspx?alId=7776
Neafsey, P. J., M’lan, C. E., Ge, M., Walsh, S. J., Lin, C. A., & Anderson, E. (2011).
Reducing adverse self-medication behaviors in older adults with hypertension:
Results of an e-health clinical efficacy trial. Ageing International, 36(2), 159-191.
Retrieved from http://rd.springer.com/article/10.1007/s12126-010-90859/fulltext.html

286
Nettleton, S. (2006). ‘I just want permission to be ill’: Towards a sociology of medically
unexplained symptoms. Social Science & Medicine, 62, 1167–1178.
doi:10.1016/j.socscimed.2005.07.030
Neumann, M., Bensing, J., Mercer, S., Ernstmann, N., Ommena, O., & Pfaff, H. (2009).
Analyzing the ‘‘nature’’ and ‘‘specific effectiveness’’ of clinical empathy: A
theoretical overview and contribution towards a theory-based research agenda.
Patient Education and Counseling, 74, 339–346. doi:10.1016/j.pec.2008.11.013
Newton, B. J., Southall, J. L., Raphael, J. H., Ashford, R. L., & LeMarchand, K. (2010).
A narrative review of the impact of disbelief in chronic pain. Pain Management
Nursing, 14(3), 161-171. doi:http://dx.doi.org/10.1016/j.pmn.2010.09.001
Nguyen, T. V., Hong, J., & Prose, N. S. (2013). Compassionate care: Enhancing
physician-patient communication and education in dermatology. Part I: Patientcentered communication. Journal of the American Academy of Dermatology,
68(3), 353.e1-353.e8.
Nicoletti, T. A. (2006). Quality of care in evaluating the doctor-patient relationship.
American Journal of Bioethics, 6(1), 44-45. doi:10.1080/15265160500394788
Novak, M., Costantini, L., Schneider, S., & Beanlands, H. (2013). Approaches to selfmanagement in chronic illness. Seminars in Dialysis, 26(2), 188-194.
doi:10.1111/sdi.12080

287
Ogdie, A. R., Reilly, J. B., Pang, W. G., Keddem, S., Barg, F. K., Von Feldt, J. M., &
Myers, J. S. (2012). Seen through their eyes: Residents’ reflections on the
cognitive and contextual components of diagnostic errors in medicine. Academic
Medicine, 87(10), 1361–1367. doi:10.1097/ACM.0b013e31826742c9
Oh, Y. S., & Cho, Y. (2015). Examining the relationships between resources and online
health information seeking among patients with chronic diseases and healthy
people. Social Work in Health Care, 54(2), 83-100.
doi:10.1080/00981389.2014.987940
Onwuegbuzie, A. J., & Johnson, R. B. (2004). Mixed method and mixed model research.
In R. B. Johnson & L. B. Christensen, Educational research: Quantitative,
qualitative, and mixed approaches (pp. 408-431). Needham Heights, MA: Allyn
& Bacon.
Palmieri, J. J., & Stern, T. A. (2009). Lies in the doctor patient relationship. Primary
Care Companion to the Journal of Clinical Psychiatry, 11(4), 163–168.
doi:10.4088/PCC.09r00780
Paterson, E. T. (2000). Æsculapian authority and the doctor-patient relationship. Journal
of Orthomolecular Medicine, 15(1), 82-88. Retrieved from
http://orthomolecular.org/library/jom/2000/pdf/2000-v15n02-p082.pdf
Patton, M. Q. (2002). Qualitative research & evaluation methods (3rd ed.). Thousand
Oaks, CA: Sage.

288
Peabody, F. W. (1927). The care of the patient. (Original address delivered in 1925).
Journal of the American Medical Association, 88, 877-882.
doi:10.1001/jama.1927.02680380001001
Pearce, E. N. (2015). The presence of hypothyroid symptoms is more reliable in
diagnosing hypothyroidism in men than in women. Clinical Thyroidology, 27(6),
152-154. doi:10.1089/ct.2015
Peck, B. M., & Connor, S. (2011). Talking with me or at me? The impact of status
characteristics on doctor-patient interaction. Sociological Perspectives, 54(4),
547–567. doi:10.1525/sop.2011.54.4.547.
Peirce, G. L., Smith, M. J., Abate, M. A., & Halverson, J. (2012). Doctor and pharmacy
shopping for controlled substances. Medical Care, 50(6), 494–500.
doi:10.1097/MLR.0b013e31824ebd81
Peters, S., Rogers, A., Salmon, P., Gask, L., Dowrick, C., Towey, M., Clifford, R., &
Morriss, R. (2008). What do patients choose to tell their doctors? Qualitative
analysis of potential barriers to reattributing medically unexplained symptoms.
Journal of General Internal Medicine, 24(4), 443-449. doi:10.1007/s11606-0080872-x
Piette, J. D., Heisler, M., Krein, S., & Kerr, E. A. (2005). The role of patient-physician
trust in moderating medication nonadherence due to cost pressures. Archives of
Internal Medicine, 165(15), 1749-1755. doi:10.1001/archinte.165.15.1749
Pinn, V. W. (2013). Women’s health research: Current state of the art. Global Advances
in Health Medicine, 2(5), 8-10. doi:10.7453/gahmj.2013.063

289
Piper, C. N. (2010). Disparities in access to care among asthmatic children in relation to
race and socioeconomic status. Journal of Child Healthcare, 14(3), 271-279.
doi:10.1177/1367493510371629
Placidi, G. P., Boldrini, M., Patronelli, A., Fiore, E., Chiovato, L., Perugi, G., &
Marazziti, D. (1998). Prevalence of psychiatric disorders in thyroid diseased
patients. Neuropsychobiology, 38, 222-225. doi:10.1159/000026545
Platanova, E. A., Kennedy, K. N., & Shewchuk, R. M. (2008). Understanding patient
satisfaction, trust, and loyalty to primary care physicians. Medical Care Research
and Review, 65(6), 696-712. doi:10.1177/1077558708322863
Platt, F. W. (2008). What drives doctors crazy? Families, Systems, & Health, 26(1), 6768. doi:10.1037/1091-7527.26.1.67
Polkinghorne, D. E. (1989). Phenomenological research methods. In R. S. Valle & S.
Hailing (Eds.), Existential-phenomenological perspectives in psychology (pp. 4160). New York, NY: Plenum.
Quaschning, K., Korner, M., & Wirtz, M. (2012). Analyzing the effects of shared
decision making, empathy and team interaction on patient satisfaction and
treatment acceptance in medical rehabilitation using a structural equation
modeling approach. Patient Education and Counseling, 91, 167–175.
doi:http://dx.doi.org/10.1016/j.pec.2012.12.007
Rack, S. K., & Makela, E. H. (2000). Hypothyroidism and depression: A therapeutic
challenge. Annals of Pharmacotherapy, 34(10), 1142-1145.
doi:10.1345/aph.10022

290
Rajoria, S., Suriano, R., Shanmugam, A., Wilson, Y. L., Schantz, S. P., Geliebter, J., &
Tiwari, R. K. (2010). Metastatic phenotype is regulated by estrogen in thyroid
cells. Thyroid, 20(1), 33-41. doi:10.1089/thy.2009.0296.
Rakel, D., Barrett, B., Zhang, Z., Hoeft, T., Chewning, B., Marchand, L., & Scheder, J.
(2011). Perception of empathy in the therapeutic encounter: Effects on the
common cold. Patient Education and Counseling, 85, 390-397.
Rakel, D. P., Hoeft, T. J., Barrett, B. P., Chewning, B. A., Craig, B. M., & Niu, M.
(2009). Practitioner empathy and the duration of the common cold. Family
Medicine, 41(7), 494-501. Retrieved from
http://www.stfm.org/fmhub/fm2009/July/David494.pdf
Rashotte, L. S., & Webster, M. (2005). Gender status beliefs. Social Science Research,
34(3), 618-633. doi:10.1016/j.ssresearch.2004.05.004
Ravichandran, N. (2015). Dimensions of patient loyalty and switching intention:
Relational outcomes for benchmarking approach. International Journal of
Healthcare Management. Retrieved from
http://www.maneyonline.com/doi/pdfplus/10.1179/2047971915Y.0000000012
Reichenbach, L., & Brown, H. (2004). Gender and academic medicine: Impacts on health
workforce. British Medical Journal, 329, 792-795. doi:10.1136/bmj.329.7469.792

291
Reynolds, H. C., & Olsen, D. B. (1969). U.S. Patent No. 3,477,954. Phosphonium iodide
complexes of thyroxine, methods of preparing same, and methods of preparing 3,
5, 3’-l-triiodothyronine therefrom. United States Patent Office, 1-8. Retrieved
from
https://docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/U
S3477954.pdf
Richard, C., Lajeunesse, Y., & Lussier, M. T. (2010). Therapeutic privilege: Between the
ethics of lying and the practice of truth. Journal of Medical Ethics, 36, 353-357.
doi:10.1136/jme.2009.033340
Richman, J., & Jason, L. A. (2001). Gender biases underlying the social construction of
illness states: The case of chronic fatigue syndrome. Current Sociology, 49(3), 1529. doi:10.1177/0011392101049003003
Richman, J., Jason, L. A., Taylor, R., & Jahn, S. (2000). Feminist perspectives on the
social construction of chronic fatigue syndrome. Health Care for Women
International, 21, 173-185. doi:10.1080/073993300245249
Risberg, G., Hamberg, K., & Johansson, E. E. (2006). Gender perspective in medicine: a
vital part of medical scientific rationality. A useful model for comprehending
structures and hierarchies within medical science. BMC Medicine, 4(20), 1-5.
Retrieved from http://www.biomedcentral.com/content/pdf/1741-7015-4-20.pdf
Risberg, G., Johansson, E. E., & Hamberg, K. (2009). A theoretical model for analysing
gender bias in medicine. International Journal for Equity in Health, 8(28), 1-8.
Retrieved from http://www.equityhealthj.com/content/pdf/1475-9276-8-28.pdf

292
Rivera, F. A., Sampson, S., & Sola, C. L. (2015). Laboratory evaluation of endocrine
disorders in patients with neuropsychiatric symptoms. In B. S. Fogel & D. B.
Greenberg (Eds.), Psychiatric Care of the Medical Patient (pp. 120-136). New
York, NY: Oxford University Press.
Roberts, C. G. P., & Ladenson, P. W. (2004). Hypothyroidism. The Lancet, 363, 793-803.
doi:10.1016/S0140-6736(04)15696-1
Robinson, J., Sareen, J., Cox, B. J., & Bolton, J. M. (2011). Role of self-medication in the
development of comorbid anxiety and substance use disorders: A longitudinal
investigation. Archives of General Psychiatry, 68(8), 800-807.
doi:10.1001/archgenpsychiatry.2011.75
Rogers, W. A. (2002). Whose autonomy? Which choice? A study of GPs' attitudes
towards patient autonomy in the management of low back pain. Family Practice,
19(2), 140-145. Retrieved from http://www.biomedcentral.com/1472-6963/5/70
Ross, E. F., & Haidet, P. (2011). Attitudes of physical therapy students toward patientcentered care, before and after a course in psychosocial aspects of care. Patient
Education and Counseling, 85(3), 529-32. doi:10.1016/j.pec.2011.01.034
Roter, D. L., & Hall, J. A. (2004). Physician gender and patient-centered communication:
A critical review of empirical research. Annual Review of Public Health, 25, 497519. doi:10.1146/annurev.publhealth.25.101802.123134
Roter, D. L., Hall, J. A., & Aoki, Y. (2002). Physician gender effects in medical
communication: A meta-analytic review. Journal of the American Medical
Association, 288, 756-764. doi:10.1001/jama.288.6.756

293
Rothman, A. A., & Wagner, E. H. (2003). Chronic illness management: What is the role
of primary care? Annals of Internal Medicine, 138, 256-261. Retrieved from
http://www.unaformecra.com/fichiers/aeu/aeu200607cd/DOCUMENTS/5BIBLIOGRAPHIE/BIBLIO%
20Medecine%20Genenrale/AIM%202003%204%20Maladies%20chroniques%20
et%20MG.pdf
Rothstein, W. H., & Hannum, S. (2007). Profession and gender in relationships between
advanced practice nurses and physicians. Journal of Professional Nursing, 23(4),
235-240. doi:10.1016/j.profnurs.2007.01.088
Ruiz, M. E. (2010). Risks of self-medication practices. Current Drug Safety, 5(4), 315323. doi:10.2174/157488610792245966
Sacks, O. (1987). Tics. New York Review of Books, 34(1), 37-41.
Salt, E., Rowles, G. D., & Reed, D. B. (2012). Patient’s perception of quality patient–
provider communication. Orthopaedic Nursing, 31(3), 169-176.
doi:10.1097/NOR.0b013e3182558cdb
Sandhu, H. Adams, A., Singleton, L., Clark-Carter, D., & Kidd, J. (2009). The impact of
gender dyads on doctor–patient communication: A systematic review. Patient
Education and Counseling 76, 348–355. doi:10.1016/j.pec.2009.07.010
Schensul, J. J., & LeCompte, M. D. (Eds.). (1999). Ethnographer’s toolkit: Volumes 1-7.
Walnut Creek, CA: AltaMira Press.
Schmitt, R. (1967). Husserl’s transcendental-phenomenological reduction. In J. J.
Kockelmans (Ed.), Phenomenology (pp. 58-68). Garden City, NY: Doubleday.

294
Schulman-Green, D., Jaser, S., & Martin, F. (2012). Processes of self-management in
chronic illness. Journal of Nursing Scholarship, 44(2), 136–144.
doi:10.1111/j.1547-5069.2012.01444.x.
Schuman-Olivier, Z., Albanese, M., Nelson, S. E., Roland, L., Puopolo, F.,Klinkera, L.,
& Shaffer, H. J. (2010). Self-treatment: Illicit buprenorphine use by opioiddependent treatment seekers. Journal of Substance Abuse Treatment, 39(1), 41–
50. doi:10.1016/j.jsat.2010.03.014
Secker, B. (1999). Labeling patient (in)competence: A feminist analysis of medico-legal
discourse. Journal of Social Philosophy, 30(2), 295-314. doi:10.1111/00472786.00019
Self, M. (2014). Case study: Deception for the patient’s own good. Annals of Behavioral
Science and Medical Education, 20(2), 34-36. Retrieved from
http://www.absame.org/annals/ojs/index.php/annals/article/viewFile/229/226
Shahidi, J. (2010). Not telling the truth: Circumstances leading to concealment of
diagnosis and prognosis from cancer patients. European Journal of Cancer Care,
19, 589-593. doi:10.1111/j.1365-2354.2009.01100.x
Sharf, B. F., Stelljes, L. A., & Gordon, H. S. (2005). ‘A little bitty spot and I’m a big
man’: Patients’ perspectives on refusing diagnosis or treatment for lung cancer.
Psycho-oncology, 14, 636-646. doi:10.1002/pon.885

295
Shattock, L., Williamson, H., Caldwell, K., Anderson, K., & Peters, S. (2013). ‘They’ve
just got symptoms without science’: Medical trainees’ acquisition of negative
attitudes towards patients with medically unexplained symptoms. Patient
Education and Counseling, 91, 249–254.
doi:http://dx.doi.org/10.1016/j.pec.2012.12.015
Sherwin, S. (1992). No longer patient: Feminist ethics and health care. Philadelphia, PA:
Temple University Press.
Sherwin, S. (1999). Women in clinical studies: A feminist view. In A. C. Mastroianni, R.
Faden, & D. Federman (Eds.) Women and Health Research: Ethical and legal
issues of including women in clinical studies: Vol. 2. Workshop and
commissioned papers (pp. 11-17). Retrieved from
http://www.nap.edu/catalog/2343.html
Sherwin, S. (2000). A relational approach to autonomy in health care. In E. Boetzkes &
W. J. Waluchow (Eds.), Readings in health care ethics (pp. 69-87). Ontario,
Canada: Broadview Press.
Shi, L., Lebrun, L. A., & Tsai, J. (2010). Access to medical care, dental care, and
prescription drugs: The roles of race/Ethnicity, health insurance, and income.
Southern Medical Journal, 103(6), 509-516. Retrieved from
http://www.jhsph.edu/research/centers-and-institutes/johns-hopkins-primary-carepolicy-center/Publications_PDFs/2010%20SMJ.pdf

296
Shin, D. W., Roter, D. L., Roh, Y. K., Hahm, S. K., Cho, B., & Park, H. (2015).
Physician gender and patient centered communication: The moderating effect of
psychosocial and biomedical case characteristics. Patient Education and
Counseling, 98(1), 55-60. doi:10.1016/j.pec.2014.10.008
Shields, C. G., Finley, M. A., Elias, C. M., Coker, C. J., Griggs, J. J., Fiscella, K., &
Epstein, R. M. (2013). Pain assessment: The roles of physician certainty and
curiosity. Health Communication, 28, 740–746.
doi:10.1080/10410236.2012.715380
Shields, S. A. (2007). Passionate men, emotional women: Psychology constructs gender
difference in the late 19th century. History of Psychology, 10(2), 92-110.
doi:10.1037/1093-4510.10.2.92
Shildrick, M. (1997). Leaky bodies and boundaries: Feminism, postmodernism and
(bio)ethics. New York, NY: Routledge.
Shimabukuro, J. L. (2008). The role of thyroid in diagnostic assessment practices of
Hawaii mental health providers (Doctoral dissertation). Retrieved from ProQuest
Dissertations and Theses Database. (UMI No. 3370210).
Shingleton, R. M., Thompson-Brenner, H., Thompson, D. R., Pratt, E. M., & Franko, D.
L. (2015). Gender differences in clinical trials of binge eating disorder: An
analysis of aggregated data. Journal of Consulting and Clinical Psychology,
83(2), 382-386. doi:10.1037/a0038849

297
Skirbekk, H., Middelthon, A., Hjortdahl, P., & Finset, A. (2011). Mandates of trust in the
doctor-patient relationship. Qualitative Health Research, 21(9), 1182–1190.
doi:10.1177/1049732311405685
Simmons, S. (2010). A delicate balance: Detecting thyroid disease. Nursing2010, 22-29.
Retrieved from http://www.nursingcenter.com/pdf.asp?AID=1028185
Skodol, A., & Bender, S. (2003). Why are women diagnosed borderline more than men?
Psychiatric Quarterly, 74(4), 349-360. doi:10.1023/A:1026087410516
Slade, S., Molloy, E., & Keating, J. (2009). Stigma experienced by people with
nonspecific chronic low back pain: A qualitative study. Pain Medicine, 10, 143–
154. doi:10.1111/j.1526-4637.2008.00540.x
Smith, J. F. (1996). Communicative ethics in medicine: The physician-patient
relationship. In S.M. Wolf (Ed.), Feminism & Bioethics (pp. 184-215). New York,
NY: Oxford University Press.
Soderberg, S., Olsson, M., & Skar, L. (2012). A hidden kind of suffering: female
patient’s complaints to Patient’s Advisory Committee. Scandinavian Journal of
Caring Sciences, 26, 144–150. doi:10.1111/j.1471-6712.2011.00936.x
Sokol, D. K. (2014). Beware the lies of patients. British Medical Journal, 348(g382), 1-2.
doi:10.1136/bmj.g382
Solomon, M., Nahas, S. J., Segal, J. Z., & Young, W. B. (2010). Medication adaptation
headache. Cephalalgia, 31(5), 515–517. doi:10.1177/0333102410387678

298
Stålnacke, B., Haukenes, I., Lehti, A., Wiklund, A. F., Wiklund, M., & Hammarström, A.
(2014). Is there a gender bias in recommendation for further rehabilitation in
primary care of patients with chronic pain after an interdisciplinary team
assessment? Journal of Rehabilitation Medicine, 47, 1-7. doi:10.2340/165019771936
Stenberg, G., Fjellman-Wiklund, A., & Ahlgren, C. (2012). “Getting confirmation”:
Gender in expectations and experiences of healthcare for neck or back patients.
Journal of Rehabilitation Medicine, 44(2), 163-171. doi:10.2340/16501977-0912
Stewart, L. P., Cooper, P. J., Stewart, A. D., & Friedley, S. A. (2003). Communication
and gender (4th ed.). Boston, MA: Allyn & Bacon.
Stogner, J. M., Sanders, A., & Miller, B. L. (2015). Deception for drugs: Self-reported
“doctor shopping” among young adults. Journal of the American Board of Family
Medicine, 28(2), 583-593. doi:10.3122/jabfm.2014.05.140107
Stone, L. (2014). Blame, shame and hopelessness: medically unexplained symptoms and
the ‘heartsink’ experience. Australian Family Physician, 43(4), 191-195.
Retrieved from http://www.racgp.org.au/afp/2014/april/blame-shame-andhopelessness/
Stokes, T., Dixon-Woods, M., & Williams, S. (2006). Breaking the ceremonial order:
Patients’ and doctors’ accounts of removal from a general practitioner’s list.
Sociology of Health & Illness, 28(5), 611–636. doi:10.1111/j.14679566.2006.00509.x

299
Street, R. L., Gordon, H., & Haidet, P. (2007). Physicians’ communication and
perceptions of patients: Is it how they look, how they talk, or is it just the doctor?
Social Science & Medicine, 65, 586–598. doi:10.1016/j.socscimed.2007.03.036
Street, R. L., Makoul, G., Arora, N. K., & Epstein, R. M. (2009). How does
communication heal? Pathways linking clinician–patient communication to health
outcomes. Patient Education and Counseling, 74, 295–301.
doi:10.1016/j.pec.2008.11.015
Sutherns, R. (2004). Adding women’s voices to the call for sustainable rural maternity
care. Canadian Journal of Rural Medicine, 9(4), 239-244. Retrieved from
http://www.srpc.ca/PDF/cjrm/vol09n4/pg239.pdf
Swancutt, D. R., Greenfield, S. M., Luesley, D. M., & Wilson, S. (2011). Women's
experience of colposcopy: A qualitative investigation. BMC Women's Health,
11(11), 1-7. Retrieved from http://www.biomedcentral.com/1472-6874/11/11
Takamura, Y., Nakano, K., Uruno, T., Ito, Y., Miya, A., Kobayashi, K., Yokozawa, T.,
Matsuzuka, F., Kuma, K., & Miyauchi A. (2003). Changes in serum TSH receptor
antibody (TRAb) values in patients with Graves' disease after total or subtotal
thyroidectomy. Endocrine Journal, 50(5), 595-601. Retrieved from
https://www.jstage.jst.go.jp/article/endocrj/50/5/50_5_595/_pdf
Tannen, D. (2007). You just don't understand: Women and men in conversation. New
York, NY: Harper.

300
Telford, K., Kralik, D., & Koch, T. (2006). Acceptance and denial: Implications for
people adapting to chronic illness. Journal of Advanced Nursing, 55(4), 457–464.
doi:10.1111/j.1365-2648.2006.03942.x
Tempest, H. V., Vowler, S., & Simpson, A. (2005). Patients’ preference for gender of
urologist. International Journal of Clinical Practice, 59(5), 526–528.
doi:10.1111/j.1368-5031.2005.0046 5.x
Thomas, C. (2001). Medicine, gender, and disability: Disabled women’s health care
encounters. Health Care for Women International, 22, 245–262.
doi:10.1080/073993301300357188
Thyrasyvoulides, A., & Lymberi, P. (2004). Antibodies cross-reacting with thyroglobulin
and thyroid peroxidase are induced by immunization of rabbits with an
immunogenic thyroglobulin 20mer peptide. Clinical & Experimental
Immunology, 138(3), 423–429. doi:10.1111/j.1365-2249.2004.02657.x
Torres, E., Vasquez-Parraga, A. Z., & Barra, C. (2009). The path of patient loyalty and
the role of doctor reputation. Health Marketing Quarterly, 26, 183–197.
doi:10.1080/07359680903263565
Tu, H. T., & Cohen, J. (2008). Striking jump in consumers seeking health care
information. Center for Studying Health System Change. Retrieved from
http://www.hschange.org/CONTENT/1006/
Tustin, N. (2010). The role of patient satisfaction in online health information seeking.
Journal of Health Communication, 15, 3-17. doi:10.1080/10810730903465491

301
Tybout, A. M., & Hennessy, J. (2013). The case of Synthroid (A): Marketing a drug
coming off patent. Kellogg Case Publishing, 1-19. Retrieved from
http://www.kellogg.northwestern.edu/kellogg-case-publishing/case-search/casedetail.aspx?caseid={DCF2BB9C-DDE9-430E-AAD8-F28B3D64D35A}
U.S. Census Bureau. (2012). State and county quick facts. Retrieved from
http://quickfacts.census.gov/qfd/states/00000.html
Vaccaro, J. A., & Huffman, F. G. (2012). Gender differences in medical advice and
health behavior of obese African Americans with and without Type 2 diabetes.
American Journal of Men’s Health, 6(5), 383-394.
doi:0.1177/1557988312449853
Van Leerdam, L., Rietveld, L., Teunissen, D., & Lagro-Janssen, A. (2014). Gender-based
education during clerkships: a focus group study. Advances in Medical Education
and Practice, 5, 53-60. doi:10.2147/AMEP.S56765
Van Manen, M. (1997). Researching lived experience: Human science for an actionsensitive pedagogy. Albany, NY: SUNY.
Vanderford, M., Stein, T., Sheeler, R. & Skochelak, S. (2001). Communication
challenges for experienced clinicians: Topics for an advanced communication
curriculum. Health Communication, 13(3), 261-284.
doi:10.1207/S15327027HC1303_3
Verdonk, P., Benschop, Y., de Haes, H., & Lagro-Janssen, A. (2008). Medical students’
gender awareness: Construction of the Nijmegen Gender Awareness in Medicine
Scale (N-GAMS). Sex Roles, 58, 222–234. doi:10.1007/s11199-007-9326-x

302
Verdonk, P., Benschop, Y., de Haes, H., & Lagro-Janssen, A. (2009). From gender bias
to gender awareness in medical education. Advances in Health Science Education,
14, 135-152. doi:10.1007/s10459-008-9100-z
Verma, R. K., Mohan, L., & Pandey, M. (2010). Evaluation of self-medication among
professional students in North India: Proper statutory drug control must be
implemented. Asian Journal of Pharmaceutical and Clinical Research, 3(1), 6064. Retrieved from http://www.ajpcr.com/Vol3Issue1/270.pdf
Vigersky, R. A., Fish, L., Hogan, P., Stewart, A., Kutler, S., Ladenson, P. W.,
McDermott, M., & Hupart, K. H. (2014). The clinical endocrinology workforce:
Current status and future projections of supply and demand. Journal of Clinical
Endocrinology & Metabolism, 99(9), 3112-3121.
doi:http://dx.doi.org/10.1210/jc.2014-2257
Vina, E. R., Masi, C. M., Green, S. L., & Utset, T. O. (2012). A study of racial/ethnic
differences in treatment preferences among lupus patients. Rheumatology, 51,
1697-1706. doi:10.1093/rheumatology/kes128
Walldorf, J., Krummenerl, A., Engler, K., Busch, J., Dollinger, M. M., Seufferlein, T., &
Albert, J. G. (2013). Health care for osteoporosis in inflammatory bowel disease:
Unmet needs in care of male patients? Journal of Crohn’s and Colitis, 7(11), 901907. doi:http://dx.doi.org/10.1016/j.crohns.2012.12.008

303
Walsh, J. P., Bremner, A. P., Bulsara, M. K., O’Leary, P., Leedman, P. J., Feddema, P.,
& Michelangeli, V. (2006). Subclinical thyroid dysfunction and blood pressure: A
community-based study. Clinical Endocrinology, 65(4) 486–491.
doi:10.1111/j.1365-2265.2006.02619.x
Wells, R. E. (2012). To tell the truth, the whole truth, may do patients harm: The problem
of the nocebo effect for informed consent. American Journal of Bioethics, 12(3),
22–29. doi:10.1080/15265161.2011.652798
Werner, A., & Malterud, K. (2003). It is hard work behaving as a credible patient:
Encounters between women with chronic pain and their doctors. Social Science &
Medicine, 57, 1409–1419. doi:10.1016/S0277-9536(02)00520-8
Werner, A., & Malterud, K. (2005). ‘‘The pain isn’t as disabling as it used to be’’: How
can the patient experience empowerment instead of vulnerability in the
consultation? Scandinavian Journal of Public Health, 33(6), 41–46.
doi:10.1080/14034950510033363
Werner, A., Isaksen, L. W., & Malterud, K. (2004). ‘I am not the kind of woman who
complains of everything’: Illness stories on self and shame in women with chronic
pain. Social Science & Medicine, 59, 1035–1045.
doi:10.1016/j.socscimed.2003.12.001
Werner, A., Steihaug, S., & Malterud, K. (2003). Encountering the continuing challenges
for women with chronic pain: Recovery through recognition. Qualitative Health
Research, 13(4), 491-509. doi:10.1177/1049732302250755

304
Wessel, M., Helgesson, G., Olsson, D., Juth, N., Alexanderson, K., & Lynoe, N. (2012).
When do patients feel wronged? Empirical study of sick-listed patients’
experiences with healthcare encounters. European Journal of Public Health,
23(2), 230–235. doi:10.1093/eurpub/cks030
Wheatland, R. (2010). Should the TSH test be utilized in the diagnostic confirmation of
suspected hypothyroidism? Medical Hypotheses, 75(5), 458-463.
doi:10.1016/j.mehy.2010.04.024
White, R. O., Osborn, C. Y., Gebretsadik, T., Kripalani, S., & Rothman, R. L. (2013).
Health literacy, physician trust, and diabetes- related self-care activities in
Hispanics with limited resources. Journal of Health Care for the Poor and
Underserved, 24, 1756–1768. doi:10.1353/hpu.2013.0177
Willig, C., & Rogers, W. S. (Eds.). (2008). Handbook of qualitative research in
psychology. London, England: Sage Publications.
Wiskin, C. M., Allan, T. F., & Skelton, J. R. (2004). Gender as a variable in the
assessment of final year degree-level communication skills. Medical Education,
38, 129-137. doi:10.1111/j.1365-2923.2004.01746.x
World Health Organization. (2013). WHO gender mainstreaming strategy: Integrating
gender analysis and actions into the work of WHO. Retrieved from
http://www.who.int/gender/mainstreaming/strategy/en/index.html
Worley, J. (2012). Prescription drug monitoring programs, a response to doctor shopping:
Purpose, effectiveness, and directions for future research. Issues in Mental Health
Nursing, 33(5), 319-328. doi:10.3109/01612840.2011.654046

305
Worley, J., & Thomas, S. P. (2014). Women who doctor shop for prescription drugs.
Western Journal of Nursing Research, 36(4), 456-474.
doi:10.1177/0193945913509692
Ye, Y. (2014). The role of illness factors and patient satisfaction in using online health
support groups. Health Communication, 29(4), 355-363.
doi:10.1080/10410236.2012.757526
Wright, N., & Owen, S. (2001). Feminist conceptualizations of women's madness: A
review of the literature. Journal of Advanced Nursing, 36(1), 143-150.
doi:10.1046/j.1365-2648.2001.01951.x
Yang, Y., Carlin, A. S., Faustino, P. J., Pagan-Motta, M. I., Hamad, M. L., He, R.,
Watanuki, Y., Pinnow, E. E., & Khan, M. A. (2009). Participation of women in
clinical trials for new drugs approved by the Food and Drug Administration in
2000–2002. Journal of Women’s Health, 18(3), 303-310. Retrieved from
http://www.fda.gov/downloads/ScienceResearch/SpecialTopics/WomensHealthR
esearch/UCM248486.pdf
Yudkowsky, R., Downing, S. M., & Ommert, D. (2006). Prior experiences associated
with residents’ scores on a communication and interpersonal skill OSCE. Patient
Education and Counseling, 62, 368–373. doi:10.1016/j.pec.2006.03.004
Yuen-man Siu, J. (2015). Communicating under medical patriarchy: Gendered doctorpatient communication between female patients with overactive bladder and male
urologists in Hong Kong. BMC Women’s Health, 15(44), 1-11. Retrieved from
http://www.biomedcentral.com/1472-6874/15/44

306
Zandbelt, L. C., Smets, E., Oort, F. J., Godfried, M. H., & de Haes, H. (2006).
Determinants of physicians’ patient-centred behaviour in the medical specialist
encounter. Social Science & Medicine, 63, 899–910.
doi:10.1016/j.socscimed.2006.01.024
Zeitlin, A. A., Heward, J. M., Newby, P. R., Carr-Smith, J. D., Franklyn, J. A., Gough, S.
C. L., & Simmonds, M. J. (2008). Analysis of HLA class II genes in Hashimoto’s
thyroiditis reveals differences compared to Grave’s disease. Genes and Immunity,
9(4) 358-363. doi:10.1038/gene.2008.26

307
Appendix A: Interview Guide
Introductory Script
Research has suggested that studies examining the factors that contribute to effective,
non-authoritative communication between doctors and patients would help educate
physicians about patients’ needs.
I am going to ask you a number of questions about your background and experience as a
woman with thyroid disease. Please answer them by typing your replies. You may use as
much space as you like. If you feel that any of the questions are too personal, you do not
have to answer them. If any of the questions are not applicable to you, please tell me. If
you begin to feel upset or uncomfortable, please inform me and I will cease the interview.
You may withdraw from the study at any time without any penalty.
Remember, all of your information will be kept confidential. Please make sure you are in
a public, non-private area. Do not type your name anywhere during this interview.
Because we are using online chat to conduct this interview, a transcript of our
conversation will be automatically recorded. This transcript will form the basis of my
study data.
Before we begin, do you have any questions?
Here is the first question.

Demographic Information
1. What is your age?
2. What is your ethnicity? (e.g., Caucasian, Black/African, Native American,
Asian/Pacific Islander, Hispanic, East Indian, Middle Eastern, Other).
3. What is your highest education level completed? (e.g., High school graduate, GED,
Some high school, Associates degree, Bachelor’s degree, Some college, Master’s degree,
Professional degree, Other/please specify).
4. What is your thyroid disease diagnosis? You can type more than one answer (e.g.,
Grave’s disease, Hashimoto’s disease, Hyperthyroid, Hypothyroid, Other/please specify).
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5. Do you have any other medical diagnoses? You can type more than one answer (e.g.,
Fibromyalgia, Chronic Fatigue Syndrome, Other/please specify).
6. What treatment(s) are you using for your thyroid disease? You can write more than
one answer (e.g., Synthroid, Armour thyroid, Other/please specify).
7. If you take medications, what are the dosages for the medications?
8. What is the gender of your doctor(s)?
9. What is the ethnicity of your doctor(s)? (e.g., Caucasian, Black/African, Native
American, Asian/Pacific Islander, Hispanic, East Indian, Middle Eastern, Other/please
specify).

Personal Experiences
1. Please tell me, what has been your experience in seeking treatment for thyroid disease?
(RQ 1)
- Possible Probe: How did you come to be diagnosed?
- Possible Probe: How long have you been being treated?
2. How would you describe your current relationship with the doctor who treats you for
thyroid disease? (RQ 1; RQ 2)
3. How do you feel about the treatments you are receiving for thyroid disease? (RQ 1, RQ
2)
4. How clearly do you believe your doctor explains things to you? (RQ 2)
-Possible probe: What do believe your doctor could do to make his or her
communication clearer?
5. Do you think it matters whether your doctor is a man or a woman? Why or why not?
(RQ 3)
6. How does being a woman, as opposed to being a man, influence your relationship with
your doctor? (RQ 1; RQ 2; RQ 3)
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7. How comfortable do you feel in talking with your doctor about symptoms or medical
issues you have experienced that you believe might be related to thyroid disease? (RQ 1;
RQ 2)
8. What do you believe might help you to feel more comfortable in sharing your
experience of these symptoms with your doctor? (RQ 2; RQ 3)
9. Is there anything else you would like to add?

Do you have a journal or diary about your experience with thyroid disease that you would
like to share with me? You are not obligated to share. If you would like to share your
journal/diary with me, please remove your real name from their journal/diary before
emailing it to me.

Would you mind reviewing the transcript of our chat to make sure everything is correct?
You are not obligated to review our chat transcript.

Thank you so much for your participation. When I have completed my study, would you
like a copy of the results?
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Appendix B: Letter of Cooperation from a Community Research Partner

This type of letter must be obtained from any type of organization involved in identifying
potential participants or collecting data. Please contact irb@waldenu.edu if you have any
questions about the appropriate content for a letter of cooperation. Either letter or e-mail
format is acceptable, from the perspective of the Walden University Institutional Review
Board (IRB).

__________________, Group Owner-Moderator
October 15, 2013
Dear Ms. McCormick,
Based on my review of your research proposal, I give permission for you to conduct the
study entitled “Women and Thyroid Disease: Treatment Experiences and the DoctorPatient Relationship” within The Thyroid Support Group. As part of this study, I
authorize you to invite members of my group to participate in the study as interview
subjects. Their participation will be voluntary and at their own discretion. We reserve the
right to withdraw from the study at any time if our circumstances change.
I understand that the data collected will remain entirely confidential and may not be
provided to anyone outside of the research team without permission from the Walden
University IRB.
Sincerely,

___________________, Group Owner-Moderator
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Appendix C: On-List Group Email Invitation
Hello everyone!
My name is Laura McCormick and I am a doctoral student at Walden University
(http://www.WaldenU.Edu).
I obtained permission from the Group Owner and Moderator to seek participants for my
study. If you are a woman age 18 or older, have a thyroid disease diagnosis, are a
member of this support group, and if you are interested in participating in research about
women’s experiences with thyroid disease treatment, then I invite you to take part in a
research study of women with thyroid disease. I am seeking 10-15 participants on a
voluntary basis.
A potential benefit to this study is that it gives participants the opportunity to share their
experiences of thyroid disease with professionals and the general public (your real names
will not be known or used). If you are interested in participating in my study, please do
the following:
1. Establish a free email account (e.g., Yahoo Mail:
https://edit.yahoo.com/registration) using a fictitious name.
2. Email me off-list through my personal email address by January 26, 2014 to
express your interest in participating. Please use your fictitious name at all
times.
3. I will respond to your email and include a consent form in my response. After
reading the consent form, if you are still interested in participating, we will
communicate via email using your fictitious name and email address to set up a
date and time for your individual interview.
4. Once we set a date and time for your interview, please be sure to participate in the
interview in a private, non-public location.
I want to assure everyone that you are in no way required to participate in my study.
Likewise, if you choose to participate in my study, you may change your mind at any
time and withdraw from the study without explanation. I will never know who does and
does not participate in this study and I will never know the true identity of any
participant.
I will be checking my email frequently. I look forward to hearing from those of you who
are interested.
Warm regards,
Laura
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Appendix D: Consent Form
You are invited to take part in a research study of women with thyroid disease. You were
chosen for the study because you are a woman with a thyroid disease diagnosis and you
expressed an interest in this study. Please read this form and ask any questions you have
before agreeing to be part of the study.
This study is being conducted by a researcher named Laura J. McCormick, who is a
doctoral student at Walden University.
Background Information:
The purpose of this study is to obtain an understanding of the experiences of women with
thyroid disease.
Procedures:
If you agree to be in this study, you will be asked to:
•

Download and install X-IM chat software, a free, encrypted chat platform (see
http://www.x-im.net/ for details) to your computer using your new e-mail account
and fictitious name in order to log in to a one-on-one chat session with Laura.

•

Before beginning the interview, please have ready a phone number of a counselor
that you trust and can call if you feel upset from the interview. If you feel upset
from the interview, you may also call the National Suicide Prevention Lifeline: 1800-273-8255 (1-800-799-4889: TTY - Hearing & Speech Impaired) or the
National Hopeline Network: 1-800-784-2433. International Suicide and Crisis
Hotlines are available here: http://suicidehotlines.com/international.html

•

Complete an interview with Laura using the X-IM encrypted chat software about
your experience as a woman with thyroid disease. This will take approximately 1
hour. At the end of the interview, you will be asked if you would like to follow up
by e-mailing Laura your journal/diary (see below) and by reviewing your
individual chat transcript. Please make sure that you participate in the interview in
a private, non-public location, and use your fictitious name at all times.

•

E-mail Laura your journal/diary (if you have one, and only if you want to) about
your experience with thyroid disease. E-mail Laura not through the support group,
but to her e-mail address and protect the journal with a password. Also, please
make sure you remove your name from your journal/diary.
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Voluntary Nature of the Study:
Your participation in this study is voluntary. This means that everyone will respect your
decision of whether or not you want to be in the study. No one in The Thyroid Support
Group will know whether you choose to participate and no one will treat you differently
if you decide not to be in the study. If you decide to join the study now, you can still
change your mind later. You may withdraw from the study at any time. You may skip
any questions that you feel are too personal. You do not have to supply a copy of your
journal/diary if you do not want to. You do not have to participate in any follow-up
activities such as reviewing the transcript of your interview if you do not want to.
No type of gift or compensation will be offered for participating in this study.
Risks and Benefits of Being in the Study:
A potential risk of participating in this study is the possibility of your e-mail being read
by someone other than Laura. In order to prevent access to your e-mails, interview
responses, and journal, Laura has password-protected her computer. No one will have
access to the login information that you use to join the chat session, so no one will be
able to see the transcript of your interview, which will be stored on a password-protected
drive.
Another possible risk is that you might feel emotional distress in talking about some
aspects of your experience. If this is the case, you are free to end the interview, take a
break, or withdraw from the study without consequences.
A potential benefit of this study is to have your “voice” be heard about what it’s like to be
a woman with thyroid disease.
Confidentiality:
Any information you provide will be kept confidential. Laura will not use your
information for any purposes outside of this research project. Also, Laura will not know
your real name and will not include anything that could identify you in any reports of the
study.
Contacts and Questions:
The researcher’s name is Laura J. McCormick. The researcher’s faculty advisor is Dr.
Ruth Crocker. You may ask any questions you have at any time. You may contact the
researcher or the advisor. If you want to talk privately about your rights as a participant,
you can call the Director of the Research Center at Walden University.
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After reading this consent form, emailing Laura to establish a date and time for
your individual interview implies your consent to participate in this study. Again,
you may change your mind and withdraw from the study at any time.
You may keep this form for your records.
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Appendix E: Confidentiality Agreement

During the course of my activity in analyzing and interpreting data for this research,
Women and Thyroid Disease: Treatment Experiences and the Doctor-Patient
Relationship, I, Mary Ann Cincotta, understand that I will have access to information
which is confidential and should not be disclosed. I acknowledge that the information
must remain confidential, and that improper disclosure of confidential information can be
damaging to participants.
By signing this Confidentiality Agreement I acknowledge and agree that:
1.

I will not disclose or discuss any confidential information with others,
including friends or family.

2.

I will not in any way divulge, copy, release, sell, loan, alter, or destroy any
confidential information except as properly authorized.

3.

I will not discuss confidential information where others can overhear the
conversation. I understand that it is not acceptable to discuss confidential
information even if the participants’ names are not used.

4.

I will not make any unauthorized transmissions, inquiries, modification or
purging of confidential information.

5.

I agree that my obligations under this agreement will continue after
termination of the job that I will perform.

6.

I understand that violation of this agreement will have legal implications.

7.

I will only access or use systems or devices I am officially authorized to
access and I will not demonstrate the operation or function of systems or
devices to unauthorized individuals.

I acknowledge that I have read the agreement and I agree to comply with all the terms
and conditions stated above.
Printed Name of
Research Assistant

Mary Ann Cincotta
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Research Assistant’s

Mary Ann Cincotta

Electronic* Signature
Researcher’s

Laura J. McCormick

Electronic* Signature
*Electronic signatures are regulated by the Uniform Electronic Transactions Act. Legally,
an "electronic signature" can be the person’s typed name, their e-mail address, or any
other identifying marker. An electronic signature is just as valid as a written signature as
long as both parties have agreed to conduct the transaction electronically.
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Appendix F: On-List Group Email at End of Interviewing
Hello everyone!
Recently, I made a post asking for volunteers for my study about women with thyroid
disease. I am writing to inform you that I no longer need volunteers.
I hope everyone has a wonderful day!
Warm regards,
Laura
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Appendix G: Participant Textural-Structural Descriptions
Participant 1: Alicia
Alicia has been receiving treatment for thyroid disease for approximately seven
years. Following her breast cancer treatments, Alicia felt like something was wrong. She
indicated that she informed her oncologist and radiation oncologist of her concerns on
more than one occasion. Since Alicia had recently lost her 8-year old son to cancer and
was recovering from treatment for breast cancer, she believed that her doctors likely
attributed her symptoms to grief. Alicia stated, “It was not until I broke down in tears
with my radiation oncologist that he suggested metabolic testing…[and to] follow this up
with my primary care physician.”
Based on the results of her blood work, Alicia’s primary care physician prescribed
her levothyroxine. Alicia expressed that she and her doctor have a good working
relationship, even if they do not always agree on the course of treatment (which is based
on the results of blood work). Alicia stated, “While he tends to be satisfied if my numbers
are within the normal range, he does listen when I tell him how I am feeling.” She
continued, “I feel that we are carefully working toward finding the best way to treat me.”
Alicia expressed feeling grateful that her doctor listens to her concerns and takes her
seriously. As a result, Alicia feels comfortable, validated, and has trust in her doctor. She
explained, “Knowing that he takes me seriously helps me to feel comfortable sharing my
symptoms with my doctor.”
In addition to sharing symptoms with her doctor, Alicia also shares with him
research she has conducted about thyroid disease treatment. Alicia explained that, since
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her son’s passing, she has “…learned to advocate for the best medical treatment
possible…” and added, “I think my doctor understands that I am not the person I used to
be—that I know how to do the research and that I know what is reasonable.” In fact,
based upon Alicia’s research, her doctor is considering prescribing her Cytomel because
her “free T3 is not where it should be.” When asked whether or not the gender of her
doctor was important, Alicia responded, “I’m not sure. I wonder if a woman might be
more understanding, but I feel that my [male] physician is very understanding.” She
concluded, “I have chosen to stay with the physician because I believe he will listen to
me. I research, bring my research to him and we discuss what to do with it.”
Participant 2: Anne
Anne has been receiving treatment for thyroid disease for approximately seven
years and currently takes compounded porcine thyroid. Anne’s doctor told her that she
became hypothyroid from the radiation used to treat her throat cancer. However, Anne
reported that, based on her own research, she believes she was hypothyroid before
receiving the radiation treatment. Anne described her overall treatment experience for
thyroid disease as “awful,” explaining that her treatment “…is being managed by
someone who does not understand that there is not ‘one size fits all’ [approach in the
treatment of thyroid disease].” Anne expressed disappointment and frustration because
her doctor bases her treatment decisions on the results of the TSH blood test and gives
little importance to the results of free T3 and free T4 blood tests, or to Anne’s symptoms.
When asked whether or not she believes her doctor’s gender influences her treatment,
Anne responded, “No…It seems that both men and women doctors are TSH driven.”
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Anne shared that she believes doctors do not take her seriously. She explained,
“…my opinion is that doctors, both men and women, take men more seriously. I do tend
to get emotional which I think makes doctors give less credence to my depiction of my
symptoms.” Anne reported knowing some women who are able to discuss their
conditions without expressing emotion, and stated, “…they seem to have better
relationships with their doctors than I am able to establish. So it may not be so much the
gender of the patient or the doctor but the ability of the patient to express oneself.” Anne
further expressed that she would feel more comfortable sharing her symptoms and
thoughts with her doctor if she believed she would be taken seriously. She stated,
…it seems to me that the vast majority of endocrinologists have on blinders. Even
the doctors I have seen that are okay with [natural medication] still put much
more weight on TSH than symptoms or the frees. It is enough to make one feel
hopeless at times.
Participant 3: April
April has been receiving treatment for thyroid disease for approximately four
years. April reported that she had a lump in her throat for 3 years, during which time her
doctor monitored the size. When she decided to have a second baby, April asked her
doctor to biopsy the lump. Due to the presence of atypical thyroid cells, April’s thyroid
was partially removed. Upon further examination by April’s doctor, her remaining
thyroid tissue was suspected to be cancerous and was totally removed in a second
surgery.
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For a period of 3 years after her surgeries, April took Synthroid and Cytomel, as
ordered by her doctor. However, April was still not feeling well. She expressed feeling
extremely dissatisfied and frustrated with this doctor. April explained, “She worked by
my levels NOT by my feelings and how I was living life…[and she had] a negative and
controlling attitude.” April reported that her doctor did not take her seriously and felt like
the doctor “hated” her for being well-informed: “I went [to my appointments] with
knowledge and she told me to get off google...[and] when I asked her to test my reverse
T3, she refused saying it was no more important than the type of blood I had.”
Recently, April switched to a male doctor who works with her collaboratively.
She explained, “[He] wants to know what I know…[he] confirms I am not stupid and if
need be, he will correct or add more info to what I already know.” April’s current doctor
also prescribes her Armour thyroid instead of Synthroid and Cytomel, which is saving
April money. When asked if the gender of her doctor is important to her, April
responded, “Not at all,” explaining that she simply wants doctors to take her research
seriously and not just humor her.
Participant 4: Autumn
Autumn has been receiving treatment for thyroid disease for approximately seven
years. After her sister was diagnosed with thyroid disease, Autumn’s doctor decided to
test her as well, and she was found to be hypothyroid. Autumn described her treatment
experience as “lackluster.” She explained that she was comfortable talking with her
previous doctor, but since the doctor has retired, she is currently unsure of what to expect
from her new doctor. Despite finding her previous doctor easy to talk to, Autumn was not
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completely satisfied with her treatment experience and still does not feel well. She
expressed feeling rushed during her appointments, stating, “It would help if they
[doctors] weren’t so rushed.”
In addition to feeling rushed during her appointments, Autumn also experienced
frustration and loss of hope when her doctor lowered her dose of Armour thyroid
medication even though she felt “really good” at that dose: “…they [doctors] could
actually find out how to really treat thyroid [disease…] but even when I thought this
place did […] still nope!” When asked how the gender of her doctor influences her
relationship with the doctor, Autumn shared her belief that female doctors understand
female patients better than male doctors do and that her two best doctors were female.
However, Autumn also commented, “I don't think it [the doctor’s gender] matters
much…most of them are just in and out doing as little as they possibly have to do.”
Participant 5: Carla
Carla has been receiving treatment off and on for thyroid disease for
approximately 20 years. She described her treatment experience as “inexcusably poor”
and explained that she remained undiagnosed and suffered unnecessarily with
hyperthyroid symptoms for a period of 10 months after being dismissed by a doctor.
Having been a body builder, Carla was naturally larger than the average woman, and
decided to see a doctor when she lost 40 pounds in one month. However, Carla did not
receive the treatment she expected. Carla explained, “[the doctor] told me that I was ‘too
fat to be sick’ went on to tell me to leave, [and that] there were others that really needed
him.” After 10 months had passed, Carla was unable to lift her arms at work and was
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rushed to another doctor who diagnosed her as being in a “thyroid storm” – a condition
that caused her to have tendonitis and made her prone to a heart attack. The doctor told
Carla that she needed to have her thyroid ablated by radioactive iodine (RAI) or that she
would die. Carla felt fear and a sense of grief during the procedure: “Sign it or die... I
signed it [and] I got to watch my iodine uptake... I had such a perfect gland... It was just
twice normal size.”
Over a period of 6 months after RAI, Carla was observed by doctors in training
while she had blood drawn weekly to determine her thyroid function. Based on her blood
work, Carla’s thyroid was determined to be dead. Carla had gained 100 pounds during
this period of time. Over the next 2 years, Carla was treated with Synthroid, which she
described as making her nauseous and giving her headaches. Despite increases in her
dose of Synthroid, Carla continued to gain weight and eventually needed crutches to
walk. As a result, she experienced difficulty maintaining a job and health insurance. Carla
felt frustrated and hopeless. She stated,
With each job change I got new insurance and new docs and they were all the
same. Weight gain is from being a lazy slob [because] I laid around eating bon
bons all day long. Didn't matter that I was a body builder before all this, didn't
matter that I used to have physical jobs before all this... I was just a lazy, fat,
stupid... slob.
Carla eventually lost her job and her health insurance. Shortly beforehand, she
called her doctor and explained that she believed she needed a higher dose of Synthroid
in order to gain more energy and lose weight. When Carla’s doctor told her she could
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increase to 200mcg of Synthroid, she felt unheard and invalidated because she was
already taking that dose of Synthroid. When Carla pointed this out to her doctor,
[The doctor] said that I was a 'smart ass' and to stay on the same dose…then hung
up on me. I felt that my dose was wrong, I was getting worse and worse each
year. Every time I talked to a doc about it I was demeaned and/or ignored.
With no health insurance, Carla reduced her daily dose of Synthroid to make it
last as long as possible. She eventually ran out of Synthroid, lost her home, and moved in
with a family member. At this point, experiencing labored breathing and a slow heart
rate, Carla decided to conduct some research on the Internet and discovered “natural
desiccated thyroid” and “adrenal support” products. Within a year of self-treating with
these products, Carla developed more energy, started to exercise, and no longer needed
her crutches to walk. However, Carla’s source for thyroid and adrenal supplements
eventually became unavailable, so she gradually reduced her dose while she searched for
a new source. Over a period of two years, Carla relied on friends who shared their
supplements and natural thyroid medication prescriptions. Within a few years, Carla
developed lymphedema, which she attributes to the RAI, and a cellulitis infection in her
leg. As she did not have access to a doctor, Carla’s condition worsened and she
eventually became mobility-impaired.
Recently, Carla became eligible for medical assistance. Although she is currently
seeing a doctor, Carla remains “In a word…guarded [because a] doctor's prejudice and
ignorance…basically cost me my life.” Carla continued, “I have two half siblings with
the same genetic defect I have. Both got proper care in a timely manner. Both are doing
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fine. Healthy weight, good jobs, real lives.” When asked to describe her relationship with
her current doctor, Carla explained that she initially seemed open-minded because she
allowed her to continue taking natural thyroid and adrenal supplements. However,
Carla’s doctor eventually recommended Synthroid. Carla explained that she has lost trust
in her doctor because she seems to not want to consider Carla’s previous negative
experiences with Synthroid. Carla expressed a desire for her doctor to “Listen to someone
that is ‘living it’ and throw away the Synthroid book” and, referring to her doctor’s
medical education, hopes that “maybe it will click in her brain that the stuff that was
shoved down her throat does not apply to all folks with thyroid disorders.”
Carla shared her belief that her current doctor bases her recommendations solely
on the results of blood work, ignores her symptoms, and does not take her seriously:
“even though she listens, and we discuss...she still tries really had to talk me into her
view point.” Carla continued, “she is certain that the only test needed for thyroid is TSH
and it's an inside joke that I will allow her to run TSH as long as she also runs Free T4
and Free T3 for me.” When asked about the potential influence of her doctor’s gender,
Carla stated, “Every woman doctor I have had, all of 3, [have] been far more empathetic
and able to listen,” but continued, “…only 1 of those was truly well trained.” Although
Carla sees her doctor regularly, she continues to self-treat with natural thyroid and
adrenal supplements based on her symptoms. Despite her negative experiences with
thyroid treatment, Carla has not lost all hope. She commented, “I have a dream... that one
day there will be a shared list of truly good thyroid docs that we will all have access to.”
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Participant 6: Diane
Diane has been receiving treatment for thyroid disease for approximately four
years, but explained that she searched for over 30 years for the cause of her rapid weight
gain and chronic fatigue. Diane believed her symptoms could be due to thyroid
malfunction, as thyroid disease runs in her family. However, Diane remained
undiagnosed:
Each time my thyroid [was] tested I was told everything was fine. Meanwhile, I
struggled daily for energy, and experienced numerous illnesses over the years that
puzzled me…As I aged, I experienced illnesses that showed me I had a
compromised immune system and something wasn't right, but no doctor would
further investigate.
Eventually, Diane’s blood work indicated that she was hypothyroid, so her doctor
prescribed her levothyroxine. Along with taking levothyroxine, Diane also started on a
weight loss plan. Within 3 weeks, Diane began to experience severe dizziness and
difficulty breathing, so she stopped the weight loss plan. However, Diane continued to
struggle with dizziness, could no longer drive, and was barely able to walk. Diane stated,
“I saw several doctors and were [sic] prescribed anti dizziness medication, depression
pills, etc. All doctors said my blood work came back fine, including thyroid. However, I
was still bedridden and in danger of losing my job.”
Diane decided to make an appointment with a reputable Endocrinologist who is
known for his research on thyroid disease and is also a thyroid patient. Although the
appointment cost her $400, Diane was pleased with the experience, stating,
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…based on his review of my labs (which were all in normal range) and hearing
my symptoms, and looking at me, he said that he suspected Hashimoto’s
[disease]…He said the one test that was missing in all my labs were an [sic]
Thyroid Antibody Test…My antibodies were 849. In a normal person they should
be less than 9.
The Endocrinologist switched Diane from levothyroxine to Tirosint and Armour
thyroid. Diane’s dizziness and weakness soon subsided.
Diane’s current doctor is an Endocrinologist who conducts research with the
Endocrinologist her diagnosed her with Hashimoto’s disease. The fact that this
Endocrinologist conducts research helps Diane to feel more confident about his advice. In
addition, the Endocrinologist listens to her concerns and validates her. Diane explained,
“…he takes me a little more seriously than most of the other doctors who poo-pooed me.”
However, Diane remains concerned that he does not understand Hashimoto’s disease to
the extent she’d prefer. Diane stated, “…it seems that I am more knowledgeable about
some areas of Hashimoto's than he is…But, he does take into consideration what I'm
saying to him, and gives me feedback. I appreciate that.”
When asked whether or not the gender of one’s doctor is important, Diane
responded, “If they have a thorough understanding of the female body, then there
shouldn't be difference [between male and female doctors].” What Diane believes is
important is that her doctor listens to her concerns, takes her seriously, and has a working
knowledge of thyroid disease. Diane explained,
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…it is scary how little doctors actually know about [thyroid] disease, let alone
Hashimoto’s [disease]. I also think the public is grossly misinformed. Their
impression is that you just take a little pill and all is well. This is far from the
truth, as it can be very complicated.
Participant 7: Emily
Emily has been receiving treatment for thyroid disease for approximately one
year. After sharing with her doctor that she had experienced rapid weight gain, loss of
eyebrows, and thinning finger nails among other symptoms, Emily’s primary care
physician (PCP) tested her thyroid. The results of the blood tests indicated that Emily had
Hashimoto’s disease. Emily reported that she is currently taking Synthroid and Cytomel.
She expressed frustration that she continues to not feel well, stating, “…it is a roller
coaster. I feel like I’m getting better and then some things start getting worse.”
Based on Emily’s research, she recognizes that her PCP does not attribute many
of her symptoms to thyroid disease. Emily explained, “…she tries to treat [my symptoms]
individually – quickly stockpiling my medicine cabinet.” Emily expressed a desire for a
more collaborative relationship with her PCP; a relationship in which her PCP would
share information and explain to Emily what to expect during treatment. However, as
Emily explained, her PCP “…doesn’t come forward with all she’s thinking unless I push
the conversation.”
Emily recently started to see an Endocrinologist and reported greater satisfaction
with the Endocrinologist than her PCP. Emily explained that she believes the
Endocrinologist is easy to talk to and appreciates that she is thorough: “I had written all
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my issues out before seeing the endocrinologist and she still went through the whole list
of possible symptoms to see which I was experiencing and to what extent.” Emily also
reported feeling hopeful that if she continues to not feel well, her Endocrinologist will
allow her to try natural hormone. Emily explained that her PCP “…seems to think
Synthroid is the only option.”
When asked if she believes the gender of her doctor is important, Emily indicated
a desire for a doctor who is empathic and willing to work with her collaboratively: “I
would probably feel comfortable with either [male or female] if they seem sympathetic to
my concerns and serious about continually working on a plan to get my body back to
normal.” She added, “Sometimes I think men doctors don’t take some female symptoms
seriously, but then I’ve had women doctors that also didn’t seem to be sympathetic to a
formally [sic] skinny patient who quickly put on 20 pounds.”
Participant 8: Jenna
Jenna has been receiving treatment for thyroid disease for approximately one year
after having a total thyroidectomy due to thyroid cancer. She currently takes
levothyroxine. Jenna described her relationship with her doctor as “tolerable,” explaining
that she is “limited in options” because she goes to a free clinic. Jenna expressed
frustration that her doctor seems to be less knowledgeable than she is about thyroid
disease: “I think he could be a little more up to date...[he tests my] free T3 and free T4
because I asked him to…[but] I don’t feel he listens to MY side too well. He thinks I
know too much, I think.”
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In addition to not feeling heard or taken seriously, Jenna explained that she often
feels dismissed by her doctor and that he ignores her symptoms: “…he doesn’t listen…I
try [to describe my symptoms] but I feel he blows me off a lot… his MAIN concern is
my TSH getting below .5.” She continued, “When I tried to explain to him my hair was
falling out and I was tired ALL the time he just blew it off as not being related.”
Jenna expressed a desire for her doctor to listen instead of being “pushy” and
commented that she would be more comfortable sharing with her doctor if he would
“…not think it’s all in my head.” When asked if the gender of her doctor might have an
impact on their relationship, she commented that she believes a woman might be more
compassionate and understanding. However, since Jenna receives treatment at a free
clinic, she does not have the option of seeking out another doctor.
Participant 9: Jessica
Jessica has been receiving treatment for thyroid disease for approximately one
year. Although she was diagnosed with Hashimoto’s disease eight years ago, she decided
to wait as long as possible before starting to take medication, stating, “I knew it would be
hell to start hormone therapy and hung in without it as long as I could. So far, I was
right.” Jessica described her treatment experience as “very frustrating” and commented
that she had seen three Endocrinologists in five months. Jessica explained that her most
recent Endocrinologist “…is really trying to work with me, but the other two got
frustrated and abusive with me because I was not tolerating the [synthetic] thyroid meds
well.” Jessica described feeling scared because synthetic thyroid medication “…altered
my mental state, and made me feel worse.” She also felt invalidated because her
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Endocrinologists did not believe that her symptoms were side effects from the
medication.
When asked whether the gender of her doctor is important to her, Jessica
indicated a preference for female doctors. She stated, “I think a woman doctor can relate
better to her female patient having the same functioning system and emotional
background caused by hormones,” but continued, “[however], my first endo was a
woman…and she was brutal.” Jessica commented that she hopes her new Endocrinologist
will care about how she feels, take her seriously, and “…take more time to figure stuff
out and explain things.” Jessica concluded, “I am tiered [sic] of doctors thinking that we
are just anxious…and will not believe us. They want to put us on antidepressants instead
of helping us. This causes more anxiety and is very sad.”
Participant 10: Karen
Karen has been receiving treatment for thyroid disease for approximately 44 years
after having a total thyroidectomy. Karen described her treatment experience as “not
favorable,” explaining, “I was treated with Synthroid for 38 years [and] getting worse and
worse every year.” She continued, “I do honestly believe that only being treated with
Synthroid and only a TSH test being run each year it actually caused me to go through
early menopause at the age of 34.” Tired of struggling with symptoms of hypothyroidism,
Karen decided to conduct some research on the Internet and learned as much as she could
about thyroid disease. Karen stated,
When I was younger I did not argue with my doctor because I always thought
they knew best. But after years of mistreatment I finally took the bull by the
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horns…I went through 5 Endos before I found one who knew what she was
doing.
Karen expressed satisfaction with the collaborative-nature of her relationship with
her current Endocrinologist: “We discuss things clearly and she listens well and makes
adjustments based on my response.” Karen also reported appreciating that her
Endocrinologist allows her to take a natural thyroid medication. However, Karen is
struggling to find a natural medication that she can afford since, as she explained,
Armour thyroid is not FDA approved. When asked whether or not the gender of her
doctor is important to her, Karen responded, “It's not the sex of the doctor but the
compassion and caring of the doctor that makes one good.”
Participant 11: Kari
Kari has been receiving treatment for thyroid disease for approximately four
years. Karen explained that she had been struggling with symptoms of hypothyroidism
for a number of years, and since her mother was hypothyroid, she insisted that her doctor
test her each year for thyroid dysfunction. Kari expressed a belief that she was
hypothyroid long before she was diagnosed because she experienced “problems long
before I pushed for more tests” based on what she learned from conducting her own
research. Kari explained that, in her experience, it has been “difficult to find a Dr. who
knows anything about Thyroid problems,” and continued, “I am explaining more to her
then [sic] she to me [about thyroid disease].” However, Kari stated that her doctor is “the
best I can get in the area I live” because the closest Endocrinologist is 150 miles from her
home.
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Despite Kari’s frustration with her treatment experience, she expressed an
appreciation that her doctor listens and takes her seriously: “My Dr. is easy to talk to […]
she takes time and the main thing [is] she does listen.” When asked whether or not the
gender of her doctor is important to her, Kari expressed a preference for female doctors,
stating, “I like woman Dr.'s better. Men are too arrogant about their education.”
Participant 12: Kim
Kim has been receiving treatment for thyroid disease for approximately 66 years.
As a young girl, Kim complained to her doctor about a lump in her throat and a “choking
sensation.” However, Kim explained, “That doctor found nothing wrong. I think he felt it
was my imagination.” By the time she was 16, Kim had been experiencing irregular
periods for five years, so her mother took her to a “well-reputed clinic.” Kim recalled her
experience:
The doctor I saw there put me on Armour Thyroid and my periods straightened
out and become regular from the very first month. The only test available back
then was the basal metabolism…but there was no way I could get to the testing
facility without an hour’s bus and streetcar rides…So he began treatment without
my having been tested.
For years, Kim was treated with Armour thyroid based on her symptoms. Kim
explained that she “started on it [Armour thyroid] so young that no one has questioned
whether I need it.” However, when Synthroid became the standard of treatment for
thyroid disease, Kim’s doctor required that she discontinue the Armour thyroid and start
to take Synthroid instead. Kim stated,
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[I had] no problems until I changed to Synthroid. When I found it didn’t work as
well and I wanted to change back to Armour I could not find a doctor who would
permit the change. They all said Armour was outmoded and Synthroid was better.
Kim decided to search for a doctor who would listen to her and consider her
symptoms. She eventually found a doctor who prescribed Cytomel in addition to
Synthroid. Kim explained that she took this combination of medication for one year and
she “felt like a new person by the 3rd day!” However, when she was tested at the end of
that year, her “TSH (the only thyroid test that doctor used) was [considered to be too
low], and he wanted me to discontinue Synthroid.” The doctor compromised with Kim
and allowed her to reduce, rather than completely stop, the Synthroid.
Disappointed with her treatment, Kim conducted research to better understand the
roles of T3 and T4 and their equivalencies from brand to brand of thyroid medication.
She also found a doctor who was willing to prescribe her Armour thyroid. Kim brought
her research to the doctor and he agreed that her “calculations were correct.” Kim was
pleased with this doctor, explaining, “This doctor was the first one ever to test my frees
[free T3 and free T4] and also the first and only to test me for Hashi’s antibodies.”
Unfortunately, since this doctor passed away, Kim had to search for another doctor to
treat her thyroid disease. In the meantime, Kim explained,
My other doctor, whom I’d kept as my primary for everything but thyroid, kept
ordering TSH and I simply refused the test when I got to the lab. I just told him I
was seeing another doctor for my thyroid treatment…We sometimes have to
resort to trickery!
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Kim expressed a desire for a doctor who is knowledgeable of thyroid disease and
treatment, and who she could trust, share with, and feel heard and validated. She
explained, “I know enough about thyroid function and my thyroid problem and what
works best for me that I am in a position to explain to the doctor what I need, not the
other way around!” Kim further explained, “A doctor’s accepting attitude and
understanding, empathetic approach helps a lot.”
Kim recently found a new doctor who is willing to prescribe natural thyroid
medication. She described the doctor as “very personable [and] seems more well
informed than many.” However, Kim is “in wait-and-see mode since I’ve had to switch to
a new natural desiccated product.” When asked whether or not the gender of her doctor is
important to her, Kim responded,
I think I may be a little more comfortable with a man. I’m more likely to argue
with a female doctor if I think her approach is wrong. If I feel a male doctor’s
approach to thyroid care is wrong for me, I simply don’t go back to him and begin
looking for another doctor.
Participant 13: Leanne
Leanne has been receiving treatment for thyroid disease for approximately eight
years after experiencing a two-year delay in treatment. Leanne explained that she was
under a significant amount of stress in 2004 and lost 25 pounds in a month. She also
developed a tremor and was sweating an unusual amount. Out of concern, her doctor
ordered tests. According to her doctor, Leanne was hyperthyroid and needed to have a
procedure called “radioactive iodine” (RAI) in order to kill her thyroid. After conducting
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research about RAI and learning that there were some serious potential side effects,
Leanne refused the treatment. Leanne reported, “My doctor was not happy with me…told
me I was being unreasonable, walked out of the room, and slammed the door behind
him.” Leanne’s doctor referred her to an Endocrinologist.
Leanne had blood drawn for this Endocrinologist and visited her one time. Leanne
reported, “She wondered why I didn’t get RAI and when I told her I refused it, she said
there was nothing she could do to help me. I felt really confused and dismissed.” When
Leanne told the Endocrinologist that she was experiencing anxiety, sadness, fatigue, and
trouble concentrating, the Endocrinologist told her that the way she felt had “nothing to
do with [her] thyroid [because her] blood work was normal” and told Leanne to “go see a
counselor.” Leanne decided to make an appointment with another Endocrinologist.
Leanne reported that the second Endocrinologist was “nice and seemed more
empathic” than the previous Endocrinologist. Leanne commented, “He listened to what I
had to share and told me that the way I felt was probably related to my thyroid problem.”
The Endocrinologist also explained to Leanne that she had Hashimoto’s disease.
However, the Endocrinologist told her that, based on the results of her blood work, there
was nothing he could do to help her feel better at the time. Leanne felt disappointed and
frustrated and decided to conduct research about Hashimoto’s disease. She also asked her
first Endocrinologist for a copy of her lab work.
Leanne reported learning that her first Endocrinologist had circled the
Hashimoto’s antibodies result on her lab work. Leanne commented, “This is the same
Endo who told me the way I felt had nothing to do with my thyroid. If this was true, why
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did she circle something on my blood work as if it was significant?” Losing trust in
Endocrinologists, Leanne decided to visit a Holistic M.D. Leanne expressed appreciation
for this doctor because he listened to her, validated her thoughts and feelings, and
demonstrated empathy. The doctor prescribed her Armour thyroid and a corticosteroid for
adrenal fatigue. Within a week, Leanne started to feel better and she gained weight.
However, over time, Leanne gained too much weight and became concerned that the
doctor rarely ordered blood work. She shared, “The previous Endos I had relied too much
on the blood work and did not consider my symptoms, but this doc seemed to want to
base his decisions on my symptoms alone.” She expressed feeling confused because she
felt good on some days and terrible on other days. After four years of feeling exhausted
much of the time and having difficulty losing weight, Leanne decided to seek the advice
of an Endocrinologist again.
Leanne visited the new Endocrinologist one time, reporting disappointment in the
Endocrinologist’s demeanor. Leanne stated, “She advised me to ‘exercise more’ and ‘eat
better’ even though I explained I had been exercising and despite the fact that I felt tired
and my stamina was poor.” The Endocrinologist also informed Leanne that she
developed Osteopenia as a result of the corticosteroid she had been taking. Leanne
explained that the Endocrinologist told her that she needed to wean off the corticosteroid
“…under a doc’s care or I could die if I did it wrong.” Leanne reported hoping that the
Endocrinologist would work with her, but would only prescribe Synthroid. Since Leanne
had read online that many women did not feel better on Synthroid, Leanne preferred to
stay on natural thyroid medication. Leanne shared,
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…she told me she would not work with me unless I took Synthroid. I felt
devastated. I did not want to wean off the corticosteroid AND Armour,
particularly when I thought the Armour was helping me. I asked her if she’d
consider working with me and let me stay on the Armour. She said “absolutely
not” but did not explain why. I didn’t even ask because I felt “shut down” and
stupid. I paid my co-pay and left…once again feeling like I had no doctor to trust,
listen, and help me.
Leanne decided to return to the Holistic M.D. because “…he at least didn’t mind
me taking the Armour. He also didn’t make me feel like everything I was experiencing
was in my head.” She secretly weaned off the corticosteroid over a period of one year
because the doctor insisted she continue to take the medication.
During this time, Leanne continued to search for another doctor and found an
Endocrinologist who was willing to prescribe Armour thyroid. Leanne stated, “I called
his office and asked [if he prescribed Armour].” Leanne continued, “He was great. He
listened to me and I could tell he cared. He was attentive, listened to my thoughts [and]
considered what I had to say.” According to Leanne, she did not feel as well as she would
like to, but she grew to trust him and appreciated the Endocrinologist’s collaborative
approach. She stated, “I at least felt like I could tell him anything and not hide
information from him.” Unfortunately, the Endocrinologist retired at the age of 70.
Leanne shared, “Once again, I felt hopeless, as I had to start over trying to find someone I
could trust and count on.”
Once again, Leanne returned to the Holistic M.D. Leanne explained,
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At this point, having had the disease for 8 years and learning a lot about it
(through reading and experience), I believed I could treat myself and just use this
doc for the Armour script. This went on for about a year. I adjusted my dose on
my own and simply reported to the doc. He never questioned my reasons for
changing my dose…up and down, depending on how I felt. At first, I felt like I
had control over my health. However, tired of the ups and downs, general fatigue,
and not having blood work to base my decisions on at all, I decided I should
search again for a doc who would look at both blood work AND symptoms. In
many ways, I feel like I know more about thyroid disease than most docs.
Leanne reported that she is currently seeing an Endocrinologist who does not
prescribe Armour thyroid, but who seems knowledgeable and demonstrates empathy.
Since she had never actually tried synthetic thyroid medication like Synthroid, Leanne
decided to give a new medication called Tirosint a chance. Leanne explained, “He knew I
preferred natural treatments, so asked me if I’d compromise and try this new med. I said
yes. I liked it that he considered how I felt.” She added, “He is attentive and seems like
he really cares about how I feel and what I think…It makes me willing to try whatever he
recommends, even if I’m scared about it.” However, Leanne also explained that she has
not been fully up-front with her Endocrinologist about how fatigued she is feeling: “In
the past, with other doctors, it seemed like when I complained, they thought I was overreacting and taking up their valuable time. So, part of me is hesitant to complain too
much.”
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According to Leanne, within a period of three months, the Tirosint caused her to
feel disoriented and gave her headaches. After trying different doses of Tirosint, Leanne
asked the Endocrinologist if she could go back to a natural thyroid medication because
she “felt better on it than on the synthetic.” Leanne expressed extreme disappointment in
the Endocrinologist’s response: “He told me no…that I had already tried natural. He
seemed to care that I wasn’t feeling well, but refused to let me go back to something
natural even though I felt better on it.” Leanne explained that, as a result, she has secretly
stopped taking the Tirosint and started to take a low dose of the Armour thyroid she has
left over from the Holistic M.D. she used to visit.
Recently, Leanne conducted more research and made an appointment with a
Doctor of Osteopathy (D.O.) who is highly recommended by other women with thyroid
disease. However, the D.O. does not have any appointments available for six months
from now. Leanne reported feeling nervous about admitting to her current
Endocrinologist what she has done and is unsure of whether or not she’ll keep her
appointment with him. When asked if she believes the gender of her doctor is important,
Leanne replied,
I used to think it mattered. When I first started to advocate for my own health and
tried to find a doc who would listen to me, I assumed that I was being treated
poorly because I’m a woman…so it must all be in my head. However, the two
most dismissive doctors I’ve had were women… What matters is that they listen,
seem to care, and take me seriously.
Participant 14: Michelle
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Michelle has been receiving treatment for thyroid disease for approximately nine
years. Michelle is hypothyroid due to Hashimoto’s disease. She explained, “When I was
finally diagnosed in 2005 after many years of begging [doctors] to be diagnosed
(numbers were “normal”), I found a female PCP to diagnose me.” Michelle was very
pleased with the collaborative nature of her relationship with this doctor, explaining, “She
was a teaching Dr. and taught me how to read the numbers on all the appropriate tests--not just TSH, but also FT3 & FT4.” However, shortly after meeting her, Michelle’s
doctor moved away due to a teaching position.
Michelle described the next three years as being difficult. More specifically, the
doctors who Michelle saw after her doctor moved tested only her TSH level to determine
her treatment plan. In addition, when she told the doctors that Synthroid was making her
“feel bad,” she was told, “that’s all we can prescribe!!” Michelle eventually decided to
discontinue Synthroid on her own and to search for a doctor who would listen to her.
Michelle explained,
I felt better not taking anything compared to taking Synthroid. It took me another
2 years before I found an Internal Medicine Dr. who would prescribe me
something other than Synthroid and would test not only TSH, but also FT3 &
FT4.
Michelle commented that she feels very comfortable with her current doctor
because “he has made clear that he is a good listener and has my best interest at heart.”
Michelle expressed that she appreciates that her doctor listens to her, takes her seriously,
and works with her collaboratively:
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He is very caring and listens to my needs in spite of what numbers will show at
times. He has learned that my body reacts differently than others termed “normal”
and is very interested in working with me to “optimize” my thyroid hormone
needs.
Due to Michelle’s negative experience with Synthroid (fatigue and weight gain),
Michelle’s doctor recently switched her to Tirosint because it is free of starch, gluten,
dyes, and sugar. Michelle explained, “The switch has helped a little, however, we are still
experimenting with Tirosint (which is new) to see how my body reacts.” When asked
whether or not the gender of her doctor is important, Michelle responded, “No----have
been treated by both [male and female doctors]. Dr./Patient relationship is most
important.” Michelle added, “I think he is so respectful of his patients that it [also] does
not matter if [the patient is] male or female.”
Participant 15: Sarah
Sarah has been receiving treatment for thyroid disease for approximately eight
years. Although blood tests indicated Hashimoto’s disease in 1989, Sarah’s doctor at the
time did not believe treatment was warranted. Sarah explained,
[My doctor] totally ignored my symptoms, any thyroid numbers but TSH, and this
resulted in [many] diagnoses…and [I was] heavily medicated for each of them, on
as many as twelve different prescriptions in any given day.
After struggling with hypothyroid symptoms for 17 years and developing
hypertension, osteoporosis, depression, asthma, a vitamin D deficiency, sleep apnea, and
high cholesterol, Sarah’s doctor prescribed her a low dose of Synthroid to “reduce her
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cholesterol [level].” After taking the same low dose of Synthroid for five years and not
feeling any better, Sarah decided to leave her doctor, conduct research, and treat herself.
She explained,
After knowing I would die if I continued this way, I started taking charge of my
own health, lost over 60 pounds with better nutrition and added supplements, and
gradually tapered off most unnecessary prescriptions over a two-year
period…started self-treating with Thyroid replacement ordered online, treating
adrenals, plus additional vitamins and supplements gradually added.
Sarah further explained, “I'm healthy and feeling good for first time in over 30
years and thrilled to be off all the over prescribed medications and no longer living in a
drug induced fog.”
Sarah currently sees a PCP for general health concerns, but continues to self-treat
for her thyroid disease. Sarah expressed feeling scared to discuss her thyroid disease with
her PCP because her previous doctor did not listen to her or take her seriously. Rather,
she “…poo-pawed anything I would bring up and [questioned] whether it was thyroid
related…instead of some new disease she wanted to prescribe more medication for.”
When asked whether or not she believed the gender of her doctor influenced her
relationship, Sarah responded, “I think sometimes a Doctor can take advantage of us
because they look at us as the 'weaker' sex,” but added, “…it really depends on the
individual.” Sarah concluded, “My distrust is at such a high level after being
misdiagnosed for over half of my life that it will be hard to share in the future.”
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Participant 16: Shawna
Shawna began to experience symptoms of thyroid disease in 2006, but could not
start treatment because, according to her Nurse Practitioner and Gynecologist, the blood
tests indicated that her thyroid was “okay.” Shawna went through five doctors before
finding one that she considered competent. After experiencing bouts of severe fatigue and
hair loss, significant weight gain, and cold intolerance for six years, Shawna began to
self-treat. Shawna explained,
I thought since the doctors kept saying my thyroid was okay, maybe I just needed
something natural as a boost, not really having a lot of information. I also was
clicking on ads on the internet and read some doctor that insisted we are all iodine
deficient and promoting his pills. I ordered them and took them 1 month in
January 2013.
After taking the iodine pills for 21 days and not feeling any better, Shawna
decided to visit a Naturopath. Based on the blood work ordered by the Naturopath,
Shawna’s thyroid peroxidase antibody levels were high, which the Naturopath attributed
to the iodine pills. As such, Shawna stopped taking the iodine pills. However, the
Naturopath also told Shawna that Hashimoto’s disease was a “possibility.” Following the
Naturopath’s instructions, Shawna began to take a low dose of levothyroxine and natural
supplements for her adrenal glands. Shawna started to feel better, but lost only three
pounds in three months. Therefore, the Naturopath switched Shawna from levothyroxine
to compounded T3/T4. Shawna lost ten more pounds in four months.
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Although Shawna was feeling better, she suspected that the Naturopath was
“…basically there to promote sales at the pharmacy” and did not feel confident in the
Naturopath’s understanding of thyroid disease. As such, Shawna decided to ask a Primary
Care Physician for his opinion:
I had taken my labs to the primary doc’s office when I went in for a tick bite, and
asked him to get back with me about what he thought and whether I could switch
from the compounded to something [that would] be covered by insurance, but he
never got back to me. I work at a hospital and lots of people think he has gotten
less caring over the years.
At the same time, the Naturopath cancelled Shawna’s next appointment because
“she was too busy as a school nurse.” So, Shawna decided to see an Endocrinologist.
However, as with previous doctors, Shawna was disappointed with the Endocrinologist.
Shawna reported that the Endocrinologist was disrespectful to her:
I start to explain [my] history…but he interrupts me at the point I say the
Naturopath put me on levo and launches into a tirade about how I don’t have a
thyroid problem and should never have been put on meds and they will cause
palpitations…hair loss and high BP etc…ignoring I have been on them 9 months
with none of those problems except the high BP […] and that was high before I
started the levo.
In addition, Shawna was disappointed with the Endocrinologist’s understanding
of thyroid disease:
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He wants me to stop [the compounded thyroid medicine] cold turkey. He says the
Hashi’s antibodies “just mean that someday your thyroid might completely stop
working. We don’t treat you unless you get a goiter. We don’t treat people as they
age unless their TSH is 10 or even 20.”
Due to her negative experience with the Endocrinologist, Shawna reluctantly
decided to return to the Naturopath. She explained that she had a plan to “…see her one
more time and get more meds then figure out who to go to next.” During her visit, the
Naturopath recommended melatonin and theanine to Shawna to help her sleep. However,
upon conducting research on these supplements, Shawna discovered that theanine can
interfere with her blood pressure medication.
Having difficulty finding a doctor she felt like she could trust, Shawna asked for
advice from coworkers at the hospital for which she works. Based upon
recommendations, Shawna started to see a Doctor of Osteopathy (D.O.). She was pleased
that the D.O. recognized and treated her low vitamin D and ferritin levels. In addition,
Shawna expressed appreciation that the D.O. “…takes a lot of time” during their visits.
Although Shawna was not pleased that the D.O. switched her from the
compounded thyroid medication to levothyroxine, she reported that her lab work for her
thyroid has been “… the best to-date.” She continued,
I don’t like that he is not open to natural thyroid and isn’t testing my T3 and
antibodies, but his focus on the iron and d3 seems to be right…[and] if I can do
fine on the levo I don’t have a problem with that.
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Shawna added, “But I feel that if I hadn’t been aggressive in all my research I
would have just been kept being told that my [levels were] ‘normal’ when they were
clearly not.” When asked whether or not the gender of her doctor is important to her,
Shawna replied, “No. I just care about their competence.”
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Appendix H: Themes and Subthemes
Themes

Subthemes

Participant Pseudonyms

Doctor-Patient Relationship
Traditional Relationships
Feeling Unheard

April, Carla, Diane,
Jenna, Jessica,
Leanne, Sarah,
Shawna

Feeling Invalidated

Anne, April, Carla,
Diane, Jenna, Jessica,
Kim, Leanne, Sarah,
Shawna

Feeling Dismissed

Anne, April, Carla,
Diane, Jenna, Leanne,
Sarah, Shawna

Experienced a Lack
of Empathy

Feeling Disrespected

Emily, Jessica,
Leanne, Shawna
Carla, Leanne,
Shawna

Collaborative Relationships
Feeling Heard

Alicia, April,
Autumn, Diane,
Emily, Karen, Kari,
Kim, Leanne,
Michelle

Feeling Validated

Alicia, April, Diane,
Emily, Karen, Kim,
Leanne, Michelle
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Feeling Unrushed

Emily, Kari, Leanne,
Shawna

Shared Decision making

Alicia, April, Carla,
Diane, Emily, Jenna,
Karen, Kari, Kim,
Leanne, Michelle,
Shawna

Patient Self-Advocacy
Health Information-Seeking

Alicia, Anne, April,
Carla, Diane, Emily,
Jenna, Karen, Kari,
Kim, Leanne, Shawna

Switching Doctors

Anne, April, Diane,
Jessica, Karen, Kim,
Leanne, Michelle,
Shawna

Belief that “Doctor Knows Best”

Karen, Kim

Doctor-Patient Communication
Desire to be Informed

Anne, April, Emily,
Kim, Leanne,
Michelle

Role of Trust
Lack of Trust in Doctor

Carla, Leanne, Sarah,
Shawna

Treatment Refusal

Anne, April, Jenna,
Leanne, Michelle,
Sarah
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Secret-Keeping

Kim, Leanne, Sarah

Self-Treatment

Anne, Carla, Jenna,
Leanne, Michelle,
Sarah, Shawna

Role of Gender
No Preference for Specific
Doctor Gender

Alicia, Anne, April,
Autumn, Diane,
Emily, Jessica, Karen,
Kim, Leanne,
Michelle, Sarah,
Shawna

Preference for Female Doctor

Carla, Jenna, Kari

Being Taken Seriously

Alicia, Anne, April,
Carla, Diane, Emily,
Jenna, Leanne, Sarah

Presence of Emotion

Alicia, Anne, Leanne

Culture of the Medical Profession
Diagnostic Bias
Symptoms Considered
Psychosomatic

Symptoms Attributed
to Lifestyle

Alicia, Anne, Diane,
Jenna, Jessica, Kim,
Leanne

Carla, Jenna, Leanne
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Medical Knowledge
TSH Testing is Standard

Synthetic Medication is
Standard

Continuing Education
May Be Needed

Anne, Carla, Diane,
Jenna, Karen, Kim,
Michelle, Sarah,
Shawna

Anne, Carla, Emily,
Karen, Jessica, Kim,
Leanne, Michelle,
Sarah, Shawna

Anne, April, Autumn,
Carla, Diane, Emily,
Jenna, Jessica, Karen,
Kari, Kim, Leanne,
Michelle, Sarah,
Shawna

Economics
Feeling Rushed

Autumn, Jessica,
Leanne

Access to Doctor

Autumn, Carla, Jenna,
Kari, Kim, Leanne,
Michelle, Shawna

Access to Medication

Anne, April, Carla,
Karen, Kim, Shawna

Additional Findings
Public is Misinformed
Experience of Grief
Experience of Empathy
Experience of Respect

Diane
Carla
Michelle
Michelle

